data_2mb0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mb0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -98.37 128.25 44.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.146 0.973 . . . . 0.0 108.438 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.29 155.62 23.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -109.48 128.92 55.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' B' ' 28' ' ' PHE . 7.7 mm -120.14 79.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 144.81 17.41 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.416 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 9.46 42.0 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.576 0.688 . . . . 0.0 111.534 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.83 164.0 15.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.745 0.783 . . . . 0.0 111.612 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.47 HD21 ' CB ' ' B' ' 75' ' ' ASP . 43.8 t-20 -74.47 159.37 32.35 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.42 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 42.2 p -74.78 -11.23 60.11 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.084 -0.385 . . . . 0.0 110.279 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.97 -9.36 28.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.107 0.963 . . . . 0.0 110.937 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -76.8 144.83 38.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.84 0.456 . . . . 0.0 109.924 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 -169.1 2.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -69.8 -34.84 74.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.72 -174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -66.83 -29.19 69.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 111.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.85 31.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.39 -28.24 22.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 109.774 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.62 -29.39 36.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.615 0.721 . . . . 0.0 110.111 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.69 -22.76 40.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.307 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.453 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.5 p -102.29 -35.16 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.453 ' CD2' HG11 ' B' ' 27' ' ' VAL . 90.3 m-85 -92.09 -10.69 38.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.182 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.57 -2.92 77.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.55 -12.8 58.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.972 1.309 . . . . 0.0 111.116 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.33 -19.04 12.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.686 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.72 165.42 36.15 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.159 0.436 . . . . 0.0 112.37 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -73.54 116.95 14.72 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.9 mt -75.9 141.65 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.636 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -22.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.131 0.573 . . . . 0.0 110.022 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.22 149.16 15.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.933 0.493 . . . . 0.0 109.83 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.36 144.99 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.306 0.574 . . . . 0.0 109.644 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.8 mt -121.12 154.59 35.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.307 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.14 117.93 6.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.442 ' HA ' ' HE2' ' B' ' 40' ' ' MET . 7.4 mmm -88.08 142.06 28.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.75 1.42 85.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.149 0.88 . . . . 0.0 112.287 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.78 161.42 38.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.307 1.053 . . . . 0.0 110.13 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.99 -177.3 6.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.7 m-85 -142.24 160.35 40.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -154.06 140.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -113.11 122.86 48.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.151 0.282 . . . . 0.0 110.357 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -92.39 156.01 17.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.96 0.904 . . . . 0.0 111.93 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -74.22 -21.99 59.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.57 0.348 . . . . 0.0 111.135 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -121.88 141.49 34.13 Favored Pre-proline 0 C--N 1.34 0.164 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.45 -9.72 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.682 2.254 . . . . 0.0 110.3 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.19 -14.48 13.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.285 0.493 . . . . 0.0 110.572 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.446 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.5 m-20 -71.95 -28.5 63.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.18 56.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -68.46 -38.35 81.02 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.93 -32.41 72.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.71 -44.03 44.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.78 42.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 122.075 -0.39 . . . . 0.0 111.253 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -105.87 5.32 30.56 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 112.349 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.74 -52.29 1.24 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.498 0.666 . . . . 0.0 109.49 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.6 mmm -83.55 -9.46 58.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.397 1.479 . . . . 0.0 111.987 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.8 124.8 27.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.85 -4.92 85.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.23 -152.97 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.569 1.148 . . . . 0.0 109.459 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -140.61 158.86 43.36 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.757 0.789 . . . . 0.0 112.915 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 128.78 31.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.835 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.47 ' CB ' HD21 ' B' ' 16' ' ' ASN . 3.3 t0 52.57 22.53 2.22 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.145 0.497 . . . . 0.0 112.214 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.92 -3.33 57.16 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 119.32 -0.711 . . . . 0.0 113.853 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -114.99 130.13 56.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.216 1.008 . . . . 0.0 110.304 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 139.47 52.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.749 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 18.9 pt -124.89 174.82 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -119.01 144.36 46.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.184 1.794 . . . . 0.0 107.799 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.32 127.26 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -62.27 138.37 58.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.05 35.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 N--CA 1.454 -0.25 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.125 171.694 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.97 126.79 39.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 68.6 mt -113.56 153.27 29.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.062 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -106.7 127.59 53.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.428 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -119.62 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.93 142.16 15.93 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.51 35.93 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.691 0.745 . . . . 0.0 111.805 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.39 164.36 16.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.155 0.502 . . . . 0.0 111.858 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t-20 -77.79 158.31 29.6 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.144 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 57.9 p -73.21 -6.97 49.34 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.401 0.68 . . . . 0.0 110.114 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.52 -10.19 21.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.654 1.181 . . . . 0.0 110.531 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 31.0 m -83.22 144.68 29.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.325 0.65 . . . . 0.0 109.822 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.89 -170.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -66.99 -34.92 78.81 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.093 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -67.6 -29.03 68.27 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 118.016 0.371 . . . . 0.0 111.099 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.27 29.42 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.44 -27.89 22.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 109.555 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.45 -28.23 34.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 109.899 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.65 -21.78 37.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.42 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' B' ' 28' ' ' PHE . 6.5 p -103.41 -36.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.441 ' CD2' HG12 ' B' ' 27' ' ' VAL . 89.9 m-85 -90.63 -11.36 40.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.817 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.9 -3.04 73.05 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.62 -11.87 58.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.682 1.193 . . . . 0.0 110.855 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -111.82 -19.5 12.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.83 166.61 37.49 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 118.046 0.384 . . . . 0.0 112.406 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 43.5 ttt-85 -73.74 117.52 15.62 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.09 142.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.56 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -22.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 123.212 0.605 . . . . 0.0 110.137 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -161.73 150.21 15.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.05 0.54 . . . . 0.0 109.878 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.58 146.4 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.056 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -121.3 154.63 36.13 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.378 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.413 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -152.68 118.36 5.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.6 mmm -91.38 139.85 30.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.851 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.413 ' HE2' HD13 ' B' ' 39' ' ' LEU . 8.9 mttt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.477 0.656 . . . . 0.0 112.472 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.58 89.45 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.401 -0.666 . . . . 0.0 111.559 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -138.49 157.46 46.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.559 1.18 . . . . 0.0 109.952 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.93 -179.1 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.455 0.302 . . . . 0.0 110.853 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 49.9 m-85 -142.67 162.61 35.01 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.848 0.459 . . . . 0.0 110.215 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.87 141.53 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.6 m -113.3 123.54 50.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.336 0.397 . . . . 0.0 110.135 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.65 156.85 16.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.695 0.798 . . . . 0.0 111.627 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.19 -22.42 59.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.608 0.363 . . . . 0.0 111.275 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -121.23 140.04 30.51 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.395 0.543 . . . . 0.0 110.084 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -76.2 0.72 9.08 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.231 2.62 . . . . 0.0 110.583 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.46 -16.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.063 0.392 . . . . 0.0 111.356 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.438 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.9 m-20 -71.75 -28.57 63.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.49 57.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.66 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -74.5 -37.01 63.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.76 -24.61 64.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.488 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.24 14.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.38 45.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -109.06 9.36 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 112.224 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -52.25 1.33 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.54 -175.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mmm -83.12 -9.17 59.35 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.846 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -75.22 127.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.829 -0.544 . . . . 0.0 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.12 83.16 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.51 -154.17 0.11 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.518 1.127 . . . . 0.0 109.436 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.8 t -140.3 159.19 42.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.0 112.311 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.567 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -133.37 126.8 32.11 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.046 177.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.43 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.7 t70 61.53 -22.24 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.513 1.125 . . . . 0.0 113.821 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.87 -6.28 0.53 Allowed Glycine 0 N--CA 1.439 -1.123 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.19 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -118.46 134.38 55.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.959 0.879 . . . . 0.0 110.341 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.55 138.42 48.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.471 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.08 175.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -119.89 142.46 48.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.13 1.772 . . . . 0.0 107.397 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.56 125.41 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -162.05 164.42 28.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -57.79 134.8 56.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.9 158.8 32.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.271 0.558 . . . . 0.0 112.359 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.491 172.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -101.13 129.9 47.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.018 0.909 . . . . 0.0 108.891 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.401 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.4 mt -113.35 153.61 28.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -107.73 129.23 55.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.442 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -121.0 82.37 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.07 144.44 17.28 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.758 -0.589 . . . . 0.0 112.001 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.71 9.21 43.96 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 117.524 0.662 . . . . 0.0 111.597 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.91 162.86 12.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.579 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.437 HD21 ' HB3' ' B' ' 75' ' ' ASP . 43.6 t-20 -73.51 159.95 32.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.598 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.9 p -74.53 -4.56 37.64 Favored 'General case' 0 N--CA 1.457 -0.075 0 C-N-CA 122.902 0.481 . . . . 0.0 110.366 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.25 -7.68 18.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 110.81 -172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.7 m -80.54 144.19 32.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.922 0.489 . . . . 0.0 109.937 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.63 -169.66 2.45 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -68.85 -35.36 76.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.778 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -65.68 -29.71 70.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.916 -0.49 . . . . 0.0 110.97 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.89 -20.99 28.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -89.34 -27.97 20.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.802 1.241 . . . . 0.0 109.606 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.35 -27.82 31.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 109.907 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -23.26 38.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.309 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.1 p -101.06 -35.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.442 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 87.8 m-85 -92.1 -10.87 37.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.283 -0.261 . . . . 0.0 111.024 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.67 -2.62 76.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.72 -11.25 59.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.431 1.092 . . . . 0.0 111.159 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.93 -18.85 11.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.39 0.676 . . . . 0.0 112.634 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -174.83 161.19 30.64 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -72.6 124.22 24.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.89 143.49 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.286 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.07 -23.56 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.351 0.66 . . . . 0.0 110.076 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.02 150.47 16.94 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.99 146.58 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 121.28 0.562 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -121.32 153.67 37.43 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.245 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.38 118.83 6.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.7 mmm -92.31 137.59 32.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.932 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 pttt . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.331 0.586 . . . . 0.0 111.293 177.176 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 . . . . . 0 C--O 1.23 0.04 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.46 0.5 79.41 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.698 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -136.92 158.42 44.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.434 1.117 . . . . 0.0 110.376 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.02 -179.5 8.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.868 0.467 . . . . 0.0 110.728 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.8 m-85 -141.85 161.98 36.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.659 0.383 . . . . 0.0 110.231 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.81 141.13 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.3 m -113.52 122.12 46.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.349 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -92.82 156.95 16.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.938 0.895 . . . . 0.0 110.768 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -79.63 -20.97 45.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.451 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -118.16 138.85 25.96 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.46 -6.6 18.55 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.635 2.224 . . . . 0.0 110.431 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.26 -14.77 12.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.201 0.455 . . . . 0.0 111.135 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.434 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.7 m-20 -71.53 -28.46 63.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 -30.52 52.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.394 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.01 -39.14 79.48 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.04 -32.17 72.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.72 45.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.39 -7.55 48.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.209 -0.307 . . . . 0.0 111.163 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -105.26 5.67 32.23 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.521 1.128 . . . . 0.0 112.344 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.16 -51.68 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.768 0.794 . . . . 0.0 109.755 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.9 mmm -83.59 -10.13 58.46 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.145 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.7 126.13 29.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.48 -5.74 84.54 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.59 -0.561 . . . . 0.0 111.841 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.54 -153.72 0.11 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.361 1.064 . . . . 0.0 109.473 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -139.84 158.75 43.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.564 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.9 126.99 31.58 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.496 177.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.5 t70 61.19 -21.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.18 -7.03 0.53 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.4 135.16 54.86 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.264 1.032 . . . . 0.0 110.218 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.31 138.89 51.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.597 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.9 pt -121.22 179.52 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -125.05 145.02 50.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.823 1.649 . . . . 0.0 107.787 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -133.12 129.49 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -158.1 163.31 37.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -65.24 137.06 57.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.22 155.57 38.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.454 -0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.228 173.145 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.244 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -86.13 129.05 34.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -116.69 155.53 28.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.362 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.58 129.67 55.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.428 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -121.72 80.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.7 144.63 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.267 -0.492 . . . . 0.0 111.977 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.48 7.52 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 117.497 0.649 . . . . 0.0 111.545 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 mt -64.24 164.75 10.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.163 0.585 . . . . 0.0 111.166 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.483 HD21 ' CB ' ' B' ' 75' ' ' ASP . 43.0 t-20 -72.1 158.94 35.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.46 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.8 p -75.79 -4.77 42.47 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.218 -0.301 . . . . 0.0 110.375 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.49 -7.38 17.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.127 0.971 . . . . 0.0 111.066 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.2 m -79.18 144.89 34.01 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.09 0.556 . . . . 0.0 109.576 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.93 2.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.171 0.51 . . . . 0.0 110.009 175.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.86 -34.37 76.56 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.756 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.41 -30.36 70.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.046 -0.409 . . . . 0.0 110.923 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.74 -21.41 30.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.84 -28.47 19.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 109.928 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.8 -27.92 33.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.237 0.542 . . . . 0.0 110.119 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.34 -22.95 38.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.241 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -100.96 -36.65 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.428 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 89.6 m-85 -91.03 -10.89 40.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.958 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.75 -3.2 72.58 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -82.12 -11.76 58.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.63 1.172 . . . . 0.0 111.034 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.43 -19.88 11.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.364 0.665 . . . . 0.0 112.538 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.71 165.36 36.06 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 118.051 0.387 . . . . 0.0 112.189 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -73.09 117.97 15.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.3 141.35 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.509 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.74 -24.49 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.871 0.468 . . . . 0.0 110.093 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -160.35 151.36 19.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.66 146.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 109.699 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -118.99 153.95 33.82 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.1 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -153.66 120.23 5.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.41 140.02 30.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.663 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 pttt . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.257 0.551 . . . . 0.0 112.304 176.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 . . . . . 0 CA--C 1.527 0.079 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.83 75.79 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.34 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -141.74 157.97 44.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.627 1.213 . . . . 0.0 110.619 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.688 0.395 . . . . 0.0 110.791 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.7 m-85 -141.93 162.44 35.46 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.004 0.522 . . . . 0.0 110.127 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.36 139.86 12.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -112.18 122.17 46.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -92.16 156.17 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.023 0.929 . . . . 0.0 111.642 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.56 -21.92 59.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 122.612 0.365 . . . . 0.0 111.061 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.7 t -121.23 140.48 31.26 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.45 -7.43 19.57 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.462 2.108 . . . . 0.0 110.472 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.13 -15.87 13.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.369 0.267 . . . . 0.0 110.902 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.443 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 75.0 m-20 -70.76 -28.35 64.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.14 54.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.553 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -68.83 -39.04 80.19 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.99 -36.34 81.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.6 64.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.5 47.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.199 -0.313 . . . . 0.0 111.185 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -105.41 7.59 33.26 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.465 1.106 . . . . 0.0 112.274 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.61 -52.27 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.826 0.739 . . . . 0.0 109.568 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.32 -9.88 59.3 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.595 1.558 . . . . 0.0 112.439 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.71 125.38 27.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.74 -5.79 84.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.54 -153.98 0.09 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.474 1.11 . . . . 0.0 109.712 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 26.2 t -139.49 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.865 0.841 . . . . 0.0 112.814 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.46 129.09 30.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.757 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.483 ' CB ' HD21 ' B' ' 16' ' ' ASN . 6.4 t0 52.89 22.24 2.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.058 0.456 . . . . 0.0 112.131 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.86 -2.46 58.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.978 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.92 130.19 56.86 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.251 1.026 . . . . 0.0 110.557 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.46 138.25 50.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.502 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.91 178.39 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -122.8 141.51 51.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.717 2.007 . . . . 0.0 107.317 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.15 130.22 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -159.12 164.15 35.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -69.57 132.44 46.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 148.1 33.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 CA--C 1.517 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.486 175.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.438 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -82.15 129.65 34.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.89 159.51 23.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.04 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -112.62 129.71 56.28 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.453 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.5 mm -122.08 81.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -174.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.38 145.5 17.78 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.197 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.76 33.24 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 117.57 0.685 . . . . 0.0 112.026 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.13 168.03 3.59 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 112.586 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' B' ' 18' ' ' GLU . 51.7 t30 -73.27 -6.41 45.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p 68.76 -13.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.652 1.581 . . . . 0.0 113.479 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' B' ' 16' ' ' ASN . 7.8 mm-40 -98.72 -7.25 28.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.42 0.688 . . . . 0.0 109.301 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -76.25 147.52 38.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.531 1.132 . . . . 0.0 109.521 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -170.14 2.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.586 0.707 . . . . 0.0 109.566 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.03 -35.79 80.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.542 -173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.83 -30.14 70.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.82 -20.39 23.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.08 -28.32 22.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.216 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -80.11 -26.94 39.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 110.058 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.57 38.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.478 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -103.89 -35.59 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.453 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.8 m-85 -92.33 -11.24 35.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.944 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.07 -2.84 73.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.77 -12.92 58.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.684 1.193 . . . . 0.0 111.073 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -111.34 -19.18 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 123.756 0.66 . . . . 0.0 112.547 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.33 165.88 35.49 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -73.29 117.09 14.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -76.1 139.08 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.246 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -24.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.944 0.497 . . . . 0.0 109.863 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -160.38 150.87 18.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.078 0.551 . . . . 0.0 109.562 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.4 145.57 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.34 0.591 . . . . 0.0 109.572 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -119.05 153.02 35.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.661 -1.154 . . . . 0.0 107.91 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.02 117.42 5.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.1 mmm -91.88 139.97 30.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.21 1.73 81.24 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.51 157.67 46.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.248 1.024 . . . . 0.0 110.775 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.53 -179.19 7.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.205 0.602 . . . . 0.0 110.62 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 42.6 m-85 -142.53 162.04 36.5 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.91 138.69 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -111.89 122.08 46.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.681 0.392 . . . . 0.0 109.975 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -92.07 156.08 17.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.822 0.849 . . . . 0.0 111.616 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.11 -22.51 60.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.857 0.463 . . . . 0.0 111.063 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.1 t -121.74 139.98 31.05 Favored Pre-proline 0 CA--C 1.52 -0.2 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.59 -3.0 13.19 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.897 2.398 . . . . 0.0 110.48 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.02 -14.84 11.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 123.141 0.276 . . . . 0.0 111.278 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.441 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 79.8 m-20 -71.57 -28.93 64.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.42 -30.79 57.56 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.507 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -68.87 -38.83 79.97 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.15 -32.6 72.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.92 -44.48 48.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 -7.38 45.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.315 -0.241 . . . . 0.0 111.41 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -105.59 5.28 31.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.129 0.972 . . . . 0.0 112.08 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.28 -53.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 29.7 mmm -82.2 -10.08 59.28 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.569 1.548 . . . . 0.0 112.205 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.98 126.37 30.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.609 -0.682 . . . . 0.0 109.381 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.11 81.22 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.43 -153.96 0.11 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.449 1.099 . . . . 0.0 109.319 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -137.53 158.68 43.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.529 0.681 . . . . 0.0 112.649 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.15 125.27 30.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' B' ' 16' ' ' ASN . 11.4 t0 57.16 -2.02 0.05 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 137.62 -11.41 3.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.762 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.35 137.2 54.41 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.315 1.058 . . . . 0.0 111.092 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 140.33 56.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.239 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.51 177.63 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -120.79 142.52 49.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.883 1.673 . . . . 0.0 107.386 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.37 127.19 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -158.88 163.58 36.47 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -65.76 134.61 53.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.14 139.25 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.171 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.437 0 CA-C-O 119.125 -0.82 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.25 127.07 38.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.088 0.944 . . . . 0.0 108.734 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.0 mt -113.39 149.23 34.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.19 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.33 127.88 49.14 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.438 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 10.0 mm -118.94 77.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -173.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.59 144.63 17.2 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.14 45.22 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 117.733 0.767 . . . . 0.0 111.752 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.52 163.88 12.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.152 0.581 . . . . 0.0 111.408 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.456 HD21 ' HB3' ' B' ' 75' ' ' ASP . 56.5 t30 -72.78 155.9 39.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.71 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 62.0 p -74.69 -0.95 19.72 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.367 0.267 . . . . 0.0 111.093 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -110.5 -5.79 15.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 110.668 -171.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -82.93 144.71 29.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.084 0.554 . . . . 0.0 109.571 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -169.74 2.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.19 -35.37 79.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.764 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.32 -29.15 68.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.041 -0.412 . . . . 0.0 111.061 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.51 -21.03 28.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.65 -28.43 20.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.91 1.284 . . . . 0.0 109.532 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.25 -28.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.632 0.73 . . . . 0.0 109.903 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.38 -23.11 40.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.162 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.42 HG12 ' CD2' ' B' ' 28' ' ' PHE . 5.4 p -101.92 -34.53 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 87.4 m-85 -91.48 -10.66 40.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.719 -0.218 . . . . 0.0 111.064 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.3 -2.44 79.17 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -82.21 -11.97 58.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.406 1.082 . . . . 0.0 111.002 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.74 -19.89 11.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.573 0.749 . . . . 0.0 112.739 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.84 166.59 37.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -74.03 116.83 15.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.94 141.13 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -22.71 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -160.85 150.06 16.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.01 0.524 . . . . 0.0 109.846 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.81 144.13 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.1 mt -120.17 158.44 26.93 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.105 175.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -155.91 123.17 5.43 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.426 ' HA ' ' HE1' ' B' ' 40' ' ' MET . 0.0 OUTLIER -93.99 137.3 33.35 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -174.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 pttt . . . . . 0 N--CA 1.451 -0.384 0 O-C-N 123.418 0.449 . . . . 0.0 110.89 173.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.566 0.222 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.15 3.7 78.85 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.436 -0.647 . . . . 0.0 112.127 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.22 157.7 45.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.357 1.079 . . . . 0.0 110.741 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.84 -178.41 7.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.893 0.477 . . . . 0.0 110.501 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.5 m-85 -142.34 163.18 33.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.568 0.347 . . . . 0.0 110.42 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -153.78 146.36 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -117.37 123.44 46.47 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.316 0.385 . . . . 0.0 110.201 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -93.55 156.15 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.33 0.652 . . . . 0.0 111.925 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.52 -22.67 58.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.2 t -121.33 141.11 32.52 Favored Pre-proline 0 C--O 1.233 0.202 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.29 -8.84 21.3 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.557 2.172 . . . . 0.0 110.08 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.02 -15.24 13.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.588 0.355 . . . . 0.0 110.732 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.2 m-20 -72.43 -29.02 63.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.07 -29.61 58.05 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.44 -38.13 77.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.24 -32.31 71.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 -46.32 40.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.12 47.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.083 -0.386 . . . . 0.0 111.49 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -102.64 7.38 39.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.468 1.107 . . . . 0.0 112.646 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.28 -51.31 0.94 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.491 1.138 . . . . 0.0 109.373 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' MET . . . . . 0.511 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 45.4 mmm -79.43 -16.45 56.14 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.669 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -73.96 119.02 17.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.94 74.86 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.359 -0.689 . . . . 0.0 112.652 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 7.9 ptpt -88.26 179.63 6.32 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 118.377 1.088 . . . . 0.0 111.316 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -107.94 146.66 32.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 -63.9 1.13 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.4 0.619 . . . . 0.0 110.573 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.456 ' HB3' HD21 ' B' ' 16' ' ' ASN . 14.6 t70 -124.45 5.49 8.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.548 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.99 -11.96 2.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.43 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -115.79 133.45 56.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.58 0.752 . . . . 0.0 109.598 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.78 136.95 41.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.793 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 pt -115.29 175.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -120.27 142.67 48.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.58 1.552 . . . . 0.0 107.625 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.21 127.02 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -160.55 162.81 33.04 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -61.12 132.44 53.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.03 27.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 CA--C 1.517 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.768 171.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.95 127.12 36.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -113.8 153.37 29.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -106.71 127.75 53.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.433 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 8.1 mm -119.05 77.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.63 144.86 17.41 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.67 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.43 10.19 42.12 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 117.589 0.694 . . . . 0.0 111.422 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.78 163.71 13.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.377 0.671 . . . . 0.0 111.96 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' B' ' 75' ' ' ASP . 43.9 t-20 -73.96 160.76 30.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.461 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.3 p -75.74 -3.87 37.28 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.706 0.402 . . . . 0.0 110.382 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.68 -7.42 18.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.358 1.063 . . . . 0.0 110.888 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -81.63 143.7 31.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.737 0.415 . . . . 0.0 110.235 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -170.25 2.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.73 -35.5 78.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.89 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.57 -28.96 68.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.275 -0.265 . . . . 0.0 111.141 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.4 -20.63 27.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.6 -29.17 20.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.969 1.308 . . . . 0.0 109.458 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.52 -29.6 37.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 0.0 109.944 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -23.3 41.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.118 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.7 p -101.37 -34.26 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 86.4 m-85 -93.55 -10.34 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.335 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -3.66 76.18 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -80.84 -13.26 59.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.697 1.199 . . . . 0.0 111.123 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -111.67 -19.04 12.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.75 163.69 32.21 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 117.897 0.317 . . . . 0.0 112.448 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -67.23 116.08 7.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.87 141.57 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.741 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -21.17 5.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.934 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.77 149.9 15.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.35 144.64 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.309 0.576 . . . . 0.0 109.663 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.465 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.4 mt -120.12 155.65 32.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.511 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -152.33 119.15 5.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.407 ' HA ' ' HE1' ' B' ' 40' ' ' MET . 6.9 mmm -92.8 139.19 30.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.763 -170.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 pttt . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.101 0.477 . . . . 0.0 111.644 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 . . . . . 0 N--CA 1.457 -0.111 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 2.01 82.94 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.313 0.959 . . . . 0.0 112.003 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -142.61 162.26 35.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.321 1.06 . . . . 0.0 110.308 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -177.85 6.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 52.6 m-85 -141.3 162.12 36.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.83 0.348 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.05 139.16 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -110.23 124.31 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.755 0.312 . . . . 0.0 110.287 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -93.53 156.09 16.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.919 0.888 . . . . 0.0 111.062 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.648 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -120.9 140.08 30.21 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.59 -2.54 12.57 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.746 2.297 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.76 -15.25 10.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.03 0.377 . . . . 0.0 111.299 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.7 m-20 -71.76 -28.43 63.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.4 58.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.172 0.589 . . . . 0.0 110.384 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.16 -37.64 75.27 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.61 -30.74 69.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.3 33.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.99 -7.81 48.87 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.95 -0.469 . . . . 0.0 111.266 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -104.3 4.94 34.2 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 112.462 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.01 -54.2 1.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.706 0.765 . . . . 0.0 109.455 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.4 mmm -81.0 -11.22 59.6 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.444 1.498 . . . . 0.0 112.076 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -73.35 127.54 32.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.93 -7.17 78.7 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.72 -153.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.281 1.032 . . . . 0.0 109.37 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 29.3 t -139.58 159.43 42.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.493 0.663 . . . . 0.0 112.777 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.554 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.0 126.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.292 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.433 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.2 t70 61.33 -21.12 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.51 -7.5 0.52 Allowed Glycine 0 N--CA 1.439 -1.119 0 CA-C-O 119.183 -0.787 . . . . 0.0 112.962 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.04 134.97 54.87 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.188 0.994 . . . . 0.0 110.205 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.99 139.03 50.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.63 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.4 pt -121.28 177.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -121.63 143.49 49.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 107.37 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.88 163.77 36.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -63.55 136.11 57.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.87 38.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.161 0.505 . . . . 0.0 112.239 -172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p . . . . . 0 CA--C 1.519 -0.245 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.265 172.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.307 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.27 129.55 47.25 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.912 0.856 . . . . 0.0 108.78 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 75.7 mt -113.31 155.11 25.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.338 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -108.39 129.41 55.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.449 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -121.62 80.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -174.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.77 148.8 19.23 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.909 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.43 11.24 45.44 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 117.736 0.768 . . . . 0.0 112.054 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.93 163.02 20.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.435 0.636 . . . . 0.0 111.907 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.522 HD21 ' HB3' ' B' ' 75' ' ' ASP . 32.2 t-20 -71.27 165.52 23.49 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.417 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -85.48 -8.34 58.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.917 -0.489 . . . . 0.0 110.962 -174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -109.41 -1.35 18.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.28 1.432 . . . . 0.0 111.147 -177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 68.6 m -76.61 144.51 39.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.35 -167.58 2.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.06 -32.11 70.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.432 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -65.0 -32.68 74.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -21.88 27.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.16 -27.27 23.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.98 1.312 . . . . 0.0 109.348 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.06 -28.98 32.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 110.121 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.25 -20.37 41.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.505 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.4 p -104.33 -35.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.449 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 90.6 m-85 -91.83 -11.59 36.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.067 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.0 -3.57 75.22 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.53 -13.1 59.37 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.869 1.267 . . . . 0.0 111.002 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.6 -19.32 12.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.58 164.47 34.16 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.1 ttm105 -72.34 117.37 13.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -75.24 141.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.295 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -23.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.203 0.601 . . . . 0.0 109.958 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -161.18 150.51 16.67 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.054 0.541 . . . . 0.0 109.846 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.48 145.58 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.287 0.565 . . . . 0.0 109.812 172.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.3 mt -119.3 156.28 30.29 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.532 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.67 119.11 5.6 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.422 ' HA ' ' HE2' ' B' ' 40' ' ' MET . 10.8 mmm -94.69 144.05 25.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.062 -169.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.425 ' CA ' ' HG2' ' B' ' 49' ' ' ARG . 30.4 mttt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.425 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 48.1 mmm-85 . . . . . 0 CA--C 1.523 -0.066 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.11 2.42 88.12 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.649 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -135.57 160.0 39.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.61 1.205 . . . . 0.0 111.039 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -178.29 7.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.099 0.56 . . . . 0.0 110.716 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 65.7 m-85 -142.42 163.08 33.82 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.893 0.477 . . . . 0.0 109.865 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.66 142.48 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.7 m -114.68 122.92 47.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.437 0.295 . . . . 0.0 110.333 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.06 155.84 17.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.865 0.866 . . . . 0.0 111.974 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.29 -22.7 60.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.883 0.473 . . . . 0.0 111.291 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -121.18 140.88 31.88 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.65 -10.68 23.72 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.588 2.192 . . . . 0.0 110.396 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.63 -14.92 13.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.091 0.405 . . . . 0.0 110.671 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.2 m-20 -72.06 -27.62 62.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.38 -31.99 54.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.207 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -68.0 -39.59 83.21 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.37 -33.99 76.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.21 -44.41 53.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.08 44.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.093 -0.379 . . . . 0.0 111.37 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -105.59 4.51 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.338 1.055 . . . . 0.0 112.181 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.31 -52.91 1.39 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.779 0.799 . . . . 0.0 109.606 -175.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.1 mmm -82.69 -11.26 58.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.216 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.05 126.88 31.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.285 0.493 . . . . 0.0 109.752 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.86 -7.53 76.91 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.797 -0.446 . . . . 0.0 112.114 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.72 -156.94 0.19 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.582 1.153 . . . . 0.0 109.926 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -134.5 153.24 52.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 111.023 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.83 -65.99 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.388 0.613 . . . . 0.0 111.17 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.522 ' HB3' HD21 ' B' ' 16' ' ' ASN . 15.4 t70 -120.54 16.27 12.04 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.628 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.8 -6.54 12.35 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.637 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -111.57 131.78 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 108.893 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.64 137.66 39.58 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.3 pt -118.58 173.74 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -116.82 140.65 49.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.026 1.73 . . . . 0.0 107.221 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.4 126.59 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.25 163.4 38.81 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -64.67 135.41 55.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.72 153.73 36.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 N--CA 1.452 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.144 169.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.85 127.84 37.47 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -113.82 147.83 37.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -102.61 127.44 49.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.448 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -117.98 81.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.6 140.74 15.22 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.809 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 5.75 32.77 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 117.272 0.536 . . . . 0.0 111.899 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mt -63.56 160.62 16.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.18 0.49 . . . . 0.0 110.958 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' B' ' 75' ' ' ASP . 45.4 t30 -69.23 159.27 33.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -71.69 -4.85 29.74 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.186 -0.321 . . . . 0.0 110.296 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.42 -8.36 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.86 1.264 . . . . 0.0 110.475 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 35.6 m -79.49 141.38 36.78 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.07 -168.03 2.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.393 0.616 . . . . 0.0 109.803 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.32 -30.57 68.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.97 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -66.77 -29.54 69.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.16 -17.73 28.59 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.68 -28.63 14.23 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.016 0.926 . . . . 0.0 110.495 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.28 -32.28 33.29 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.098 0.475 . . . . 0.0 109.72 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -29.7 43.28 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.208 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' B' ' 28' ' ' PHE . 3.6 p -91.6 -34.83 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.448 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 81.5 m-85 -91.42 -9.47 44.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.84 -4.88 86.17 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -78.61 -12.16 60.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.548 1.139 . . . . 0.0 111.193 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -115.63 -13.34 11.5 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.52 171.64 36.84 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 119.88 -1.152 . . . . 0.0 112.127 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -80.89 115.35 20.33 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.397 0.618 . . . . 0.0 109.689 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mt -74.18 139.84 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.745 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -19.06 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.061 175.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -163.15 149.66 12.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.407 0.683 . . . . 0.0 110.025 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.89 144.23 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 109.71 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -119.26 154.42 33.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.573 1.149 . . . . 0.0 108.047 173.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.93 118.97 6.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.402 ' HE2' ' HA ' ' B' ' 40' ' ' MET . 7.6 mmm -92.93 142.41 27.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.665 -169.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.062 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 1.44 78.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -136.07 157.7 46.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.33 1.065 . . . . 0.0 110.421 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.32 6.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.2 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 48.1 m-85 -141.95 161.09 38.84 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -154.67 140.74 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 46.9 m -111.48 126.94 55.49 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.03 162.35 13.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.451 0.701 . . . . 0.0 110.328 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -72.26 -18.7 61.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -129.28 153.49 80.49 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 123.577 0.751 . . . . 0.0 110.126 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.58 3.14 8.05 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 122.714 2.276 . . . . 0.0 110.391 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.46 -15.18 7.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -86.22 -21.44 27.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.74 -28.27 61.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.055 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -69.23 -33.56 73.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.94 -27.33 63.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.97 -46.43 21.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.09 54.63 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.248 0.219 . . . . 0.0 111.369 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -101.69 9.31 41.11 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.298 1.039 . . . . 0.0 112.189 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -50.96 0.88 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.349 1.071 . . . . 0.0 109.127 -175.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' MET . . . . . 0.453 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 50.4 mmm -77.26 -18.56 57.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.27 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -75.95 110.42 10.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.06 -7.94 53.11 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.323 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.6 ptpt -90.15 -173.17 3.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.239 1.02 . . . . 0.0 110.446 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -122.84 153.52 39.48 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.778 0.799 . . . . 0.0 112.14 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -131.29 126.47 35.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.011 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.439 ' HB3' HD21 ' B' ' 16' ' ' ASN . 3.0 t70 62.25 -24.04 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 156.62 -10.99 0.29 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.081 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -118.14 137.23 53.11 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.977 0.888 . . . . 0.0 110.591 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.52 138.39 50.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.886 0.475 . . . . 0.0 110.82 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.53 166.24 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -115.18 146.31 41.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.598 1.559 . . . . 0.0 108.127 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.22 129.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.58 163.53 32.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -61.65 134.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.31 157.49 29.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.948 0.404 . . . . 0.0 112.028 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 63.1 p . . . . . 0 N--CA 1.454 -0.252 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.392 172.518 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -85.61 129.32 34.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.664 0.732 . . . . 0.0 109.209 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.22 153.37 35.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.379 0.671 . . . . 0.0 110.091 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -106.48 131.2 53.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 9.5 mm -121.85 80.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.19 148.7 19.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.937 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.8 11.02 51.63 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.619 0.709 . . . . 0.0 111.484 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.64 164.39 14.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.449 0.699 . . . . 0.0 111.449 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.458 HD21 ' HB3' ' B' ' 75' ' ' ASP . 56.3 t30 -72.59 156.91 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.889 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -76.36 -1.29 26.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.78 0.324 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.09 -5.8 15.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.392 1.077 . . . . 0.0 110.875 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.5 m -80.46 145.65 31.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.349 0.66 . . . . 0.0 110.186 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.59 -168.84 2.13 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.22 -33.19 71.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.48 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.13 -32.9 74.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.27 -22.1 27.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.84 -28.37 22.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.194 1.398 . . . . 0.0 109.453 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.08 -27.91 32.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.391 0.615 . . . . 0.0 110.05 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.6 -21.26 38.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.611 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.2 p -103.51 -34.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.427 ' CD2' HG11 ' B' ' 27' ' ' VAL . 87.3 m-85 -91.41 -11.63 37.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.949 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.23 -3.44 76.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.72 -12.81 59.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.758 1.223 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.55 -19.52 12.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.608 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.97 166.38 37.06 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.072 0.396 . . . . 0.0 112.369 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -73.9 117.13 15.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.2 mt -75.52 142.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -23.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.049 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.84 150.58 17.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.177 0.591 . . . . 0.0 109.794 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.09 144.63 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 109.75 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -116.74 154.19 31.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.47 117.68 6.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.5 mmm -92.68 138.08 31.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.753 -170.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttt . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 111.117 176.709 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.06 76.84 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.12 160.71 39.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.536 1.168 . . . . 0.0 110.991 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.14 -176.87 6.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 110.589 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 37.5 m-85 -143.17 162.84 34.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -154.13 144.72 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -116.68 122.63 45.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.327 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -92.17 156.27 17.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.536 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.22 -22.53 59.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.085 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.6 t -121.58 140.98 32.61 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.52 -7.45 19.54 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.809 2.34 . . . . 0.0 110.137 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.69 -15.77 12.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.764 0.256 . . . . 0.0 110.623 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.462 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.9 m-20 -71.59 -28.48 63.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.42 56.55 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.91 -37.25 75.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.43 -30.85 67.81 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.27 -46.37 34.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.58 -9.97 52.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.13 -0.356 . . . . 0.0 111.191 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -102.16 8.14 40.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.398 1.079 . . . . 0.0 112.499 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.43 -51.38 0.93 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.323 1.059 . . . . 0.0 109.392 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' MET . . . . . 0.497 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 47.3 mmm -78.66 -17.26 56.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.846 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -73.31 118.4 16.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -7.91 75.6 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.641 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.5 ptpt -89.89 178.21 6.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.728 1.264 . . . . 0.0 111.261 175.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -105.45 147.18 28.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.705 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -65.1 1.01 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.325 0.583 . . . . 0.0 110.559 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.458 ' HB3' HD21 ' B' ' 16' ' ' ASN . 14.0 t70 -123.15 4.15 9.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.652 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.14 -11.36 2.55 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.214 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -115.51 133.58 55.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.824 0.85 . . . . 0.0 109.834 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.13 136.29 41.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.392 0.432 . . . . 0.0 110.395 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 16.9 pt -112.84 175.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -119.7 142.76 48.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 107.131 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.56 129.94 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.2 163.09 37.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 123.07 20.42 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.58 149.94 47.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.951 173.103 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.02 127.73 45.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 117.981 0.891 . . . . 0.0 109.132 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.402 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 74.7 mt -114.67 155.94 25.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.286 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.56 129.74 55.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.445 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 9.1 mm -121.32 75.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.63 146.96 18.41 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.226 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.42 11.0 30.22 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.834 0.817 . . . . 0.0 112.004 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.87 166.55 8.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.28 0.562 . . . . 0.0 112.184 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' B' ' 18' ' ' GLU . 58.4 t30 -79.0 -2.65 41.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -171.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 1.2 p 66.39 -13.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.929 1.292 . . . . 0.0 112.998 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' B' ' 16' ' ' ASN . 48.1 mm-40 -91.26 -9.05 46.57 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.969 0.908 . . . . 0.0 109.328 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -78.77 144.9 34.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 109.605 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 -172.31 3.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' B' ' 21' ' ' GLU . 36.2 mp0 -65.22 -37.93 88.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.453 0.701 . . . . 0.0 110.342 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -32.41 74.04 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.191 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.48 -21.03 25.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.16 -27.48 24.55 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.903 1.281 . . . . 0.0 109.034 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.64 -27.21 34.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.41 0.624 . . . . 0.0 110.026 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.0 -20.19 35.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.603 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.3 p -104.2 -35.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.445 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 88.4 m-85 -92.69 -10.05 38.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.134 175.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.93 -2.93 79.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.5 -11.27 59.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.557 1.143 . . . . 0.0 111.02 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -113.4 -19.34 11.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.786 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.36 161.15 30.12 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -74.07 123.06 23.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.99 143.79 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 -22.78 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.925 178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.95 150.43 15.18 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.32 0.648 . . . . 0.0 109.744 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.66 145.62 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.396 0.617 . . . . 0.0 109.655 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.9 mt -118.52 154.44 32.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.291 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -149.13 117.54 6.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.82 140.15 29.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.913 -169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 pttt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.424 0.63 . . . . 0.0 112.342 178.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.44 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 40.1 mmm-85 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.83 0.09 75.64 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' B' ' 49' ' ' ARG . 48.1 p90 -139.13 161.88 36.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 117.822 0.811 . . . . 0.0 111.083 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.72 -178.92 7.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.448 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 44.7 m-85 -140.34 162.3 35.63 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -152.98 142.51 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.9 m -114.06 121.7 44.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.29 156.54 17.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.753 0.821 . . . . 0.0 110.731 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -78.72 -23.75 45.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.376 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -114.03 138.09 22.7 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.74 -8.13 20.06 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.457 2.105 . . . . 0.0 110.434 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.99 -15.06 13.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.389 0.276 . . . . 0.0 110.891 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.433 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 70.3 m-20 -71.34 -28.17 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.41 51.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.31 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.41 -39.18 81.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.95 -32.62 73.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.58 -43.7 47.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.56 42.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.286 -0.259 . . . . 0.0 110.943 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -106.47 5.03 28.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.294 1.038 . . . . 0.0 112.324 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.81 -53.29 1.33 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 30.2 mmm -82.35 -10.19 59.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.779 1.632 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.27 126.0 29.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.32 -6.74 81.12 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -80.81 -154.15 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.172 0.989 . . . . 0.0 109.16 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -137.77 159.53 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.798 0.808 . . . . 0.0 112.507 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.43 126.69 31.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.849 176.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.417 ' HB3' HD21 ' B' ' 16' ' ' ASN . 1.9 t70 60.98 -18.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.91 -8.38 0.6 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 119.33 -0.706 . . . . 0.0 113.154 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -121.91 138.51 54.38 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.259 1.03 . . . . 0.0 110.592 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.42 139.38 54.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.808 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 pt -121.43 176.66 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -120.1 141.44 49.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.712 1.605 . . . . 0.0 107.505 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.38 124.56 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.07 163.15 36.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -60.7 133.77 56.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.63 153.71 30.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.8 p . . . . . 0 CA--C 1.518 -0.251 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.242 170.009 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -98.3 129.93 45.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.054 0.927 . . . . 0.0 108.926 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -114.88 154.04 29.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.87 130.92 55.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.414 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -122.3 80.34 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.2 143.25 16.44 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.538 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 9.65 38.7 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 117.477 0.639 . . . . 0.0 111.882 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.88 165.04 13.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.134 0.573 . . . . 0.0 111.672 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t30 -77.94 157.06 29.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 123.292 0.637 . . . . 0.0 110.924 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -72.63 -8.33 54.73 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.678 0.791 . . . . 0.0 110.283 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.94 -10.46 22.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 110.471 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.1 m -83.49 143.85 29.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -169.02 2.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -68.72 -33.29 73.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -64.6 -33.4 75.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.56 -20.89 27.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -86.5 -26.74 24.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.125 1.37 . . . . 0.0 109.431 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.9 -28.84 32.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.427 0.632 . . . . 0.0 110.119 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.33 -20.08 41.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.675 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -105.25 -36.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' B' ' 27' ' ' VAL . 84.5 m-85 -88.53 -11.89 44.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.923 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.63 -4.24 75.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -81.5 -12.88 58.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.319 1.048 . . . . 0.0 110.911 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.7 m-85 -109.73 -20.65 12.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.254 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.91 164.66 33.15 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 118.048 0.386 . . . . 0.0 112.959 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -66.41 117.84 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.7 mt -79.16 142.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.966 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -21.7 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.142 0.577 . . . . 0.0 109.91 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.69 150.39 15.64 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.464 0.706 . . . . 0.0 109.826 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.7 145.81 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.138 0.494 . . . . 0.0 110.059 172.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.0 mt -120.3 154.41 35.03 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.362 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.44 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -150.71 119.51 6.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 170.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' B' ' 40' ' ' MET . 12.1 mmm -92.59 141.66 28.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -169.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.44 ' HE2' HD13 ' B' ' 39' ' ' LEU . 11.9 mttt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.401 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 42.9 mmm-85 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.92 2.73 88.34 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.351 -0.694 . . . . 0.0 111.582 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' B' ' 49' ' ' ARG . 51.1 p90 -135.49 161.45 35.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.764 1.282 . . . . 0.0 110.072 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.2 -177.62 6.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.779 0.431 . . . . 0.0 111.164 -174.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 63.2 m-85 -142.73 162.28 35.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.3 142.27 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m -113.35 123.99 51.42 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -95.04 156.35 16.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.931 0.892 . . . . 0.0 110.686 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.47 -21.26 45.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.493 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -116.5 137.93 24.01 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.85 -0.13 10.22 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.089 2.526 . . . . 0.0 110.568 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 -15.5 9.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 117.877 0.308 . . . . 0.0 111.198 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 84.5 m-20 -72.19 -27.96 62.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.62 -27.66 55.81 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.452 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -74.5 -36.59 63.23 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.24 -26.1 64.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.2 -46.38 14.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.03 63.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.3 7.7 46.03 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 -55.58 1.31 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.915 0.864 . . . . 0.0 109.371 -173.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' MET . . . . . 0.531 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 0.0 OUTLIER -75.48 -15.76 60.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.626 -1.625 . . . . 0.0 111.775 -177.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -73.91 124.06 25.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.32 -7.05 82.14 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -82.91 -153.46 0.12 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 109.361 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -139.69 158.73 43.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.464 0.706 . . . . 0.0 112.395 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -132.43 126.56 33.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.426 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.7 t70 61.5 -23.34 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.62 -6.51 0.47 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 119.512 -0.604 . . . . 0.0 112.631 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -117.36 134.51 54.74 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.027 0.913 . . . . 0.0 110.134 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.96 139.17 50.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.479 -174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.22 174.55 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -120.89 144.19 48.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.3 1.84 . . . . 0.0 107.776 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -135.97 130.03 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -160.92 163.83 31.61 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -61.43 137.15 58.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.39 158.89 27.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.154 169.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.335 0 CA-C-O 119.23 -0.761 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -99.55 128.86 45.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 117.99 0.895 . . . . 0.0 108.872 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -112.56 151.31 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.517 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -104.65 128.41 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.444 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.9 79.05 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 146.48 18.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.937 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.28 10.44 41.87 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 117.68 0.74 . . . . 0.0 111.672 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.63 164.98 13.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.529 0.732 . . . . 0.0 112.129 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' B' ' 75' ' ' ASP . 46.7 t30 -77.1 162.38 27.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 110.657 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -76.71 -1.47 28.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.284 0.233 . . . . 0.0 110.607 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.6 -4.61 16.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.378 1.071 . . . . 0.0 110.815 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 45.2 m -82.7 144.51 30.18 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.945 0.498 . . . . 0.0 110.047 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 -169.23 2.44 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.369 0.604 . . . . 0.0 109.443 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.34 -35.51 73.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.558 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.1 -30.0 70.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.37 -21.02 23.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.07 -28.82 22.33 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.135 0.974 . . . . 0.0 109.36 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.26 -25.51 39.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.186 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.37 -22.19 35.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -103.87 -29.3 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.444 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 82.6 m-85 -99.1 -10.39 22.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.382 174.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.21 -5.83 85.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.435 ' CB ' ' HZ2' ' B' ' 30' ' ' LYS . 5.5 mtpm? -77.05 -22.97 52.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.853 1.261 . . . . 0.0 111.081 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.7 -19.9 15.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.528 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.44 165.28 34.98 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 118.024 0.374 . . . . 0.0 112.215 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -74.07 116.87 15.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.66 139.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.39 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -23.64 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 122.849 0.46 . . . . 0.0 110.134 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -160.28 149.48 17.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.026 0.53 . . . . 0.0 109.614 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.71 143.58 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 172.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.9 mt -117.39 154.13 31.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.07 119.41 5.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.0 mmm -94.32 136.94 34.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.93 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 pttt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.363 0.602 . . . . 0.0 111.333 176.579 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.66 1.57 68.17 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.424 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.84 158.87 43.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.62 1.21 . . . . 0.0 110.553 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -178.52 7.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.051 0.541 . . . . 0.0 110.489 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.5 m-85 -142.58 162.39 35.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.846 0.459 . . . . 0.0 110.433 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.21 143.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -115.85 122.37 45.17 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 123.142 0.276 . . . . 0.0 110.306 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.71 156.58 17.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.589 0.755 . . . . 0.0 111.996 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -75.18 -22.89 57.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.599 0.36 . . . . 0.0 111.071 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -120.54 140.69 30.81 Favored Pre-proline 0 CA--C 1.518 -0.262 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.41 -12.77 25.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.436 2.091 . . . . 0.0 110.189 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.57 -15.59 14.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.165 0.439 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.447 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.8 m-20 -70.95 -29.01 64.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 169.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.57 58.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.008 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -67.59 -38.9 84.68 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.35 -33.56 74.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.05 52.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.73 -8.45 52.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.256 -0.277 . . . . 0.0 110.906 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -104.94 5.35 32.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.191 0.996 . . . . 0.0 112.286 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -52.05 1.28 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.862 0.755 . . . . 0.0 109.442 -175.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.7 mmm -83.36 -10.52 58.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.405 1.482 . . . . 0.0 112.529 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.85 127.26 32.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.83 76.28 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.149 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.84 -157.38 0.22 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -134.46 153.01 52.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.664 0.786 . . . . 0.0 110.891 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.93 -68.32 0.81 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.943 -176.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' B' ' 16' ' ' ASN . 11.7 t70 -117.59 7.25 12.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.652 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.25 -7.66 5.37 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -113.41 132.84 55.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 108.932 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 136.62 38.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.27 175.68 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -120.98 140.4 51.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.846 1.658 . . . . 0.0 107.302 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.86 125.12 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.44 162.72 35.72 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -60.71 133.6 56.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.2 158.33 27.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 N--CA 1.454 -0.246 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.143 171.325 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.288 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -85.88 129.98 34.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.3 mt -118.19 152.67 35.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.102 0.561 . . . . 0.0 109.961 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -105.42 128.65 53.64 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.436 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.73 81.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.94 146.83 18.41 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.861 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.33 51.09 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 117.707 0.754 . . . . 0.0 111.585 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.23 164.06 11.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.457 0.703 . . . . 0.0 111.295 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' B' ' 75' ' ' ASP . 44.5 t30 -73.1 158.86 34.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.294 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 76.0 p -74.96 -2.75 28.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.99 -7.15 16.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.647 1.179 . . . . 0.0 110.776 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.6 m -80.96 144.34 31.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.532 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -170.24 2.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.58 -34.64 77.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.646 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -65.78 -31.51 72.53 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.974 -0.454 . . . . 0.0 111.022 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -20.1 29.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -89.78 -28.34 19.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.819 1.248 . . . . 0.0 109.848 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -81.77 -28.55 33.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 109.896 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.81 -23.71 39.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.317 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.9 p -99.77 -37.8 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.436 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 87.7 m-85 -88.96 -10.58 47.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.772 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.13 -4.61 73.46 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -79.2 -14.59 58.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.808 1.243 . . . . 0.0 111.377 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.1 m-85 -110.33 -19.8 12.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.723 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.56 163.07 31.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -74.95 125.61 29.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.69 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.342 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.18 -23.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.963 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -161.07 151.08 17.38 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.173 0.589 . . . . 0.0 109.557 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.92 147.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 109.722 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -122.23 156.0 34.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.589 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.24 121.39 5.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.419 ' HA ' ' HE2' ' B' ' 40' ' ' MET . 0.6 OUTLIER -89.73 138.3 31.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -174.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.164 0.507 . . . . 0.0 112.086 174.378 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.88 0.7 83.31 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.746 0.689 . . . . 0.0 112.591 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.66 158.34 43.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.439 1.12 . . . . 0.0 110.6 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.42 -179.28 7.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.8 m-85 -140.95 161.51 37.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.03 139.23 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -111.65 121.7 45.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.853 0.359 . . . . 0.0 110.121 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -92.16 155.26 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.74 0.816 . . . . 0.0 110.444 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.97 -22.88 48.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -114.57 135.72 22.33 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.67 0.86 9.13 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.847 2.365 . . . . 0.0 110.499 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.35 -14.76 9.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.525 0.33 . . . . 0.0 111.202 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -72.07 -28.76 63.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.79 58.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.31 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -70.69 -37.82 73.65 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.23 -31.07 70.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.38 -44.91 42.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.262 -0.274 . . . . 0.0 111.333 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -99.8 5.72 45.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.047 0.939 . . . . 0.0 112.642 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.49 -51.75 1.27 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.913 0.778 . . . . 0.0 109.197 -174.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' MET . . . . . 0.437 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mtp -83.74 -11.16 57.51 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.74 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.89 114.17 10.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.03 -4.81 59.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.54 -154.53 0.11 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.327 1.051 . . . . 0.0 109.309 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -139.77 159.49 42.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 112.474 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.63 127.3 30.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.386 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.412 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.2 t70 60.92 -20.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 150.26 -6.06 0.68 Allowed Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.042 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -118.38 134.73 54.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.869 0.834 . . . . 0.0 110.063 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.81 137.42 47.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.322 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.1 pt -118.5 177.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -122.01 143.35 49.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.562 1.945 . . . . 0.0 107.177 170.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.66 130.42 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -158.96 164.2 35.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -67.53 132.73 48.15 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.34 147.83 34.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.936 173.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -98.68 128.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.373 1.087 . . . . 0.0 109.044 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.34 153.8 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.048 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -108.08 128.93 55.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.429 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -121.1 80.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.39 144.21 17.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.237 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.71 38.98 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 117.709 0.755 . . . . 0.0 111.466 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.29 162.46 22.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.048 0.539 . . . . 0.0 112.087 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' B' ' 75' ' ' ASP . 39.5 t-20 -76.35 155.15 34.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.014 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -68.93 -10.47 57.41 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 123.548 0.739 . . . . 0.0 110.284 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.78 -11.25 23.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 110.309 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -81.29 144.72 31.33 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.287 0.635 . . . . 0.0 109.345 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.74 -165.98 1.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.392 0.615 . . . . 0.0 109.536 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -70.61 -38.84 74.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.858 -173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -68.71 -25.84 64.97 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.5 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.95 -20.19 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.37 -28.46 18.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.675 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.11 -26.65 48.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 109.79 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.85 -23.87 36.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.82 -36.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 83.9 m-85 -90.47 -11.61 39.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.21 -0.306 . . . . 0.0 110.951 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.16 -3.13 68.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -81.51 -12.23 58.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.14 . . . . 0.0 111.264 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -111.96 -20.48 11.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.6 0.76 . . . . 0.0 112.412 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.47 161.58 29.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -74.0 124.97 27.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.88 143.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.154 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -20.7 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.477 0.711 . . . . 0.0 110.477 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -160.37 148.82 16.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.304 0.642 . . . . 0.0 109.66 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.06 143.54 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 110.039 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -118.94 156.03 30.28 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.178 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.485 HD13 ' HE2' ' B' ' 41' ' ' LYS . 2.9 tm? -154.98 119.44 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 171.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 13.8 mmm -93.17 142.87 26.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.097 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.485 ' HE2' HD13 ' B' ' 39' ' ' LEU . 13.8 mttt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.17 87.18 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.158 -0.801 . . . . 0.0 111.943 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -136.94 160.34 39.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.922 1.361 . . . . 0.0 110.249 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.9 -178.71 7.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.749 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.9 m-85 -142.93 162.59 35.07 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.61 141.84 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 33.6 m -111.97 122.9 49.03 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.245 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -93.06 156.67 16.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 110.503 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.82 -23.08 42.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.461 -0.305 . . . . 0.0 110.284 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -115.19 137.56 23.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 -7.04 18.78 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.568 2.179 . . . . 0.0 110.474 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.75 -14.71 13.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.844 0.293 . . . . 0.0 110.728 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.6 m-20 -71.67 -28.13 63.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.14 53.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.556 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.05 -38.94 79.39 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.44 -32.74 72.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.94 -44.78 46.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.43 -8.47 51.16 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.057 -0.402 . . . . 0.0 111.203 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -104.23 4.74 34.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.395 1.078 . . . . 0.0 112.088 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.58 -52.67 1.26 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.759 0.79 . . . . 0.0 109.447 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.2 mmm -82.22 -10.55 59.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.586 1.555 . . . . 0.0 112.401 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.56 126.15 29.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.39 -6.63 83.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -80.64 -153.86 0.09 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.595 1.158 . . . . 0.0 109.691 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -139.88 159.05 43.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.292 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.66 126.18 32.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.024 177.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.9 t70 61.05 -21.38 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.08 -6.35 0.6 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.724 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -117.42 133.16 56.29 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.002 0.901 . . . . 0.0 110.119 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.36 50.78 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.301 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -120.64 178.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -122.57 142.74 50.3 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.399 1.88 . . . . 0.0 107.33 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.97 129.25 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -159.24 162.39 36.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -63.59 134.37 55.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 158.27 29.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.519 -0.249 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.949 169.63 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -92.24 125.49 36.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -110.44 150.84 28.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -105.31 128.85 53.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.424 HD11 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.19 78.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.42 142.59 16.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.493 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.56 6.52 46.97 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 122.216 -0.579 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.27 162.32 6.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.331 0.652 . . . . 0.0 111.773 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' B' ' 75' ' ' ASP . 47.6 t30 -71.25 160.11 33.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 70.9 p -77.85 -1.28 30.87 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.878 0.471 . . . . 0.0 110.669 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.26 -6.1 15.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.409 1.083 . . . . 0.0 111.025 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -83.4 145.74 28.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.285 0.634 . . . . 0.0 110.087 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -169.96 2.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.51 -35.83 79.89 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.54 -174.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -67.89 -27.9 67.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.964 -0.46 . . . . 0.0 111.247 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.02 28.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.71 -26.78 24.07 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.166 1.386 . . . . 0.0 109.352 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -80.19 -32.75 38.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.427 0.632 . . . . 0.0 110.163 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.49 -21.65 45.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.308 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.1 p -103.06 -34.29 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.431 ' CD2' HG11 ' B' ' 27' ' ' VAL . 84.2 m-85 -91.83 -12.0 34.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.073 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -3.08 72.11 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -81.57 -13.58 57.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.66 1.184 . . . . 0.0 110.89 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -110.94 -19.58 12.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.696 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.13 166.2 36.67 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 118.025 0.375 . . . . 0.0 112.332 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttm105 -72.86 117.81 15.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.2 144.21 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.566 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -18.84 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.167 0.587 . . . . 0.0 110.323 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -160.22 147.35 16.11 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.212 0.605 . . . . 0.0 109.652 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.44 141.75 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.459 0.647 . . . . 0.0 109.583 170.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.2 mt -120.26 155.81 32.49 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.738 175.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.37 120.19 6.14 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.431 ' HE3' ' HA ' ' B' ' 40' ' ' MET . 6.5 mmm -93.59 136.99 33.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.59 -172.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 pttp . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.116 0.484 . . . . 0.0 111.199 179.185 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 32.1 mmm-85 . . . . . 0 CA--C 1.525 0.013 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -1.13 75.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.904 0.764 . . . . 0.0 111.306 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.89 156.64 48.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.724 1.262 . . . . 0.0 110.522 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.54 7.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.872 0.469 . . . . 0.0 110.422 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.0 m-85 -142.42 161.79 37.13 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.534 0.334 . . . . 0.0 110.736 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.56 141.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.0 m -112.08 126.08 54.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -94.3 155.77 16.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 111.427 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.36 -22.8 61.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.266 -0.397 . . . . 0.0 111.364 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -121.49 141.47 33.51 Favored Pre-proline 0 CA--C 1.518 -0.254 0 CA-C-N 118.295 0.498 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.14 -3.81 14.45 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.819 2.346 . . . . 0.0 110.289 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.46 -15.84 11.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.581 0.352 . . . . 0.0 110.998 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.456 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -71.77 -29.15 64.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.14 59.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.143 0.577 . . . . 0.0 110.526 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -70.84 -37.84 73.17 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.91 -30.36 68.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.27 -9.41 53.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.176 -0.327 . . . . 0.0 111.228 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -101.82 7.18 41.77 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.546 1.138 . . . . 0.0 112.158 174.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.29 -53.6 1.03 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.862 0.839 . . . . 0.0 109.108 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' MET . . . . . 0.5 ' HA ' ' CG ' ' B' ' 72' ' ' LYS . 49.7 mmm -78.44 -10.5 59.72 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.154 1.782 . . . . 0.0 111.916 -176.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -80.65 117.34 21.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.16 62.26 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.609 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.5 ' CG ' ' HA ' ' B' ' 69' ' ' MET . 20.7 ptmt -106.93 176.75 5.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.578 1.189 . . . . 0.0 111.954 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -97.76 155.91 16.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -127.23 123.84 37.51 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.359 172.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.423 ' HB3' HD21 ' B' ' 16' ' ' ASN . 3.8 t70 61.66 -23.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 157.56 -11.37 0.25 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.141 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -116.57 135.57 53.7 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.014 0.907 . . . . 0.0 110.513 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.34 140.51 57.26 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 123.199 0.6 . . . . 0.0 110.823 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -125.91 171.9 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -115.35 144.08 44.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.981 1.712 . . . . 0.0 108.015 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.76 130.14 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -160.44 163.86 32.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -63.31 133.31 53.95 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.36 158.55 30.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.038 0.446 . . . . 0.0 111.883 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.613 171.649 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.28 127.1 45.24 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 72.7 mt -112.5 154.45 25.87 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.16 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -107.96 127.3 53.63 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.434 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -118.85 80.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.29 143.78 16.83 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.624 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.04 36.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.16 163.5 22.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.465 HD21 ' CB ' ' B' ' 75' ' ' ASP . 40.3 t-20 -73.51 158.85 34.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -73.62 -8.29 55.36 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.301 0.64 . . . . 0.0 110.161 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.38 -11.04 20.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 110.48 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 41.2 m -79.87 144.78 33.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.71 -168.14 2.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.06 -32.27 68.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.578 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -64.4 -32.57 74.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.13 -21.91 27.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.87 -27.88 24.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.226 1.41 . . . . 0.0 109.635 -176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.93 -29.97 35.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 110.17 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -22.55 41.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.586 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.0 p -102.36 -35.51 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -174.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 89.0 m-85 -91.56 -10.06 42.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.873 176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -3.94 71.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -80.4 -13.08 59.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.619 1.168 . . . . 0.0 111.208 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -112.29 -18.78 12.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.7 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.34 167.31 38.35 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.161 0.437 . . . . 0.0 112.63 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -74.22 117.28 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.2 142.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.461 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.47 -23.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.148 0.579 . . . . 0.0 110.194 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.51 150.1 15.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.238 0.615 . . . . 0.0 109.683 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.66 147.09 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 109.547 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.5 mt -123.09 156.36 35.08 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.787 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.453 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.44 119.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.422 ' HA ' ' HE1' ' B' ' 40' ' ' MET . 11.7 mmm -93.03 142.58 27.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.902 -169.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.453 ' HE2' HD12 ' B' ' 39' ' ' LEU . 22.8 mttt . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 . . . . . 0 CA--C 1.527 0.061 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.67 3.89 87.89 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.351 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.9 161.03 37.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.695 1.248 . . . . 0.0 109.803 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.34 -177.97 6.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.098 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.3 m-85 -142.91 160.93 39.4 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.168 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.3 140.6 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -112.71 121.71 45.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -92.62 155.95 17.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.695 0.798 . . . . 0.0 111.723 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -73.43 -22.57 60.17 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.455 0.302 . . . . 0.0 111.255 174.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -121.16 140.81 31.74 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 118.352 0.524 . . . . 0.0 109.834 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 -1.3 11.32 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 123.122 2.548 . . . . 0.0 110.342 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.36 -16.39 10.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.808 0.443 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 82.5 m-20 -71.28 -27.91 63.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.41 -29.09 56.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -72.97 -38.69 66.6 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.15 -25.39 66.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.71 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.59 -43.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 172.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.2 -6.6 48.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.896 -0.502 . . . . 0.0 112.305 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -107.46 7.97 29.21 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.532 0.733 . . . . 0.0 112.311 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.92 -55.07 1.39 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.628 0.728 . . . . 0.0 109.329 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.5 mmm -79.57 -10.03 59.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.538 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -73.46 128.08 34.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.65 79.28 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -81.64 -153.44 0.11 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.628 1.171 . . . . 0.0 109.639 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.1 t -140.03 158.69 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -173.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.74 128.9 31.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.543 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.465 ' CB ' HD21 ' B' ' 16' ' ' ASN . 2.4 t0 52.73 21.52 1.93 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.328 0.585 . . . . 0.0 112.223 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.73 56.29 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.707 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -114.97 130.45 56.93 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.43 1.115 . . . . 0.0 109.875 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.81 139.12 50.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.344 0.258 . . . . 0.0 111.658 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.79 177.55 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -121.84 144.54 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.049 1.74 . . . . 0.0 107.567 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.42 126.54 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.79 164.83 28.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -60.36 135.95 57.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.2 159.84 23.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.518 -0.263 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.649 169.541 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -92.51 127.88 38.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -113.3 149.24 34.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -102.72 127.47 49.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.438 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 8.0 mm -118.61 78.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.73 144.54 17.13 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.729 -0.607 . . . . 0.0 112.157 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 13.45 40.97 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 117.908 0.854 . . . . 0.0 111.827 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -65.81 166.33 11.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.042 0.925 . . . . 0.0 112.928 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.473 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.2 OUTLIER -78.71 145.77 34.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.312 1.445 . . . . 0.0 109.888 176.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 78.7 p -74.32 -8.61 56.83 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.995 0.918 . . . . 0.0 112.301 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.96 -12.39 18.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.265 1.426 . . . . 0.0 109.583 -174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.6 m -77.73 149.02 34.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.55 1.14 . . . . 0.0 110.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 -165.0 1.67 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -66.1 -29.48 69.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.134 0.424 . . . . 0.0 110.952 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.05 -19.7 31.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.84 -29.18 21.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.64 1.176 . . . . 0.0 109.472 -176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.52 -27.66 46.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.443 0.64 . . . . 0.0 109.825 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.29 -23.38 37.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.347 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.87 -34.45 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 84.7 m-85 -90.84 -11.7 38.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.107 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.29 -5.16 76.15 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -79.31 -12.82 59.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.833 1.253 . . . . 0.0 110.729 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.63 -13.5 12.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.48 171.32 37.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.359 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -79.89 115.04 19.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.59 0.71 . . . . 0.0 109.982 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.8 mt -75.0 141.67 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.991 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -21.32 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.206 0.602 . . . . 0.0 110.354 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -161.29 150.38 16.36 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.21 146.11 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.4 0.619 . . . . 0.0 109.849 172.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.4 mt -123.24 155.32 37.39 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.528 1.131 . . . . 0.0 108.234 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.467 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.1 tm? -154.0 119.76 5.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.417 ' HE3' ' HA ' ' B' ' 40' ' ' MET . 9.2 mmm -92.81 139.82 30.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -170.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.467 ' HE2' HD13 ' B' ' 39' ' ' LEU . 18.1 mttt . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.408 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 40.6 mmm-85 . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 4.07 80.68 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.992 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 157.37 45.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.719 1.26 . . . . 0.0 109.95 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.36 -177.98 6.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.401 0.28 . . . . 0.0 111.076 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 64.7 m-85 -142.68 160.75 39.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.797 0.439 . . . . 0.0 110.463 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -154.1 138.79 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 56.9 m -110.34 126.84 54.66 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.106 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -98.2 161.81 13.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.403 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -71.52 -18.4 62.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -130.25 153.43 81.21 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 110.104 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.68 1.12 9.53 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.1 -15.59 9.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.76 -21.22 25.26 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 -27.78 61.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -69.58 -32.14 70.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.82 -22.24 61.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.1 -44.16 13.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.25 -15.62 62.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.184 -0.323 . . . . 0.0 111.858 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.36 6.74 46.02 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.19 -55.08 1.36 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.041 0.837 . . . . 0.0 109.461 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 24.4 mmm -78.05 -12.21 59.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.18 1.392 . . . . 0.0 111.965 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -72.83 130.12 39.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -10.05 63.36 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.671 -0.516 . . . . 0.0 112.356 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -83.28 -160.3 0.41 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.166 0.986 . . . . 0.0 109.509 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -132.9 152.61 51.85 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.716 0.806 . . . . 0.0 110.723 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.73 -62.81 1.23 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.962 -174.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.473 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 15.6 t70 -130.18 0.92 4.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.141 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.75 -14.07 0.78 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.821 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.25 134.5 55.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.05 135.62 38.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.8 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.4 pt -114.26 174.32 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -173.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.55 141.85 47.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.564 1.546 . . . . 0.0 107.554 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.36 125.86 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.29 164.99 34.41 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -63.05 135.71 57.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.46 158.91 29.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 112.309 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.453 -0.307 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.535 173.221 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -84.52 129.0 34.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -119.1 155.62 31.21 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.991 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -109.44 130.02 55.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.456 HD11 ' CZ ' ' B' ' 28' ' ' PHE . 6.2 mm -121.68 86.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.87 145.07 16.91 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 121.999 -0.438 . . . . 0.0 112.555 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.12 8.08 45.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.28 162.65 14.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.085 0.945 . . . . 0.0 112.089 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.429 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.4 OUTLIER -70.14 145.18 51.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.432 1.493 . . . . 0.0 109.568 175.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -70.83 -4.88 26.46 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.927 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.83 -6.49 15.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.984 1.314 . . . . 0.0 109.609 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.3 m -76.52 143.79 40.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.412 1.085 . . . . 0.0 108.751 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.96 -166.7 1.95 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.34 -29.89 68.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.692 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -66.76 -30.61 70.87 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.87 -17.13 28.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -95.28 -28.27 15.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.336 1.054 . . . . 0.0 109.909 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.97 -29.38 29.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.24 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.31 -28.54 38.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.127 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.456 HG13 ' CD2' ' B' ' 28' ' ' PHE . 4.3 p -92.64 -36.45 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.456 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.2 m-85 -92.15 -10.48 38.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.276 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.35 -3.48 77.13 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -79.77 -14.73 58.51 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.71 1.204 . . . . 0.0 111.608 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -111.5 -19.0 12.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.803 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.52 164.61 33.28 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 118.208 0.458 . . . . 0.0 112.312 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -72.23 117.45 13.89 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.96 141.23 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.386 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -23.81 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 122.877 0.471 . . . . 0.0 110.067 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.11 150.37 16.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.383 0.673 . . . . 0.0 109.687 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.55 146.06 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.517 0.675 . . . . 0.0 109.951 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.3 mt -118.14 152.13 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.3 119.33 6.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.3 mmm -93.4 139.66 30.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.9 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 pttt . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.129 0.49 . . . . 0.0 112.059 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.75 74.07 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -138.94 158.58 43.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.452 1.126 . . . . 0.0 110.671 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -179.04 7.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.385 0.674 . . . . 0.0 110.682 -174.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.2 m-85 -142.84 163.36 33.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.88 140.96 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -113.33 122.89 48.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.693 0.397 . . . . 0.0 110.08 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -93.27 156.63 16.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 111.632 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.72 -22.92 60.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 122.606 0.363 . . . . 0.0 111.441 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -121.54 141.07 32.72 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 118.428 0.558 . . . . 0.0 110.042 174.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.33 -0.98 10.96 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.833 2.355 . . . . 0.0 110.599 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.6 -16.8 10.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.198 0.454 . . . . 0.0 110.827 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.434 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.4 m-20 -70.56 -29.05 65.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.74 -29.98 59.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.438 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -70.9 -39.25 72.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.21 -29.84 69.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.253 -0.276 . . . . 0.0 110.253 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.273 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.53 -12.58 61.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.501 0.32 . . . . 0.0 111.055 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -97.19 6.85 47.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.946 0.899 . . . . 0.0 112.052 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.92 -52.04 1.22 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.002 0.819 . . . . 0.0 109.892 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 54.3 mmm -81.65 -14.75 56.28 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.07 1.748 . . . . 0.0 112.055 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -74.35 116.33 14.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.14 -8.15 60.7 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.372 0.511 . . . . 0.0 112.027 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -82.54 -156.57 0.18 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.361 1.064 . . . . 0.0 109.392 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -144.35 158.8 43.55 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 123.786 0.834 . . . . 0.0 111.779 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.75 125.68 27.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.0 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.429 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 3.5 t70 61.07 -24.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 161.05 -12.2 0.14 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.78 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -118.29 137.32 53.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.468 1.134 . . . . 0.0 109.948 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.56 138.32 50.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.037 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.65 163.74 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -112.56 144.01 42.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.302 1.841 . . . . 0.0 107.963 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 29.2 t -135.07 130.6 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.87 162.26 39.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.12 123.43 21.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.33 146.48 43.97 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 CA--C 1.518 -0.272 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.36 173.304 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -98.24 127.1 44.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -113.4 153.26 28.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.971 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -106.4 128.94 54.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.431 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.53 81.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.86 143.2 16.46 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.951 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.6 11.63 34.97 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 117.74 0.77 . . . . 0.0 111.752 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -67.33 162.33 23.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 111.706 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' B' ' 75' ' ' ASP . 47.2 t30 -75.29 156.54 35.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.642 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -71.34 -8.27 52.59 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.244 0.618 . . . . 0.0 110.383 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.26 -10.17 20.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.607 1.163 . . . . 0.0 110.489 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -81.79 146.18 30.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.29 0.636 . . . . 0.0 109.918 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.58 -167.26 2.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.174 -173.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -67.72 -28.54 67.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 118.055 0.388 . . . . 0.0 111.075 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.39 -21.89 30.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.56 -29.02 22.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.107 1.363 . . . . 0.0 109.403 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.23 -28.21 38.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 109.937 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.12 37.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.352 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -104.35 -35.0 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.431 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 89.9 m-85 -91.95 -10.99 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.909 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.38 -2.9 75.73 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -81.9 -12.17 58.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.708 1.203 . . . . 0.0 111.04 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -112.14 -19.16 12.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.39 166.41 37.39 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 118.264 0.484 . . . . 0.0 112.716 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -73.88 117.1 15.26 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mt -76.29 142.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.67 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -21.97 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.178 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.71 150.17 15.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.019 0.528 . . . . 0.0 109.834 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.98 145.92 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.352 0.596 . . . . 0.0 109.546 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -121.9 154.77 36.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.451 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.452 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.42 119.55 5.44 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.49 141.07 28.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.5 -170.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.452 ' HE2' HD13 ' B' ' 39' ' ' LEU . 13.3 mttt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 . . . . . 0 CA--C 1.523 -0.065 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.51 0.31 89.32 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.855 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -133.92 157.11 46.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.637 1.219 . . . . 0.0 110.604 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.137 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 62.5 m-85 -143.05 162.41 35.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.623 0.369 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.79 140.31 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.8 m -112.75 122.56 48.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 123.271 0.357 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.5 156.69 16.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.859 0.864 . . . . 0.0 111.791 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.7 -21.81 59.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.215 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -122.26 139.83 31.38 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.94 -0.15 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.161 2.574 . . . . 0.0 110.65 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.01 -14.99 9.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.822 0.283 . . . . 0.0 111.141 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.458 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.3 m-20 -72.43 -28.5 63.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.27 -29.24 60.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -73.03 -37.25 66.96 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.1 -25.5 65.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.533 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.64 16.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.204 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.4 -8.93 57.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.26 9.03 34.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.341 0.657 . . . . 0.0 112.727 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.09 -53.77 1.3 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.546 0.689 . . . . 0.0 109.461 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 26.8 mmm -81.73 -10.22 59.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.63 1.572 . . . . 0.0 112.055 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -73.43 127.02 31.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.68 79.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.333 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -82.38 -157.42 0.21 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.608 1.163 . . . . 0.0 109.824 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -136.15 153.12 51.37 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.593 0.757 . . . . 0.0 110.858 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.75 -65.88 0.95 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.124 -175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' B' ' 16' ' ' ASN . 14.5 t70 -121.54 14.49 11.06 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.391 -175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.44 -6.09 9.25 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.846 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -112.88 131.04 55.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.734 0.814 . . . . 0.0 108.843 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.19 134.98 37.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.116 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 pt -115.12 175.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -118.27 141.72 48.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.058 1.743 . . . . 0.0 107.099 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.71 127.42 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.76 163.79 37.72 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -63.75 134.09 54.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.87 152.7 38.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 169.493 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.419 0.152 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -98.89 109.77 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -132.55 136.12 46.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.33 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.85 116.24 10.62 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -73.91 74.18 1.64 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 112.297 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.17 147.5 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 129.02 2.928 . . . . 0.0 116.206 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.16 145.01 67.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.847 3.031 . . . . 0.0 112.631 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.03 -15.66 51.19 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -98.37 128.25 44.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.146 0.973 . . . . 0.0 108.438 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.7 mt -112.29 155.62 23.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -109.48 128.92 55.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' B' ' 28' ' ' PHE . 7.7 mm -120.14 79.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 144.81 17.41 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.416 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 9.46 42.0 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.576 0.688 . . . . 0.0 111.534 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.83 164.0 15.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.745 0.783 . . . . 0.0 111.612 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.47 HD21 ' CB ' ' B' ' 75' ' ' ASP . 43.8 t-20 -74.47 159.37 32.35 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.42 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 42.2 p -74.78 -11.23 60.11 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.084 -0.385 . . . . 0.0 110.279 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.97 -9.36 28.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.107 0.963 . . . . 0.0 110.937 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -76.8 144.83 38.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.84 0.456 . . . . 0.0 109.924 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 -169.1 2.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -69.8 -34.84 74.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.72 -174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -66.83 -29.19 69.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 111.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.85 31.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.39 -28.24 22.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 109.774 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.62 -29.39 36.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.615 0.721 . . . . 0.0 110.111 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.69 -22.76 40.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.307 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.453 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.5 p -102.29 -35.16 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.453 ' CD2' HG11 ' B' ' 27' ' ' VAL . 90.3 m-85 -92.09 -10.69 38.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.182 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.57 -2.92 77.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.55 -12.8 58.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.972 1.309 . . . . 0.0 111.116 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.33 -19.04 12.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.686 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.72 165.42 36.15 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.159 0.436 . . . . 0.0 112.37 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -73.54 116.95 14.72 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.9 mt -75.9 141.65 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.636 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -22.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.131 0.573 . . . . 0.0 110.022 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.22 149.16 15.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.933 0.493 . . . . 0.0 109.83 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.36 144.99 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.306 0.574 . . . . 0.0 109.644 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.8 mt -121.12 154.59 35.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.307 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.14 117.93 6.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.442 ' HA ' ' HE2' ' B' ' 40' ' ' MET . 7.4 mmm -88.08 142.06 28.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.38 158.59 44.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.77 146.78 24.94 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.101 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -90.0 -2.38 58.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.48 -14.51 10.31 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.03 0.532 . . . . 0.0 112.08 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.8 p -127.98 -15.74 4.74 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.189 0.449 . . . . 0.0 111.609 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 57.01 23.53 8.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -73.66 -90.71 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.28 1.032 . . . . 0.0 111.17 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 23.2 t -165.79 152.47 9.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.649 1.579 . . . . 0.0 108.868 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -89.93 -2.3 58.14 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.75 1.42 85.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.149 0.88 . . . . 0.0 112.287 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.78 161.42 38.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.307 1.053 . . . . 0.0 110.13 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.99 -177.3 6.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.7 m-85 -142.24 160.35 40.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -154.06 140.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -113.11 122.86 48.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.151 0.282 . . . . 0.0 110.357 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -92.39 156.01 17.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.96 0.904 . . . . 0.0 111.93 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -74.22 -21.99 59.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.57 0.348 . . . . 0.0 111.135 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -121.88 141.49 34.13 Favored Pre-proline 0 C--N 1.34 0.164 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.45 -9.72 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.682 2.254 . . . . 0.0 110.3 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.19 -14.48 13.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.285 0.493 . . . . 0.0 110.572 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.446 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.5 m-20 -71.95 -28.5 63.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.18 56.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -68.46 -38.35 81.02 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.93 -32.41 72.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.71 -44.03 44.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.78 42.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 122.075 -0.39 . . . . 0.0 111.253 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -105.87 5.32 30.56 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 112.349 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.74 -52.29 1.24 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.498 0.666 . . . . 0.0 109.49 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.6 mmm -83.55 -9.46 58.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.397 1.479 . . . . 0.0 111.987 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.8 124.8 27.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.85 -4.92 85.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.23 -152.97 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.569 1.148 . . . . 0.0 109.459 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -140.61 158.86 43.36 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.757 0.789 . . . . 0.0 112.915 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 128.78 31.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.835 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.47 ' CB ' HD21 ' B' ' 16' ' ' ASN . 3.3 t0 52.57 22.53 2.22 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.145 0.497 . . . . 0.0 112.214 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.92 -3.33 57.16 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 119.32 -0.711 . . . . 0.0 113.853 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -114.99 130.13 56.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.216 1.008 . . . . 0.0 110.304 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 139.47 52.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.749 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 18.9 pt -124.89 174.82 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -119.01 144.36 46.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.184 1.794 . . . . 0.0 107.799 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.32 127.26 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -62.27 138.37 58.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.05 35.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 75.1 p -112.37 -179.62 3.72 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.125 171.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.34 154.04 59.52 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 123.228 0.611 . . . . 0.0 111.138 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.93 162.63 37.06 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.858 3.039 . . . . 0.0 111.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -130.58 10.33 5.17 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -81.71 2.07 31.42 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.699 -0.626 . . . . 0.0 111.986 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -143.54 156.95 44.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.531 0.333 . . . . 0.0 110.46 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 44.5 m -142.81 167.65 21.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.703 0.801 . . . . 0.0 110.795 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 156.16 48.61 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.43 160.38 42.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.439 0.696 . . . . 0.0 111.211 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 56.17 179.39 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.904 1.282 . . . . 0.0 112.468 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.302 0 CA-C-O 117.421 -1.766 . . . . 0.0 111.23 -179.512 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.539 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.301 1 O4'-C1'-N19 112.438 4.238 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.6 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.86 0 O4'-C1'-N19 111.388 3.188 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.021 0 C5'-C4'-C3' 112.411 -2.059 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 1 O4'-C1'-N19 114.683 6.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 2 C5'-C4'-C3' 108.069 -4.954 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C5'-C4'-C3' 111.135 -2.91 . 0.156 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.33 0.586 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.23 13.54 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.681 1.592 . . . . 0.0 107.351 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -74.56 142.95 44.66 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.502 -167.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.4 105.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -51.99 -70.99 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -148.04 138.98 13.34 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 118.731 0.696 . . . . 0.0 109.999 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.12 142.45 66.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.92 2.413 . . . . 0.0 110.781 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.82 67.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.97 126.79 39.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 68.6 mt -113.56 153.27 29.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.062 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -106.7 127.59 53.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.428 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -119.62 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.93 142.16 15.93 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.51 35.93 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.691 0.745 . . . . 0.0 111.805 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.39 164.36 16.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.155 0.502 . . . . 0.0 111.858 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t-20 -77.79 158.31 29.6 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.144 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 57.9 p -73.21 -6.97 49.34 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.401 0.68 . . . . 0.0 110.114 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.52 -10.19 21.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.654 1.181 . . . . 0.0 110.531 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 31.0 m -83.22 144.68 29.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.325 0.65 . . . . 0.0 109.822 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.89 -170.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -66.99 -34.92 78.81 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.093 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -67.6 -29.03 68.27 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 118.016 0.371 . . . . 0.0 111.099 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.27 29.42 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.44 -27.89 22.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 109.555 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.45 -28.23 34.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 109.899 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.65 -21.78 37.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.42 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' B' ' 28' ' ' PHE . 6.5 p -103.41 -36.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.441 ' CD2' HG12 ' B' ' 27' ' ' VAL . 89.9 m-85 -90.63 -11.36 40.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.817 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.9 -3.04 73.05 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.62 -11.87 58.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.682 1.193 . . . . 0.0 110.855 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -111.82 -19.5 12.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.83 166.61 37.49 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 118.046 0.384 . . . . 0.0 112.406 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 43.5 ttt-85 -73.74 117.52 15.62 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.09 142.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.56 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -22.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 123.212 0.605 . . . . 0.0 110.137 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -161.73 150.21 15.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.05 0.54 . . . . 0.0 109.878 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.58 146.4 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.056 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -121.3 154.63 36.13 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.378 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.413 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -152.68 118.36 5.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.6 mmm -91.38 139.85 30.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.851 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.413 ' HE2' HD13 ' B' ' 39' ' ' LEU . 8.9 mttt -135.84 152.55 51.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.477 0.656 . . . . 0.0 112.472 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.5 143.03 54.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.862 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -82.49 -8.21 59.62 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -117.46 -12.72 10.38 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -129.51 -14.88 4.11 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.217 0.462 . . . . 0.0 111.714 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.8 22.49 7.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.0 -106.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.772 1.229 . . . . 0.0 109.651 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 22.8 t -151.14 143.72 24.33 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -76.59 -6.05 50.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.58 89.45 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.401 -0.666 . . . . 0.0 111.559 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -138.49 157.46 46.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.559 1.18 . . . . 0.0 109.952 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.93 -179.1 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.455 0.302 . . . . 0.0 110.853 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 49.9 m-85 -142.67 162.61 35.01 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.848 0.459 . . . . 0.0 110.215 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.87 141.53 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.6 m -113.3 123.54 50.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.336 0.397 . . . . 0.0 110.135 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.65 156.85 16.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.695 0.798 . . . . 0.0 111.627 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.19 -22.42 59.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.608 0.363 . . . . 0.0 111.275 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -121.23 140.04 30.51 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.395 0.543 . . . . 0.0 110.084 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -76.2 0.72 9.08 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.231 2.62 . . . . 0.0 110.583 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.46 -16.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.063 0.392 . . . . 0.0 111.356 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.438 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.9 m-20 -71.75 -28.57 63.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.49 57.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.66 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -74.5 -37.01 63.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.76 -24.61 64.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.488 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.24 14.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.38 45.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -109.06 9.36 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 112.224 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -52.25 1.33 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.54 -175.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mmm -83.12 -9.17 59.35 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.846 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -75.22 127.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.829 -0.544 . . . . 0.0 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.12 83.16 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.51 -154.17 0.11 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.518 1.127 . . . . 0.0 109.436 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.8 t -140.3 159.19 42.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.0 112.311 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.567 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -133.37 126.8 32.11 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.046 177.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.43 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.7 t70 61.53 -22.24 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.513 1.125 . . . . 0.0 113.821 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.87 -6.28 0.53 Allowed Glycine 0 N--CA 1.439 -1.123 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.19 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -118.46 134.38 55.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.959 0.879 . . . . 0.0 110.341 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.55 138.42 48.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.471 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.08 175.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -119.89 142.46 48.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.13 1.772 . . . . 0.0 107.397 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.56 125.41 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -162.05 164.42 28.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -57.79 134.8 56.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.9 158.8 32.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.271 0.558 . . . . 0.0 112.359 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -119.31 168.04 11.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.491 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -68.17 151.78 96.96 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.526 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.82 164.9 32.9 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.878 3.052 . . . . 0.0 110.369 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -119.44 2.84 11.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -88.23 -1.51 58.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.34 0.518 . . . . 0.0 111.011 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.35 176.97 8.35 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.427 0.691 . . . . 0.0 111.235 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 11.7 t -147.12 165.08 31.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.875 0.47 . . . . 0.0 110.398 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.52 128.11 32.38 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.6 167.42 28.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.601 0.761 . . . . 0.0 110.479 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 53.04 29.95 8.78 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 0.0 111.992 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.116 -1.936 . . . . 0.0 110.934 -179.063 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.55 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.344 2 C5'-C4'-C3' 109.32 -4.12 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.634 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.985 0 O4'-C1'-N19 111.403 3.203 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . 0.419 ' P ' HO2' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 O4'-C1'-N19 110.493 2.293 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 114.085 5.885 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 2 C5'-C4'-C3' 109.161 -4.226 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.96 0 O4'-C1'-N19 111.471 3.271 . 0.583 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.287 0.565 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.6 15.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.316 1.446 . . . . 0.0 107.749 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -76.74 139.99 40.65 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.317 -168.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.43 115.86 16.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -73.18 51.63 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 113.068 -173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 60.98 147.02 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 127.261 2.224 . . . . 0.0 114.708 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.17 150.43 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.991 3.127 . . . . 0.0 112.841 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.76 -15.81 58.07 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -101.13 129.9 47.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.018 0.909 . . . . 0.0 108.891 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.401 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.4 mt -113.35 153.61 28.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -107.73 129.23 55.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.442 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -121.0 82.37 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.07 144.44 17.28 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.758 -0.589 . . . . 0.0 112.001 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.71 9.21 43.96 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 117.524 0.662 . . . . 0.0 111.597 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.91 162.86 12.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.579 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.437 HD21 ' HB3' ' B' ' 75' ' ' ASP . 43.6 t-20 -73.51 159.95 32.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.598 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.9 p -74.53 -4.56 37.64 Favored 'General case' 0 N--CA 1.457 -0.075 0 C-N-CA 122.902 0.481 . . . . 0.0 110.366 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.25 -7.68 18.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 110.81 -172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.7 m -80.54 144.19 32.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.922 0.489 . . . . 0.0 109.937 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.63 -169.66 2.45 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -68.85 -35.36 76.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.778 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -65.68 -29.71 70.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.916 -0.49 . . . . 0.0 110.97 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.89 -20.99 28.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -89.34 -27.97 20.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.802 1.241 . . . . 0.0 109.606 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.35 -27.82 31.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 109.907 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -23.26 38.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.309 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.1 p -101.06 -35.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.442 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 87.8 m-85 -92.1 -10.87 37.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.283 -0.261 . . . . 0.0 111.024 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.67 -2.62 76.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.72 -11.25 59.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.431 1.092 . . . . 0.0 111.159 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.93 -18.85 11.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.39 0.676 . . . . 0.0 112.634 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -174.83 161.19 30.64 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -72.6 124.22 24.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.89 143.49 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.286 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.07 -23.56 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.351 0.66 . . . . 0.0 110.076 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.02 150.47 16.94 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.99 146.58 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 121.28 0.562 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -121.32 153.67 37.43 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.245 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.38 118.83 6.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.7 mmm -92.31 137.59 32.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.932 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -148.2 154.04 39.57 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.331 0.586 . . . . 0.0 111.293 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.73 163.94 10.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.047 0.939 . . . . 0.0 110.622 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -111.96 -4.47 14.53 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.86 0.464 . . . . 0.0 111.878 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.24 -14.19 15.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.595 0.758 . . . . 0.0 110.727 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -131.21 -14.95 3.33 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 122.773 0.429 . . . . 0.0 111.722 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 13.1 6.42 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -87.87 144.67 26.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.402 0.681 . . . . 0.0 110.178 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -55.53 138.75 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.474 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -71.09 -9.45 58.07 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.253 1.021 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.46 0.5 79.41 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.698 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -136.92 158.42 44.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.434 1.117 . . . . 0.0 110.376 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.02 -179.5 8.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.868 0.467 . . . . 0.0 110.728 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.8 m-85 -141.85 161.98 36.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.659 0.383 . . . . 0.0 110.231 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.81 141.13 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.3 m -113.52 122.12 46.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.349 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -92.82 156.95 16.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.938 0.895 . . . . 0.0 110.768 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -79.63 -20.97 45.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.451 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -118.16 138.85 25.96 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.46 -6.6 18.55 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.635 2.224 . . . . 0.0 110.431 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.26 -14.77 12.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.201 0.455 . . . . 0.0 111.135 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.434 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.7 m-20 -71.53 -28.46 63.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 -30.52 52.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.394 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.01 -39.14 79.48 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.04 -32.17 72.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.72 45.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.39 -7.55 48.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.209 -0.307 . . . . 0.0 111.163 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -105.26 5.67 32.23 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.521 1.128 . . . . 0.0 112.344 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.16 -51.68 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.768 0.794 . . . . 0.0 109.755 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.9 mmm -83.59 -10.13 58.46 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.145 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.7 126.13 29.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.48 -5.74 84.54 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.59 -0.561 . . . . 0.0 111.841 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.54 -153.72 0.11 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.361 1.064 . . . . 0.0 109.473 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -139.84 158.75 43.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.564 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.9 126.99 31.58 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.496 177.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.5 t70 61.19 -21.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.18 -7.03 0.53 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.4 135.16 54.86 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.264 1.032 . . . . 0.0 110.218 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.31 138.89 51.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.597 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.9 pt -121.22 179.52 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -125.05 145.02 50.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.823 1.649 . . . . 0.0 107.787 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -133.12 129.49 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -158.1 163.31 37.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -65.24 137.06 57.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.22 155.57 38.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p -120.77 175.29 6.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.228 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.63 152.36 92.84 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.078 0.551 . . . . 0.0 110.426 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.95 154.63 73.2 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.378 2.718 . . . . 0.0 110.331 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 35.2 m -80.7 1.2 31.17 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -97.42 3.37 50.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.06 0.391 . . . . 0.0 111.073 175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.66 154.02 42.96 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.337 0.589 . . . . 0.0 111.539 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 70.5 m -144.17 20.2 1.75 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.304 1.042 . . . . 0.0 110.623 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.05 -148.56 28.6 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.461 ' HG2' ' H ' ' B' ' 94' ' ' ARG . 25.9 ttp180 49.97 -142.28 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.687 0.795 . . . . 0.0 110.681 -177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' B' ' 93' ' ' ARG . 61.3 ttp180 -148.37 150.56 33.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.861 1.264 . . . . 0.0 109.067 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.475 -1.736 . . . . 0.0 110.928 179.586 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.549 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 O4'-C1'-N19 112.051 3.851 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.606 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.064 0 C3'-C2'-C1' 104.607 3.452 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 C5'-C4'-C3' 112.522 -1.986 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 1 O4'-C1'-N19 114.246 6.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.368 2 O4'-C1'-N19 114.066 5.866 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 0 O4'-C1'-N19 111.244 3.044 . 0.202 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.358 0.599 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.08 127.58 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -130.85 125.12 32.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.058 0.456 . . . . 0.0 111.142 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.33 105.2 13.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.75 -36.18 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -162.75 134.11 3.78 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 118.473 0.579 . . . . 0.0 111.225 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.29 149.01 67.29 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.282 2.655 . . . . 0.0 111.637 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.96 -19.14 54.76 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -86.13 129.05 34.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -116.69 155.53 28.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.362 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.58 129.67 55.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.428 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -121.72 80.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.7 144.63 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.267 -0.492 . . . . 0.0 111.977 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.48 7.52 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 117.497 0.649 . . . . 0.0 111.545 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 mt -64.24 164.75 10.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.163 0.585 . . . . 0.0 111.166 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.483 HD21 ' CB ' ' B' ' 75' ' ' ASP . 43.0 t-20 -72.1 158.94 35.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.46 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.8 p -75.79 -4.77 42.47 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.218 -0.301 . . . . 0.0 110.375 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.49 -7.38 17.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.127 0.971 . . . . 0.0 111.066 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.2 m -79.18 144.89 34.01 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.09 0.556 . . . . 0.0 109.576 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.93 2.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.171 0.51 . . . . 0.0 110.009 175.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.86 -34.37 76.56 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.756 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.41 -30.36 70.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.046 -0.409 . . . . 0.0 110.923 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.74 -21.41 30.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.84 -28.47 19.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 109.928 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.8 -27.92 33.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.237 0.542 . . . . 0.0 110.119 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.34 -22.95 38.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.241 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -100.96 -36.65 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.428 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 89.6 m-85 -91.03 -10.89 40.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.958 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.75 -3.2 72.58 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -82.12 -11.76 58.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.63 1.172 . . . . 0.0 111.034 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.43 -19.88 11.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.364 0.665 . . . . 0.0 112.538 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.71 165.36 36.06 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 118.051 0.387 . . . . 0.0 112.189 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -73.09 117.97 15.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.3 141.35 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.509 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.74 -24.49 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.871 0.468 . . . . 0.0 110.093 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -160.35 151.36 19.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.66 146.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 109.699 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -118.99 153.95 33.82 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.1 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -153.66 120.23 5.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.41 140.02 30.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.663 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -145.98 155.51 42.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.257 0.551 . . . . 0.0 112.304 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.38 161.18 23.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.925 1.29 . . . . 0.0 111.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -103.83 -3.93 24.24 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.045 0.538 . . . . 0.0 112.266 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.17 -14.03 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 111.65 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 33.9 p -128.14 -14.93 4.82 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.546 0.339 . . . . 0.0 111.292 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 63.11 9.56 3.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -83.8 148.86 26.78 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.745 0.818 . . . . 0.0 110.043 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 m -57.73 139.49 53.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.517 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -72.94 -2.7 21.94 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.666 0.786 . . . . 0.0 110.133 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.83 75.79 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.34 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -141.74 157.97 44.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.627 1.213 . . . . 0.0 110.619 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.688 0.395 . . . . 0.0 110.791 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.7 m-85 -141.93 162.44 35.46 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.004 0.522 . . . . 0.0 110.127 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.36 139.86 12.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -112.18 122.17 46.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -92.16 156.17 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.023 0.929 . . . . 0.0 111.642 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.56 -21.92 59.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 122.612 0.365 . . . . 0.0 111.061 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.7 t -121.23 140.48 31.26 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.45 -7.43 19.57 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.462 2.108 . . . . 0.0 110.472 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.13 -15.87 13.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.369 0.267 . . . . 0.0 110.902 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.443 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 75.0 m-20 -70.76 -28.35 64.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.14 54.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.553 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -68.83 -39.04 80.19 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.99 -36.34 81.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.6 64.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.5 47.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.199 -0.313 . . . . 0.0 111.185 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -105.41 7.59 33.26 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.465 1.106 . . . . 0.0 112.274 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.61 -52.27 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.826 0.739 . . . . 0.0 109.568 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.32 -9.88 59.3 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.595 1.558 . . . . 0.0 112.439 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.71 125.38 27.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.74 -5.79 84.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.54 -153.98 0.09 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.474 1.11 . . . . 0.0 109.712 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 26.2 t -139.49 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.865 0.841 . . . . 0.0 112.814 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.46 129.09 30.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.757 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.483 ' CB ' HD21 ' B' ' 16' ' ' ASN . 6.4 t0 52.89 22.24 2.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.058 0.456 . . . . 0.0 112.131 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.86 -2.46 58.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.978 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.92 130.19 56.86 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.251 1.026 . . . . 0.0 110.557 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.46 138.25 50.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.502 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.91 178.39 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -122.8 141.51 51.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.717 2.007 . . . . 0.0 107.317 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.15 130.22 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -159.12 164.15 35.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -69.57 132.44 46.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 148.1 33.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.9 p -112.25 167.49 10.38 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.486 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -59.14 149.51 67.07 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.107 0.563 . . . . 0.0 111.024 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.02 157.64 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.709 2.939 . . . . 0.0 110.356 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.6 t -71.9 -10.74 60.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.684 0.794 . . . . 0.0 111.698 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -106.91 6.71 29.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.047 -0.408 . . . . 0.0 111.304 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 49.47 -169.31 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.89 1.676 . . . . 0.0 113.846 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 36.2 t -148.31 148.18 30.13 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.738 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.04 -3.86 88.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -103.77 -30.13 10.59 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 112.078 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -141.4 11.7 2.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.261 -1.855 . . . . 0.0 111.037 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.546 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.367 1 C5'-C4'-C3' 109.104 -4.264 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.623 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.03 0 C3'-C2'-C1' 104.41 3.234 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.821 1 C5'-C4'-C3' 109.432 -4.045 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.773 1 O4'-C1'-N19 114.183 5.983 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 2 O4'-C1'-N19 112.924 4.724 . 0.013 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C5'-C4'-C3' 111.478 -2.682 . 0.578 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.427 0.156 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.54 109.77 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -135.12 141.57 46.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.037 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.64 101.4 3.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 129.17 34.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.707 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 45.96 107.6 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 127.33 2.252 . . . . 0.0 115.066 175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.406 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 79.2 Cg_exo -52.56 144.05 43.26 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.925 2.416 . . . . 0.0 110.679 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.86 -17.94 57.65 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -82.15 129.65 34.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.89 159.51 23.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.04 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -112.62 129.71 56.28 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.453 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.5 mm -122.08 81.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -174.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.38 145.5 17.78 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.197 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.76 33.24 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 117.57 0.685 . . . . 0.0 112.026 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.13 168.03 3.59 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 112.586 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' B' ' 18' ' ' GLU . 51.7 t30 -73.27 -6.41 45.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 1.7 p 68.76 -13.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.652 1.581 . . . . 0.0 113.479 -170.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' B' ' 16' ' ' ASN . 7.8 mm-40 -98.72 -7.25 28.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.42 0.688 . . . . 0.0 109.301 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -76.25 147.52 38.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.531 1.132 . . . . 0.0 109.521 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -170.14 2.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.586 0.707 . . . . 0.0 109.566 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.03 -35.79 80.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.542 -173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.83 -30.14 70.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.82 -20.39 23.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.08 -28.32 22.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.216 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -80.11 -26.94 39.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 110.058 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.57 38.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.478 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -103.89 -35.59 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.453 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.8 m-85 -92.33 -11.24 35.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.944 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.07 -2.84 73.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.77 -12.92 58.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.684 1.193 . . . . 0.0 111.073 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -111.34 -19.18 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 123.756 0.66 . . . . 0.0 112.547 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.33 165.88 35.49 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -73.29 117.09 14.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -76.1 139.08 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.246 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -24.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.944 0.497 . . . . 0.0 109.863 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -160.38 150.87 18.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.078 0.551 . . . . 0.0 109.562 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.4 145.57 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.34 0.591 . . . . 0.0 109.572 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -119.05 153.02 35.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.661 -1.154 . . . . 0.0 107.91 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.02 117.42 5.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.1 mmm -91.88 139.97 30.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.65 152.29 39.42 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.38 165.45 9.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.978 1.311 . . . . 0.0 111.834 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -109.77 -5.4 15.6 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.375 0.67 . . . . 0.0 111.77 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -111.16 -13.69 13.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.534 0.734 . . . . 0.0 111.63 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 51.6 p -128.38 -15.76 4.53 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.506 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 30.8 m120 59.62 10.35 1.92 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 123.107 0.254 . . . . 0.0 111.609 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -82.23 155.13 25.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 37.3 t -59.66 148.93 32.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.754 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -69.99 -5.12 24.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.21 1.73 81.24 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.51 157.67 46.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.248 1.024 . . . . 0.0 110.775 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.53 -179.19 7.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.205 0.602 . . . . 0.0 110.62 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 42.6 m-85 -142.53 162.04 36.5 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.91 138.69 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -111.89 122.08 46.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.681 0.392 . . . . 0.0 109.975 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -92.07 156.08 17.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.822 0.849 . . . . 0.0 111.616 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.11 -22.51 60.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.857 0.463 . . . . 0.0 111.063 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.1 t -121.74 139.98 31.05 Favored Pre-proline 0 CA--C 1.52 -0.2 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . 0.406 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 61.6 Cg_endo -74.59 -3.0 13.19 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.897 2.398 . . . . 0.0 110.48 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.02 -14.84 11.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 123.141 0.276 . . . . 0.0 111.278 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.441 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 79.8 m-20 -71.57 -28.93 64.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.42 -30.79 57.56 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.507 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -68.87 -38.83 79.97 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.15 -32.6 72.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.92 -44.48 48.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 -7.38 45.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.315 -0.241 . . . . 0.0 111.41 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -105.59 5.28 31.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.129 0.972 . . . . 0.0 112.08 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.28 -53.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 29.7 mmm -82.2 -10.08 59.28 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.569 1.548 . . . . 0.0 112.205 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.98 126.37 30.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.609 -0.682 . . . . 0.0 109.381 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.11 81.22 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.43 -153.96 0.11 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.449 1.099 . . . . 0.0 109.319 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -137.53 158.68 43.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.529 0.681 . . . . 0.0 112.649 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.15 125.27 30.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' B' ' 16' ' ' ASN . 11.4 t0 57.16 -2.02 0.05 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 137.62 -11.41 3.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.762 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.35 137.2 54.41 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.315 1.058 . . . . 0.0 111.092 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 140.33 56.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.239 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.51 177.63 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -120.79 142.52 49.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.883 1.673 . . . . 0.0 107.386 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.37 127.19 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -158.88 163.58 36.47 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -65.76 134.61 53.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.14 139.25 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.2 p -95.8 167.78 11.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.7 154.34 85.37 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.55 159.43 48.02 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.922 2.415 . . . . 0.0 110.15 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -122.8 5.28 9.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.336 0.654 . . . . 0.0 112.638 -170.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -75.37 -2.57 29.1 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.913 -0.492 . . . . 0.0 110.726 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' B' ' 92' ' ' GLY . 26.5 tt0 -143.36 143.91 31.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.011 0.524 . . . . 0.0 109.826 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -100.9 -0.18 37.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.762 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . -70.66 133.32 23.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -142.64 173.17 11.78 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.679 0.792 . . . . 0.0 110.15 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -127.27 152.28 47.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.715 0.806 . . . . 0.0 110.504 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.02 -1.989 . . . . 0.0 111.128 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.538 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 1 C5'-C4'-C3' 108.581 -4.613 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.6 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.97 0 C3'-C2'-C1' 104.65 3.5 OUTLIER-DELTA 0.013 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.938 0 C5'-C4'-O4' 111.924 1.946 . 0.026 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 1 O4'-C1'-N19 113.153 4.953 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.283 1 O4'-C1'-N19 113.132 4.932 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 O4'-C1'-N19 111.316 3.116 . 0.439 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.626 ' HE3' ' HA ' ' B' ' 1' ' ' MET . 8.7 mmt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.63 6.63 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 122.109 0.957 . . . . 0.0 109.801 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' B' ' 1' ' ' MET . 40.6 mm-40 -83.76 129.44 34.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.994 0.918 . . . . 0.0 109.825 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.66 102.54 11.99 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.24 75.32 2.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.402 1.081 . . . . 0.0 112.477 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 60.7 137.75 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 126.425 1.89 . . . . 0.0 114.114 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -51.96 147.56 25.78 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.22 2.614 . . . . 0.0 112.169 173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.61 56.34 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-O 119.125 -0.82 . . . . 0.0 111.137 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.25 127.07 38.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.088 0.944 . . . . 0.0 108.734 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.0 mt -113.39 149.23 34.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.19 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.33 127.88 49.14 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.438 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 10.0 mm -118.94 77.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -173.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.59 144.63 17.2 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.14 45.22 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 117.733 0.767 . . . . 0.0 111.752 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.52 163.88 12.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.152 0.581 . . . . 0.0 111.408 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.456 HD21 ' HB3' ' B' ' 75' ' ' ASP . 56.5 t30 -72.78 155.9 39.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.71 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 62.0 p -74.69 -0.95 19.72 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.367 0.267 . . . . 0.0 111.093 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -110.5 -5.79 15.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 110.668 -171.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -82.93 144.71 29.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.084 0.554 . . . . 0.0 109.571 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -169.74 2.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.19 -35.37 79.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.764 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.32 -29.15 68.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.041 -0.412 . . . . 0.0 111.061 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.51 -21.03 28.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.65 -28.43 20.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.91 1.284 . . . . 0.0 109.532 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.25 -28.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.632 0.73 . . . . 0.0 109.903 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.38 -23.11 40.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.162 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.42 HG12 ' CD2' ' B' ' 28' ' ' PHE . 5.4 p -101.92 -34.53 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 87.4 m-85 -91.48 -10.66 40.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.719 -0.218 . . . . 0.0 111.064 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.3 -2.44 79.17 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -82.21 -11.97 58.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.406 1.082 . . . . 0.0 111.002 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.74 -19.89 11.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.573 0.749 . . . . 0.0 112.739 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.84 166.59 37.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -74.03 116.83 15.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.94 141.13 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -22.71 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -160.85 150.06 16.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.01 0.524 . . . . 0.0 109.846 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.81 144.13 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.1 mt -120.17 158.44 26.93 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.105 175.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -155.91 123.17 5.43 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.426 ' HA ' ' HE1' ' B' ' 40' ' ' MET . 0.0 OUTLIER -93.99 137.3 33.35 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -174.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -143.06 150.86 40.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.418 0.449 . . . . 0.0 110.89 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.84 157.37 35.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.662 0.785 . . . . 0.0 111.579 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -89.13 -11.37 44.11 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.338 0.255 . . . . 0.0 111.2 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -106.05 -15.16 14.96 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 112.106 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 71.2 p -133.33 -13.18 2.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 58.18 14.12 2.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.881 0.309 . . . . 0.0 111.488 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -86.27 147.18 26.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 m -57.0 134.12 55.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -76.31 4.76 8.2 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.566 0.222 . . . . 0.0 110.5 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.15 3.7 78.85 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.436 -0.647 . . . . 0.0 112.127 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.22 157.7 45.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.357 1.079 . . . . 0.0 110.741 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.84 -178.41 7.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.893 0.477 . . . . 0.0 110.501 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.5 m-85 -142.34 163.18 33.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.568 0.347 . . . . 0.0 110.42 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -153.78 146.36 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -117.37 123.44 46.47 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.316 0.385 . . . . 0.0 110.201 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -93.55 156.15 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.33 0.652 . . . . 0.0 111.925 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.52 -22.67 58.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.2 t -121.33 141.11 32.52 Favored Pre-proline 0 C--O 1.233 0.202 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.29 -8.84 21.3 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.557 2.172 . . . . 0.0 110.08 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.02 -15.24 13.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.588 0.355 . . . . 0.0 110.732 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.2 m-20 -72.43 -29.02 63.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.07 -29.61 58.05 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.44 -38.13 77.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.24 -32.31 71.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 -46.32 40.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.12 47.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.083 -0.386 . . . . 0.0 111.49 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -102.64 7.38 39.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.468 1.107 . . . . 0.0 112.646 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.28 -51.31 0.94 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.491 1.138 . . . . 0.0 109.373 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' MET . . . . . 0.511 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 45.4 mmm -79.43 -16.45 56.14 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.669 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -73.96 119.02 17.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.94 74.86 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.359 -0.689 . . . . 0.0 112.652 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 7.9 ptpt -88.26 179.63 6.32 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 118.377 1.088 . . . . 0.0 111.316 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -107.94 146.66 32.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 -63.9 1.13 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.4 0.619 . . . . 0.0 110.573 -176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.456 ' HB3' HD21 ' B' ' 16' ' ' ASN . 14.6 t70 -124.45 5.49 8.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.548 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.99 -11.96 2.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.43 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -115.79 133.45 56.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.58 0.752 . . . . 0.0 109.598 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.78 136.95 41.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.793 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 pt -115.29 175.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -120.27 142.67 48.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.58 1.552 . . . . 0.0 107.625 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.21 127.02 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -160.55 162.81 33.04 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -61.12 132.44 53.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.03 27.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.2 p -116.41 164.44 14.54 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.768 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.75 152.1 82.98 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.461 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.84 152.69 80.84 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.429 2.753 . . . . 0.0 110.69 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 70.5 m -79.67 0.22 31.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.824 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -100.9 17.76 21.36 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.176 0.444 . . . . 0.0 110.884 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' B' ' 91' ' ' SER . 12.3 tt0 -134.8 166.34 23.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.2 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' B' ' 90' ' ' GLU . 8.1 t -117.56 15.97 14.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.236 0.614 . . . . 0.0 111.51 -175.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.68 15.38 81.38 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.859 -0.526 . . . . 0.0 112.04 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -70.15 -3.05 14.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.271 0.628 . . . . 0.0 112.684 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -138.75 153.38 48.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.352 0.661 . . . . 0.0 109.934 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 CA-C-O 117.631 -1.649 . . . . 0.0 110.827 -178.495 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.581 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.511 1 C5'-C4'-C3' 109.241 -4.173 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.586 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.11 0 C3'-C2'-C1' 104.468 3.298 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 C5'-C4'-C3' 110.166 -3.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.945 1 O4'-C1'-N19 113.848 5.648 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 2 O4'-C1'-N19 112.558 4.358 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 C5'-C4'-C3' 111.411 -2.726 . 0.62 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.614 ' HE3' ' HA ' ' B' ' 1' ' ' MET . 5.3 mmt . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.917 0.389 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.1 1.64 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-O 122.538 1.161 . . . . 0.0 109.729 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' B' ' 1' ' ' MET . 28.4 mm-40 -75.81 146.11 40.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.28 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.39 96.64 3.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.28 123.18 29.35 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 49.83 106.7 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.347 1.859 . . . . 0.0 113.919 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.422 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 91.7 Cg_exo -49.88 136.53 35.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 171.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.0 -11.55 58.87 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.95 127.12 36.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -113.8 153.37 29.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -106.71 127.75 53.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.433 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 8.1 mm -119.05 77.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.63 144.86 17.41 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.67 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.43 10.19 42.12 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 117.589 0.694 . . . . 0.0 111.422 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.78 163.71 13.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.377 0.671 . . . . 0.0 111.96 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' B' ' 75' ' ' ASP . 43.9 t-20 -73.96 160.76 30.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.461 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.3 p -75.74 -3.87 37.28 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.706 0.402 . . . . 0.0 110.382 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.68 -7.42 18.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.358 1.063 . . . . 0.0 110.888 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -81.63 143.7 31.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.737 0.415 . . . . 0.0 110.235 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -170.25 2.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.73 -35.5 78.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.89 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.57 -28.96 68.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.275 -0.265 . . . . 0.0 111.141 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.4 -20.63 27.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.6 -29.17 20.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.969 1.308 . . . . 0.0 109.458 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.52 -29.6 37.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 0.0 109.944 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -23.3 41.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.118 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.7 p -101.37 -34.26 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 86.4 m-85 -93.55 -10.34 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.335 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -3.66 76.18 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -80.84 -13.26 59.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.697 1.199 . . . . 0.0 111.123 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -111.67 -19.04 12.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.75 163.69 32.21 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 117.897 0.317 . . . . 0.0 112.448 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -67.23 116.08 7.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.87 141.57 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.741 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -21.17 5.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.934 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.77 149.9 15.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.35 144.64 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.309 0.576 . . . . 0.0 109.663 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.465 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.4 mt -120.12 155.65 32.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.511 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -152.33 119.15 5.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.407 ' HA ' ' HE1' ' B' ' 40' ' ' MET . 6.9 mmm -92.8 139.19 30.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.763 -170.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.68 153.67 37.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.101 0.477 . . . . 0.0 111.644 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -65.49 163.02 16.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.0 111.987 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -102.62 -7.92 21.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.669 0.387 . . . . 0.0 111.867 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.62 -14.33 15.31 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.959 0.504 . . . . 0.0 111.216 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -133.19 -13.28 2.75 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.729 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 32.1 m120 59.0 13.24 2.74 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.155 0.284 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.42 145.96 27.2 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.328 0.651 . . . . 0.0 109.546 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 m -52.9 139.24 27.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.562 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -73.95 -2.19 22.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.395 0.678 . . . . 0.0 109.518 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 2.01 82.94 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.313 0.959 . . . . 0.0 112.003 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -142.61 162.26 35.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.321 1.06 . . . . 0.0 110.308 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -177.85 6.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 52.6 m-85 -141.3 162.12 36.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.83 0.348 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.05 139.16 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -110.23 124.31 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.755 0.312 . . . . 0.0 110.287 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -93.53 156.09 16.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.919 0.888 . . . . 0.0 111.062 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.648 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -120.9 140.08 30.21 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . 0.422 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 65.5 Cg_endo -74.59 -2.54 12.57 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.746 2.297 . . . . 0.0 110.376 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.76 -15.25 10.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.03 0.377 . . . . 0.0 111.299 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.7 m-20 -71.76 -28.43 63.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.4 58.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.172 0.589 . . . . 0.0 110.384 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.16 -37.64 75.27 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.61 -30.74 69.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.3 33.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.99 -7.81 48.87 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.95 -0.469 . . . . 0.0 111.266 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -104.3 4.94 34.2 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 112.462 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.01 -54.2 1.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.706 0.765 . . . . 0.0 109.455 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.4 mmm -81.0 -11.22 59.6 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.444 1.498 . . . . 0.0 112.076 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -73.35 127.54 32.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.93 -7.17 78.7 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.72 -153.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.281 1.032 . . . . 0.0 109.37 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 29.3 t -139.58 159.43 42.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.493 0.663 . . . . 0.0 112.777 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.554 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.0 126.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.292 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.433 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.2 t70 61.33 -21.12 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.51 -7.5 0.52 Allowed Glycine 0 N--CA 1.439 -1.119 0 CA-C-O 119.183 -0.787 . . . . 0.0 112.962 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.04 134.97 54.87 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.188 0.994 . . . . 0.0 110.205 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.99 139.03 50.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.63 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.4 pt -121.28 177.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -121.63 143.49 49.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 107.37 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.88 163.77 36.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -63.55 136.11 57.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.87 38.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.161 0.505 . . . . 0.0 112.239 -172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p -110.16 174.94 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.265 172.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.4 151.4 87.56 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.892 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.402 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 73.7 Cg_endo -67.67 159.98 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.031 3.154 . . . . 0.0 111.283 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.08 -8.32 57.98 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -96.46 16.05 19.72 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.69 0.677 . . . . 0.0 112.343 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -114.94 148.84 38.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.618 0.723 . . . . 0.0 111.42 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 29.8 m -86.97 15.15 6.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.984 1.314 . . . . 0.0 112.069 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.91 -4.57 34.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.888 -0.396 . . . . 0.0 112.376 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 ptp85 -80.68 -1.94 44.6 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.677 0.739 . . . . 0.0 111.991 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.77 168.4 22.23 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 122.994 0.518 . . . . 0.0 111.237 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.482 -1.732 . . . . 0.0 110.893 177.141 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.549 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.276 1 C5'-C4'-C3' 109.434 -4.044 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.593 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.997 0 C3'-C2'-C1' 104.147 2.941 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 O4'-C1'-N19 110.449 2.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 1 O4'-C1'-N19 114.401 6.201 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.402 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.423 -2.492 2 C5'-C4'-C3' 108.854 -4.431 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.825 0 C5'-C4'-C3' 110.628 -3.248 . 0.215 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.385 0.612 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.06 126.19 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -132.27 137.2 47.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.726 0.774 . . . . 0.0 111.782 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.26 11.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.44 48.6 0.35 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.407 1.083 . . . . 0.0 112.422 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 61.3 153.02 0.11 Allowed Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 126.977 2.111 . . . . 0.0 114.108 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -53.91 151.86 25.26 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.923 3.082 . . . . 0.0 113.063 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.68 -17.45 45.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.27 129.55 47.25 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.912 0.856 . . . . 0.0 108.78 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 75.7 mt -113.31 155.11 25.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.338 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -108.39 129.41 55.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.449 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -121.62 80.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -174.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.77 148.8 19.23 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.909 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.43 11.24 45.44 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 117.736 0.768 . . . . 0.0 112.054 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.93 163.02 20.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.435 0.636 . . . . 0.0 111.907 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.522 HD21 ' HB3' ' B' ' 75' ' ' ASP . 32.2 t-20 -71.27 165.52 23.49 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.417 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -85.48 -8.34 58.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.917 -0.489 . . . . 0.0 110.962 -174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -109.41 -1.35 18.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.28 1.432 . . . . 0.0 111.147 -177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 68.6 m -76.61 144.51 39.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.35 -167.58 2.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.06 -32.11 70.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.432 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -65.0 -32.68 74.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -21.88 27.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.16 -27.27 23.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.98 1.312 . . . . 0.0 109.348 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.06 -28.98 32.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 110.121 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.25 -20.37 41.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.505 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.4 p -104.33 -35.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.449 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 90.6 m-85 -91.83 -11.59 36.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.067 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.0 -3.57 75.22 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.53 -13.1 59.37 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.869 1.267 . . . . 0.0 111.002 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.6 -19.32 12.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.58 164.47 34.16 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.1 ttm105 -72.34 117.37 13.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -75.24 141.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.295 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -23.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.203 0.601 . . . . 0.0 109.958 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -161.18 150.51 16.67 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.054 0.541 . . . . 0.0 109.846 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.48 145.58 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.287 0.565 . . . . 0.0 109.812 172.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.3 mt -119.3 156.28 30.29 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.532 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.67 119.11 5.6 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.422 ' HA ' ' HE2' ' B' ' 40' ' ' MET . 10.8 mmm -94.69 144.05 25.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.062 -169.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.425 ' CA ' ' HG2' ' B' ' 49' ' ' ARG . 30.4 mttt -138.34 158.29 44.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.07 141.45 58.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.779 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -89.22 -2.95 58.7 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -115.66 -14.17 11.45 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.243 0.617 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -128.97 -13.83 4.52 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.116 0.416 . . . . 0.0 111.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 57.56 20.72 6.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.01 -116.55 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.489 1.115 . . . . 0.0 108.969 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -141.1 147.78 39.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.075 1.35 . . . . 0.0 107.95 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.425 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 48.1 mmm-85 -69.45 -10.56 58.54 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.11 2.42 88.12 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.649 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -135.57 160.0 39.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.61 1.205 . . . . 0.0 111.039 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -178.29 7.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.099 0.56 . . . . 0.0 110.716 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 65.7 m-85 -142.42 163.08 33.82 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.893 0.477 . . . . 0.0 109.865 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.66 142.48 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.7 m -114.68 122.92 47.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.437 0.295 . . . . 0.0 110.333 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.06 155.84 17.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.865 0.866 . . . . 0.0 111.974 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.29 -22.7 60.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.883 0.473 . . . . 0.0 111.291 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -121.18 140.88 31.88 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.65 -10.68 23.72 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.588 2.192 . . . . 0.0 110.396 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.63 -14.92 13.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.091 0.405 . . . . 0.0 110.671 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.2 m-20 -72.06 -27.62 62.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.38 -31.99 54.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.207 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -68.0 -39.59 83.21 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.37 -33.99 76.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.21 -44.41 53.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.08 44.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.093 -0.379 . . . . 0.0 111.37 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -105.59 4.51 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.338 1.055 . . . . 0.0 112.181 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.31 -52.91 1.39 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.779 0.799 . . . . 0.0 109.606 -175.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.1 mmm -82.69 -11.26 58.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.216 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.05 126.88 31.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.285 0.493 . . . . 0.0 109.752 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.86 -7.53 76.91 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.797 -0.446 . . . . 0.0 112.114 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.72 -156.94 0.19 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.582 1.153 . . . . 0.0 109.926 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -134.5 153.24 52.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 111.023 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.83 -65.99 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.388 0.613 . . . . 0.0 111.17 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.522 ' HB3' HD21 ' B' ' 16' ' ' ASN . 15.4 t70 -120.54 16.27 12.04 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.628 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.8 -6.54 12.35 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.637 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -111.57 131.78 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 108.893 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.64 137.66 39.58 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.3 pt -118.58 173.74 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -116.82 140.65 49.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.026 1.73 . . . . 0.0 107.221 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.4 126.59 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.25 163.4 38.81 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -64.67 135.41 55.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.72 153.73 36.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 73.8 p -116.44 170.49 8.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.144 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -73.23 152.17 90.25 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.161 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.404 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 59.7 Cg_endo -65.79 155.85 67.13 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.519 2.813 . . . . 0.0 110.655 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -80.92 -12.52 59.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.471 0.709 . . . . 0.0 112.661 -173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -95.47 19.93 10.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.023 -0.423 . . . . 0.0 111.606 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.47 156.84 48.24 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.096 0.475 . . . . 0.0 110.99 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -87.91 9.6 21.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 111.714 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.8 84.76 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.807 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.14 162.64 38.45 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.199 1.0 . . . . 0.0 110.873 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -161.87 151.16 15.97 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.853 0.461 . . . . 0.0 109.932 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 117.33 -1.817 . . . . 0.0 111.332 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.547 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.212 0 C5'-C4'-C3' 110.208 -3.528 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.629 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.004 0 C3'-C2'-C1' 104.524 3.36 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 1 C5'-C4'-C3' 108.973 -4.352 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 O4'-C1'-N19 113.696 5.496 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.404 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.423 -2.526 2 O4'-C1'-N19 112.521 4.321 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 0 O4'-C1'-N19 110.975 2.775 . 0.676 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.604 ' HA ' ' HE1' ' B' ' 1' ' ' MET . 6.0 mmt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.035 0.445 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.28 3.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 CA-C-O 122.612 1.196 . . . . 0.0 109.717 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' B' ' 1' ' ' MET . 26.0 mm-40 -80.87 128.0 33.17 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.127 -170.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.17 101.32 9.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.92 126.82 33.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.359 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 46.11 102.94 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 126.405 1.882 . . . . 0.0 113.992 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.491 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 96.8 Cg_exo -49.22 134.78 30.97 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.593 2.195 . . . . 0.0 109.943 171.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.68 50.33 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.85 127.84 37.47 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -113.82 147.83 37.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -102.61 127.44 49.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.448 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -117.98 81.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.6 140.74 15.22 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.809 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 5.75 32.77 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 117.272 0.536 . . . . 0.0 111.899 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mt -63.56 160.62 16.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.18 0.49 . . . . 0.0 110.958 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' B' ' 75' ' ' ASP . 45.4 t30 -69.23 159.27 33.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -71.69 -4.85 29.74 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.186 -0.321 . . . . 0.0 110.296 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.42 -8.36 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.86 1.264 . . . . 0.0 110.475 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 35.6 m -79.49 141.38 36.78 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.07 -168.03 2.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.393 0.616 . . . . 0.0 109.803 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.32 -30.57 68.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.97 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -66.77 -29.54 69.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.16 -17.73 28.59 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.68 -28.63 14.23 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.016 0.926 . . . . 0.0 110.495 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.28 -32.28 33.29 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.098 0.475 . . . . 0.0 109.72 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -29.7 43.28 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.208 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' B' ' 28' ' ' PHE . 3.6 p -91.6 -34.83 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.448 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 81.5 m-85 -91.42 -9.47 44.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.84 -4.88 86.17 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -78.61 -12.16 60.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.548 1.139 . . . . 0.0 111.193 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -115.63 -13.34 11.5 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.52 171.64 36.84 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 119.88 -1.152 . . . . 0.0 112.127 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -80.89 115.35 20.33 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.397 0.618 . . . . 0.0 109.689 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mt -74.18 139.84 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.745 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -19.06 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.061 175.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -163.15 149.66 12.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.407 0.683 . . . . 0.0 110.025 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.89 144.23 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 109.71 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -119.26 154.42 33.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.573 1.149 . . . . 0.0 108.047 173.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.93 118.97 6.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.402 ' HE2' ' HA ' ' B' ' 40' ' ' MET . 7.6 mmm -92.93 142.41 27.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.665 -169.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.58 151.63 35.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.062 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.42 153.82 18.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.385 1.074 . . . . 0.0 111.66 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -89.28 -14.22 36.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.745 0.418 . . . . 0.0 111.698 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -110.46 -14.05 14.16 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.806 0.443 . . . . 0.0 112.037 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 38.9 p -127.78 -12.94 5.35 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.538 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 59.61 11.71 2.51 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.367 0.417 . . . . 0.0 111.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -82.02 144.14 31.07 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -55.56 136.35 50.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.019 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -66.53 -11.38 52.51 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.218 0.607 . . . . 0.0 109.871 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 1.44 78.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -136.07 157.7 46.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.33 1.065 . . . . 0.0 110.421 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.32 6.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.2 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 48.1 m-85 -141.95 161.09 38.84 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -154.67 140.74 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 46.9 m -111.48 126.94 55.49 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.03 162.35 13.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.451 0.701 . . . . 0.0 110.328 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -72.26 -18.7 61.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -129.28 153.49 80.49 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 123.577 0.751 . . . . 0.0 110.126 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . 0.491 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 22.2 Cg_endo -81.58 3.14 8.05 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 122.714 2.276 . . . . 0.0 110.391 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.46 -15.18 7.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -86.22 -21.44 27.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.74 -28.27 61.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.055 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -69.23 -33.56 73.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.94 -27.33 63.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.97 -46.43 21.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.09 54.63 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.248 0.219 . . . . 0.0 111.369 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -101.69 9.31 41.11 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.298 1.039 . . . . 0.0 112.189 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -50.96 0.88 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.349 1.071 . . . . 0.0 109.127 -175.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' MET . . . . . 0.453 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 50.4 mmm -77.26 -18.56 57.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.27 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -75.95 110.42 10.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.06 -7.94 53.11 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.323 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.6 ptpt -90.15 -173.17 3.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.239 1.02 . . . . 0.0 110.446 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -122.84 153.52 39.48 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.778 0.799 . . . . 0.0 112.14 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -131.29 126.47 35.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.011 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.439 ' HB3' HD21 ' B' ' 16' ' ' ASN . 3.0 t70 62.25 -24.04 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 156.62 -10.99 0.29 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.081 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -118.14 137.23 53.11 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.977 0.888 . . . . 0.0 110.591 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.52 138.39 50.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.886 0.475 . . . . 0.0 110.82 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.53 166.24 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -115.18 146.31 41.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.598 1.559 . . . . 0.0 108.127 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.22 129.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.58 163.53 32.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -61.65 134.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.31 157.49 29.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.948 0.404 . . . . 0.0 112.028 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 63.1 p -116.18 169.44 9.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.392 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.65 153.56 90.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.72 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.402 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 43.3 Cg_endo -62.11 155.36 56.52 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.995 3.13 . . . . 0.0 111.199 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 44.4 m -76.93 -0.03 22.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.693 0.397 . . . . 0.0 111.676 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . 0.513 ' CD2' " H2'" ' A' ' 101' ' ' ' A' . 1.2 p90 -97.42 9.79 41.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.92 0.488 . . . . 0.0 111.453 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -130.14 164.71 23.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.909 0.484 . . . . 0.0 110.826 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 21.6 t -143.82 165.61 27.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.898 0.479 . . . . 0.0 110.866 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.84 0.32 82.8 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.615 0.626 . . . . 0.0 112.38 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -136.59 169.41 17.75 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.591 0.696 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -139.94 152.01 46.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.419 -1.767 . . . . 0.0 110.814 179.797 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.547 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.18 1 O4'-C1'-N19 112.42 4.22 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.604 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.091 0 C3'-C2'-C1' 104.424 3.249 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.727 -3.849 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 O4'-C1'-N19 113.348 5.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.402 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 112.835 4.635 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . 0.513 " H2'" ' CD2' ' B' ' 89' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.129 1 O4'-C1'-N19 114.077 5.877 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.478 ' HA ' ' CE ' ' B' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.314 0.578 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.21 8.51 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 122.689 1.233 . . . . 0.0 109.125 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -78.77 126.79 31.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.86 105.95 13.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.32 123.31 27.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.094 -171.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 46.87 118.55 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.886 2.474 . . . . 0.0 116.041 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.05 148.98 16.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.053 2.502 . . . . 0.0 111.306 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.74 -20.08 47.26 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -85.61 129.32 34.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.664 0.732 . . . . 0.0 109.209 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.22 153.37 35.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.379 0.671 . . . . 0.0 110.091 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -106.48 131.2 53.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 9.5 mm -121.85 80.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.19 148.7 19.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.937 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.8 11.02 51.63 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.619 0.709 . . . . 0.0 111.484 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.64 164.39 14.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.449 0.699 . . . . 0.0 111.449 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.458 HD21 ' HB3' ' B' ' 75' ' ' ASP . 56.3 t30 -72.59 156.91 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.889 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -76.36 -1.29 26.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.78 0.324 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.09 -5.8 15.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.392 1.077 . . . . 0.0 110.875 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.5 m -80.46 145.65 31.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.349 0.66 . . . . 0.0 110.186 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.59 -168.84 2.13 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.22 -33.19 71.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.48 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.13 -32.9 74.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.27 -22.1 27.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.84 -28.37 22.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.194 1.398 . . . . 0.0 109.453 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.08 -27.91 32.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.391 0.615 . . . . 0.0 110.05 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.6 -21.26 38.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.611 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.2 p -103.51 -34.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.427 ' CD2' HG11 ' B' ' 27' ' ' VAL . 87.3 m-85 -91.41 -11.63 37.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.949 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.23 -3.44 76.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.72 -12.81 59.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.758 1.223 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.55 -19.52 12.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.608 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.97 166.38 37.06 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.072 0.396 . . . . 0.0 112.369 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -73.9 117.13 15.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.2 mt -75.52 142.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -23.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.049 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.84 150.58 17.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.177 0.591 . . . . 0.0 109.794 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.09 144.63 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 109.75 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -116.74 154.19 31.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.47 117.68 6.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.5 mmm -92.68 138.08 31.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.753 -170.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -145.18 151.7 38.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 111.117 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.52 165.92 11.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.121 0.969 . . . . 0.0 112.006 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -107.44 -2.31 20.62 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.333 0.653 . . . . 0.0 111.824 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.65 -12.07 13.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.359 0.663 . . . . 0.0 111.439 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -132.69 -14.38 2.82 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.688 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 58.86 11.26 1.8 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.84 0.291 . . . . 0.0 111.667 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -85.32 149.54 25.38 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 109.243 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -54.95 139.3 41.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.33 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -67.87 -8.24 34.83 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 109.778 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.06 76.84 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . 0.515 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 46.1 p90 -140.12 160.71 39.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.536 1.168 . . . . 0.0 110.991 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.14 -176.87 6.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 110.589 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 37.5 m-85 -143.17 162.84 34.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -154.13 144.72 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -116.68 122.63 45.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.327 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -92.17 156.27 17.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.536 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.22 -22.53 59.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.085 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.6 t -121.58 140.98 32.61 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.52 -7.45 19.54 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.809 2.34 . . . . 0.0 110.137 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.69 -15.77 12.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.764 0.256 . . . . 0.0 110.623 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.462 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.9 m-20 -71.59 -28.48 63.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.42 56.55 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.91 -37.25 75.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.43 -30.85 67.81 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.27 -46.37 34.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.58 -9.97 52.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.13 -0.356 . . . . 0.0 111.191 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -102.16 8.14 40.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.398 1.079 . . . . 0.0 112.499 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.43 -51.38 0.93 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.323 1.059 . . . . 0.0 109.392 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' MET . . . . . 0.497 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 47.3 mmm -78.66 -17.26 56.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.846 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -73.31 118.4 16.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -7.91 75.6 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.641 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.5 ptpt -89.89 178.21 6.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.728 1.264 . . . . 0.0 111.261 175.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -105.45 147.18 28.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.705 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -65.1 1.01 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.325 0.583 . . . . 0.0 110.559 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.458 ' HB3' HD21 ' B' ' 16' ' ' ASN . 14.0 t70 -123.15 4.15 9.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.652 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.14 -11.36 2.55 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.214 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -115.51 133.58 55.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.824 0.85 . . . . 0.0 109.834 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.13 136.29 41.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.392 0.432 . . . . 0.0 110.395 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 16.9 pt -112.84 175.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -119.7 142.76 48.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 107.131 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.56 129.94 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.2 163.09 37.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 123.07 20.42 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.58 149.94 47.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 52.2 p -107.27 169.87 8.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.951 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.06 152.78 96.19 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.414 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 60.7 Cg_endo -66.39 148.29 83.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.141 2.561 . . . . 0.0 110.162 -177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -82.3 2.19 33.28 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.109 0.563 . . . . 0.0 112.1 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.24 11.99 12.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.918 0.487 . . . . 0.0 110.051 173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 52.11 176.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.281 2.233 . . . . 0.0 114.492 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 22.1 t -149.52 162.35 40.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.896 0.479 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' B' ' 94' ' ' ARG . . . 76.24 1.3 68.99 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.566 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 60.58 -14.2 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.868 1.667 . . . . 0.0 114.036 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' B' ' 92' ' ' GLY . 61.1 ttp180 -151.99 151.88 31.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.791 -0.568 . . . . 0.0 110.123 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.348 -1.807 . . . . 0.0 110.742 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.545 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.481 0 O4'-C1'-N19 112.081 3.881 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.627 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C3'-C2'-C1' 104.583 3.425 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 C5'-C4'-C3' 112.221 -2.186 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 1 O4'-C1'-N19 114.181 5.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.515 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 C4'-C3'-C2' 98.486 -4.214 . 0.362 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . 0.405 ' P ' HO2' ' A' ' 100' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.916 0 O4'-C1'-N19 111.664 3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.536 0.208 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 p -94.45 112.16 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.35 139.36 50.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.812 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.81 113.04 25.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.93 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.14 169.8 3.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.737 174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -59.13 153.82 43.89 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -170.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.53 154.37 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 125.033 3.822 . . . . 0.0 113.747 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -14.27 61.22 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.02 127.73 45.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 117.981 0.891 . . . . 0.0 109.132 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.402 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 74.7 mt -114.67 155.94 25.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.286 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.56 129.74 55.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.445 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 9.1 mm -121.32 75.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.63 146.96 18.41 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.226 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.42 11.0 30.22 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.834 0.817 . . . . 0.0 112.004 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.87 166.55 8.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.28 0.562 . . . . 0.0 112.184 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' B' ' 18' ' ' GLU . 58.4 t30 -79.0 -2.65 41.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -171.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 1.2 p 66.39 -13.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.929 1.292 . . . . 0.0 112.998 -169.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' B' ' 16' ' ' ASN . 48.1 mm-40 -91.26 -9.05 46.57 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.969 0.908 . . . . 0.0 109.328 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -78.77 144.9 34.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 109.605 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 -172.31 3.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' B' ' 21' ' ' GLU . 36.2 mp0 -65.22 -37.93 88.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.453 0.701 . . . . 0.0 110.342 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -32.41 74.04 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.191 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.48 -21.03 25.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.16 -27.48 24.55 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.903 1.281 . . . . 0.0 109.034 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.64 -27.21 34.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.41 0.624 . . . . 0.0 110.026 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.0 -20.19 35.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.603 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.3 p -104.2 -35.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.445 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 88.4 m-85 -92.69 -10.05 38.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.134 175.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.93 -2.93 79.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.5 -11.27 59.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.557 1.143 . . . . 0.0 111.02 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -113.4 -19.34 11.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.786 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.36 161.15 30.12 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -74.07 123.06 23.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.99 143.79 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 -22.78 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.925 178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.95 150.43 15.18 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.32 0.648 . . . . 0.0 109.744 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.66 145.62 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.396 0.617 . . . . 0.0 109.655 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.9 mt -118.52 154.44 32.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.291 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -149.13 117.54 6.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.82 140.15 29.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.913 -169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -149.06 151.22 34.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.424 0.63 . . . . 0.0 112.342 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.23 157.44 16.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.836 1.255 . . . . 0.0 111.333 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -93.36 -22.12 19.13 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 122.813 0.445 . . . . 0.0 111.404 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -102.12 -15.09 16.82 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.773 0.429 . . . . 0.0 112.089 -174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 27.4 p -125.37 -15.39 6.19 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 122.629 0.372 . . . . 0.0 110.819 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.24 7.87 1.84 Allowed 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 123.313 0.383 . . . . 0.0 111.728 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -81.39 147.28 29.88 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 42.3 t -55.86 145.85 23.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.44 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 40.1 mmm-85 -67.16 -8.78 33.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.83 0.09 75.64 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . 0.447 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 48.1 p90 -139.13 161.88 36.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 117.822 0.811 . . . . 0.0 111.083 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.72 -178.92 7.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.448 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 44.7 m-85 -140.34 162.3 35.63 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -152.98 142.51 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.9 m -114.06 121.7 44.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.29 156.54 17.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.753 0.821 . . . . 0.0 110.731 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -78.72 -23.75 45.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.376 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -114.03 138.09 22.7 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.74 -8.13 20.06 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.457 2.105 . . . . 0.0 110.434 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.99 -15.06 13.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.389 0.276 . . . . 0.0 110.891 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.433 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 70.3 m-20 -71.34 -28.17 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.41 51.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.31 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.41 -39.18 81.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.95 -32.62 73.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.58 -43.7 47.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.56 42.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.286 -0.259 . . . . 0.0 110.943 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -106.47 5.03 28.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.294 1.038 . . . . 0.0 112.324 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.81 -53.29 1.33 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 30.2 mmm -82.35 -10.19 59.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.779 1.632 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.27 126.0 29.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.32 -6.74 81.12 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -80.81 -154.15 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.172 0.989 . . . . 0.0 109.16 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -137.77 159.53 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.798 0.808 . . . . 0.0 112.507 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.43 126.69 31.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.849 176.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.417 ' HB3' HD21 ' B' ' 16' ' ' ASN . 1.9 t70 60.98 -18.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.91 -8.38 0.6 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 119.33 -0.706 . . . . 0.0 113.154 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -121.91 138.51 54.38 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.259 1.03 . . . . 0.0 110.592 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.42 139.38 54.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.808 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 pt -121.43 176.66 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -120.1 141.44 49.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.712 1.605 . . . . 0.0 107.505 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.38 124.56 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.07 163.15 36.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -60.7 133.77 56.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.63 153.71 30.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.8 p -107.56 173.0 6.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.242 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -80.19 153.9 74.57 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.065 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.419 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 74.4 Cg_endo -66.78 157.75 59.66 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.463 2.775 . . . . 0.0 110.842 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 90.1 p -91.39 -7.23 51.37 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -93.39 15.35 15.96 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 117.943 0.338 . . . . 0.0 111.287 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -139.32 158.01 44.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 122.677 0.391 . . . . 0.0 110.607 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.4 t -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.697 0.799 . . . . 0.0 111.605 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.12 0.28 65.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.074 0.368 . . . . 0.0 112.601 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -147.71 -26.36 0.36 Allowed 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.455 0.702 . . . . 0.0 110.696 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -150.9 165.87 32.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.587 0.755 . . . . 0.0 110.109 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-O 117.212 -1.882 . . . . 0.0 110.523 179.818 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.483 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.521 1 C5'-C4'-C3' 109.341 -4.106 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.452 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.115 0 C3'-C2'-C1' 103.911 2.679 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 1 C5'-C4'-C3' 109.18 -4.213 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . 0.431 " H4'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.626 1 O4'-C1'-N19 114.311 6.111 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.447 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 O5'-C5'-C4' 115.437 3.741 . 0.536 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.937 0 O4'-C1'-N19 111.032 2.832 . 0.512 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 30.8 ttp . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.18 6.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 122.796 1.284 . . . . 0.0 109.686 171.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.4 139.74 38.75 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.396 -168.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.1 111.71 5.78 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -77.68 55.77 1.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.932 0.893 . . . . 0.0 112.689 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 60.8 153.31 0.1 Allowed Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.781 2.032 . . . . 0.0 114.303 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -54.31 151.38 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.864 3.043 . . . . 0.0 112.887 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.45 -17.93 45.84 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 170.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -98.3 129.93 45.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.054 0.927 . . . . 0.0 108.926 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -114.88 154.04 29.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.87 130.92 55.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.414 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -122.3 80.34 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.2 143.25 16.44 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.538 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 9.65 38.7 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 117.477 0.639 . . . . 0.0 111.882 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.88 165.04 13.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.134 0.573 . . . . 0.0 111.672 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t30 -77.94 157.06 29.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 123.292 0.637 . . . . 0.0 110.924 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -72.63 -8.33 54.73 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.678 0.791 . . . . 0.0 110.283 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.94 -10.46 22.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 110.471 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.1 m -83.49 143.85 29.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -169.02 2.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -68.72 -33.29 73.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -64.6 -33.4 75.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.56 -20.89 27.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -86.5 -26.74 24.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.125 1.37 . . . . 0.0 109.431 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.9 -28.84 32.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.427 0.632 . . . . 0.0 110.119 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.33 -20.08 41.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.675 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -105.25 -36.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' B' ' 27' ' ' VAL . 84.5 m-85 -88.53 -11.89 44.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.923 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.63 -4.24 75.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -81.5 -12.88 58.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.319 1.048 . . . . 0.0 110.911 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.7 m-85 -109.73 -20.65 12.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.254 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.91 164.66 33.15 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 118.048 0.386 . . . . 0.0 112.959 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -66.41 117.84 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.7 mt -79.16 142.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.966 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -21.7 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.142 0.577 . . . . 0.0 109.91 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.69 150.39 15.64 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.464 0.706 . . . . 0.0 109.826 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.7 145.81 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.138 0.494 . . . . 0.0 110.059 172.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.0 mt -120.3 154.41 35.03 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.362 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.44 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -150.71 119.51 6.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 170.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' B' ' 40' ' ' MET . 12.1 mmm -92.59 141.66 28.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -169.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.44 ' HE2' HD13 ' B' ' 39' ' ' LEU . 11.9 mttt -137.95 158.09 45.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.73 147.57 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.195 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -86.16 -9.58 56.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -122.22 -12.64 8.25 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.9 p -124.19 -14.88 6.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.233 0.47 . . . . 0.0 111.343 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 56.57 20.99 5.32 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.5 -103.05 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.349 1.06 . . . . 0.0 110.009 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 27.0 t -153.06 145.61 24.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.598 1.159 . . . . 0.0 108.343 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.401 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 42.9 mmm-85 -74.11 -10.36 59.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.92 2.73 88.34 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.351 -0.694 . . . . 0.0 111.582 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . 0.525 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 51.1 p90 -135.49 161.45 35.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.764 1.282 . . . . 0.0 110.072 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.2 -177.62 6.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.779 0.431 . . . . 0.0 111.164 -174.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.493 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 63.2 m-85 -142.73 162.28 35.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.3 142.27 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m -113.35 123.99 51.42 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -95.04 156.35 16.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.931 0.892 . . . . 0.0 110.686 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.47 -21.26 45.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.493 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -116.5 137.93 24.01 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.85 -0.13 10.22 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.089 2.526 . . . . 0.0 110.568 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 -15.5 9.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 117.877 0.308 . . . . 0.0 111.198 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 84.5 m-20 -72.19 -27.96 62.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.62 -27.66 55.81 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.452 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -74.5 -36.59 63.23 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.24 -26.1 64.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.2 -46.38 14.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.03 63.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.3 7.7 46.03 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 -55.58 1.31 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.915 0.864 . . . . 0.0 109.371 -173.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' MET . . . . . 0.531 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 0.0 OUTLIER -75.48 -15.76 60.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.626 -1.625 . . . . 0.0 111.775 -177.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -73.91 124.06 25.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.32 -7.05 82.14 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -82.91 -153.46 0.12 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 109.361 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -139.69 158.73 43.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.464 0.706 . . . . 0.0 112.395 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -132.43 126.56 33.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.426 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.7 t70 61.5 -23.34 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.62 -6.51 0.47 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 119.512 -0.604 . . . . 0.0 112.631 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -117.36 134.51 54.74 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.027 0.913 . . . . 0.0 110.134 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.96 139.17 50.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.479 -174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.22 174.55 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -120.89 144.19 48.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.3 1.84 . . . . 0.0 107.776 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -135.97 130.03 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -160.92 163.83 31.61 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -61.43 137.15 58.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.39 158.89 27.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 66.4 p -122.92 172.33 8.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.154 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.43 155.52 91.18 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.356 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.432 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 56.0 Cg_endo -63.52 151.06 86.81 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.81 2.34 . . . . 0.0 110.635 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 95.0 p -77.13 -9.09 58.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.007 0.523 . . . . 0.0 111.596 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . 0.567 ' CD2' " H2'" ' A' ' 101' ' ' ' A' . 6.1 p90 -87.17 4.17 43.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.298 0.239 . . . . 0.0 111.196 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -133.24 167.16 20.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.251 0.62 . . . . 0.0 110.284 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.9 t -144.76 166.06 26.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.963 0.505 . . . . 0.0 110.813 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.53 67.01 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.952 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.01 24.6 0.39 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.979 1.712 . . . . 0.0 114.419 177.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.34 163.19 32.47 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.234 0.614 . . . . 0.0 111.198 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.196 -1.891 . . . . 0.0 111.205 -179.68 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.548 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.455 1 C5'-C4'-C3' 108.675 -4.55 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.589 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.991 0 C3'-C2'-C1' 104.879 3.754 OUTLIER-DELTA 0.026 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 C5'-C4'-O4' 112.271 2.193 . 0.02 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 1 O4'-C1'-N19 113.732 5.532 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.525 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.764 0 O5'-C5'-C4' 115.76 3.971 . 0.13 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . 0.567 " H2'" ' CD2' ' B' ' 89' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.052 1 O4'-C1'-N19 114.836 6.636 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.89 13.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.373 1.869 . . . . 0.0 107.12 172.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.1 139.84 36.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.536 -167.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.47 113.31 13.54 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.588 -1.642 . . . . 0.0 106.664 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -73.66 60.81 0.7 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.65 1.18 . . . . 0.0 113.394 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 60.44 154.46 0.1 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 126.228 1.811 . . . . 0.0 114.412 173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.31 148.55 41.11 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.681 2.921 . . . . 0.0 112.632 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.5 33.78 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.23 -0.761 . . . . 0.0 111.729 170.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -99.55 128.86 45.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 117.99 0.895 . . . . 0.0 108.872 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -112.56 151.31 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.517 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -104.65 128.41 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.444 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.9 79.05 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 146.48 18.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.937 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.28 10.44 41.87 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 117.68 0.74 . . . . 0.0 111.672 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.63 164.98 13.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.529 0.732 . . . . 0.0 112.129 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' B' ' 75' ' ' ASP . 46.7 t30 -77.1 162.38 27.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 110.657 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -76.71 -1.47 28.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.284 0.233 . . . . 0.0 110.607 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.6 -4.61 16.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.378 1.071 . . . . 0.0 110.815 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 45.2 m -82.7 144.51 30.18 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.945 0.498 . . . . 0.0 110.047 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 -169.23 2.44 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.369 0.604 . . . . 0.0 109.443 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.34 -35.51 73.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.558 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.1 -30.0 70.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.37 -21.02 23.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.07 -28.82 22.33 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.135 0.974 . . . . 0.0 109.36 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.26 -25.51 39.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.186 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.37 -22.19 35.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -103.87 -29.3 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.444 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 82.6 m-85 -99.1 -10.39 22.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.382 174.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.21 -5.83 85.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.435 ' CB ' ' HZ2' ' B' ' 30' ' ' LYS . 5.5 mtpm? -77.05 -22.97 52.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.853 1.261 . . . . 0.0 111.081 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.7 -19.9 15.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.528 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.44 165.28 34.98 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 118.024 0.374 . . . . 0.0 112.215 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -74.07 116.87 15.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.66 139.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.39 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -23.64 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 122.849 0.46 . . . . 0.0 110.134 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -160.28 149.48 17.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.026 0.53 . . . . 0.0 109.614 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.71 143.58 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 172.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.9 mt -117.39 154.13 31.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.07 119.41 5.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.0 mmm -94.32 136.94 34.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.93 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -145.53 154.02 41.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.363 0.602 . . . . 0.0 111.333 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.81 153.07 17.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.517 1.127 . . . . 0.0 111.318 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -95.58 -0.13 52.29 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.27 -14.08 7.54 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.102 0.561 . . . . 0.0 112.012 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 19.9 p -127.62 -14.12 5.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.203 0.456 . . . . 0.0 111.296 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 62.06 12.21 4.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -80.74 142.24 34.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -53.04 137.9 32.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.955 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -70.23 -10.09 57.83 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.804 0.842 . . . . 0.0 109.965 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.66 1.57 68.17 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.424 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.84 158.87 43.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.62 1.21 . . . . 0.0 110.553 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -178.52 7.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.051 0.541 . . . . 0.0 110.489 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.5 m-85 -142.58 162.39 35.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.846 0.459 . . . . 0.0 110.433 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.21 143.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -115.85 122.37 45.17 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 123.142 0.276 . . . . 0.0 110.306 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.71 156.58 17.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.589 0.755 . . . . 0.0 111.996 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -75.18 -22.89 57.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.599 0.36 . . . . 0.0 111.071 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -120.54 140.69 30.81 Favored Pre-proline 0 CA--C 1.518 -0.262 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.41 -12.77 25.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.436 2.091 . . . . 0.0 110.189 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.57 -15.59 14.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.165 0.439 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.447 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.8 m-20 -70.95 -29.01 64.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 169.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.57 58.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.008 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -67.59 -38.9 84.68 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.35 -33.56 74.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.05 52.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.73 -8.45 52.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.256 -0.277 . . . . 0.0 110.906 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -104.94 5.35 32.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.191 0.996 . . . . 0.0 112.286 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -52.05 1.28 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.862 0.755 . . . . 0.0 109.442 -175.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.7 mmm -83.36 -10.52 58.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.405 1.482 . . . . 0.0 112.529 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.85 127.26 32.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.83 76.28 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.149 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.84 -157.38 0.22 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -134.46 153.01 52.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.664 0.786 . . . . 0.0 110.891 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.93 -68.32 0.81 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.943 -176.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' B' ' 16' ' ' ASN . 11.7 t70 -117.59 7.25 12.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.652 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.25 -7.66 5.37 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -113.41 132.84 55.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 108.932 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 136.62 38.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.27 175.68 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -120.98 140.4 51.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.846 1.658 . . . . 0.0 107.302 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.86 125.12 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.44 162.72 35.72 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -60.71 133.6 56.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.2 158.33 27.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.4 p -116.97 163.21 16.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.143 171.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -62.78 152.59 81.95 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.384 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.408 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 56.0 Cg_endo -65.08 157.17 58.75 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.488 2.792 . . . . 0.0 110.206 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -80.91 -10.27 59.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -97.11 18.39 15.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.001 0.364 . . . . 0.0 111.202 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -144.33 162.71 35.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 111.062 -175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.3 t -153.64 147.04 24.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.751 0.42 . . . . 0.0 110.119 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.72 -135.03 52.13 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' B' ' 93' ' ' ARG . 37.6 mmt180 56.78 165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.515 1.526 . . . . 0.0 114.29 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -145.41 162.08 38.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.84 -174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.468 -1.74 . . . . 0.0 110.497 179.525 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.568 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.34 1 C5'-C4'-C3' 109.11 -4.26 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.618 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.967 0 C3'-C2'-C1' 104.671 3.523 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 C5'-C4'-C3' 109.745 -3.837 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.937 1 O4'-C1'-N19 113.672 5.472 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.408 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.605 2 C5'-C4'-C3' 109.004 -4.331 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 110.958 2.758 . 0.607 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.1 tmm? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.567 0.698 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.38 17.17 2.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.915 1.686 . . . . 0.0 107.101 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -84.58 138.74 32.56 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.954 -167.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.91 104.08 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.82 -43.15 76.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.997 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -165.64 153.38 9.73 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 118.476 0.58 . . . . 0.0 111.61 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.27 147.09 94.97 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.699 2.266 . . . . 0.0 110.706 168.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.63 -18.56 56.24 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -85.88 129.98 34.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.3 mt -118.19 152.67 35.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.102 0.561 . . . . 0.0 109.961 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -105.42 128.65 53.64 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.436 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.73 81.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.94 146.83 18.41 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.861 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.33 51.09 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 117.707 0.754 . . . . 0.0 111.585 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.23 164.06 11.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.457 0.703 . . . . 0.0 111.295 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' B' ' 75' ' ' ASP . 44.5 t30 -73.1 158.86 34.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.294 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 76.0 p -74.96 -2.75 28.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.99 -7.15 16.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.647 1.179 . . . . 0.0 110.776 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.6 m -80.96 144.34 31.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.532 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -170.24 2.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.58 -34.64 77.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.646 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -65.78 -31.51 72.53 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.974 -0.454 . . . . 0.0 111.022 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -20.1 29.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -89.78 -28.34 19.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.819 1.248 . . . . 0.0 109.848 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -81.77 -28.55 33.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 109.896 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.81 -23.71 39.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.317 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.9 p -99.77 -37.8 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.436 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 87.7 m-85 -88.96 -10.58 47.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.772 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.13 -4.61 73.46 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -79.2 -14.59 58.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.808 1.243 . . . . 0.0 111.377 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.1 m-85 -110.33 -19.8 12.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.723 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.56 163.07 31.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -74.95 125.61 29.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.69 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.342 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.18 -23.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.963 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -161.07 151.08 17.38 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.173 0.589 . . . . 0.0 109.557 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.92 147.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 109.722 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -122.23 156.0 34.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.589 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.24 121.39 5.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.419 ' HA ' ' HE2' ' B' ' 40' ' ' MET . 0.6 OUTLIER -89.73 138.3 31.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -174.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -150.75 155.21 38.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.164 0.507 . . . . 0.0 112.086 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.13 159.4 11.96 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.706 1.202 . . . . 0.0 111.505 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -99.04 -8.75 24.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.79 0.436 . . . . 0.0 111.793 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.35 -12.6 12.38 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.927 0.491 . . . . 0.0 111.709 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 42.5 p -127.73 -13.99 5.2 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 122.686 0.395 . . . . 0.0 111.304 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 59.21 12.94 2.76 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 123.234 0.334 . . . . 0.0 111.701 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -83.34 143.3 30.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.018 0.527 . . . . 0.0 110.115 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -55.78 140.76 41.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.062 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -77.88 3.42 14.48 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.783 0.433 . . . . 0.0 110.278 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.88 0.7 83.31 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.746 0.689 . . . . 0.0 112.591 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.66 158.34 43.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.439 1.12 . . . . 0.0 110.6 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.42 -179.28 7.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.8 m-85 -140.95 161.51 37.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.03 139.23 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -111.65 121.7 45.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.853 0.359 . . . . 0.0 110.121 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -92.16 155.26 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.74 0.816 . . . . 0.0 110.444 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.97 -22.88 48.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -114.57 135.72 22.33 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.67 0.86 9.13 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.847 2.365 . . . . 0.0 110.499 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.35 -14.76 9.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.525 0.33 . . . . 0.0 111.202 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -72.07 -28.76 63.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.79 58.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.31 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -70.69 -37.82 73.65 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.23 -31.07 70.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.38 -44.91 42.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.262 -0.274 . . . . 0.0 111.333 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -99.8 5.72 45.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.047 0.939 . . . . 0.0 112.642 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.49 -51.75 1.27 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.913 0.778 . . . . 0.0 109.197 -174.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' MET . . . . . 0.437 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mtp -83.74 -11.16 57.51 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.74 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.89 114.17 10.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.03 -4.81 59.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.54 -154.53 0.11 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.327 1.051 . . . . 0.0 109.309 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -139.77 159.49 42.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 112.474 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.63 127.3 30.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.386 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.412 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.2 t70 60.92 -20.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 150.26 -6.06 0.68 Allowed Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.042 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -118.38 134.73 54.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.869 0.834 . . . . 0.0 110.063 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.81 137.42 47.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.322 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.1 pt -118.5 177.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -122.01 143.35 49.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.562 1.945 . . . . 0.0 107.177 170.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.66 130.42 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -158.96 164.2 35.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -67.53 132.73 48.15 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.34 147.83 34.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 62.9 p -115.58 170.74 8.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.936 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.19 154.38 90.21 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.451 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 57.7 Cg_endo -64.87 169.44 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.79 2.994 . . . . 0.0 110.685 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' SER . . . . . 0.553 ' C ' ' H ' ' B' ' 90' ' ' GLU . 49.6 m -108.92 3.68 22.57 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -170.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . 0.564 ' CE2' " H2'" ' A' ' 101' ' ' ' A' . 4.9 m-85 -63.89 -0.07 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.796 1.18 . . . . 0.0 110.457 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' B' ' 88' ' ' SER . 5.2 pt-20 -122.07 0.38 9.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.966 1.706 . . . . 0.0 112.186 -172.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 4.3 t -167.45 -3.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.41 5.38 0.14 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.808 0.731 . . . . 0.0 113.845 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.6 147.76 28.52 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.054 0.941 . . . . 0.0 109.048 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 51.39 32.26 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.749 0.819 . . . . 0.0 111.653 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.368 -179.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.512 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.266 1 C5'-C4'-C3' 109.484 -4.011 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.421 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.963 0 C3'-C2'-C1' 104.076 2.862 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.673 1 C5'-C4'-C3' 109.308 -4.128 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.0 1 O4'-C1'-N19 112.914 4.714 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.451 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.212 1 C4'-C3'-C2' 98.386 -4.314 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . 0.637 ' C8 ' " H5'" ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.967 1 O4'-C1'-N19 114.354 6.154 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p 47.62 42.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 123.031 1.396 . . . . 0.0 108.758 -168.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.54 132.15 46.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.118 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.67 103.23 12.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.47 172.77 5.65 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -52.77 153.1 6.12 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -51.5 154.94 7.95 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.552 3.502 . . . . 0.0 113.21 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.85 -15.37 55.56 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -98.68 128.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.373 1.087 . . . . 0.0 109.044 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.34 153.8 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.048 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -108.08 128.93 55.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.429 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -121.1 80.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.39 144.21 17.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.237 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.71 38.98 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 117.709 0.755 . . . . 0.0 111.466 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.29 162.46 22.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.048 0.539 . . . . 0.0 112.087 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' B' ' 75' ' ' ASP . 39.5 t-20 -76.35 155.15 34.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.014 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -68.93 -10.47 57.41 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 123.548 0.739 . . . . 0.0 110.284 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.78 -11.25 23.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 110.309 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -81.29 144.72 31.33 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.287 0.635 . . . . 0.0 109.345 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.74 -165.98 1.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.392 0.615 . . . . 0.0 109.536 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -70.61 -38.84 74.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.858 -173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -68.71 -25.84 64.97 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.5 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.95 -20.19 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.37 -28.46 18.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.675 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.11 -26.65 48.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 109.79 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.85 -23.87 36.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.82 -36.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 83.9 m-85 -90.47 -11.61 39.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.21 -0.306 . . . . 0.0 110.951 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.16 -3.13 68.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -81.51 -12.23 58.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.14 . . . . 0.0 111.264 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -111.96 -20.48 11.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.6 0.76 . . . . 0.0 112.412 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.47 161.58 29.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -74.0 124.97 27.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.88 143.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.154 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -20.7 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.477 0.711 . . . . 0.0 110.477 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -160.37 148.82 16.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.304 0.642 . . . . 0.0 109.66 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.06 143.54 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 110.039 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -118.94 156.03 30.28 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.178 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.485 HD13 ' HE2' ' B' ' 41' ' ' LYS . 2.9 tm? -154.98 119.44 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 171.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 13.8 mmm -93.17 142.87 26.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.097 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.485 ' HE2' HD13 ' B' ' 39' ' ' LEU . 13.8 mttt -140.78 157.23 45.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.91 141.74 56.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.187 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.7 -4.57 58.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.41 -14.15 9.74 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.5 p -128.84 -14.94 4.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.223 0.465 . . . . 0.0 111.574 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 56.8 21.77 6.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -70.48 -109.31 0.0 OUTLIER 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.911 1.284 . . . . 0.0 109.429 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 t -151.31 146.35 25.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -72.6 -9.98 59.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.17 87.18 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.158 -0.801 . . . . 0.0 111.943 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -136.94 160.34 39.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.922 1.361 . . . . 0.0 110.249 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.9 -178.71 7.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.749 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.9 m-85 -142.93 162.59 35.07 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.61 141.84 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 33.6 m -111.97 122.9 49.03 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.245 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -93.06 156.67 16.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 110.503 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.82 -23.08 42.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.461 -0.305 . . . . 0.0 110.284 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -115.19 137.56 23.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 -7.04 18.78 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.568 2.179 . . . . 0.0 110.474 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.75 -14.71 13.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.844 0.293 . . . . 0.0 110.728 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.6 m-20 -71.67 -28.13 63.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.14 53.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.556 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.05 -38.94 79.39 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.44 -32.74 72.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.94 -44.78 46.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.43 -8.47 51.16 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.057 -0.402 . . . . 0.0 111.203 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -104.23 4.74 34.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.395 1.078 . . . . 0.0 112.088 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.58 -52.67 1.26 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.759 0.79 . . . . 0.0 109.447 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.2 mmm -82.22 -10.55 59.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.586 1.555 . . . . 0.0 112.401 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.56 126.15 29.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.39 -6.63 83.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -80.64 -153.86 0.09 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.595 1.158 . . . . 0.0 109.691 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -139.88 159.05 43.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.292 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.66 126.18 32.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.024 177.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HB3' HD21 ' B' ' 16' ' ' ASN . 4.9 t70 61.05 -21.38 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.08 -6.35 0.6 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.724 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -117.42 133.16 56.29 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.002 0.901 . . . . 0.0 110.119 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.36 50.78 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.301 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -120.64 178.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -122.57 142.74 50.3 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.399 1.88 . . . . 0.0 107.33 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.97 129.25 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -159.24 162.39 36.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -63.59 134.37 55.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 158.27 29.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 29.5 p -117.55 160.46 21.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.949 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -63.12 154.12 78.79 Favored Pre-proline 0 N--CA 1.45 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.434 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 52.9 Cg_endo -62.36 145.66 95.83 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.049 2.499 . . . . 0.0 110.544 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.8 m -93.27 6.56 47.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.72 0.808 . . . . 0.0 111.53 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.19 7.68 8.85 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.46 172.73 13.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.743 0.817 . . . . 0.0 111.303 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 6.4 t -83.13 10.31 8.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.212 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 94' ' ' ARG . . . 78.58 4.63 87.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.808 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 63.12 -18.1 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.911 1.684 . . . . 0.0 113.618 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' B' ' 92' ' ' GLY . 41.3 ptt180 -153.77 164.57 38.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.237 0.472 . . . . 0.0 110.81 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.317 -1.824 . . . . 0.0 110.569 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.531 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.227 1 O4'-C1'-N19 112.512 4.312 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.608 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 C3'-C2'-C1' 104.467 3.296 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 C5'-C4'-C3' 110.329 -3.447 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.946 1 O4'-C1'-N19 114.056 5.856 . 0.109 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.434 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.424 -2.436 1 O4'-C1'-N19 112.621 4.421 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 112.539 4.339 . 0.524 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpp . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.458 0.647 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 120.82 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.12 126.28 26.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.892 0.477 . . . . 0.0 111.213 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.62 106.66 14.79 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.7 -45.5 81.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -170.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -162.09 141.13 7.21 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 118.288 0.494 . . . . 0.0 110.322 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.83 140.73 78.14 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.883 2.389 . . . . 0.0 110.727 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.79 65.07 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -92.24 125.49 36.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -110.44 150.84 28.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -105.31 128.85 53.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.424 HD11 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.19 78.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.42 142.59 16.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.493 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.56 6.52 46.97 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 122.216 -0.579 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.27 162.32 6.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.331 0.652 . . . . 0.0 111.773 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' B' ' 75' ' ' ASP . 47.6 t30 -71.25 160.11 33.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 70.9 p -77.85 -1.28 30.87 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.878 0.471 . . . . 0.0 110.669 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.26 -6.1 15.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.409 1.083 . . . . 0.0 111.025 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -83.4 145.74 28.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.285 0.634 . . . . 0.0 110.087 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -169.96 2.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.51 -35.83 79.89 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.54 -174.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -67.89 -27.9 67.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.964 -0.46 . . . . 0.0 111.247 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.02 28.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.71 -26.78 24.07 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.166 1.386 . . . . 0.0 109.352 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -80.19 -32.75 38.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.427 0.632 . . . . 0.0 110.163 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.49 -21.65 45.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.308 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' B' ' 28' ' ' PHE . 5.1 p -103.06 -34.29 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.431 ' CD2' HG11 ' B' ' 27' ' ' VAL . 84.2 m-85 -91.83 -12.0 34.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.073 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -3.08 72.11 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -81.57 -13.58 57.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.66 1.184 . . . . 0.0 110.89 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -110.94 -19.58 12.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.696 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.13 166.2 36.67 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 118.025 0.375 . . . . 0.0 112.332 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttm105 -72.86 117.81 15.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.2 144.21 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.566 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -18.84 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.167 0.587 . . . . 0.0 110.323 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -160.22 147.35 16.11 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.212 0.605 . . . . 0.0 109.652 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.44 141.75 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.459 0.647 . . . . 0.0 109.583 170.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.2 mt -120.26 155.81 32.49 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.738 175.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.37 120.19 6.14 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.431 ' HE3' ' HA ' ' B' ' 40' ' ' MET . 6.5 mmm -93.59 136.99 33.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.59 -172.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -147.51 153.25 39.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.116 0.484 . . . . 0.0 111.199 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.45 153.47 38.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.109 0.964 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.45 ' HD2' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -93.07 -7.05 46.7 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -105.1 -14.76 15.29 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.556 . . . . 0.0 111.75 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 61.8 p -133.35 -14.18 2.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.791 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 62.92 11.74 5.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 117.746 0.248 . . . . 0.0 111.479 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -87.37 145.32 26.36 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.894 0.878 . . . . 0.0 109.926 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 17.2 m -53.13 139.4 28.82 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.372 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 32.1 mmm-85 -71.67 -8.71 55.8 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.538 1.135 . . . . 0.0 109.75 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -1.13 75.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.904 0.764 . . . . 0.0 111.306 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.89 156.64 48.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.724 1.262 . . . . 0.0 110.522 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.54 7.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.872 0.469 . . . . 0.0 110.422 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.0 m-85 -142.42 161.79 37.13 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.534 0.334 . . . . 0.0 110.736 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.56 141.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.0 m -112.08 126.08 54.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -94.3 155.77 16.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 111.427 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.36 -22.8 61.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.266 -0.397 . . . . 0.0 111.364 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -121.49 141.47 33.51 Favored Pre-proline 0 CA--C 1.518 -0.254 0 CA-C-N 118.295 0.498 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.14 -3.81 14.45 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.819 2.346 . . . . 0.0 110.289 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.46 -15.84 11.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.581 0.352 . . . . 0.0 110.998 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.456 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -71.77 -29.15 64.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.14 59.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.143 0.577 . . . . 0.0 110.526 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -70.84 -37.84 73.17 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.91 -30.36 68.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.27 -9.41 53.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.176 -0.327 . . . . 0.0 111.228 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -101.82 7.18 41.77 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.546 1.138 . . . . 0.0 112.158 174.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.29 -53.6 1.03 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.862 0.839 . . . . 0.0 109.108 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' MET . . . . . 0.5 ' HA ' ' CG ' ' B' ' 72' ' ' LYS . 49.7 mmm -78.44 -10.5 59.72 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.154 1.782 . . . . 0.0 111.916 -176.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -80.65 117.34 21.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.16 62.26 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.609 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.5 ' CG ' ' HA ' ' B' ' 69' ' ' MET . 20.7 ptmt -106.93 176.75 5.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.578 1.189 . . . . 0.0 111.954 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -97.76 155.91 16.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -127.23 123.84 37.51 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.359 172.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.423 ' HB3' HD21 ' B' ' 16' ' ' ASN . 3.8 t70 61.66 -23.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 157.56 -11.37 0.25 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.141 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -116.57 135.57 53.7 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.014 0.907 . . . . 0.0 110.513 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.34 140.51 57.26 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 123.199 0.6 . . . . 0.0 110.823 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -125.91 171.9 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -115.35 144.08 44.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.981 1.712 . . . . 0.0 108.015 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.76 130.14 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -160.44 163.86 32.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -63.31 133.31 53.95 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.36 158.55 30.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.038 0.446 . . . . 0.0 111.883 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.8 p -115.82 168.72 9.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.613 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.36 152.36 85.25 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.369 0.668 . . . . 0.0 110.817 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -63.21 154.54 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.619 2.879 . . . . 0.0 111.365 -175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 m -80.68 -3.03 49.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -91.69 4.4 52.82 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.12 0.418 . . . . 0.0 111.066 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.21 158.81 40.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.774 0.43 . . . . 0.0 110.636 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.9 t -152.99 165.12 36.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.474 0.309 . . . . 0.0 110.971 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.05 -2.65 66.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.201 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -143.47 151.55 40.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.714 0.806 . . . . 0.0 109.616 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 54.37 25.62 6.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.083 0.953 . . . . 0.0 111.898 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.307 -1.83 . . . . 0.0 111.125 179.527 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.571 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.435 1 C5'-C4'-C3' 109.13 -4.247 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.546 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 C3'-C2'-C1' 104.099 2.887 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 112.428 -2.048 . 0.102 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 1 O4'-C1'-N19 114.587 6.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 2 O4'-C1'-N19 113.83 5.63 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 O4'-C1'-N19 111.231 3.031 . 0.191 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tmm? . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.195 0.522 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.67 11.29 6.64 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-O 123.022 1.391 . . . . 0.0 107.987 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -84.11 147.44 27.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.961 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.11 103.26 5.48 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.48 168.51 5.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.271 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -53.87 153.72 8.21 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.501 0.72 . . . . 0.0 112.8 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -51.24 154.9 7.28 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.435 3.423 . . . . 0.0 113.114 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.06 -13.22 62.08 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.28 127.1 45.24 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 72.7 mt -112.5 154.45 25.87 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.16 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -107.96 127.3 53.63 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.434 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -118.85 80.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.29 143.78 16.83 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.624 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.04 36.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.16 163.5 22.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.465 HD21 ' CB ' ' B' ' 75' ' ' ASP . 40.3 t-20 -73.51 158.85 34.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -73.62 -8.29 55.36 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.301 0.64 . . . . 0.0 110.161 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.38 -11.04 20.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 110.48 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 41.2 m -79.87 144.78 33.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.71 -168.14 2.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.06 -32.27 68.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.578 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -64.4 -32.57 74.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.13 -21.91 27.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.87 -27.88 24.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.226 1.41 . . . . 0.0 109.635 -176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.93 -29.97 35.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 110.17 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -22.55 41.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.586 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.0 p -102.36 -35.51 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -174.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 89.0 m-85 -91.56 -10.06 42.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.873 176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -3.94 71.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -80.4 -13.08 59.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.619 1.168 . . . . 0.0 111.208 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -112.29 -18.78 12.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.7 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.34 167.31 38.35 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.161 0.437 . . . . 0.0 112.63 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -74.22 117.28 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.2 142.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.461 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.47 -23.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.148 0.579 . . . . 0.0 110.194 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.51 150.1 15.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.238 0.615 . . . . 0.0 109.683 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.66 147.09 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 109.547 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.5 mt -123.09 156.36 35.08 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.787 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.453 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.44 119.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.422 ' HA ' ' HE1' ' B' ' 40' ' ' MET . 11.7 mmm -93.03 142.58 27.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.902 -169.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.453 ' HE2' HD12 ' B' ' 39' ' ' LEU . 22.8 mttt -140.58 163.86 31.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.5 147.18 53.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.316 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -88.83 -9.36 51.99 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.33 -12.74 8.57 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 19.0 p -122.89 -14.8 7.56 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.332 0.515 . . . . 0.0 111.222 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.18 22.17 7.28 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -77.36 -111.28 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.696 1.198 . . . . 0.0 109.613 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.5 t -148.58 147.21 28.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -73.8 -10.27 59.5 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.67 3.89 87.89 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.351 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . 0.409 ' CZ ' " H4'" ' A' ' 99' ' ' ' A' . 41.7 p90 -137.9 161.03 37.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.695 1.248 . . . . 0.0 109.803 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.34 -177.97 6.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.098 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.3 m-85 -142.91 160.93 39.4 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.168 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.3 140.6 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -112.71 121.71 45.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -92.62 155.95 17.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.695 0.798 . . . . 0.0 111.723 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -73.43 -22.57 60.17 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.455 0.302 . . . . 0.0 111.255 174.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -121.16 140.81 31.74 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 118.352 0.524 . . . . 0.0 109.834 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 -1.3 11.32 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 123.122 2.548 . . . . 0.0 110.342 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.36 -16.39 10.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.808 0.443 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 82.5 m-20 -71.28 -27.91 63.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.41 -29.09 56.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -72.97 -38.69 66.6 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.15 -25.39 66.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.71 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.59 -43.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 172.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.2 -6.6 48.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.896 -0.502 . . . . 0.0 112.305 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -107.46 7.97 29.21 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.532 0.733 . . . . 0.0 112.311 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.92 -55.07 1.39 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.628 0.728 . . . . 0.0 109.329 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.5 mmm -79.57 -10.03 59.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.538 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -73.46 128.08 34.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.65 79.28 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -81.64 -153.44 0.11 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.628 1.171 . . . . 0.0 109.639 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.1 t -140.03 158.69 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -173.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.74 128.9 31.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.543 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.465 ' CB ' HD21 ' B' ' 16' ' ' ASN . 2.4 t0 52.73 21.52 1.93 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.328 0.585 . . . . 0.0 112.223 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.73 56.29 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.707 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -114.97 130.45 56.93 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.43 1.115 . . . . 0.0 109.875 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.81 139.12 50.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.344 0.258 . . . . 0.0 111.658 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.79 177.55 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -121.84 144.54 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.049 1.74 . . . . 0.0 107.567 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.42 126.54 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.79 164.83 28.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -60.36 135.95 57.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.2 159.84 23.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.5 p -113.69 169.59 8.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.649 169.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -70.96 158.69 87.6 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.826 0.451 . . . . 0.0 110.472 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.71 151.73 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.118 2.545 . . . . 0.0 110.928 -176.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 17.0 t -77.84 -11.49 59.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.78 4.61 32.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.954 -0.466 . . . . 0.0 111.278 176.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.03 148.52 46.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.814 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.6 m -155.59 12.55 0.33 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.29 1.036 . . . . 0.0 110.523 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 -158.27 52.68 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 58.56 161.27 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 112.505 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -149.96 151.39 33.29 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.209 0.603 . . . . 0.0 109.851 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.534 -1.704 . . . . 0.0 111.455 179.538 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.474 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.238 1 O4'-C1'-N19 112.332 4.132 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.472 " C5'" " H3'" ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.906 0 C5'-C4'-C3' 109.933 -3.712 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 C5'-C4'-C3' 109.761 -3.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . 0.409 " H4'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.671 1 O4'-C1'-N19 114.368 6.168 . 0.013 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 2 O4'-C1'-N19 113.08 4.88 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.639 0 C5'-C4'-C3' 110.618 -3.254 . 0.165 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.58 12.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 107.962 173.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.22 145.35 48.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.607 -168.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.01 99.1 3.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.12 128.22 33.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 43.39 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 126.832 2.053 . . . . 0.0 113.915 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.495 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 82.4 Cg_exo -47.78 133.47 22.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 123.069 2.513 . . . . 0.0 110.291 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.78 -10.63 49.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -92.51 127.88 38.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -113.3 149.24 34.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -102.72 127.47 49.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.438 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 8.0 mm -118.61 78.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.73 144.54 17.13 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.729 -0.607 . . . . 0.0 112.157 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 13.45 40.97 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 117.908 0.854 . . . . 0.0 111.827 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -65.81 166.33 11.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.042 0.925 . . . . 0.0 112.928 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.473 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.2 OUTLIER -78.71 145.77 34.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.312 1.445 . . . . 0.0 109.888 176.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 78.7 p -74.32 -8.61 56.83 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.995 0.918 . . . . 0.0 112.301 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.96 -12.39 18.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.265 1.426 . . . . 0.0 109.583 -174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.6 m -77.73 149.02 34.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.55 1.14 . . . . 0.0 110.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 -165.0 1.67 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -66.1 -29.48 69.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.134 0.424 . . . . 0.0 110.952 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.05 -19.7 31.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.84 -29.18 21.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.64 1.176 . . . . 0.0 109.472 -176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.52 -27.66 46.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.443 0.64 . . . . 0.0 109.825 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.29 -23.38 37.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.347 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.87 -34.45 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 84.7 m-85 -90.84 -11.7 38.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.107 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.29 -5.16 76.15 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -79.31 -12.82 59.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.833 1.253 . . . . 0.0 110.729 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.63 -13.5 12.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.48 171.32 37.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.359 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -79.89 115.04 19.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.59 0.71 . . . . 0.0 109.982 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.8 mt -75.0 141.67 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.991 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -21.32 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.206 0.602 . . . . 0.0 110.354 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -161.29 150.38 16.36 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.21 146.11 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.4 0.619 . . . . 0.0 109.849 172.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.4 mt -123.24 155.32 37.39 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.528 1.131 . . . . 0.0 108.234 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.467 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.1 tm? -154.0 119.76 5.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.417 ' HE3' ' HA ' ' B' ' 40' ' ' MET . 9.2 mmm -92.81 139.82 30.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -170.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.467 ' HE2' HD13 ' B' ' 39' ' ' LEU . 18.1 mttt -137.32 160.61 38.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.51 148.61 50.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.783 173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -93.81 -7.55 43.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.557 0.343 . . . . 0.0 111.844 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -117.57 -12.68 10.32 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.114 0.565 . . . . 0.0 112.337 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 24.5 p -123.88 -14.81 7.08 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 111.071 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.65 18.87 5.01 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -76.65 -108.22 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.36 1.064 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -150.1 148.53 29.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.898 0.879 . . . . 0.0 108.83 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.408 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 40.6 mmm-85 -73.08 -10.81 60.18 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 4.07 80.68 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.992 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 157.37 45.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.719 1.26 . . . . 0.0 109.95 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.36 -177.98 6.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.401 0.28 . . . . 0.0 111.076 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 64.7 m-85 -142.68 160.75 39.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.797 0.439 . . . . 0.0 110.463 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -154.1 138.79 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 56.9 m -110.34 126.84 54.66 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.106 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -98.2 161.81 13.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.403 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -71.52 -18.4 62.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -130.25 153.43 81.21 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 110.104 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . 0.495 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 29.6 Cg_endo -80.68 1.12 9.53 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 171.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.1 -15.59 9.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.76 -21.22 25.26 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 -27.78 61.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -69.58 -32.14 70.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.82 -22.24 61.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.1 -44.16 13.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.25 -15.62 62.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.184 -0.323 . . . . 0.0 111.858 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.36 6.74 46.02 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.19 -55.08 1.36 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.041 0.837 . . . . 0.0 109.461 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 24.4 mmm -78.05 -12.21 59.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.18 1.392 . . . . 0.0 111.965 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -72.83 130.12 39.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -10.05 63.36 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.671 -0.516 . . . . 0.0 112.356 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -83.28 -160.3 0.41 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.166 0.986 . . . . 0.0 109.509 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -132.9 152.61 51.85 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.716 0.806 . . . . 0.0 110.723 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.73 -62.81 1.23 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.962 -174.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.473 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 15.6 t70 -130.18 0.92 4.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.141 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.75 -14.07 0.78 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.821 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.25 134.5 55.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.05 135.62 38.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.8 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.4 pt -114.26 174.32 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -173.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.55 141.85 47.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.564 1.546 . . . . 0.0 107.554 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.36 125.86 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.29 164.99 34.41 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -63.05 135.71 57.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.46 158.91 29.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 112.309 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 82.5 p -117.54 164.21 15.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.535 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 150.3 89.74 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.421 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 65.0 Cg_endo -67.47 160.66 46.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.543 2.828 . . . . 0.0 110.152 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 68.3 p -78.3 -9.73 59.37 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.245 0.618 . . . . 0.0 112.576 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -98.5 20.04 13.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.492 0.317 . . . . 0.0 110.987 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -144.54 158.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 111.234 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.3 t -154.54 156.74 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.668 0.387 . . . . 0.0 110.555 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.5 -133.85 49.37 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -149.59 163.75 37.01 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.718 0.807 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.92 16.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.274 1.83 . . . . 0.0 114.679 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.655 -1.636 . . . . 0.0 111.118 -177.858 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.697 0 O4'-C1'-N19 111.879 3.679 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.652 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 C3'-C2'-C1' 105.079 3.976 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 1 C5'-C4'-C3' 109.007 -4.328 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.763 1 O4'-C1'-N19 113.872 5.672 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.421 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.424 -2.454 2 C5'-C4'-C3' 108.541 -4.639 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 110.855 2.655 . 0.637 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.49 121.2 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -136.96 132.37 34.28 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.206 0.527 . . . . 0.0 111.38 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.03 113.68 7.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.07 135.18 33.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.432 -172.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 45.65 112.34 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 128.149 2.58 . . . . 0.0 115.514 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.19 147.54 34.95 Favored 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.472 2.115 . . . . 0.0 110.573 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.71 -20.58 37.89 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -84.52 129.0 34.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -119.1 155.62 31.21 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.991 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -109.44 130.02 55.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.456 HD11 ' CZ ' ' B' ' 28' ' ' PHE . 6.2 mm -121.68 86.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.87 145.07 16.91 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 121.999 -0.438 . . . . 0.0 112.555 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.12 8.08 45.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.28 162.65 14.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.085 0.945 . . . . 0.0 112.089 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.429 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.4 OUTLIER -70.14 145.18 51.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.432 1.493 . . . . 0.0 109.568 175.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -70.83 -4.88 26.46 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.927 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.83 -6.49 15.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.984 1.314 . . . . 0.0 109.609 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.3 m -76.52 143.79 40.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.412 1.085 . . . . 0.0 108.751 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.96 -166.7 1.95 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.34 -29.89 68.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.692 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -66.76 -30.61 70.87 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.87 -17.13 28.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -95.28 -28.27 15.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.336 1.054 . . . . 0.0 109.909 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.97 -29.38 29.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.24 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.31 -28.54 38.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.127 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.456 HG13 ' CD2' ' B' ' 28' ' ' PHE . 4.3 p -92.64 -36.45 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.456 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.2 m-85 -92.15 -10.48 38.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.276 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.35 -3.48 77.13 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -79.77 -14.73 58.51 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.71 1.204 . . . . 0.0 111.608 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -111.5 -19.0 12.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.803 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.52 164.61 33.28 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 118.208 0.458 . . . . 0.0 112.312 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -72.23 117.45 13.89 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.96 141.23 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.386 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -23.81 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 122.877 0.471 . . . . 0.0 110.067 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.11 150.37 16.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.383 0.673 . . . . 0.0 109.687 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.55 146.06 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.517 0.675 . . . . 0.0 109.951 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.3 mt -118.14 152.13 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.3 119.33 6.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.3 mmm -93.4 139.66 30.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.9 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -143.94 153.7 42.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.129 0.49 . . . . 0.0 112.059 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.58 165.59 14.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.822 1.249 . . . . 0.0 111.721 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -107.31 -8.22 16.44 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.217 0.607 . . . . 0.0 111.55 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -103.64 -14.88 15.97 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.121 0.568 . . . . 0.0 111.113 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -133.42 -15.93 2.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.48 8.7 3.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -83.96 153.56 23.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.492 0.717 . . . . 0.0 109.49 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.2 m -58.07 140.74 51.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.327 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -68.6 -8.64 43.71 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.576 0.75 . . . . 0.0 109.234 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.75 74.07 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -138.94 158.58 43.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.452 1.126 . . . . 0.0 110.671 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -179.04 7.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.385 0.674 . . . . 0.0 110.682 -174.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.2 m-85 -142.84 163.36 33.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.88 140.96 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -113.33 122.89 48.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.693 0.397 . . . . 0.0 110.08 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -93.27 156.63 16.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 111.632 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.72 -22.92 60.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 122.606 0.363 . . . . 0.0 111.441 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -121.54 141.07 32.72 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 118.428 0.558 . . . . 0.0 110.042 174.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.33 -0.98 10.96 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.833 2.355 . . . . 0.0 110.599 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.6 -16.8 10.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.198 0.454 . . . . 0.0 110.827 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.434 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.4 m-20 -70.56 -29.05 65.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.74 -29.98 59.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.438 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -70.9 -39.25 72.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.21 -29.84 69.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.253 -0.276 . . . . 0.0 110.253 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.273 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.53 -12.58 61.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.501 0.32 . . . . 0.0 111.055 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -97.19 6.85 47.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.946 0.899 . . . . 0.0 112.052 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.92 -52.04 1.22 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.002 0.819 . . . . 0.0 109.892 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 54.3 mmm -81.65 -14.75 56.28 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.07 1.748 . . . . 0.0 112.055 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -74.35 116.33 14.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.14 -8.15 60.7 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.372 0.511 . . . . 0.0 112.027 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -82.54 -156.57 0.18 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.361 1.064 . . . . 0.0 109.392 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -144.35 158.8 43.55 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 123.786 0.834 . . . . 0.0 111.779 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.75 125.68 27.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.0 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.429 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 3.5 t70 61.07 -24.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 161.05 -12.2 0.14 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.78 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -118.29 137.32 53.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.468 1.134 . . . . 0.0 109.948 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.56 138.32 50.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.037 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.65 163.74 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -112.56 144.01 42.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.302 1.841 . . . . 0.0 107.963 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 29.2 t -135.07 130.6 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.87 162.26 39.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.12 123.43 21.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.33 146.48 43.97 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 61.8 p -101.09 168.85 9.32 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.36 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.38 150.72 97.6 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.284 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.76 160.92 47.9 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.432 2.754 . . . . 0.0 109.901 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.1 m -118.06 5.5 12.06 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -89.75 9.59 26.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.376 0.534 . . . . 0.0 111.756 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -140.41 148.42 41.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.478 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 39.8 m -148.0 14.89 1.05 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.797 0.839 . . . . 0.0 111.538 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.88 141.62 47.61 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.08 34.88 14.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.365 1.066 . . . . 0.0 111.735 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -150.89 154.07 36.51 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.61 0.364 . . . . 0.0 110.232 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.513 -1.715 . . . . 0.0 111.23 -179.798 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.571 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.32 1 C5'-C4'-C3' 109.257 -4.162 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.641 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.045 0 C3'-C2'-C1' 104.726 3.585 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 C5'-C4'-C3' 109.243 -4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 113.448 5.248 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 2 O4'-C1'-N19 112.96 4.76 . 0.015 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 O4'-C1'-N19 111.163 2.963 . 0.584 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.97 109.18 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.41 135.17 40.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.7 113.19 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -65.77 171.81 4.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.541 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -52.37 149.47 10.24 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.601 0.76 . . . . 0.0 112.617 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -51.54 155.24 7.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.623 3.549 . . . . 0.0 113.233 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.83 -13.02 66.83 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -98.24 127.1 44.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -113.4 153.26 28.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.971 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -106.4 128.94 54.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.431 HD13 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.53 81.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.86 143.2 16.46 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.951 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.6 11.63 34.97 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 117.74 0.77 . . . . 0.0 111.752 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -67.33 162.33 23.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 111.706 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' B' ' 75' ' ' ASP . 47.2 t30 -75.29 156.54 35.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.642 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -71.34 -8.27 52.59 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.244 0.618 . . . . 0.0 110.383 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.26 -10.17 20.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.607 1.163 . . . . 0.0 110.489 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -81.79 146.18 30.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.29 0.636 . . . . 0.0 109.918 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.58 -167.26 2.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.174 -173.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -67.72 -28.54 67.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 118.055 0.388 . . . . 0.0 111.075 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.39 -21.89 30.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.56 -29.02 22.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.107 1.363 . . . . 0.0 109.403 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.23 -28.21 38.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 109.937 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.12 37.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.352 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -104.35 -35.0 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.431 ' CZ ' HD13 ' B' ' 12' ' ' ILE . 89.9 m-85 -91.95 -10.99 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.909 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.38 -2.9 75.73 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -81.9 -12.17 58.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.708 1.203 . . . . 0.0 111.04 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -112.14 -19.16 12.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.39 166.41 37.39 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 118.264 0.484 . . . . 0.0 112.716 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -73.88 117.1 15.26 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mt -76.29 142.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.67 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -21.97 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.178 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.71 150.17 15.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.019 0.528 . . . . 0.0 109.834 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.98 145.92 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.352 0.596 . . . . 0.0 109.546 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -121.9 154.77 36.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.451 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.452 HD13 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.42 119.55 5.44 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.49 141.07 28.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.5 -170.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.452 ' HE2' HD13 ' B' ' 39' ' ' LEU . 13.3 mttt -137.91 160.24 39.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.53 149.16 39.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.183 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -93.4 -1.63 55.59 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.76 -13.65 7.86 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.8 p -125.94 -15.79 5.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 118.295 0.498 . . . . 0.0 111.377 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.71 21.9 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.66 -105.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.84 1.256 . . . . 0.0 109.886 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -152.88 146.26 24.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.865 0.866 . . . . 0.0 108.681 172.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.35 -10.31 59.34 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.51 0.31 89.32 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.855 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -133.92 157.11 46.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.637 1.219 . . . . 0.0 110.604 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.137 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 62.5 m-85 -143.05 162.41 35.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.623 0.369 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.79 140.31 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.8 m -112.75 122.56 48.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 123.271 0.357 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.5 156.69 16.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.859 0.864 . . . . 0.0 111.791 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.7 -21.81 59.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.215 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -122.26 139.83 31.38 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.94 -0.15 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.161 2.574 . . . . 0.0 110.65 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.01 -14.99 9.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.822 0.283 . . . . 0.0 111.141 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.458 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.3 m-20 -72.43 -28.5 63.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.27 -29.24 60.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -73.03 -37.25 66.96 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.1 -25.5 65.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.533 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.64 16.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.204 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.4 -8.93 57.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.26 9.03 34.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.341 0.657 . . . . 0.0 112.727 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.09 -53.77 1.3 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.546 0.689 . . . . 0.0 109.461 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 26.8 mmm -81.73 -10.22 59.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.63 1.572 . . . . 0.0 112.055 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -73.43 127.02 31.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.68 79.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.333 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -82.38 -157.42 0.21 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.608 1.163 . . . . 0.0 109.824 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -136.15 153.12 51.37 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.593 0.757 . . . . 0.0 110.858 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.75 -65.88 0.95 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.124 -175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' B' ' 16' ' ' ASN . 14.5 t70 -121.54 14.49 11.06 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.391 -175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.44 -6.09 9.25 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.846 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -112.88 131.04 55.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.734 0.814 . . . . 0.0 108.843 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.19 134.98 37.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.116 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 pt -115.12 175.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -118.27 141.72 48.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.058 1.743 . . . . 0.0 107.099 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.71 127.42 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.76 163.79 37.72 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -63.75 134.09 54.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.87 152.7 38.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -106.31 175.75 5.39 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -78.86 155.86 77.65 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 123.036 0.534 . . . . 0.0 109.963 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.35 158.8 47.02 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.444 2.763 . . . . 0.0 111.554 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.9 m -113.04 7.58 18.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -80.12 2.91 22.23 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.962 0.801 . . . . 0.0 112.041 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.34 153.4 35.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.015 0.436 . . . . 0.0 111.939 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 39.7 m -149.0 33.79 0.75 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.267 1.027 . . . . 0.0 110.228 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.36 -6.12 39.04 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.415 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -146.7 135.36 22.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.933 0.866 . . . . 0.0 110.041 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 53.32 -179.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.93 1.292 . . . . 0.0 112.98 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.316 -1.824 . . . . 0.0 110.628 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ' A' . . . . . 0.54 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.43 -1.954 1 C5'-C4'-C3' 109.365 -4.09 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ' U' . . . . . 0.603 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.149 0 C3'-C2'-C1' 104.18 2.977 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 C5'-C4'-C3' 110.422 -3.386 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 1 O4'-C1'-N19 113.787 5.587 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ' A' . . . . . 0.409 ' C8 ' ' CZ ' ' B' ' 53' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.616 2 O4'-C1'-N19 114.279 6.079 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C5'-C4'-C3' 110.696 -3.202 . 0.144 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -98.37 128.25 44.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.146 0.973 . . . . 0.0 108.438 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.7 mt -112.29 155.62 23.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -109.48 128.92 55.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.508 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.7 mm -120.14 79.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 144.81 17.41 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.416 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 9.46 42.0 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.576 0.688 . . . . 0.0 111.534 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.83 164.0 15.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.745 0.783 . . . . 0.0 111.612 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.8 t-20 -74.47 159.37 32.35 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.42 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 42.2 p -74.78 -11.23 60.11 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.084 -0.385 . . . . 0.0 110.279 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.97 -9.36 28.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.107 0.963 . . . . 0.0 110.937 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -76.8 144.83 38.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.84 0.456 . . . . 0.0 109.924 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 -169.1 2.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -69.8 -34.84 74.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.72 -174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -66.83 -29.19 69.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 111.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.85 31.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.39 -28.24 22.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 109.774 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.62 -29.39 36.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.615 0.721 . . . . 0.0 110.111 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.69 -22.76 40.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.307 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.5 p -102.29 -35.16 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.528 ' CD2' HG13 ' B' ' 27' ' ' VAL . 90.3 m-85 -92.09 -10.69 38.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.182 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.57 -2.92 77.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.55 -12.8 58.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.972 1.309 . . . . 0.0 111.116 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.33 -19.04 12.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.686 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.72 165.42 36.15 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.159 0.436 . . . . 0.0 112.37 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -73.54 116.95 14.72 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.9 mt -75.9 141.65 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.636 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -22.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.131 0.573 . . . . 0.0 110.022 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.22 149.16 15.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.933 0.493 . . . . 0.0 109.83 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.36 144.99 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.306 0.574 . . . . 0.0 109.644 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.8 mt -121.12 154.59 35.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.307 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.14 117.93 6.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.4 mmm -88.08 142.06 28.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.75 1.42 85.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.149 0.88 . . . . 0.0 112.287 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.78 161.42 38.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.307 1.053 . . . . 0.0 110.13 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.99 -177.3 6.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.7 m-85 -142.24 160.35 40.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -154.06 140.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -113.11 122.86 48.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.151 0.282 . . . . 0.0 110.357 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -92.39 156.01 17.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.96 0.904 . . . . 0.0 111.93 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -74.22 -21.99 59.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.57 0.348 . . . . 0.0 111.135 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -121.88 141.49 34.13 Favored Pre-proline 0 C--N 1.34 0.164 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.45 -9.72 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.682 2.254 . . . . 0.0 110.3 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.19 -14.48 13.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.285 0.493 . . . . 0.0 110.572 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.5 m-20 -71.95 -28.5 63.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.18 56.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -68.46 -38.35 81.02 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.93 -32.41 72.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.71 -44.03 44.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.78 42.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 122.075 -0.39 . . . . 0.0 111.253 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -105.87 5.32 30.56 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 112.349 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.74 -52.29 1.24 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.498 0.666 . . . . 0.0 109.49 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.4 ' HE3' HD11 ' B' ' 79' ' ' ILE . 31.6 mmm -83.55 -9.46 58.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.397 1.479 . . . . 0.0 111.987 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.8 124.8 27.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.85 -4.92 85.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.23 -152.97 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.569 1.148 . . . . 0.0 109.459 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -140.61 158.86 43.36 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.757 0.789 . . . . 0.0 112.915 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 128.78 31.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.835 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.3 t0 52.57 22.53 2.22 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.145 0.497 . . . . 0.0 112.214 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.92 -3.33 57.16 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 119.32 -0.711 . . . . 0.0 113.853 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -114.99 130.13 56.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.216 1.008 . . . . 0.0 110.304 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 139.47 52.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.749 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.4 HD11 ' HE3' ' B' ' 69' ' ' MET . 18.9 pt -124.89 174.82 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -119.01 144.36 46.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.184 1.794 . . . . 0.0 107.799 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.32 127.26 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -62.27 138.37 58.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.05 35.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 N--CA 1.454 -0.25 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.125 171.694 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.97 126.79 39.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 68.6 mt -113.56 153.27 29.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.062 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -106.7 127.59 53.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -119.62 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.93 142.16 15.93 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.51 35.93 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.691 0.745 . . . . 0.0 111.805 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.39 164.36 16.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.155 0.502 . . . . 0.0 111.858 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.537 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t-20 -77.79 158.31 29.6 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.144 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 57.9 p -73.21 -6.97 49.34 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.401 0.68 . . . . 0.0 110.114 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.52 -10.19 21.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.654 1.181 . . . . 0.0 110.531 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 31.0 m -83.22 144.68 29.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.325 0.65 . . . . 0.0 109.822 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.89 -170.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -66.99 -34.92 78.81 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.093 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -67.6 -29.03 68.27 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 118.016 0.371 . . . . 0.0 111.099 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.27 29.42 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.423 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -87.44 -27.89 22.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 109.555 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.45 -28.23 34.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 109.899 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.65 -21.78 37.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.42 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.522 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.5 p -103.41 -36.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.522 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -90.63 -11.36 40.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.817 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.9 -3.04 73.05 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.62 -11.87 58.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.682 1.193 . . . . 0.0 110.855 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -111.82 -19.5 12.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.83 166.61 37.49 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 118.046 0.384 . . . . 0.0 112.406 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 43.5 ttt-85 -73.74 117.52 15.62 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.09 142.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.56 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -22.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 123.212 0.605 . . . . 0.0 110.137 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -161.73 150.21 15.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.05 0.54 . . . . 0.0 109.878 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.58 146.4 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.056 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -121.3 154.63 36.13 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.378 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.423 HD23 ' CD1' ' B' ' 24' ' ' LEU . 3.0 tm? -152.68 118.36 5.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.6 mmm -91.38 139.85 30.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.851 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.414 ' HE2' HD12 ' B' ' 39' ' ' LEU . 8.9 mttt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.477 0.656 . . . . 0.0 112.472 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.58 89.45 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.401 -0.666 . . . . 0.0 111.559 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -138.49 157.46 46.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.559 1.18 . . . . 0.0 109.952 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.93 -179.1 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.455 0.302 . . . . 0.0 110.853 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 49.9 m-85 -142.67 162.61 35.01 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.848 0.459 . . . . 0.0 110.215 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.87 141.53 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.6 m -113.3 123.54 50.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.336 0.397 . . . . 0.0 110.135 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.65 156.85 16.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.695 0.798 . . . . 0.0 111.627 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.19 -22.42 59.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.608 0.363 . . . . 0.0 111.275 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -121.23 140.04 30.51 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.395 0.543 . . . . 0.0 110.084 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -76.2 0.72 9.08 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.231 2.62 . . . . 0.0 110.583 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.46 -16.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.063 0.392 . . . . 0.0 111.356 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.9 m-20 -71.75 -28.57 63.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.49 57.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.66 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -74.5 -37.01 63.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.76 -24.61 64.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.488 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.24 14.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.38 45.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -109.06 9.36 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 112.224 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -52.25 1.33 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.54 -175.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mmm -83.12 -9.17 59.35 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.846 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -75.22 127.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.829 -0.544 . . . . 0.0 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.12 83.16 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.51 -154.17 0.11 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.518 1.127 . . . . 0.0 109.436 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.8 t -140.3 159.19 42.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.0 112.311 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -133.37 126.8 32.11 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.046 177.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.537 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.53 -22.24 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.513 1.125 . . . . 0.0 113.821 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.87 -6.28 0.53 Allowed Glycine 0 N--CA 1.439 -1.123 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.19 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -118.46 134.38 55.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.959 0.879 . . . . 0.0 110.341 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.55 138.42 48.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.471 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.08 175.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -119.89 142.46 48.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.13 1.772 . . . . 0.0 107.397 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.56 125.41 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -162.05 164.42 28.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -57.79 134.8 56.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.9 158.8 32.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.271 0.558 . . . . 0.0 112.359 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.491 172.853 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -101.13 129.9 47.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.018 0.909 . . . . 0.0 108.891 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.406 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.4 mt -113.35 153.61 28.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -107.73 129.23 55.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -121.0 82.37 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.07 144.44 17.28 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.758 -0.589 . . . . 0.0 112.001 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.71 9.21 43.96 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 117.524 0.662 . . . . 0.0 111.597 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.91 162.86 12.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.579 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.6 t-20 -73.51 159.95 32.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.598 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.9 p -74.53 -4.56 37.64 Favored 'General case' 0 N--CA 1.457 -0.075 0 C-N-CA 122.902 0.481 . . . . 0.0 110.366 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.25 -7.68 18.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 110.81 -172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.7 m -80.54 144.19 32.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.922 0.489 . . . . 0.0 109.937 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.63 -169.66 2.45 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -68.85 -35.36 76.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.778 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -65.68 -29.71 70.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.916 -0.49 . . . . 0.0 110.97 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.89 -20.99 28.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -89.34 -27.97 20.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.802 1.241 . . . . 0.0 109.606 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.35 -27.82 31.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 109.907 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -23.26 38.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.309 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.1 p -101.06 -35.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.506 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.8 m-85 -92.1 -10.87 37.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.283 -0.261 . . . . 0.0 111.024 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.67 -2.62 76.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.72 -11.25 59.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.431 1.092 . . . . 0.0 111.159 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.93 -18.85 11.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.39 0.676 . . . . 0.0 112.634 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -174.83 161.19 30.64 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -72.6 124.22 24.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.89 143.49 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.286 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.07 -23.56 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.351 0.66 . . . . 0.0 110.076 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.02 150.47 16.94 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.99 146.58 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 121.28 0.562 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -121.32 153.67 37.43 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.245 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.38 118.83 6.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.7 mmm -92.31 137.59 32.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.932 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 pttt . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.331 0.586 . . . . 0.0 111.293 177.176 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 . . . . . 0 C--O 1.23 0.04 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.46 0.5 79.41 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.698 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -136.92 158.42 44.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.434 1.117 . . . . 0.0 110.376 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.02 -179.5 8.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.868 0.467 . . . . 0.0 110.728 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.8 m-85 -141.85 161.98 36.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.659 0.383 . . . . 0.0 110.231 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.81 141.13 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.3 m -113.52 122.12 46.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.349 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -92.82 156.95 16.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.938 0.895 . . . . 0.0 110.768 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -79.63 -20.97 45.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.451 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -118.16 138.85 25.96 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.46 -6.6 18.55 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.635 2.224 . . . . 0.0 110.431 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.26 -14.77 12.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.201 0.455 . . . . 0.0 111.135 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.464 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.7 m-20 -71.53 -28.46 63.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 -30.52 52.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.394 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.01 -39.14 79.48 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.04 -32.17 72.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.72 45.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.39 -7.55 48.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.209 -0.307 . . . . 0.0 111.163 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -105.26 5.67 32.23 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.521 1.128 . . . . 0.0 112.344 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.16 -51.68 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.768 0.794 . . . . 0.0 109.755 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.404 ' HE3' HD11 ' B' ' 79' ' ' ILE . 28.9 mmm -83.59 -10.13 58.46 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.145 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.7 126.13 29.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.48 -5.74 84.54 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.59 -0.561 . . . . 0.0 111.841 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.54 -153.72 0.11 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.361 1.064 . . . . 0.0 109.473 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -139.84 158.75 43.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.9 126.99 31.58 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.496 177.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.546 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.5 t70 61.19 -21.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.18 -7.03 0.53 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.4 135.16 54.86 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.264 1.032 . . . . 0.0 110.218 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.31 138.89 51.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.597 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.404 HD11 ' HE3' ' B' ' 69' ' ' MET . 19.9 pt -121.22 179.52 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -125.05 145.02 50.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.823 1.649 . . . . 0.0 107.787 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -133.12 129.49 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -158.1 163.31 37.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -65.24 137.06 57.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.22 155.57 38.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.454 -0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.228 173.145 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.244 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -86.13 129.05 34.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' B' ' 56' ' ' PHE . 78.0 mt -116.69 155.53 28.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.362 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.58 129.67 55.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -121.72 80.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.7 144.63 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.267 -0.492 . . . . 0.0 111.977 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.48 7.52 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 117.497 0.649 . . . . 0.0 111.545 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 mt -64.24 164.75 10.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.163 0.585 . . . . 0.0 111.166 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.573 HD21 ' H ' ' B' ' 17' ' ' THR . 0.7 OUTLIER -72.1 158.94 35.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.46 176.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.573 ' H ' HD21 ' B' ' 16' ' ' ASN . 79.8 p -75.79 -4.77 42.47 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.218 -0.301 . . . . 0.0 110.375 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.49 -7.38 17.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.127 0.971 . . . . 0.0 111.066 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.2 m -79.18 144.89 34.01 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.09 0.556 . . . . 0.0 109.576 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.93 2.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.171 0.51 . . . . 0.0 110.009 175.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.86 -34.37 76.56 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.756 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.41 -30.36 70.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.046 -0.409 . . . . 0.0 110.923 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.74 -21.41 30.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.84 -28.47 19.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 109.928 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.8 -27.92 33.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.237 0.542 . . . . 0.0 110.119 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.34 -22.95 38.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.241 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -100.96 -36.65 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.6 m-85 -91.03 -10.89 40.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.958 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.75 -3.2 72.58 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -82.12 -11.76 58.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.63 1.172 . . . . 0.0 111.034 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.43 -19.88 11.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.364 0.665 . . . . 0.0 112.538 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.71 165.36 36.06 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 118.051 0.387 . . . . 0.0 112.189 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -73.09 117.97 15.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.3 141.35 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.509 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.74 -24.49 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.871 0.468 . . . . 0.0 110.093 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -160.35 151.36 19.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.66 146.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 109.699 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -118.99 153.95 33.82 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.1 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -153.66 120.23 5.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.41 140.02 30.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.663 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 pttt . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.257 0.551 . . . . 0.0 112.304 176.91 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 . . . . . 0 CA--C 1.527 0.079 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.83 75.79 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.34 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -141.74 157.97 44.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.627 1.213 . . . . 0.0 110.619 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.688 0.395 . . . . 0.0 110.791 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.7 m-85 -141.93 162.44 35.46 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.004 0.522 . . . . 0.0 110.127 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.36 139.86 12.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -112.18 122.17 46.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.7 m-85 -92.16 156.17 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.023 0.929 . . . . 0.0 111.642 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.56 -21.92 59.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 122.612 0.365 . . . . 0.0 111.061 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.7 t -121.23 140.48 31.26 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.45 -7.43 19.57 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.462 2.108 . . . . 0.0 110.472 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.13 -15.87 13.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.369 0.267 . . . . 0.0 110.902 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 75.0 m-20 -70.76 -28.35 64.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.14 54.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.553 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -68.83 -39.04 80.19 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.99 -36.34 81.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.6 64.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.5 47.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.199 -0.313 . . . . 0.0 111.185 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -105.41 7.59 33.26 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.465 1.106 . . . . 0.0 112.274 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.61 -52.27 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.826 0.739 . . . . 0.0 109.568 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.32 -9.88 59.3 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.595 1.558 . . . . 0.0 112.439 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.71 125.38 27.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.74 -5.79 84.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.54 -153.98 0.09 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.474 1.11 . . . . 0.0 109.712 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 26.2 t -139.49 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.865 0.841 . . . . 0.0 112.814 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.46 129.09 30.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.757 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.436 ' HB3' ' CB ' ' B' ' 16' ' ' ASN . 6.4 t0 52.89 22.24 2.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.058 0.456 . . . . 0.0 112.131 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.86 -2.46 58.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.978 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.92 130.19 56.86 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.251 1.026 . . . . 0.0 110.557 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.46 138.25 50.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.502 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.91 178.39 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -122.8 141.51 51.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.717 2.007 . . . . 0.0 107.317 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.15 130.22 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -159.12 164.15 35.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -69.57 132.44 46.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 148.1 33.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 CA--C 1.517 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.486 175.663 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.438 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -82.15 129.65 34.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.4 mt -118.89 159.51 23.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.04 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -112.62 129.71 56.28 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.5 mm -122.08 81.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -174.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.38 145.5 17.78 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.197 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.76 33.24 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 117.57 0.685 . . . . 0.0 112.026 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.13 168.03 3.59 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 112.586 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.402 ' CB ' ' HB3' ' B' ' 75' ' ' ASP . 3.1 t-20 -73.27 -6.41 45.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p 68.76 -13.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.652 1.581 . . . . 0.0 113.479 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.72 -7.25 28.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.42 0.688 . . . . 0.0 109.301 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -76.25 147.52 38.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.531 1.132 . . . . 0.0 109.521 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -170.14 2.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.586 0.707 . . . . 0.0 109.566 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.03 -35.79 80.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.542 -173.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.83 -30.14 70.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.82 -20.39 23.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' B' ' 27' ' ' VAL . 8.6 mt -87.08 -28.32 22.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.216 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -80.11 -26.94 39.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 110.058 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.57 38.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.478 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -103.89 -35.59 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.8 m-85 -92.33 -11.24 35.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.944 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.07 -2.84 73.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.77 -12.92 58.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.684 1.193 . . . . 0.0 111.073 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -111.34 -19.18 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 123.756 0.66 . . . . 0.0 112.547 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.33 165.88 35.49 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -73.29 117.09 14.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -76.1 139.08 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.246 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -24.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.944 0.497 . . . . 0.0 109.863 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -160.38 150.87 18.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.078 0.551 . . . . 0.0 109.562 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.4 145.57 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.34 0.591 . . . . 0.0 109.572 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -119.05 153.02 35.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.661 -1.154 . . . . 0.0 107.91 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.02 117.42 5.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.1 mmm -91.88 139.97 30.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.21 1.73 81.24 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.51 157.67 46.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.248 1.024 . . . . 0.0 110.775 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.53 -179.19 7.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.205 0.602 . . . . 0.0 110.62 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 42.6 m-85 -142.53 162.04 36.5 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.91 138.69 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -111.89 122.08 46.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.681 0.392 . . . . 0.0 109.975 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 12.8 m-85 -92.07 156.08 17.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.822 0.849 . . . . 0.0 111.616 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.11 -22.51 60.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.857 0.463 . . . . 0.0 111.063 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.1 t -121.74 139.98 31.05 Favored Pre-proline 0 CA--C 1.52 -0.2 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.59 -3.0 13.19 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.897 2.398 . . . . 0.0 110.48 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.02 -14.84 11.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 123.141 0.276 . . . . 0.0 111.278 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 79.8 m-20 -71.57 -28.93 64.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.42 -30.79 57.56 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.507 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -68.87 -38.83 79.97 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.15 -32.6 72.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.92 -44.48 48.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 -7.38 45.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.315 -0.241 . . . . 0.0 111.41 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -105.59 5.28 31.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.129 0.972 . . . . 0.0 112.08 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.28 -53.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 29.7 mmm -82.2 -10.08 59.28 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.569 1.548 . . . . 0.0 112.205 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.98 126.37 30.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.609 -0.682 . . . . 0.0 109.381 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.11 81.22 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.43 -153.96 0.11 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.449 1.099 . . . . 0.0 109.319 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -137.53 158.68 43.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.529 0.681 . . . . 0.0 112.649 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.422 HD21 HG11 ' B' ' 27' ' ' VAL . 0.1 OUTLIER -132.15 125.27 30.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.402 ' HB3' ' CB ' ' B' ' 16' ' ' ASN . 11.4 t0 57.16 -2.02 0.05 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 137.62 -11.41 3.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.762 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.35 137.2 54.41 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.315 1.058 . . . . 0.0 111.092 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 140.33 56.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.239 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.51 177.63 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -120.79 142.52 49.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.883 1.673 . . . . 0.0 107.386 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.37 127.19 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -158.88 163.58 36.47 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -65.76 134.61 53.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.14 139.25 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.171 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.437 0 CA-C-O 119.125 -0.82 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.25 127.07 38.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.088 0.944 . . . . 0.0 108.734 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' B' ' 56' ' ' PHE . 76.0 mt -113.39 149.23 34.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.19 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.33 127.88 49.14 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 10.0 mm -118.94 77.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -173.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.59 144.63 17.2 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.14 45.22 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 117.733 0.767 . . . . 0.0 111.752 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.52 163.88 12.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.152 0.581 . . . . 0.0 111.408 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.5 t30 -72.78 155.9 39.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.71 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 62.0 p -74.69 -0.95 19.72 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.367 0.267 . . . . 0.0 111.093 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -110.5 -5.79 15.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 110.668 -171.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -82.93 144.71 29.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.084 0.554 . . . . 0.0 109.571 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -169.74 2.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.19 -35.37 79.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.764 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.32 -29.15 68.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.041 -0.412 . . . . 0.0 111.061 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.51 -21.03 28.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.65 -28.43 20.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.91 1.284 . . . . 0.0 109.532 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.25 -28.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.632 0.73 . . . . 0.0 109.903 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.38 -23.11 40.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.162 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 74' ' ' LEU . 5.4 p -101.92 -34.53 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.4 m-85 -91.48 -10.66 40.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.719 -0.218 . . . . 0.0 111.064 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.3 -2.44 79.17 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -82.21 -11.97 58.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.406 1.082 . . . . 0.0 111.002 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.74 -19.89 11.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.573 0.749 . . . . 0.0 112.739 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.84 166.59 37.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -74.03 116.83 15.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.94 141.13 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -22.71 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -160.85 150.06 16.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.01 0.524 . . . . 0.0 109.846 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.81 144.13 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.1 mt -120.17 158.44 26.93 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.105 175.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -155.91 123.17 5.43 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.99 137.3 33.35 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 pttt . . . . . 0 N--CA 1.451 -0.384 0 O-C-N 123.418 0.449 . . . . 0.0 110.89 173.74 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.566 0.222 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.15 3.7 78.85 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.436 -0.647 . . . . 0.0 112.127 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.22 157.7 45.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.357 1.079 . . . . 0.0 110.741 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.84 -178.41 7.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.893 0.477 . . . . 0.0 110.501 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.5 m-85 -142.34 163.18 33.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.568 0.347 . . . . 0.0 110.42 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -153.78 146.36 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -117.37 123.44 46.47 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.316 0.385 . . . . 0.0 110.201 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.4 m-85 -93.55 156.15 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.33 0.652 . . . . 0.0 111.925 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.52 -22.67 58.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.2 t -121.33 141.11 32.52 Favored Pre-proline 0 C--O 1.233 0.202 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.29 -8.84 21.3 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.557 2.172 . . . . 0.0 110.08 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.02 -15.24 13.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.588 0.355 . . . . 0.0 110.732 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.498 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.2 m-20 -72.43 -29.02 63.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.07 -29.61 58.05 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.44 -38.13 77.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.24 -32.31 71.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 -46.32 40.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.12 47.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.083 -0.386 . . . . 0.0 111.49 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -102.64 7.38 39.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.468 1.107 . . . . 0.0 112.646 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.28 -51.31 0.94 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.491 1.138 . . . . 0.0 109.373 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 45.4 mmm -79.43 -16.45 56.14 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.669 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -73.96 119.02 17.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.94 74.86 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.359 -0.689 . . . . 0.0 112.652 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 7.9 ptpt -88.26 179.63 6.32 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 118.377 1.088 . . . . 0.0 111.316 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -107.94 146.66 32.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.77 -63.9 1.13 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.4 0.619 . . . . 0.0 110.573 -176.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.579 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.6 t70 -124.45 5.49 8.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.548 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.99 -11.96 2.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.43 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -115.79 133.45 56.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.58 0.752 . . . . 0.0 109.598 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.78 136.95 41.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.793 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 pt -115.29 175.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -120.27 142.67 48.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.58 1.552 . . . . 0.0 107.625 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.21 127.02 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -160.55 162.81 33.04 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -61.12 132.44 53.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.03 27.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 CA--C 1.517 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.768 171.824 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.95 127.12 36.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' B' ' 56' ' ' PHE . 73.8 mt -113.8 153.37 29.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -106.71 127.75 53.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.1 mm -119.05 77.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.63 144.86 17.41 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.67 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.43 10.19 42.12 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 117.589 0.694 . . . . 0.0 111.422 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.78 163.71 13.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.377 0.671 . . . . 0.0 111.96 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.9 t-20 -73.96 160.76 30.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.461 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.3 p -75.74 -3.87 37.28 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.706 0.402 . . . . 0.0 110.382 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.68 -7.42 18.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.358 1.063 . . . . 0.0 110.888 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -81.63 143.7 31.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.737 0.415 . . . . 0.0 110.235 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -170.25 2.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.73 -35.5 78.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.89 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.57 -28.96 68.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.275 -0.265 . . . . 0.0 111.141 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.4 -20.63 27.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.6 -29.17 20.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.969 1.308 . . . . 0.0 109.458 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.52 -29.6 37.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 0.0 109.944 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -23.3 41.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.118 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.49 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.7 p -101.37 -34.26 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 86.4 m-85 -93.55 -10.34 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.335 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -3.66 76.18 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -80.84 -13.26 59.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.697 1.199 . . . . 0.0 111.123 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -111.67 -19.04 12.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.75 163.69 32.21 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 117.897 0.317 . . . . 0.0 112.448 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -67.23 116.08 7.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.87 141.57 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.741 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -21.17 5.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.934 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.77 149.9 15.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.35 144.64 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.309 0.576 . . . . 0.0 109.663 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.4 mt -120.12 155.65 32.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.511 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -152.33 119.15 5.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.8 139.19 30.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.763 -170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 pttt . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.101 0.477 . . . . 0.0 111.644 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 . . . . . 0 N--CA 1.457 -0.111 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 2.01 82.94 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.313 0.959 . . . . 0.0 112.003 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -142.61 162.26 35.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.321 1.06 . . . . 0.0 110.308 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -177.85 6.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.53 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 52.6 m-85 -141.3 162.12 36.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.83 0.348 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -154.05 139.16 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -110.23 124.31 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.755 0.312 . . . . 0.0 110.287 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.1 m-85 -93.53 156.09 16.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.919 0.888 . . . . 0.0 111.062 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.648 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -120.9 140.08 30.21 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.59 -2.54 12.57 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.746 2.297 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.76 -15.25 10.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.03 0.377 . . . . 0.0 111.299 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.486 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.7 m-20 -71.76 -28.43 63.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.4 58.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.172 0.589 . . . . 0.0 110.384 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.16 -37.64 75.27 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.61 -30.74 69.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.3 33.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.99 -7.81 48.87 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.95 -0.469 . . . . 0.0 111.266 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -104.3 4.94 34.2 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 112.462 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.01 -54.2 1.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.706 0.765 . . . . 0.0 109.455 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.4 mmm -81.0 -11.22 59.6 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.444 1.498 . . . . 0.0 112.076 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -73.35 127.54 32.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.93 -7.17 78.7 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.72 -153.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.281 1.032 . . . . 0.0 109.37 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 29.3 t -139.58 159.43 42.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.493 0.663 . . . . 0.0 112.777 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.0 126.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.292 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.547 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 61.33 -21.12 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.51 -7.5 0.52 Allowed Glycine 0 N--CA 1.439 -1.119 0 CA-C-O 119.183 -0.787 . . . . 0.0 112.962 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.04 134.97 54.87 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.188 0.994 . . . . 0.0 110.205 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.99 139.03 50.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.63 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.4 pt -121.28 177.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -121.63 143.49 49.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 107.37 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.88 163.77 36.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -63.55 136.11 57.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.87 38.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.161 0.505 . . . . 0.0 112.239 -172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p . . . . . 0 CA--C 1.519 -0.245 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.265 172.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.307 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.27 129.55 47.25 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.912 0.856 . . . . 0.0 108.78 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.4 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 75.7 mt -113.31 155.11 25.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.338 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -108.39 129.41 55.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.526 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -121.62 80.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -174.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.77 148.8 19.23 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.909 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.43 11.24 45.44 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 117.736 0.768 . . . . 0.0 112.054 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.93 163.02 20.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.435 0.636 . . . . 0.0 111.907 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.622 HD22 ' HB3' ' B' ' 75' ' ' ASP . 32.2 t-20 -71.27 165.52 23.49 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.417 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -85.48 -8.34 58.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.917 -0.489 . . . . 0.0 110.962 -174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -109.41 -1.35 18.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.28 1.432 . . . . 0.0 111.147 -177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 68.6 m -76.61 144.51 39.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.35 -167.58 2.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.06 -32.11 70.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.432 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -65.0 -32.68 74.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -21.88 27.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.16 -27.27 23.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.98 1.312 . . . . 0.0 109.348 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.06 -28.98 32.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 110.121 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.25 -20.37 41.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.505 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 74' ' ' LEU . 6.4 p -104.33 -35.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 90.6 m-85 -91.83 -11.59 36.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.067 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.0 -3.57 75.22 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.53 -13.1 59.37 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.869 1.267 . . . . 0.0 111.002 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.6 -19.32 12.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.58 164.47 34.16 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.1 ttm105 -72.34 117.37 13.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -75.24 141.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.295 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -23.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.203 0.601 . . . . 0.0 109.958 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -161.18 150.51 16.67 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.054 0.541 . . . . 0.0 109.846 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.48 145.58 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.287 0.565 . . . . 0.0 109.812 172.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.3 mt -119.3 156.28 30.29 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.532 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.67 119.11 5.6 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.8 mmm -94.69 144.05 25.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.062 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.428 ' CA ' ' HG2' ' B' ' 49' ' ' ARG . 30.4 mttt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.428 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 48.1 mmm-85 . . . . . 0 CA--C 1.523 -0.066 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.11 2.42 88.12 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.649 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -135.57 160.0 39.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.61 1.205 . . . . 0.0 111.039 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -178.29 7.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.099 0.56 . . . . 0.0 110.716 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 65.7 m-85 -142.42 163.08 33.82 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.893 0.477 . . . . 0.0 109.865 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.66 142.48 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.7 m -114.68 122.92 47.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.437 0.295 . . . . 0.0 110.333 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.06 155.84 17.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.865 0.866 . . . . 0.0 111.974 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.29 -22.7 60.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.883 0.473 . . . . 0.0 111.291 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -121.18 140.88 31.88 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.65 -10.68 23.72 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.588 2.192 . . . . 0.0 110.396 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.63 -14.92 13.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.091 0.405 . . . . 0.0 110.671 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.2 m-20 -72.06 -27.62 62.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.38 -31.99 54.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.207 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -68.0 -39.59 83.21 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.37 -33.99 76.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.21 -44.41 53.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.08 44.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.093 -0.379 . . . . 0.0 111.37 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -105.59 4.51 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.338 1.055 . . . . 0.0 112.181 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.31 -52.91 1.39 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.779 0.799 . . . . 0.0 109.606 -175.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.1 mmm -82.69 -11.26 58.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.216 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.05 126.88 31.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.285 0.493 . . . . 0.0 109.752 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.86 -7.53 76.91 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.797 -0.446 . . . . 0.0 112.114 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.72 -156.94 0.19 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.582 1.153 . . . . 0.0 109.926 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -134.5 153.24 52.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 111.023 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -100.83 -65.99 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.388 0.613 . . . . 0.0 111.17 -176.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.622 ' HB3' HD22 ' B' ' 16' ' ' ASN . 15.4 t70 -120.54 16.27 12.04 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.628 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.8 -6.54 12.35 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.637 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -111.57 131.78 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 108.893 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.64 137.66 39.58 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.3 pt -118.58 173.74 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -116.82 140.65 49.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.026 1.73 . . . . 0.0 107.221 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.4 126.59 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.25 163.4 38.81 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -64.67 135.41 55.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.72 153.73 36.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 N--CA 1.452 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.144 169.961 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.85 127.84 37.47 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.51 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.4 mt -113.82 147.83 37.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -102.61 127.44 49.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -117.98 81.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.6 140.74 15.22 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.809 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 5.75 32.77 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 117.272 0.536 . . . . 0.0 111.899 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 19' ' ' THR . 8.0 mt -63.56 160.62 16.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.18 0.49 . . . . 0.0 110.958 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 45.4 t30 -69.23 159.27 33.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -71.69 -4.85 29.74 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.186 -0.321 . . . . 0.0 110.296 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.42 -8.36 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.86 1.264 . . . . 0.0 110.475 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.515 HG21 HD22 ' B' ' 15' ' ' LEU . 35.6 m -79.49 141.38 36.78 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.07 -168.03 2.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.393 0.616 . . . . 0.0 109.803 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.32 -30.57 68.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.97 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -66.77 -29.54 69.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.16 -17.73 28.59 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.68 -28.63 14.23 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.016 0.926 . . . . 0.0 110.495 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.28 -32.28 33.29 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.098 0.475 . . . . 0.0 109.72 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -29.7 43.28 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.208 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' B' ' 28' ' ' PHE . 3.6 p -91.6 -34.83 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 81.5 m-85 -91.42 -9.47 44.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.84 -4.88 86.17 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -78.61 -12.16 60.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.548 1.139 . . . . 0.0 111.193 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -115.63 -13.34 11.5 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.52 171.64 36.84 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 119.88 -1.152 . . . . 0.0 112.127 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -80.89 115.35 20.33 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.397 0.618 . . . . 0.0 109.689 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mt -74.18 139.84 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.745 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -19.06 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.061 175.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -163.15 149.66 12.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.407 0.683 . . . . 0.0 110.025 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.89 144.23 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 109.71 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -119.26 154.42 33.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.573 1.149 . . . . 0.0 108.047 173.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.93 118.97 6.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.6 mmm -92.93 142.41 27.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.665 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.062 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 1.44 78.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -136.07 157.7 46.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.33 1.065 . . . . 0.0 110.421 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.32 6.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.2 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 48.1 m-85 -141.95 161.09 38.84 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -154.67 140.74 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 46.9 m -111.48 126.94 55.49 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' B' ' 10' ' ' LEU . 4.9 m-85 -99.03 162.35 13.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.451 0.701 . . . . 0.0 110.328 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -72.26 -18.7 61.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -129.28 153.49 80.49 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 123.577 0.751 . . . . 0.0 110.126 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.58 3.14 8.05 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 122.714 2.276 . . . . 0.0 110.391 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.46 -15.18 7.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -86.22 -21.44 27.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.74 -28.27 61.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.055 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -69.23 -33.56 73.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.94 -27.33 63.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.97 -46.43 21.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.09 54.63 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.248 0.219 . . . . 0.0 111.369 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -101.69 9.31 41.11 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.298 1.039 . . . . 0.0 112.189 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -50.96 0.88 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.349 1.071 . . . . 0.0 109.127 -175.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.487 ' HA ' ' HG2' ' B' ' 72' ' ' LYS . 50.4 mmm -77.26 -18.56 57.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.27 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -75.95 110.42 10.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.06 -7.94 53.11 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.323 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' B' ' 69' ' ' MET . 8.6 ptpt -90.15 -173.17 3.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.239 1.02 . . . . 0.0 110.446 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' SER . . . . . 0.412 ' N ' ' HG3' ' B' ' 72' ' ' LYS . 47.2 t -122.84 153.52 39.48 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.778 0.799 . . . . 0.0 112.14 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -131.29 126.47 35.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.011 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.0 t70 62.25 -24.04 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 156.62 -10.99 0.29 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.081 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -118.14 137.23 53.11 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.977 0.888 . . . . 0.0 110.591 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.52 138.39 50.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.886 0.475 . . . . 0.0 110.82 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.495 HG21 HD23 ' B' ' 15' ' ' LEU . 23.8 pt -122.53 166.24 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -115.18 146.31 41.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.598 1.559 . . . . 0.0 108.127 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.22 129.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.58 163.53 32.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -61.65 134.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.31 157.49 29.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.948 0.404 . . . . 0.0 112.028 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 63.1 p . . . . . 0 N--CA 1.454 -0.252 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.392 172.518 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -85.61 129.32 34.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.664 0.732 . . . . 0.0 109.209 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.402 HD12 ' CE1' ' B' ' 56' ' ' PHE . 79.1 mt -119.22 153.37 35.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.379 0.671 . . . . 0.0 110.091 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -106.48 131.2 53.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.5 mm -121.85 80.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.19 148.7 19.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.937 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.8 11.02 51.63 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.619 0.709 . . . . 0.0 111.484 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.64 164.39 14.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.449 0.699 . . . . 0.0 111.449 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.585 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.3 t30 -72.59 156.91 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.889 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -76.36 -1.29 26.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.78 0.324 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.09 -5.8 15.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.392 1.077 . . . . 0.0 110.875 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.5 m -80.46 145.65 31.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.349 0.66 . . . . 0.0 110.186 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.59 -168.84 2.13 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.22 -33.19 71.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.48 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.13 -32.9 74.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.27 -22.1 27.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.84 -28.37 22.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.194 1.398 . . . . 0.0 109.453 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.08 -27.91 32.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.391 0.615 . . . . 0.0 110.05 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.6 -21.26 38.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.611 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.574 HG11 HD21 ' B' ' 74' ' ' LEU . 6.2 p -103.51 -34.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.3 m-85 -91.41 -11.63 37.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.949 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.23 -3.44 76.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.72 -12.81 59.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.758 1.223 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.55 -19.52 12.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.608 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.97 166.38 37.06 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.072 0.396 . . . . 0.0 112.369 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -73.9 117.13 15.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.2 mt -75.52 142.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -23.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.049 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.84 150.58 17.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.177 0.591 . . . . 0.0 109.794 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.09 144.63 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 109.75 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -116.74 154.19 31.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.47 117.68 6.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.5 mmm -92.68 138.08 31.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.753 -170.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttt . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 111.117 176.709 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.06 76.84 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.12 160.71 39.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.536 1.168 . . . . 0.0 110.991 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.14 -176.87 6.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 110.589 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 37.5 m-85 -143.17 162.84 34.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -154.13 144.72 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -116.68 122.63 45.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.327 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.402 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.1 m-85 -92.17 156.27 17.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.536 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.22 -22.53 59.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.085 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.6 t -121.58 140.98 32.61 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.52 -7.45 19.54 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.809 2.34 . . . . 0.0 110.137 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.69 -15.77 12.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.764 0.256 . . . . 0.0 110.623 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.9 m-20 -71.59 -28.48 63.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.42 56.55 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.91 -37.25 75.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.43 -30.85 67.81 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.27 -46.37 34.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.58 -9.97 52.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.13 -0.356 . . . . 0.0 111.191 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -102.16 8.14 40.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.398 1.079 . . . . 0.0 112.499 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.43 -51.38 0.93 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.323 1.059 . . . . 0.0 109.392 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 47.3 mmm -78.66 -17.26 56.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.846 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -73.31 118.4 16.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -7.91 75.6 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.641 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.5 ptpt -89.89 178.21 6.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.728 1.264 . . . . 0.0 111.261 175.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -105.45 147.18 28.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.705 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.574 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.53 -65.1 1.01 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.325 0.583 . . . . 0.0 110.559 -177.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.585 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.0 t70 -123.15 4.15 9.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.652 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.14 -11.36 2.55 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.214 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -115.51 133.58 55.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.824 0.85 . . . . 0.0 109.834 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.13 136.29 41.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.392 0.432 . . . . 0.0 110.395 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 16.9 pt -112.84 175.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -119.7 142.76 48.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 107.131 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.56 129.94 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.2 163.09 37.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 123.07 20.42 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.58 149.94 47.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.951 173.103 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.02 127.73 45.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 117.981 0.891 . . . . 0.0 109.132 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 74.7 mt -114.67 155.94 25.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.286 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.56 129.74 55.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.517 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.1 mm -121.32 75.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.63 146.96 18.41 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.226 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.42 11.0 30.22 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.834 0.817 . . . . 0.0 112.004 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.87 166.55 8.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.28 0.562 . . . . 0.0 112.184 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 58.4 t30 -79.0 -2.65 41.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 1.2 p 66.39 -13.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.929 1.292 . . . . 0.0 112.998 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' B' ' 16' ' ' ASN . 48.1 mm-40 -91.26 -9.05 46.57 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.969 0.908 . . . . 0.0 109.328 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -78.77 144.9 34.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 109.605 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 -172.31 3.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' B' ' 21' ' ' GLU . 36.2 mp0 -65.22 -37.93 88.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.453 0.701 . . . . 0.0 110.342 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -32.41 74.04 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.191 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.48 -21.03 25.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.16 -27.48 24.55 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.903 1.281 . . . . 0.0 109.034 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.64 -27.21 34.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.41 0.624 . . . . 0.0 110.026 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.0 -20.19 35.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.603 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.3 p -104.2 -35.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 88.4 m-85 -92.69 -10.05 38.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.134 175.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.93 -2.93 79.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.5 -11.27 59.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.557 1.143 . . . . 0.0 111.02 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -113.4 -19.34 11.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.786 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.36 161.15 30.12 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -74.07 123.06 23.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.99 143.79 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 -22.78 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.925 178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.95 150.43 15.18 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.32 0.648 . . . . 0.0 109.744 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.66 145.62 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.396 0.617 . . . . 0.0 109.655 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.9 mt -118.52 154.44 32.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.291 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -149.13 117.54 6.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.82 140.15 29.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.913 -169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 pttt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.424 0.63 . . . . 0.0 112.342 178.756 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 40.1 mmm-85 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.83 0.09 75.64 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' B' ' 49' ' ' ARG . 48.1 p90 -139.13 161.88 36.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 117.822 0.811 . . . . 0.0 111.083 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.72 -178.92 7.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.448 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 44.7 m-85 -140.34 162.3 35.63 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -152.98 142.51 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.9 m -114.06 121.7 44.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.29 156.54 17.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.753 0.821 . . . . 0.0 110.731 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -78.72 -23.75 45.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.376 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -114.03 138.09 22.7 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.74 -8.13 20.06 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.457 2.105 . . . . 0.0 110.434 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.99 -15.06 13.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.389 0.276 . . . . 0.0 110.891 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.466 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 70.3 m-20 -71.34 -28.17 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.41 51.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.31 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.41 -39.18 81.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.95 -32.62 73.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.58 -43.7 47.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.56 42.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.286 -0.259 . . . . 0.0 110.943 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -106.47 5.03 28.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.294 1.038 . . . . 0.0 112.324 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.81 -53.29 1.33 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.403 ' HE3' HD11 ' B' ' 79' ' ' ILE . 30.2 mmm -82.35 -10.19 59.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.779 1.632 . . . . 0.0 112.102 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.27 126.0 29.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.32 -6.74 81.12 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -80.81 -154.15 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.172 0.989 . . . . 0.0 109.16 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -137.77 159.53 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.798 0.808 . . . . 0.0 112.507 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.43 126.69 31.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.849 176.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 1.9 t70 60.98 -18.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.91 -8.38 0.6 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 119.33 -0.706 . . . . 0.0 113.154 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -121.91 138.51 54.38 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.259 1.03 . . . . 0.0 110.592 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.42 139.38 54.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.808 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.403 HD11 ' HE3' ' B' ' 69' ' ' MET . 25.2 pt -121.43 176.66 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -120.1 141.44 49.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.712 1.605 . . . . 0.0 107.505 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.38 124.56 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.07 163.15 36.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -60.7 133.77 56.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.63 153.71 30.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.8 p . . . . . 0 CA--C 1.518 -0.251 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.242 170.009 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -98.3 129.93 45.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.054 0.927 . . . . 0.0 108.926 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -114.88 154.04 29.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.87 130.92 55.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.479 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -122.3 80.34 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.2 143.25 16.44 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.538 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 9.65 38.7 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 117.477 0.639 . . . . 0.0 111.882 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.88 165.04 13.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.134 0.573 . . . . 0.0 111.672 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t30 -77.94 157.06 29.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 123.292 0.637 . . . . 0.0 110.924 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -72.63 -8.33 54.73 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.678 0.791 . . . . 0.0 110.283 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.94 -10.46 22.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 110.471 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.1 m -83.49 143.85 29.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -169.02 2.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -68.72 -33.29 73.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -64.6 -33.4 75.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.56 -20.89 27.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.449 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -86.5 -26.74 24.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.125 1.37 . . . . 0.0 109.431 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.9 -28.84 32.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.427 0.632 . . . . 0.0 110.119 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.33 -20.08 41.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.675 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -105.25 -36.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.5 m-85 -88.53 -11.89 44.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.923 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.63 -4.24 75.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -81.5 -12.88 58.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.319 1.048 . . . . 0.0 110.911 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.7 m-85 -109.73 -20.65 12.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.254 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.91 164.66 33.15 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 118.048 0.386 . . . . 0.0 112.959 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -66.41 117.84 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.7 mt -79.16 142.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.966 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -21.7 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.142 0.577 . . . . 0.0 109.91 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.69 150.39 15.64 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.464 0.706 . . . . 0.0 109.826 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.7 145.81 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.138 0.494 . . . . 0.0 110.059 172.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.0 mt -120.3 154.41 35.03 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.362 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.456 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -150.71 119.51 6.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 170.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 12.1 mmm -92.59 141.66 28.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.456 ' HE2' HD12 ' B' ' 39' ' ' LEU . 11.9 mttt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.408 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 42.9 mmm-85 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.92 2.73 88.34 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.351 -0.694 . . . . 0.0 111.582 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' B' ' 49' ' ' ARG . 51.1 p90 -135.49 161.45 35.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.764 1.282 . . . . 0.0 110.072 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.2 -177.62 6.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.779 0.431 . . . . 0.0 111.164 -174.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 63.2 m-85 -142.73 162.28 35.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.3 142.27 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m -113.35 123.99 51.42 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -95.04 156.35 16.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.931 0.892 . . . . 0.0 110.686 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.47 -21.26 45.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.493 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -116.5 137.93 24.01 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.85 -0.13 10.22 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.089 2.526 . . . . 0.0 110.568 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 -15.5 9.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 117.877 0.308 . . . . 0.0 111.198 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.521 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 84.5 m-20 -72.19 -27.96 62.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.62 -27.66 55.81 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.452 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -74.5 -36.59 63.23 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.24 -26.1 64.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.2 -46.38 14.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.03 63.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.3 7.7 46.03 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 -55.58 1.31 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.915 0.864 . . . . 0.0 109.371 -173.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 0.0 OUTLIER -75.48 -15.76 60.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.626 -1.625 . . . . 0.0 111.775 -177.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -73.91 124.06 25.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.32 -7.05 82.14 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -82.91 -153.46 0.12 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 109.361 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -139.69 158.73 43.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.464 0.706 . . . . 0.0 112.395 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -132.43 126.56 33.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.5 -23.34 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.62 -6.51 0.47 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 119.512 -0.604 . . . . 0.0 112.631 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -117.36 134.51 54.74 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.027 0.913 . . . . 0.0 110.134 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.96 139.17 50.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.479 -174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.22 174.55 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -120.89 144.19 48.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.3 1.84 . . . . 0.0 107.776 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -135.97 130.03 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -160.92 163.83 31.61 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -61.43 137.15 58.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.39 158.89 27.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.154 169.933 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.335 0 CA-C-O 119.23 -0.761 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -99.55 128.86 45.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 117.99 0.895 . . . . 0.0 108.872 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -112.56 151.31 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.517 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -104.65 128.41 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.512 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.9 79.05 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 146.48 18.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.937 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.28 10.44 41.87 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 117.68 0.74 . . . . 0.0 111.672 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.63 164.98 13.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.529 0.732 . . . . 0.0 112.129 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' B' ' 75' ' ' ASP . 46.7 t30 -77.1 162.38 27.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 110.657 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -76.71 -1.47 28.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.284 0.233 . . . . 0.0 110.607 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.6 -4.61 16.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.378 1.071 . . . . 0.0 110.815 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 45.2 m -82.7 144.51 30.18 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.945 0.498 . . . . 0.0 110.047 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 -169.23 2.44 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.369 0.604 . . . . 0.0 109.443 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.34 -35.51 73.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.558 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.1 -30.0 70.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.37 -21.02 23.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' B' ' 27' ' ' VAL . 9.9 mt -87.07 -28.82 22.33 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.135 0.974 . . . . 0.0 109.36 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.26 -25.51 39.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.186 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.37 -22.19 35.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.598 HG11 HD21 ' B' ' 74' ' ' LEU . 5.0 p -103.87 -29.3 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.512 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.6 m-85 -99.1 -10.39 22.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.382 174.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.21 -5.83 85.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -77.05 -22.97 52.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.853 1.261 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.7 -19.9 15.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.528 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.44 165.28 34.98 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 118.024 0.374 . . . . 0.0 112.215 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -74.07 116.87 15.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.66 139.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.39 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -23.64 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 122.849 0.46 . . . . 0.0 110.134 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -160.28 149.48 17.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.026 0.53 . . . . 0.0 109.614 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.71 143.58 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 172.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.9 mt -117.39 154.13 31.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.07 119.41 5.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.0 mmm -94.32 136.94 34.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.93 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 pttt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.363 0.602 . . . . 0.0 111.333 176.579 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.66 1.57 68.17 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.424 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.84 158.87 43.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.62 1.21 . . . . 0.0 110.553 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -178.52 7.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.051 0.541 . . . . 0.0 110.489 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.5 m-85 -142.58 162.39 35.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.846 0.459 . . . . 0.0 110.433 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.21 143.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -115.85 122.37 45.17 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 123.142 0.276 . . . . 0.0 110.306 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.71 156.58 17.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.589 0.755 . . . . 0.0 111.996 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -75.18 -22.89 57.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.599 0.36 . . . . 0.0 111.071 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -120.54 140.69 30.81 Favored Pre-proline 0 CA--C 1.518 -0.262 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.41 -12.77 25.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.436 2.091 . . . . 0.0 110.189 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.57 -15.59 14.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.165 0.439 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.493 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.8 m-20 -70.95 -29.01 64.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 169.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.57 58.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.008 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -67.59 -38.9 84.68 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.35 -33.56 74.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.05 52.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.73 -8.45 52.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.256 -0.277 . . . . 0.0 110.906 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -104.94 5.35 32.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.191 0.996 . . . . 0.0 112.286 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -52.05 1.28 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.862 0.755 . . . . 0.0 109.442 -175.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.7 mmm -83.36 -10.52 58.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.405 1.482 . . . . 0.0 112.529 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.85 127.26 32.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.83 76.28 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.149 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.84 -157.38 0.22 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -134.46 153.01 52.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.664 0.786 . . . . 0.0 110.891 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.598 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -99.93 -68.32 0.81 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.943 -176.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.601 ' HB3' HD22 ' B' ' 16' ' ' ASN . 11.7 t70 -117.59 7.25 12.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.652 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.25 -7.66 5.37 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -113.41 132.84 55.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 108.932 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 136.62 38.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.27 175.68 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -120.98 140.4 51.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.846 1.658 . . . . 0.0 107.302 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.86 125.12 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.44 162.72 35.72 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -60.71 133.6 56.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.2 158.33 27.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 N--CA 1.454 -0.246 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.143 171.325 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.288 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -85.88 129.98 34.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.3 mt -118.19 152.67 35.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.102 0.561 . . . . 0.0 109.961 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -105.42 128.65 53.64 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.73 81.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.94 146.83 18.41 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.861 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.33 51.09 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 117.707 0.754 . . . . 0.0 111.585 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.23 164.06 11.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.457 0.703 . . . . 0.0 111.295 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' B' ' 75' ' ' ASP . 44.5 t30 -73.1 158.86 34.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.294 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 76.0 p -74.96 -2.75 28.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.99 -7.15 16.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.647 1.179 . . . . 0.0 110.776 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.6 m -80.96 144.34 31.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.532 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -170.24 2.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.58 -34.64 77.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.646 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -65.78 -31.51 72.53 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.974 -0.454 . . . . 0.0 111.022 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -20.1 29.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -89.78 -28.34 19.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.819 1.248 . . . . 0.0 109.848 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -81.77 -28.55 33.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 109.896 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.81 -23.71 39.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.317 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.5 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.9 p -99.77 -37.8 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.5 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.7 m-85 -88.96 -10.58 47.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.772 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.13 -4.61 73.46 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.1 mtpt -79.2 -14.59 58.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.808 1.243 . . . . 0.0 111.377 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.1 m-85 -110.33 -19.8 12.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.723 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.56 163.07 31.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -74.95 125.61 29.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.69 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.342 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.18 -23.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.963 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -161.07 151.08 17.38 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.173 0.589 . . . . 0.0 109.557 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.92 147.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 109.722 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -122.23 156.0 34.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.589 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.24 121.39 5.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.73 138.3 31.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -174.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.164 0.507 . . . . 0.0 112.086 174.378 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.88 0.7 83.31 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.746 0.689 . . . . 0.0 112.591 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.66 158.34 43.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.439 1.12 . . . . 0.0 110.6 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.42 -179.28 7.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.8 m-85 -140.95 161.51 37.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.03 139.23 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -111.65 121.7 45.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.853 0.359 . . . . 0.0 110.121 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.7 m-85 -92.16 155.26 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.74 0.816 . . . . 0.0 110.444 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.97 -22.88 48.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -114.57 135.72 22.33 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.67 0.86 9.13 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.847 2.365 . . . . 0.0 110.499 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.35 -14.76 9.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.525 0.33 . . . . 0.0 111.202 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -72.07 -28.76 63.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.79 58.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.31 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -70.69 -37.82 73.65 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.23 -31.07 70.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -75.38 -44.91 42.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.262 -0.274 . . . . 0.0 111.333 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -99.8 5.72 45.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.047 0.939 . . . . 0.0 112.642 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.49 -51.75 1.27 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.913 0.778 . . . . 0.0 109.197 -174.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.443 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mtp -83.74 -11.16 57.51 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.74 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.89 114.17 10.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.03 -4.81 59.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.54 -154.53 0.11 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.327 1.051 . . . . 0.0 109.309 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -139.77 159.49 42.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 112.474 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.63 127.3 30.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.386 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 60.92 -20.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 150.26 -6.06 0.68 Allowed Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.042 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -118.38 134.73 54.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.869 0.834 . . . . 0.0 110.063 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.81 137.42 47.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.322 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.1 pt -118.5 177.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -122.01 143.35 49.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.562 1.945 . . . . 0.0 107.177 170.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.66 130.42 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -158.96 164.2 35.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -67.53 132.73 48.15 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.34 147.83 34.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.936 173.928 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -98.68 128.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.373 1.087 . . . . 0.0 109.044 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.34 153.8 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.048 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -108.08 128.93 55.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.485 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -121.1 80.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.39 144.21 17.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.237 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.71 38.98 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 117.709 0.755 . . . . 0.0 111.466 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.29 162.46 22.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.048 0.539 . . . . 0.0 112.087 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' B' ' 75' ' ' ASP . 39.5 t-20 -76.35 155.15 34.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.014 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -68.93 -10.47 57.41 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 123.548 0.739 . . . . 0.0 110.284 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.78 -11.25 23.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 110.309 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -81.29 144.72 31.33 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.287 0.635 . . . . 0.0 109.345 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.74 -165.98 1.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.392 0.615 . . . . 0.0 109.536 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' B' ' 21' ' ' GLU . 37.1 mp0 -70.61 -38.84 74.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.858 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -68.71 -25.84 64.97 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.5 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.95 -20.19 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' B' ' 27' ' ' VAL . 10.9 mt -90.37 -28.46 18.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.675 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.11 -26.65 48.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 109.79 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.85 -23.87 36.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' B' ' 24' ' ' LEU . 5.3 p -101.82 -36.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.485 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 83.9 m-85 -90.47 -11.61 39.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.21 -0.306 . . . . 0.0 110.951 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.16 -3.13 68.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -81.51 -12.23 58.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.14 . . . . 0.0 111.264 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -111.96 -20.48 11.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.6 0.76 . . . . 0.0 112.412 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.47 161.58 29.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -74.0 124.97 27.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.88 143.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.154 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -20.7 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.477 0.711 . . . . 0.0 110.477 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -160.37 148.82 16.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.304 0.642 . . . . 0.0 109.66 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.06 143.54 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 110.039 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -118.94 156.03 30.28 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.178 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.536 HD12 ' HE2' ' B' ' 41' ' ' LYS . 2.9 tm? -154.98 119.44 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 171.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 13.8 mmm -93.17 142.87 26.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.097 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.536 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.8 mttt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.17 87.18 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.158 -0.801 . . . . 0.0 111.943 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -136.94 160.34 39.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.922 1.361 . . . . 0.0 110.249 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.9 -178.71 7.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.749 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.9 m-85 -142.93 162.59 35.07 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.61 141.84 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 33.6 m -111.97 122.9 49.03 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.245 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -93.06 156.67 16.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 110.503 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.82 -23.08 42.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.461 -0.305 . . . . 0.0 110.284 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -115.19 137.56 23.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 -7.04 18.78 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.568 2.179 . . . . 0.0 110.474 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.75 -14.71 13.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.844 0.293 . . . . 0.0 110.728 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.484 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.6 m-20 -71.67 -28.13 63.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.14 53.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.556 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.05 -38.94 79.39 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.44 -32.74 72.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.94 -44.78 46.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.43 -8.47 51.16 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.057 -0.402 . . . . 0.0 111.203 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -104.23 4.74 34.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.395 1.078 . . . . 0.0 112.088 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.58 -52.67 1.26 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.759 0.79 . . . . 0.0 109.447 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.2 mmm -82.22 -10.55 59.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.586 1.555 . . . . 0.0 112.401 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.56 126.15 29.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.39 -6.63 83.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -80.64 -153.86 0.09 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.595 1.158 . . . . 0.0 109.691 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -139.88 159.05 43.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.292 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.66 126.18 32.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.024 177.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.9 t70 61.05 -21.38 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.08 -6.35 0.6 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.724 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -117.42 133.16 56.29 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.002 0.901 . . . . 0.0 110.119 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.36 50.78 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.301 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -120.64 178.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -122.57 142.74 50.3 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.399 1.88 . . . . 0.0 107.33 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.97 129.25 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -159.24 162.39 36.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -63.59 134.37 55.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 158.27 29.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.519 -0.249 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.949 169.63 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -92.24 125.49 36.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.432 HD12 ' CE1' ' B' ' 56' ' ' PHE . 74.4 mt -110.44 150.84 28.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -105.31 128.85 53.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.486 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.19 78.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.42 142.59 16.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.493 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.56 6.52 46.97 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 122.216 -0.579 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.27 162.32 6.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.331 0.652 . . . . 0.0 111.773 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.52 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.6 t30 -71.25 160.11 33.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 70.9 p -77.85 -1.28 30.87 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.878 0.471 . . . . 0.0 110.669 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.26 -6.1 15.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.409 1.083 . . . . 0.0 111.025 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -83.4 145.74 28.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.285 0.634 . . . . 0.0 110.087 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -169.96 2.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.51 -35.83 79.89 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.54 -174.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -67.89 -27.9 67.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.964 -0.46 . . . . 0.0 111.247 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.02 28.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.71 -26.78 24.07 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.166 1.386 . . . . 0.0 109.352 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -80.19 -32.75 38.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.427 0.632 . . . . 0.0 110.163 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.49 -21.65 45.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.308 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.1 p -103.06 -34.29 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.2 m-85 -91.83 -12.0 34.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.073 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -3.08 72.11 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -81.57 -13.58 57.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.66 1.184 . . . . 0.0 110.89 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -110.94 -19.58 12.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.696 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.13 166.2 36.67 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 118.025 0.375 . . . . 0.0 112.332 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttm105 -72.86 117.81 15.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.2 144.21 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.566 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -18.84 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.167 0.587 . . . . 0.0 110.323 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -160.22 147.35 16.11 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.212 0.605 . . . . 0.0 109.652 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.44 141.75 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.459 0.647 . . . . 0.0 109.583 170.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.2 mt -120.26 155.81 32.49 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.738 175.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.37 120.19 6.14 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.5 mmm -93.59 136.99 33.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.59 -172.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 pttp . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.116 0.484 . . . . 0.0 111.199 179.185 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 32.1 mmm-85 . . . . . 0 CA--C 1.525 0.013 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -1.13 75.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.904 0.764 . . . . 0.0 111.306 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.89 156.64 48.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.724 1.262 . . . . 0.0 110.522 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.54 7.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.872 0.469 . . . . 0.0 110.422 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.0 m-85 -142.42 161.79 37.13 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.534 0.334 . . . . 0.0 110.736 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.56 141.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.0 m -112.08 126.08 54.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.2 m-85 -94.3 155.77 16.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 111.427 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.36 -22.8 61.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.266 -0.397 . . . . 0.0 111.364 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -121.49 141.47 33.51 Favored Pre-proline 0 CA--C 1.518 -0.254 0 CA-C-N 118.295 0.498 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.14 -3.81 14.45 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.819 2.346 . . . . 0.0 110.289 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.46 -15.84 11.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.581 0.352 . . . . 0.0 110.998 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.494 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -71.77 -29.15 64.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.14 59.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.143 0.577 . . . . 0.0 110.526 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -70.84 -37.84 73.17 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.91 -30.36 68.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.27 -9.41 53.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.176 -0.327 . . . . 0.0 111.228 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -101.82 7.18 41.77 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.546 1.138 . . . . 0.0 112.158 174.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.29 -53.6 1.03 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.862 0.839 . . . . 0.0 109.108 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.531 ' HA ' ' CG ' ' B' ' 72' ' ' LYS . 49.7 mmm -78.44 -10.5 59.72 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.154 1.782 . . . . 0.0 111.916 -176.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -80.65 117.34 21.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.16 62.26 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.609 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' B' ' 69' ' ' MET . 20.7 ptmt -106.93 176.75 5.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.578 1.189 . . . . 0.0 111.954 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -97.76 155.91 16.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -127.23 123.84 37.51 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.359 172.229 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.8 t70 61.66 -23.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 157.56 -11.37 0.25 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.141 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -116.57 135.57 53.7 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.014 0.907 . . . . 0.0 110.513 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.34 140.51 57.26 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 123.199 0.6 . . . . 0.0 110.823 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -125.91 171.9 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -115.35 144.08 44.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.981 1.712 . . . . 0.0 108.015 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.76 130.14 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -160.44 163.86 32.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -63.31 133.31 53.95 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.36 158.55 30.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.038 0.446 . . . . 0.0 111.883 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.613 171.649 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.28 127.1 45.24 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 72.7 mt -112.5 154.45 25.87 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.16 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -107.96 127.3 53.63 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -118.85 80.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.29 143.78 16.83 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.624 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.04 36.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.16 163.5 22.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' B' ' 75' ' ' ASP . 40.3 t-20 -73.51 158.85 34.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -73.62 -8.29 55.36 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.301 0.64 . . . . 0.0 110.161 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.38 -11.04 20.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 110.48 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 41.2 m -79.87 144.78 33.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.71 -168.14 2.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.06 -32.27 68.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.578 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -64.4 -32.57 74.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.13 -21.91 27.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.421 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -85.87 -27.88 24.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.226 1.41 . . . . 0.0 109.635 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.93 -29.97 35.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 110.17 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -22.55 41.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.586 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.0 p -102.36 -35.51 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -174.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.508 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.0 m-85 -91.56 -10.06 42.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.873 176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -3.94 71.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.2 mtpt -80.4 -13.08 59.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.619 1.168 . . . . 0.0 111.208 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' B' ' 65' ' ' ALA . 80.3 m-85 -112.29 -18.78 12.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.7 -176.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.34 167.31 38.35 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.161 0.437 . . . . 0.0 112.63 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -74.22 117.28 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.2 142.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.461 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.47 -23.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.148 0.579 . . . . 0.0 110.194 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.51 150.1 15.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.238 0.615 . . . . 0.0 109.683 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.66 147.09 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 109.547 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.5 mt -123.09 156.36 35.08 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.787 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.487 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.44 119.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.7 mmm -93.03 142.58 27.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.902 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE2' HD12 ' B' ' 39' ' ' LEU . 22.8 mttt . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 . . . . . 0 CA--C 1.527 0.061 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.67 3.89 87.89 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.351 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.9 161.03 37.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.695 1.248 . . . . 0.0 109.803 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.34 -177.97 6.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.098 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.3 m-85 -142.91 160.93 39.4 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.168 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.3 140.6 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -112.71 121.71 45.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -92.62 155.95 17.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.695 0.798 . . . . 0.0 111.723 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -73.43 -22.57 60.17 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.455 0.302 . . . . 0.0 111.255 174.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -121.16 140.81 31.74 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 118.352 0.524 . . . . 0.0 109.834 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 -1.3 11.32 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 123.122 2.548 . . . . 0.0 110.342 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.36 -16.39 10.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.808 0.443 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 82.5 m-20 -71.28 -27.91 63.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.41 -29.09 56.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -72.97 -38.69 66.6 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.15 -25.39 66.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.71 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -83.59 -43.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 172.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.2 -6.6 48.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.896 -0.502 . . . . 0.0 112.305 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -107.46 7.97 29.21 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.532 0.733 . . . . 0.0 112.311 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.92 -55.07 1.39 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.628 0.728 . . . . 0.0 109.329 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' MET . . . . . 0.408 ' HE3' HD11 ' B' ' 79' ' ' ILE . 25.5 mmm -79.57 -10.03 59.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.538 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -73.46 128.08 34.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.65 79.28 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -81.64 -153.44 0.11 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.628 1.171 . . . . 0.0 109.639 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.1 t -140.03 158.69 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -173.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.74 128.9 31.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.543 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.549 ' HB3' HD22 ' B' ' 16' ' ' ASN . 2.4 t0 52.73 21.52 1.93 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.328 0.585 . . . . 0.0 112.223 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.73 56.29 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.707 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -114.97 130.45 56.93 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.43 1.115 . . . . 0.0 109.875 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.81 139.12 50.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.344 0.258 . . . . 0.0 111.658 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.408 HD11 ' HE3' ' B' ' 69' ' ' MET . 21.9 pt -123.79 177.55 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -121.84 144.54 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.049 1.74 . . . . 0.0 107.567 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.42 126.54 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.79 164.83 28.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -60.36 135.95 57.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.2 159.84 23.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.518 -0.263 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.649 169.541 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -92.51 127.88 38.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.9 mt -113.3 149.24 34.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -102.72 127.47 49.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.488 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.0 mm -118.61 78.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.73 144.54 17.13 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.729 -0.607 . . . . 0.0 112.157 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 13.45 40.97 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 117.908 0.854 . . . . 0.0 111.827 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -65.81 166.33 11.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.042 0.925 . . . . 0.0 112.928 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.497 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.2 OUTLIER -78.71 145.77 34.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.312 1.445 . . . . 0.0 109.888 176.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 78.7 p -74.32 -8.61 56.83 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.995 0.918 . . . . 0.0 112.301 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.96 -12.39 18.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.265 1.426 . . . . 0.0 109.583 -174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.6 m -77.73 149.02 34.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.55 1.14 . . . . 0.0 110.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 -165.0 1.67 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -66.1 -29.48 69.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.134 0.424 . . . . 0.0 110.952 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.05 -19.7 31.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' B' ' 27' ' ' VAL . 4.9 mt -87.84 -29.18 21.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.64 1.176 . . . . 0.0 109.472 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.52 -27.66 46.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.443 0.64 . . . . 0.0 109.825 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.29 -23.38 37.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.347 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.596 HG11 HD21 ' B' ' 74' ' ' LEU . 5.6 p -102.87 -34.45 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.7 m-85 -90.84 -11.7 38.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.107 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.29 -5.16 76.15 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -79.31 -12.82 59.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.833 1.253 . . . . 0.0 110.729 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.63 -13.5 12.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.48 171.32 37.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.359 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -79.89 115.04 19.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.59 0.71 . . . . 0.0 109.982 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.8 mt -75.0 141.67 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.991 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -21.32 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.206 0.602 . . . . 0.0 110.354 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -161.29 150.38 16.36 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.21 146.11 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.4 0.619 . . . . 0.0 109.849 172.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.4 mt -123.24 155.32 37.39 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.528 1.131 . . . . 0.0 108.234 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.509 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.1 tm? -154.0 119.76 5.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 9.2 mmm -92.81 139.82 30.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.509 ' HE2' HD12 ' B' ' 39' ' ' LEU . 18.1 mttt . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 40.6 mmm-85 . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 4.07 80.68 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.992 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 157.37 45.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.719 1.26 . . . . 0.0 109.95 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.36 -177.98 6.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.401 0.28 . . . . 0.0 111.076 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 64.7 m-85 -142.68 160.75 39.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.797 0.439 . . . . 0.0 110.463 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -154.1 138.79 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 56.9 m -110.34 126.84 54.66 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.106 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' B' ' 10' ' ' LEU . 3.9 m-85 -98.2 161.81 13.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.403 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -71.52 -18.4 62.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -130.25 153.43 81.21 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 110.104 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.68 1.12 9.53 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.1 -15.59 9.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.76 -21.22 25.26 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 -27.78 61.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -69.58 -32.14 70.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.82 -22.24 61.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.1 -44.16 13.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.25 -15.62 62.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.184 -0.323 . . . . 0.0 111.858 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.36 6.74 46.02 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.19 -55.08 1.36 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.041 0.837 . . . . 0.0 109.461 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 24.4 mmm -78.05 -12.21 59.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.18 1.392 . . . . 0.0 111.965 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -72.83 130.12 39.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -10.05 63.36 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.671 -0.516 . . . . 0.0 112.356 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -83.28 -160.3 0.41 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.166 0.986 . . . . 0.0 109.509 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -132.9 152.61 51.85 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.716 0.806 . . . . 0.0 110.723 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.596 HD21 HG11 ' B' ' 27' ' ' VAL . 0.4 OUTLIER -95.73 -62.81 1.23 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.962 -174.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 15.6 t70 -130.18 0.92 4.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.141 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.75 -14.07 0.78 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.821 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.25 134.5 55.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.05 135.62 38.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.8 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.4 pt -114.26 174.32 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -173.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.55 141.85 47.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.564 1.546 . . . . 0.0 107.554 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.36 125.86 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.29 164.99 34.41 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -63.05 135.71 57.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.46 158.91 29.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 112.309 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.453 -0.307 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.535 173.221 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -84.52 129.0 34.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 76.6 mt -119.1 155.62 31.21 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.991 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -109.44 130.02 55.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.2 mm -121.68 86.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.87 145.07 16.91 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 121.999 -0.438 . . . . 0.0 112.555 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.12 8.08 45.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.48 HD23 HG21 ' B' ' 79' ' ' ILE . 9.7 mt -64.28 162.65 14.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.085 0.945 . . . . 0.0 112.089 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.476 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.4 OUTLIER -70.14 145.18 51.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.432 1.493 . . . . 0.0 109.568 175.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -70.83 -4.88 26.46 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.927 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.83 -6.49 15.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.984 1.314 . . . . 0.0 109.609 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.3 m -76.52 143.79 40.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.412 1.085 . . . . 0.0 108.751 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.96 -166.7 1.95 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.34 -29.89 68.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.692 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -66.76 -30.61 70.87 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.87 -17.13 28.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -95.28 -28.27 15.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.336 1.054 . . . . 0.0 109.909 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.97 -29.38 29.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.24 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.31 -28.54 38.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.127 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.514 HG13 ' CD2' ' B' ' 28' ' ' PHE . 4.3 p -92.64 -36.45 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.2 m-85 -92.15 -10.48 38.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.276 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.35 -3.48 77.13 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -79.77 -14.73 58.51 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.71 1.204 . . . . 0.0 111.608 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -111.5 -19.0 12.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.803 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.52 164.61 33.28 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 118.208 0.458 . . . . 0.0 112.312 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -72.23 117.45 13.89 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.96 141.23 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.386 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -23.81 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 122.877 0.471 . . . . 0.0 110.067 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.11 150.37 16.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.383 0.673 . . . . 0.0 109.687 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.55 146.06 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.517 0.675 . . . . 0.0 109.951 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.3 mt -118.14 152.13 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.3 119.33 6.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.3 mmm -93.4 139.66 30.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.9 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 pttt . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.129 0.49 . . . . 0.0 112.059 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.75 74.07 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -138.94 158.58 43.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.452 1.126 . . . . 0.0 110.671 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -179.04 7.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.385 0.674 . . . . 0.0 110.682 -174.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.2 m-85 -142.84 163.36 33.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.88 140.96 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -113.33 122.89 48.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.693 0.397 . . . . 0.0 110.08 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -93.27 156.63 16.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 111.632 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.72 -22.92 60.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 122.606 0.363 . . . . 0.0 111.441 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -121.54 141.07 32.72 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 118.428 0.558 . . . . 0.0 110.042 174.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.33 -0.98 10.96 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.833 2.355 . . . . 0.0 110.599 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.6 -16.8 10.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.198 0.454 . . . . 0.0 110.827 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.4 m-20 -70.56 -29.05 65.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.74 -29.98 59.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.438 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -70.9 -39.25 72.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.21 -29.84 69.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.253 -0.276 . . . . 0.0 110.253 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.273 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.53 -12.58 61.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.501 0.32 . . . . 0.0 111.055 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -97.19 6.85 47.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.946 0.899 . . . . 0.0 112.052 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.92 -52.04 1.22 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.002 0.819 . . . . 0.0 109.892 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 54.3 mmm -81.65 -14.75 56.28 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.07 1.748 . . . . 0.0 112.055 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -74.35 116.33 14.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.14 -8.15 60.7 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.372 0.511 . . . . 0.0 112.027 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -82.54 -156.57 0.18 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.361 1.064 . . . . 0.0 109.392 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -144.35 158.8 43.55 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 123.786 0.834 . . . . 0.0 111.779 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.75 125.68 27.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.0 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 3.5 t70 61.07 -24.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 161.05 -12.2 0.14 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.78 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -118.29 137.32 53.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.468 1.134 . . . . 0.0 109.948 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.56 138.32 50.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.037 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.48 HG21 HD23 ' B' ' 15' ' ' LEU . 27.0 pt -120.65 163.74 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -112.56 144.01 42.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.302 1.841 . . . . 0.0 107.963 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 29.2 t -135.07 130.6 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.87 162.26 39.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.12 123.43 21.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.33 146.48 43.97 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 CA--C 1.518 -0.272 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.36 173.304 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -98.24 127.1 44.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' B' ' 56' ' ' PHE . 77.1 mt -113.4 153.26 28.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.971 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -106.4 128.94 54.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.53 81.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.86 143.2 16.46 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.951 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.6 11.63 34.97 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 117.74 0.77 . . . . 0.0 111.752 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -67.33 162.33 23.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 111.706 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.592 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.2 t30 -75.29 156.54 35.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.642 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -71.34 -8.27 52.59 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.244 0.618 . . . . 0.0 110.383 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.26 -10.17 20.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.607 1.163 . . . . 0.0 110.489 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -81.79 146.18 30.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.29 0.636 . . . . 0.0 109.918 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.58 -167.26 2.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.174 -173.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -67.72 -28.54 67.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 118.055 0.388 . . . . 0.0 111.075 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.39 -21.89 30.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.56 -29.02 22.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.107 1.363 . . . . 0.0 109.403 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.23 -28.21 38.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 109.937 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.12 37.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.352 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.589 HG11 HD21 ' B' ' 74' ' ' LEU . 6.0 p -104.35 -35.0 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.524 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -91.95 -10.99 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.909 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.38 -2.9 75.73 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -81.9 -12.17 58.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.708 1.203 . . . . 0.0 111.04 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -112.14 -19.16 12.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.39 166.41 37.39 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 118.264 0.484 . . . . 0.0 112.716 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -73.88 117.1 15.26 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mt -76.29 142.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.67 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -21.97 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.178 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.71 150.17 15.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.019 0.528 . . . . 0.0 109.834 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.98 145.92 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.352 0.596 . . . . 0.0 109.546 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -121.9 154.77 36.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.451 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.501 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.42 119.55 5.44 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.49 141.07 28.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.5 -170.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.501 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.3 mttt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 . . . . . 0 CA--C 1.523 -0.065 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.51 0.31 89.32 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.855 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -133.92 157.11 46.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.637 1.219 . . . . 0.0 110.604 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.137 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 62.5 m-85 -143.05 162.41 35.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.623 0.369 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.79 140.31 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.8 m -112.75 122.56 48.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 123.271 0.357 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' B' ' 10' ' ' LEU . 13.8 m-85 -92.5 156.69 16.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.859 0.864 . . . . 0.0 111.791 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.7 -21.81 59.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.215 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -122.26 139.83 31.38 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.94 -0.15 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.161 2.574 . . . . 0.0 110.65 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.01 -14.99 9.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.822 0.283 . . . . 0.0 111.141 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.3 m-20 -72.43 -28.5 63.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.27 -29.24 60.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -73.03 -37.25 66.96 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.1 -25.5 65.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.533 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.64 16.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.204 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.4 -8.93 57.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.26 9.03 34.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.341 0.657 . . . . 0.0 112.727 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.09 -53.77 1.3 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.546 0.689 . . . . 0.0 109.461 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 26.8 mmm -81.73 -10.22 59.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.63 1.572 . . . . 0.0 112.055 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -73.43 127.02 31.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.68 79.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.333 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -82.38 -157.42 0.21 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.608 1.163 . . . . 0.0 109.824 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -136.15 153.12 51.37 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.593 0.757 . . . . 0.0 110.858 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.589 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -101.75 -65.88 0.95 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.124 -175.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.592 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.5 t70 -121.54 14.49 11.06 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.391 -175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.44 -6.09 9.25 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.846 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -112.88 131.04 55.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.734 0.814 . . . . 0.0 108.843 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.19 134.98 37.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.116 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 pt -115.12 175.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -118.27 141.72 48.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.058 1.743 . . . . 0.0 107.099 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.71 127.42 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.76 163.79 37.72 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -63.75 134.09 54.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.87 152.7 38.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 169.493 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.419 0.152 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -98.89 109.77 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -132.55 136.12 46.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.33 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.85 116.24 10.62 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -73.91 74.18 1.64 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 112.297 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' B' ' 7' ' ' PRO . 0.0 OUTLIER 52.17 147.5 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 129.02 2.928 . . . . 0.0 116.206 176.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 73.7 Cg_exo -55.16 145.01 67.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.847 3.031 . . . . 0.0 112.631 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.03 -15.66 51.19 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -98.37 128.25 44.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.146 0.973 . . . . 0.0 108.438 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.7 mt -112.29 155.62 23.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -109.48 128.92 55.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.508 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.7 mm -120.14 79.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 144.81 17.41 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.416 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 9.46 42.0 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.576 0.688 . . . . 0.0 111.534 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.83 164.0 15.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.745 0.783 . . . . 0.0 111.612 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.8 t-20 -74.47 159.37 32.35 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.42 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.479 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 42.2 p -74.78 -11.23 60.11 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.084 -0.385 . . . . 0.0 110.279 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.97 -9.36 28.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.107 0.963 . . . . 0.0 110.937 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -76.8 144.83 38.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.84 0.456 . . . . 0.0 109.924 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 -169.1 2.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -69.8 -34.84 74.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.72 -174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -66.83 -29.19 69.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 111.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.85 31.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.39 -28.24 22.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 109.774 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.62 -29.39 36.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.615 0.721 . . . . 0.0 110.111 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.69 -22.76 40.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.307 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.5 p -102.29 -35.16 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.528 ' CD2' HG13 ' B' ' 27' ' ' VAL . 90.3 m-85 -92.09 -10.69 38.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.182 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.57 -2.92 77.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.55 -12.8 58.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.972 1.309 . . . . 0.0 111.116 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.33 -19.04 12.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.686 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.72 165.42 36.15 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.159 0.436 . . . . 0.0 112.37 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -73.54 116.95 14.72 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.9 mt -75.9 141.65 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.636 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -22.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.131 0.573 . . . . 0.0 110.022 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.22 149.16 15.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.933 0.493 . . . . 0.0 109.83 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.36 144.99 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.306 0.574 . . . . 0.0 109.644 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.8 mt -121.12 154.59 35.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.307 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.14 117.93 6.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.4 mmm -88.08 142.06 28.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.38 158.59 44.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.77 146.78 24.94 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.101 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -90.0 -2.38 58.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.48 -14.51 10.31 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.03 0.532 . . . . 0.0 112.08 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.8 p -127.98 -15.74 4.74 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.189 0.449 . . . . 0.0 111.609 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 57.01 23.53 8.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -73.66 -90.71 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.28 1.032 . . . . 0.0 111.17 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 23.2 t -165.79 152.47 9.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.649 1.579 . . . . 0.0 108.868 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -89.93 -2.3 58.14 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.75 1.42 85.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.149 0.88 . . . . 0.0 112.287 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.78 161.42 38.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.307 1.053 . . . . 0.0 110.13 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.99 -177.3 6.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.7 m-85 -142.24 160.35 40.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -154.06 140.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -113.11 122.86 48.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.151 0.282 . . . . 0.0 110.357 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -92.39 156.01 17.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.96 0.904 . . . . 0.0 111.93 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -74.22 -21.99 59.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.57 0.348 . . . . 0.0 111.135 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -121.88 141.49 34.13 Favored Pre-proline 0 C--N 1.34 0.164 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 98.4 Cg_endo -73.45 -9.72 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.682 2.254 . . . . 0.0 110.3 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.19 -14.48 13.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.285 0.493 . . . . 0.0 110.572 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.5 m-20 -71.95 -28.5 63.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.18 56.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -68.46 -38.35 81.02 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.93 -32.41 72.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.71 -44.03 44.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.78 42.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 122.075 -0.39 . . . . 0.0 111.253 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -105.87 5.32 30.56 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 112.349 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.74 -52.29 1.24 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.498 0.666 . . . . 0.0 109.49 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.4 ' HE3' HD11 ' B' ' 79' ' ' ILE . 31.6 mmm -83.55 -9.46 58.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.397 1.479 . . . . 0.0 111.987 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.8 124.8 27.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.85 -4.92 85.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.23 -152.97 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.569 1.148 . . . . 0.0 109.459 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -140.61 158.86 43.36 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.757 0.789 . . . . 0.0 112.915 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 128.78 31.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.835 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.3 t0 52.57 22.53 2.22 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.145 0.497 . . . . 0.0 112.214 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.92 -3.33 57.16 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 119.32 -0.711 . . . . 0.0 113.853 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -114.99 130.13 56.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.216 1.008 . . . . 0.0 110.304 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 139.47 52.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.749 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.4 HD11 ' HE3' ' B' ' 69' ' ' MET . 18.9 pt -124.89 174.82 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -119.01 144.36 46.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.184 1.794 . . . . 0.0 107.799 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.32 127.26 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -62.27 138.37 58.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.05 35.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 75.1 p -112.37 -179.62 3.72 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.125 171.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.34 154.04 59.52 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 123.228 0.611 . . . . 0.0 111.138 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.93 162.63 37.06 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.858 3.039 . . . . 0.0 111.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -130.58 10.33 5.17 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -81.71 2.07 31.42 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.699 -0.626 . . . . 0.0 111.986 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -143.54 156.95 44.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.531 0.333 . . . . 0.0 110.46 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 44.5 m -142.81 167.65 21.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.703 0.801 . . . . 0.0 110.795 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 156.16 48.61 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.43 160.38 42.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.439 0.696 . . . . 0.0 111.211 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 56.17 179.39 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.904 1.282 . . . . 0.0 112.468 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.302 0 CA-C-O 117.421 -1.766 . . . . 0.0 111.23 -179.512 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.548 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.301 1 O4'-C1'-N19 112.438 4.238 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.612 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.86 0 O4'-C1'-N19 111.388 3.188 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.021 0 C5'-C4'-C3' 112.411 -2.059 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 1 O4'-C1'-N19 114.683 6.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 2 C5'-C4'-C3' 108.069 -4.954 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C5'-C4'-C3' 111.135 -2.91 . 0.156 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.33 0.586 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.527 HG22 ' O ' ' B' ' 2' ' ' VAL . 3.6 p -133.23 13.54 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.681 1.592 . . . . 0.0 107.351 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -74.56 142.95 44.66 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.502 -167.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.4 105.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -51.99 -70.99 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -148.04 138.98 13.34 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 118.731 0.696 . . . . 0.0 109.999 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 73.9 Cg_exo -54.12 142.45 66.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.92 2.413 . . . . 0.0 110.781 174.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.82 67.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.97 126.79 39.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 68.6 mt -113.56 153.27 29.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.062 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -106.7 127.59 53.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -119.62 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.93 142.16 15.93 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.51 35.93 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.691 0.745 . . . . 0.0 111.805 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.39 164.36 16.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.155 0.502 . . . . 0.0 111.858 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.537 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t-20 -77.79 158.31 29.6 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.144 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 57.9 p -73.21 -6.97 49.34 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.401 0.68 . . . . 0.0 110.114 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.52 -10.19 21.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.654 1.181 . . . . 0.0 110.531 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 31.0 m -83.22 144.68 29.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.325 0.65 . . . . 0.0 109.822 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.89 -170.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -66.99 -34.92 78.81 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.093 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -67.6 -29.03 68.27 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 118.016 0.371 . . . . 0.0 111.099 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.27 29.42 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.423 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -87.44 -27.89 22.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 109.555 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.45 -28.23 34.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 109.899 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.65 -21.78 37.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.42 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.522 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.5 p -103.41 -36.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.522 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -90.63 -11.36 40.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.817 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.9 -3.04 73.05 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.62 -11.87 58.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.682 1.193 . . . . 0.0 110.855 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -111.82 -19.5 12.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.83 166.61 37.49 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 118.046 0.384 . . . . 0.0 112.406 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 43.5 ttt-85 -73.74 117.52 15.62 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.09 142.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.56 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -22.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 123.212 0.605 . . . . 0.0 110.137 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -161.73 150.21 15.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.05 0.54 . . . . 0.0 109.878 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.58 146.4 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.056 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -121.3 154.63 36.13 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.378 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.423 HD23 ' CD1' ' B' ' 24' ' ' LEU . 3.0 tm? -152.68 118.36 5.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.6 mmm -91.38 139.85 30.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.851 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.414 ' HE2' HD12 ' B' ' 39' ' ' LEU . 8.9 mttt -135.84 152.55 51.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.477 0.656 . . . . 0.0 112.472 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.5 143.03 54.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.862 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -82.49 -8.21 59.62 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -117.46 -12.72 10.38 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -129.51 -14.88 4.11 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.217 0.462 . . . . 0.0 111.714 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.8 22.49 7.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.0 -106.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.772 1.229 . . . . 0.0 109.651 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 22.8 t -151.14 143.72 24.33 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -76.59 -6.05 50.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.58 89.45 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.401 -0.666 . . . . 0.0 111.559 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -138.49 157.46 46.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.559 1.18 . . . . 0.0 109.952 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.93 -179.1 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.455 0.302 . . . . 0.0 110.853 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 49.9 m-85 -142.67 162.61 35.01 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.848 0.459 . . . . 0.0 110.215 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.87 141.53 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.6 m -113.3 123.54 50.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.336 0.397 . . . . 0.0 110.135 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.65 156.85 16.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.695 0.798 . . . . 0.0 111.627 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.19 -22.42 59.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.608 0.363 . . . . 0.0 111.275 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -121.23 140.04 30.51 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.395 0.543 . . . . 0.0 110.084 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 56.6 Cg_endo -76.2 0.72 9.08 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.231 2.62 . . . . 0.0 110.583 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.46 -16.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.063 0.392 . . . . 0.0 111.356 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.9 m-20 -71.75 -28.57 63.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.49 57.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.66 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -74.5 -37.01 63.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.76 -24.61 64.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.488 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.24 14.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.38 45.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -109.06 9.36 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 112.224 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -52.25 1.33 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.54 -175.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mmm -83.12 -9.17 59.35 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.846 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -75.22 127.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.829 -0.544 . . . . 0.0 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.12 83.16 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.51 -154.17 0.11 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.518 1.127 . . . . 0.0 109.436 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.8 t -140.3 159.19 42.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.0 112.311 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -133.37 126.8 32.11 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.046 177.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.537 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.53 -22.24 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.513 1.125 . . . . 0.0 113.821 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.87 -6.28 0.53 Allowed Glycine 0 N--CA 1.439 -1.123 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.19 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -118.46 134.38 55.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.959 0.879 . . . . 0.0 110.341 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.55 138.42 48.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.471 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.08 175.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -119.89 142.46 48.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.13 1.772 . . . . 0.0 107.397 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.56 125.41 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -162.05 164.42 28.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -57.79 134.8 56.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.9 158.8 32.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.271 0.558 . . . . 0.0 112.359 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -119.31 168.04 11.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.491 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -68.17 151.78 96.96 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.526 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.82 164.9 32.9 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.878 3.052 . . . . 0.0 110.369 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -119.44 2.84 11.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -88.23 -1.51 58.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.34 0.518 . . . . 0.0 111.011 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.35 176.97 8.35 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.427 0.691 . . . . 0.0 111.235 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 11.7 t -147.12 165.08 31.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.875 0.47 . . . . 0.0 110.398 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.52 128.11 32.38 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.6 167.42 28.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.601 0.761 . . . . 0.0 110.479 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 53.04 29.95 8.78 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 0.0 111.992 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.116 -1.936 . . . . 0.0 110.934 -179.063 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.564 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.344 2 C5'-C4'-C3' 109.32 -4.12 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.65 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.985 0 O4'-C1'-N19 111.403 3.203 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 O4'-C1'-N19 110.493 2.293 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 114.085 5.885 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 2 C5'-C4'-C3' 109.161 -4.226 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.96 0 O4'-C1'-N19 111.471 3.271 . 0.583 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.287 0.565 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.537 HG22 ' O ' ' B' ' 2' ' ' VAL . 3.5 p -127.6 15.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.316 1.446 . . . . 0.0 107.749 172.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -76.74 139.99 40.65 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.317 -168.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.43 115.86 16.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -73.18 51.63 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 113.068 -173.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' B' ' 7' ' ' PRO . 81.9 mtp180 60.98 147.02 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 127.261 2.224 . . . . 0.0 114.708 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 72.0 Cg_exo -54.17 150.43 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.991 3.127 . . . . 0.0 112.841 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.76 -15.81 58.07 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -101.13 129.9 47.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.018 0.909 . . . . 0.0 108.891 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.406 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.4 mt -113.35 153.61 28.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -107.73 129.23 55.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -121.0 82.37 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.07 144.44 17.28 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.758 -0.589 . . . . 0.0 112.001 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.71 9.21 43.96 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 117.524 0.662 . . . . 0.0 111.597 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.91 162.86 12.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.579 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.6 t-20 -73.51 159.95 32.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.598 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.9 p -74.53 -4.56 37.64 Favored 'General case' 0 N--CA 1.457 -0.075 0 C-N-CA 122.902 0.481 . . . . 0.0 110.366 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.25 -7.68 18.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 110.81 -172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.7 m -80.54 144.19 32.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.922 0.489 . . . . 0.0 109.937 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.63 -169.66 2.45 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -68.85 -35.36 76.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.778 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -65.68 -29.71 70.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.916 -0.49 . . . . 0.0 110.97 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.89 -20.99 28.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -89.34 -27.97 20.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.802 1.241 . . . . 0.0 109.606 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.35 -27.82 31.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 109.907 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -23.26 38.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.309 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.1 p -101.06 -35.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.506 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.8 m-85 -92.1 -10.87 37.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.283 -0.261 . . . . 0.0 111.024 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.67 -2.62 76.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.72 -11.25 59.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.431 1.092 . . . . 0.0 111.159 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.93 -18.85 11.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.39 0.676 . . . . 0.0 112.634 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -174.83 161.19 30.64 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -72.6 124.22 24.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.89 143.49 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.286 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.07 -23.56 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.351 0.66 . . . . 0.0 110.076 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.02 150.47 16.94 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.99 146.58 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 121.28 0.562 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -121.32 153.67 37.43 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.245 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.38 118.83 6.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.7 mmm -92.31 137.59 32.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.932 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -148.2 154.04 39.57 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.331 0.586 . . . . 0.0 111.293 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.73 163.94 10.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.047 0.939 . . . . 0.0 110.622 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -111.96 -4.47 14.53 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.86 0.464 . . . . 0.0 111.878 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.24 -14.19 15.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.595 0.758 . . . . 0.0 110.727 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -131.21 -14.95 3.33 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 122.773 0.429 . . . . 0.0 111.722 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 13.1 6.42 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -87.87 144.67 26.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.402 0.681 . . . . 0.0 110.178 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -55.53 138.75 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.474 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -71.09 -9.45 58.07 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.253 1.021 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.46 0.5 79.41 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.698 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -136.92 158.42 44.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.434 1.117 . . . . 0.0 110.376 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.02 -179.5 8.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.868 0.467 . . . . 0.0 110.728 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.8 m-85 -141.85 161.98 36.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.659 0.383 . . . . 0.0 110.231 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.81 141.13 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.3 m -113.52 122.12 46.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.349 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -92.82 156.95 16.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.938 0.895 . . . . 0.0 110.768 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -79.63 -20.97 45.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.451 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -118.16 138.85 25.96 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 80.2 Cg_endo -74.46 -6.6 18.55 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.635 2.224 . . . . 0.0 110.431 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.26 -14.77 12.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.201 0.455 . . . . 0.0 111.135 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.464 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.7 m-20 -71.53 -28.46 63.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 -30.52 52.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.394 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.01 -39.14 79.48 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.04 -32.17 72.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.72 45.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.39 -7.55 48.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.209 -0.307 . . . . 0.0 111.163 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -105.26 5.67 32.23 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.521 1.128 . . . . 0.0 112.344 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.16 -51.68 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.768 0.794 . . . . 0.0 109.755 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.404 ' HE3' HD11 ' B' ' 79' ' ' ILE . 28.9 mmm -83.59 -10.13 58.46 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.145 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.7 126.13 29.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.48 -5.74 84.54 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.59 -0.561 . . . . 0.0 111.841 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.54 -153.72 0.11 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.361 1.064 . . . . 0.0 109.473 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -139.84 158.75 43.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.9 126.99 31.58 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.496 177.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.546 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.5 t70 61.19 -21.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.18 -7.03 0.53 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.4 135.16 54.86 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.264 1.032 . . . . 0.0 110.218 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.31 138.89 51.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.597 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.404 HD11 ' HE3' ' B' ' 69' ' ' MET . 19.9 pt -121.22 179.52 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -125.05 145.02 50.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.823 1.649 . . . . 0.0 107.787 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -133.12 129.49 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -158.1 163.31 37.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -65.24 137.06 57.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.22 155.57 38.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p -120.77 175.29 6.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.228 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.63 152.36 92.84 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.078 0.551 . . . . 0.0 110.426 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.95 154.63 73.2 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.378 2.718 . . . . 0.0 110.331 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 35.2 m -80.7 1.2 31.17 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -97.42 3.37 50.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.06 0.391 . . . . 0.0 111.073 175.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.66 154.02 42.96 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.337 0.589 . . . . 0.0 111.539 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 70.5 m -144.17 20.2 1.75 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.304 1.042 . . . . 0.0 110.623 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.05 -148.56 28.6 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.443 ' HG2' ' H ' ' B' ' 94' ' ' ARG . 25.9 ttp180 49.97 -142.28 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.687 0.795 . . . . 0.0 110.681 -177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' B' ' 93' ' ' ARG . 61.3 ttp180 -148.37 150.56 33.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.861 1.264 . . . . 0.0 109.067 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.475 -1.736 . . . . 0.0 110.928 179.586 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.564 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 O4'-C1'-N19 112.051 3.851 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.621 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.064 0 C3'-C2'-C1' 104.607 3.452 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 C5'-C4'-C3' 112.522 -1.986 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 1 O4'-C1'-N19 114.246 6.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.368 2 O4'-C1'-N19 114.066 5.866 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 0 O4'-C1'-N19 111.244 3.044 . 0.202 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.358 0.599 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.08 127.58 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -130.85 125.12 32.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.058 0.456 . . . . 0.0 111.142 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.33 105.2 13.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.75 -36.18 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -162.75 134.11 3.78 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 118.473 0.579 . . . . 0.0 111.225 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.458 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 71.3 Cg_exo -57.29 149.01 67.29 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.282 2.655 . . . . 0.0 111.637 171.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.96 -19.14 54.76 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -86.13 129.05 34.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' B' ' 56' ' ' PHE . 78.0 mt -116.69 155.53 28.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.362 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.58 129.67 55.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -121.72 80.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.7 144.63 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.267 -0.492 . . . . 0.0 111.977 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.48 7.52 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 117.497 0.649 . . . . 0.0 111.545 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 mt -64.24 164.75 10.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.163 0.585 . . . . 0.0 111.166 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.573 HD21 ' H ' ' B' ' 17' ' ' THR . 0.7 OUTLIER -72.1 158.94 35.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.46 176.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.573 ' H ' HD21 ' B' ' 16' ' ' ASN . 79.8 p -75.79 -4.77 42.47 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.218 -0.301 . . . . 0.0 110.375 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.49 -7.38 17.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.127 0.971 . . . . 0.0 111.066 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.2 m -79.18 144.89 34.01 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.09 0.556 . . . . 0.0 109.576 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.93 2.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.171 0.51 . . . . 0.0 110.009 175.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.86 -34.37 76.56 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.756 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.41 -30.36 70.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.046 -0.409 . . . . 0.0 110.923 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.74 -21.41 30.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.84 -28.47 19.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 109.928 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.8 -27.92 33.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.237 0.542 . . . . 0.0 110.119 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.34 -22.95 38.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.241 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -100.96 -36.65 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.6 m-85 -91.03 -10.89 40.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.958 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.75 -3.2 72.58 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -82.12 -11.76 58.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.63 1.172 . . . . 0.0 111.034 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.43 -19.88 11.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.364 0.665 . . . . 0.0 112.538 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.71 165.36 36.06 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 118.051 0.387 . . . . 0.0 112.189 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -73.09 117.97 15.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.3 141.35 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.509 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.74 -24.49 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.871 0.468 . . . . 0.0 110.093 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -160.35 151.36 19.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.66 146.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 109.699 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -118.99 153.95 33.82 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.1 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -153.66 120.23 5.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.41 140.02 30.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.663 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -145.98 155.51 42.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.257 0.551 . . . . 0.0 112.304 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.38 161.18 23.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.925 1.29 . . . . 0.0 111.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -103.83 -3.93 24.24 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.045 0.538 . . . . 0.0 112.266 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.17 -14.03 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 111.65 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 33.9 p -128.14 -14.93 4.82 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.546 0.339 . . . . 0.0 111.292 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 63.11 9.56 3.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -83.8 148.86 26.78 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.745 0.818 . . . . 0.0 110.043 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 m -57.73 139.49 53.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.517 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -72.94 -2.7 21.94 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.666 0.786 . . . . 0.0 110.133 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.83 75.79 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.34 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -141.74 157.97 44.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.627 1.213 . . . . 0.0 110.619 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.688 0.395 . . . . 0.0 110.791 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.7 m-85 -141.93 162.44 35.46 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.004 0.522 . . . . 0.0 110.127 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.36 139.86 12.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -112.18 122.17 46.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.7 m-85 -92.16 156.17 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.023 0.929 . . . . 0.0 111.642 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.56 -21.92 59.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 122.612 0.365 . . . . 0.0 111.061 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.7 t -121.23 140.48 31.26 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.458 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 68.1 Cg_endo -74.45 -7.43 19.57 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.462 2.108 . . . . 0.0 110.472 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.13 -15.87 13.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.369 0.267 . . . . 0.0 110.902 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 75.0 m-20 -70.76 -28.35 64.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.14 54.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.553 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -68.83 -39.04 80.19 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.99 -36.34 81.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.6 64.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.5 47.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.199 -0.313 . . . . 0.0 111.185 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -105.41 7.59 33.26 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.465 1.106 . . . . 0.0 112.274 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.61 -52.27 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.826 0.739 . . . . 0.0 109.568 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.32 -9.88 59.3 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.595 1.558 . . . . 0.0 112.439 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.71 125.38 27.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.74 -5.79 84.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.54 -153.98 0.09 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.474 1.11 . . . . 0.0 109.712 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 26.2 t -139.49 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.865 0.841 . . . . 0.0 112.814 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.46 129.09 30.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.757 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.436 ' HB3' ' CB ' ' B' ' 16' ' ' ASN . 6.4 t0 52.89 22.24 2.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.058 0.456 . . . . 0.0 112.131 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.86 -2.46 58.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.978 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.92 130.19 56.86 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.251 1.026 . . . . 0.0 110.557 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.46 138.25 50.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.502 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.91 178.39 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -122.8 141.51 51.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.717 2.007 . . . . 0.0 107.317 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.15 130.22 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -159.12 164.15 35.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -69.57 132.44 46.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 148.1 33.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.9 p -112.25 167.49 10.38 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.486 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -59.14 149.51 67.07 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.107 0.563 . . . . 0.0 111.024 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.02 157.64 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.709 2.939 . . . . 0.0 110.356 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.6 t -71.9 -10.74 60.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.684 0.794 . . . . 0.0 111.698 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -106.91 6.71 29.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.047 -0.408 . . . . 0.0 111.304 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 49.47 -169.31 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.89 1.676 . . . . 0.0 113.846 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 36.2 t -148.31 148.18 30.13 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.738 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.04 -3.86 88.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -103.77 -30.13 10.59 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 112.078 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -141.4 11.7 2.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.261 -1.855 . . . . 0.0 111.037 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.568 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.367 1 C5'-C4'-C3' 109.104 -4.264 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.634 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.03 0 C3'-C2'-C1' 104.41 3.234 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . 0.433 " H3'" H5'' ' A' ' 99' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.821 1 C5'-C4'-C3' 109.432 -4.045 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . 0.433 H5'' " H3'" ' A' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.773 1 O4'-C1'-N19 114.183 5.983 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 2 O4'-C1'-N19 112.924 4.724 . 0.013 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C5'-C4'-C3' 111.478 -2.682 . 0.578 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.427 0.156 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.54 109.77 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -135.12 141.57 46.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.037 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.64 101.4 3.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 129.17 34.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.707 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 45.96 107.6 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 127.33 2.252 . . . . 0.0 115.066 175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 79.2 Cg_exo -52.56 144.05 43.26 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.925 2.416 . . . . 0.0 110.679 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.86 -17.94 57.65 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -82.15 129.65 34.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.4 mt -118.89 159.51 23.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.04 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -112.62 129.71 56.28 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.5 mm -122.08 81.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -174.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.38 145.5 17.78 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.197 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.76 33.24 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 117.57 0.685 . . . . 0.0 112.026 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.13 168.03 3.59 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 112.586 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.402 ' CB ' ' HB3' ' B' ' 75' ' ' ASP . 3.1 t-20 -73.27 -6.41 45.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 1.7 p 68.76 -13.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.652 1.581 . . . . 0.0 113.479 -170.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.72 -7.25 28.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.42 0.688 . . . . 0.0 109.301 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -76.25 147.52 38.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.531 1.132 . . . . 0.0 109.521 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -170.14 2.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.586 0.707 . . . . 0.0 109.566 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.03 -35.79 80.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.542 -173.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.83 -30.14 70.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.82 -20.39 23.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' B' ' 27' ' ' VAL . 8.6 mt -87.08 -28.32 22.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.216 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -80.11 -26.94 39.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 110.058 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.57 38.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.478 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -103.89 -35.59 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.8 m-85 -92.33 -11.24 35.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.944 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.07 -2.84 73.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.77 -12.92 58.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.684 1.193 . . . . 0.0 111.073 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -111.34 -19.18 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 123.756 0.66 . . . . 0.0 112.547 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.33 165.88 35.49 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -73.29 117.09 14.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -76.1 139.08 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.246 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -24.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.944 0.497 . . . . 0.0 109.863 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -160.38 150.87 18.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.078 0.551 . . . . 0.0 109.562 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.4 145.57 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.34 0.591 . . . . 0.0 109.572 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -119.05 153.02 35.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.661 -1.154 . . . . 0.0 107.91 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.02 117.42 5.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.1 mmm -91.88 139.97 30.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.65 152.29 39.42 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.38 165.45 9.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.978 1.311 . . . . 0.0 111.834 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -109.77 -5.4 15.6 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.375 0.67 . . . . 0.0 111.77 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -111.16 -13.69 13.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.534 0.734 . . . . 0.0 111.63 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 51.6 p -128.38 -15.76 4.53 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.506 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 30.8 m120 59.62 10.35 1.92 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 123.107 0.254 . . . . 0.0 111.609 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -82.23 155.13 25.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 37.3 t -59.66 148.93 32.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.754 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -69.99 -5.12 24.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.21 1.73 81.24 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.51 157.67 46.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.248 1.024 . . . . 0.0 110.775 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.53 -179.19 7.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.205 0.602 . . . . 0.0 110.62 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 42.6 m-85 -142.53 162.04 36.5 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.91 138.69 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -111.89 122.08 46.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.681 0.392 . . . . 0.0 109.975 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 12.8 m-85 -92.07 156.08 17.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.822 0.849 . . . . 0.0 111.616 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.11 -22.51 60.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.857 0.463 . . . . 0.0 111.063 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.1 t -121.74 139.98 31.05 Favored Pre-proline 0 CA--C 1.52 -0.2 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 61.6 Cg_endo -74.59 -3.0 13.19 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.897 2.398 . . . . 0.0 110.48 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.02 -14.84 11.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 123.141 0.276 . . . . 0.0 111.278 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 79.8 m-20 -71.57 -28.93 64.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.42 -30.79 57.56 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.507 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -68.87 -38.83 79.97 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.15 -32.6 72.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.92 -44.48 48.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 -7.38 45.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.315 -0.241 . . . . 0.0 111.41 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -105.59 5.28 31.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.129 0.972 . . . . 0.0 112.08 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.28 -53.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 29.7 mmm -82.2 -10.08 59.28 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.569 1.548 . . . . 0.0 112.205 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.98 126.37 30.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.609 -0.682 . . . . 0.0 109.381 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.11 81.22 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.43 -153.96 0.11 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.449 1.099 . . . . 0.0 109.319 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -137.53 158.68 43.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.529 0.681 . . . . 0.0 112.649 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.422 HD21 HG11 ' B' ' 27' ' ' VAL . 0.1 OUTLIER -132.15 125.27 30.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.402 ' HB3' ' CB ' ' B' ' 16' ' ' ASN . 11.4 t0 57.16 -2.02 0.05 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 137.62 -11.41 3.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.762 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.35 137.2 54.41 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.315 1.058 . . . . 0.0 111.092 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 140.33 56.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.239 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.51 177.63 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -120.79 142.52 49.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.883 1.673 . . . . 0.0 107.386 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.37 127.19 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -158.88 163.58 36.47 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -65.76 134.61 53.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.14 139.25 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.2 p -95.8 167.78 11.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.7 154.34 85.37 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.55 159.43 48.02 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.922 2.415 . . . . 0.0 110.15 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -122.8 5.28 9.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.336 0.654 . . . . 0.0 112.638 -170.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -75.37 -2.57 29.1 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.913 -0.492 . . . . 0.0 110.726 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 92' ' ' GLY . 26.5 tt0 -143.36 143.91 31.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.011 0.524 . . . . 0.0 109.826 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -100.9 -0.18 37.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.762 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . -70.66 133.32 23.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -142.64 173.17 11.78 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.679 0.792 . . . . 0.0 110.15 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -127.27 152.28 47.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.715 0.806 . . . . 0.0 110.504 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.02 -1.989 . . . . 0.0 111.128 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.555 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 1 C5'-C4'-C3' 108.581 -4.613 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.609 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.97 0 C3'-C2'-C1' 104.65 3.5 OUTLIER-DELTA 0.013 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.938 0 C5'-C4'-O4' 111.924 1.946 . 0.026 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 1 O4'-C1'-N19 113.153 4.953 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.283 1 O4'-C1'-N19 113.132 4.932 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 O4'-C1'-N19 111.316 3.116 . 0.439 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.526 ' HA ' ' CE ' ' B' ' 1' ' ' MET . 8.7 mmt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 2' ' ' VAL . 7.5 p -76.63 6.63 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 122.109 0.957 . . . . 0.0 109.801 170.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' B' ' 1' ' ' MET . 40.6 mm-40 -83.76 129.44 34.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.994 0.918 . . . . 0.0 109.825 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.66 102.54 11.99 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.24 75.32 2.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.402 1.081 . . . . 0.0 112.477 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 60.7 137.75 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 126.425 1.89 . . . . 0.0 114.114 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 88.3 Cg_exo -51.96 147.56 25.78 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.22 2.614 . . . . 0.0 112.169 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.61 56.34 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-O 119.125 -0.82 . . . . 0.0 111.137 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.25 127.07 38.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.088 0.944 . . . . 0.0 108.734 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' B' ' 56' ' ' PHE . 76.0 mt -113.39 149.23 34.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.19 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.33 127.88 49.14 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 10.0 mm -118.94 77.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -173.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.59 144.63 17.2 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.14 45.22 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 117.733 0.767 . . . . 0.0 111.752 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.52 163.88 12.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.152 0.581 . . . . 0.0 111.408 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.5 t30 -72.78 155.9 39.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.71 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 62.0 p -74.69 -0.95 19.72 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.367 0.267 . . . . 0.0 111.093 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -110.5 -5.79 15.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 110.668 -171.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -82.93 144.71 29.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.084 0.554 . . . . 0.0 109.571 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -169.74 2.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.19 -35.37 79.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.764 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.32 -29.15 68.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.041 -0.412 . . . . 0.0 111.061 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.51 -21.03 28.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.65 -28.43 20.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.91 1.284 . . . . 0.0 109.532 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.25 -28.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.632 0.73 . . . . 0.0 109.903 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.38 -23.11 40.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.162 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 74' ' ' LEU . 5.4 p -101.92 -34.53 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.4 m-85 -91.48 -10.66 40.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.719 -0.218 . . . . 0.0 111.064 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.3 -2.44 79.17 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -82.21 -11.97 58.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.406 1.082 . . . . 0.0 111.002 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.74 -19.89 11.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.573 0.749 . . . . 0.0 112.739 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.84 166.59 37.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -74.03 116.83 15.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.94 141.13 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -22.71 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -160.85 150.06 16.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.01 0.524 . . . . 0.0 109.846 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.81 144.13 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.1 mt -120.17 158.44 26.93 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.105 175.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -155.91 123.17 5.43 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.99 137.3 33.35 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -143.06 150.86 40.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.418 0.449 . . . . 0.0 110.89 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.84 157.37 35.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.662 0.785 . . . . 0.0 111.579 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -89.13 -11.37 44.11 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.338 0.255 . . . . 0.0 111.2 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -106.05 -15.16 14.96 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 112.106 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 71.2 p -133.33 -13.18 2.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 58.18 14.12 2.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.881 0.309 . . . . 0.0 111.488 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -86.27 147.18 26.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 m -57.0 134.12 55.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -76.31 4.76 8.2 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.566 0.222 . . . . 0.0 110.5 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.15 3.7 78.85 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.436 -0.647 . . . . 0.0 112.127 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.22 157.7 45.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.357 1.079 . . . . 0.0 110.741 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.84 -178.41 7.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.893 0.477 . . . . 0.0 110.501 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.5 m-85 -142.34 163.18 33.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.568 0.347 . . . . 0.0 110.42 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -153.78 146.36 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -117.37 123.44 46.47 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.316 0.385 . . . . 0.0 110.201 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.4 m-85 -93.55 156.15 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.33 0.652 . . . . 0.0 111.925 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.52 -22.67 58.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.2 t -121.33 141.11 32.52 Favored Pre-proline 0 C--O 1.233 0.202 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.5 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 66.8 Cg_endo -74.29 -8.84 21.3 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.557 2.172 . . . . 0.0 110.08 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.02 -15.24 13.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.588 0.355 . . . . 0.0 110.732 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.498 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.2 m-20 -72.43 -29.02 63.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.07 -29.61 58.05 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.44 -38.13 77.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.24 -32.31 71.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 -46.32 40.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.12 47.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.083 -0.386 . . . . 0.0 111.49 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -102.64 7.38 39.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.468 1.107 . . . . 0.0 112.646 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.28 -51.31 0.94 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.491 1.138 . . . . 0.0 109.373 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 45.4 mmm -79.43 -16.45 56.14 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.669 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -73.96 119.02 17.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.94 74.86 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.359 -0.689 . . . . 0.0 112.652 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 7.9 ptpt -88.26 179.63 6.32 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 118.377 1.088 . . . . 0.0 111.316 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -107.94 146.66 32.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.77 -63.9 1.13 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.4 0.619 . . . . 0.0 110.573 -176.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.579 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.6 t70 -124.45 5.49 8.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.548 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.99 -11.96 2.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.43 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -115.79 133.45 56.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.58 0.752 . . . . 0.0 109.598 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.78 136.95 41.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.793 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 pt -115.29 175.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -120.27 142.67 48.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.58 1.552 . . . . 0.0 107.625 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.21 127.02 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -160.55 162.81 33.04 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -61.12 132.44 53.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.03 27.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.2 p -116.41 164.44 14.54 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.768 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.75 152.1 82.98 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.461 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.84 152.69 80.84 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.429 2.753 . . . . 0.0 110.69 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 70.5 m -79.67 0.22 31.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.824 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -100.9 17.76 21.36 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.176 0.444 . . . . 0.0 110.884 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' B' ' 91' ' ' SER . 12.3 tt0 -134.8 166.34 23.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.2 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' B' ' 90' ' ' GLU . 8.1 t -117.56 15.97 14.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.236 0.614 . . . . 0.0 111.51 -175.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.68 15.38 81.38 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.859 -0.526 . . . . 0.0 112.04 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -70.15 -3.05 14.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.271 0.628 . . . . 0.0 112.684 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -138.75 153.38 48.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.352 0.661 . . . . 0.0 109.934 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 CA-C-O 117.631 -1.649 . . . . 0.0 110.827 -178.495 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.594 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.511 1 C5'-C4'-C3' 109.241 -4.173 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.596 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.11 0 C3'-C2'-C1' 104.468 3.298 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 C5'-C4'-C3' 110.166 -3.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.945 1 O4'-C1'-N19 113.848 5.648 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 2 O4'-C1'-N19 112.558 4.358 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 C5'-C4'-C3' 111.411 -2.726 . 0.62 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.521 ' HA ' ' HE2' ' B' ' 1' ' ' MET . 5.3 mmt . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.917 0.389 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 2' ' ' VAL . 7.2 p -78.1 1.64 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-O 122.538 1.161 . . . . 0.0 109.729 171.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.81 146.11 40.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.28 -170.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.39 96.64 3.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.28 123.18 29.35 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 49.83 106.7 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.347 1.859 . . . . 0.0 113.919 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 91.7 Cg_exo -49.88 136.53 35.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 171.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.0 -11.55 58.87 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.95 127.12 36.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' B' ' 56' ' ' PHE . 73.8 mt -113.8 153.37 29.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -106.71 127.75 53.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.1 mm -119.05 77.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.63 144.86 17.41 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.67 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.43 10.19 42.12 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 117.589 0.694 . . . . 0.0 111.422 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.78 163.71 13.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.377 0.671 . . . . 0.0 111.96 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.9 t-20 -73.96 160.76 30.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.461 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.3 p -75.74 -3.87 37.28 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.706 0.402 . . . . 0.0 110.382 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.68 -7.42 18.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.358 1.063 . . . . 0.0 110.888 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -81.63 143.7 31.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.737 0.415 . . . . 0.0 110.235 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -170.25 2.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.73 -35.5 78.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.89 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.57 -28.96 68.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.275 -0.265 . . . . 0.0 111.141 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.4 -20.63 27.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.6 -29.17 20.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.969 1.308 . . . . 0.0 109.458 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.52 -29.6 37.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 0.0 109.944 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -23.3 41.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.118 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.49 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.7 p -101.37 -34.26 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 86.4 m-85 -93.55 -10.34 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.335 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -3.66 76.18 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -80.84 -13.26 59.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.697 1.199 . . . . 0.0 111.123 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -111.67 -19.04 12.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.75 163.69 32.21 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 117.897 0.317 . . . . 0.0 112.448 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -67.23 116.08 7.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.87 141.57 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.741 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -21.17 5.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.934 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.77 149.9 15.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.35 144.64 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.309 0.576 . . . . 0.0 109.663 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.4 mt -120.12 155.65 32.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.511 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -152.33 119.15 5.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.8 139.19 30.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.763 -170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.68 153.67 37.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.101 0.477 . . . . 0.0 111.644 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -65.49 163.02 16.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.0 111.987 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -102.62 -7.92 21.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.669 0.387 . . . . 0.0 111.867 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.62 -14.33 15.31 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.959 0.504 . . . . 0.0 111.216 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -133.19 -13.28 2.75 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.729 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 32.1 m120 59.0 13.24 2.74 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.155 0.284 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.42 145.96 27.2 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.328 0.651 . . . . 0.0 109.546 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 m -52.9 139.24 27.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.562 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -73.95 -2.19 22.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.395 0.678 . . . . 0.0 109.518 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 2.01 82.94 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.313 0.959 . . . . 0.0 112.003 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -142.61 162.26 35.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.321 1.06 . . . . 0.0 110.308 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -177.85 6.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.53 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 52.6 m-85 -141.3 162.12 36.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.83 0.348 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -154.05 139.16 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -110.23 124.31 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.755 0.312 . . . . 0.0 110.287 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.1 m-85 -93.53 156.09 16.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.919 0.888 . . . . 0.0 111.062 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.648 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -120.9 140.08 30.21 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 65.5 Cg_endo -74.59 -2.54 12.57 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.746 2.297 . . . . 0.0 110.376 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.76 -15.25 10.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.03 0.377 . . . . 0.0 111.299 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.486 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.7 m-20 -71.76 -28.43 63.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.4 58.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.172 0.589 . . . . 0.0 110.384 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.16 -37.64 75.27 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.61 -30.74 69.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.3 33.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.99 -7.81 48.87 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.95 -0.469 . . . . 0.0 111.266 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -104.3 4.94 34.2 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 112.462 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.01 -54.2 1.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.706 0.765 . . . . 0.0 109.455 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.4 mmm -81.0 -11.22 59.6 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.444 1.498 . . . . 0.0 112.076 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -73.35 127.54 32.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.93 -7.17 78.7 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.72 -153.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.281 1.032 . . . . 0.0 109.37 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 29.3 t -139.58 159.43 42.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.493 0.663 . . . . 0.0 112.777 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.0 126.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.292 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.547 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 61.33 -21.12 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.51 -7.5 0.52 Allowed Glycine 0 N--CA 1.439 -1.119 0 CA-C-O 119.183 -0.787 . . . . 0.0 112.962 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.04 134.97 54.87 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.188 0.994 . . . . 0.0 110.205 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.99 139.03 50.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.63 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.4 pt -121.28 177.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -121.63 143.49 49.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 107.37 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.88 163.77 36.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -63.55 136.11 57.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.87 38.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.161 0.505 . . . . 0.0 112.239 -172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p -110.16 174.94 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.265 172.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.4 151.4 87.56 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.892 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.67 159.98 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.031 3.154 . . . . 0.0 111.283 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.08 -8.32 57.98 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -96.46 16.05 19.72 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.69 0.677 . . . . 0.0 112.343 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -114.94 148.84 38.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.618 0.723 . . . . 0.0 111.42 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 29.8 m -86.97 15.15 6.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.984 1.314 . . . . 0.0 112.069 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.91 -4.57 34.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.888 -0.396 . . . . 0.0 112.376 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 ptp85 -80.68 -1.94 44.6 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.677 0.739 . . . . 0.0 111.991 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.77 168.4 22.23 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 122.994 0.518 . . . . 0.0 111.237 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.482 -1.732 . . . . 0.0 110.893 177.141 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.566 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.276 1 C5'-C4'-C3' 109.434 -4.044 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.606 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.997 0 C3'-C2'-C1' 104.147 2.941 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 O4'-C1'-N19 110.449 2.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 1 O4'-C1'-N19 114.401 6.201 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 2 C5'-C4'-C3' 108.854 -4.431 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.825 0 C5'-C4'-C3' 110.628 -3.248 . 0.215 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.385 0.612 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.06 126.19 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -132.27 137.2 47.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.726 0.774 . . . . 0.0 111.782 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.26 11.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.44 48.6 0.35 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.407 1.083 . . . . 0.0 112.422 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 61.3 153.02 0.11 Allowed Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 126.977 2.111 . . . . 0.0 114.108 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 88.1 Cg_exo -53.91 151.86 25.26 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.923 3.082 . . . . 0.0 113.063 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.68 -17.45 45.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.27 129.55 47.25 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.912 0.856 . . . . 0.0 108.78 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.4 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 75.7 mt -113.31 155.11 25.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.338 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -108.39 129.41 55.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.526 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -121.62 80.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -174.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.77 148.8 19.23 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.909 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.43 11.24 45.44 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 117.736 0.768 . . . . 0.0 112.054 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.93 163.02 20.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.435 0.636 . . . . 0.0 111.907 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.622 HD22 ' HB3' ' B' ' 75' ' ' ASP . 32.2 t-20 -71.27 165.52 23.49 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.417 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -85.48 -8.34 58.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.917 -0.489 . . . . 0.0 110.962 -174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -109.41 -1.35 18.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.28 1.432 . . . . 0.0 111.147 -177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 68.6 m -76.61 144.51 39.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.35 -167.58 2.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.06 -32.11 70.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.432 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -65.0 -32.68 74.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -21.88 27.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.16 -27.27 23.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.98 1.312 . . . . 0.0 109.348 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.06 -28.98 32.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 110.121 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.25 -20.37 41.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.505 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 74' ' ' LEU . 6.4 p -104.33 -35.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 90.6 m-85 -91.83 -11.59 36.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.067 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.0 -3.57 75.22 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.53 -13.1 59.37 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.869 1.267 . . . . 0.0 111.002 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.6 -19.32 12.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.58 164.47 34.16 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.1 ttm105 -72.34 117.37 13.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -75.24 141.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.295 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -23.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.203 0.601 . . . . 0.0 109.958 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -161.18 150.51 16.67 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.054 0.541 . . . . 0.0 109.846 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.48 145.58 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.287 0.565 . . . . 0.0 109.812 172.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.3 mt -119.3 156.28 30.29 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.532 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.67 119.11 5.6 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.8 mmm -94.69 144.05 25.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.062 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.428 ' CA ' ' HG2' ' B' ' 49' ' ' ARG . 30.4 mttt -138.34 158.29 44.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.07 141.45 58.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.779 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -89.22 -2.95 58.7 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -115.66 -14.17 11.45 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.243 0.617 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -128.97 -13.83 4.52 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.116 0.416 . . . . 0.0 111.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 57.56 20.72 6.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.01 -116.55 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.489 1.115 . . . . 0.0 108.969 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -141.1 147.78 39.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.075 1.35 . . . . 0.0 107.95 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.428 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 48.1 mmm-85 -69.45 -10.56 58.54 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.11 2.42 88.12 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.649 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -135.57 160.0 39.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.61 1.205 . . . . 0.0 111.039 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -178.29 7.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.099 0.56 . . . . 0.0 110.716 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 65.7 m-85 -142.42 163.08 33.82 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.893 0.477 . . . . 0.0 109.865 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.66 142.48 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.7 m -114.68 122.92 47.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.437 0.295 . . . . 0.0 110.333 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.06 155.84 17.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.865 0.866 . . . . 0.0 111.974 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.29 -22.7 60.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.883 0.473 . . . . 0.0 111.291 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -121.18 140.88 31.88 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.507 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 93.5 Cg_endo -73.65 -10.68 23.72 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.588 2.192 . . . . 0.0 110.396 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.63 -14.92 13.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.091 0.405 . . . . 0.0 110.671 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.2 m-20 -72.06 -27.62 62.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.38 -31.99 54.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.207 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -68.0 -39.59 83.21 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.37 -33.99 76.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.21 -44.41 53.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.08 44.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.093 -0.379 . . . . 0.0 111.37 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -105.59 4.51 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.338 1.055 . . . . 0.0 112.181 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.31 -52.91 1.39 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.779 0.799 . . . . 0.0 109.606 -175.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.1 mmm -82.69 -11.26 58.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.216 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.05 126.88 31.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.285 0.493 . . . . 0.0 109.752 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.86 -7.53 76.91 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.797 -0.446 . . . . 0.0 112.114 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.72 -156.94 0.19 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.582 1.153 . . . . 0.0 109.926 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -134.5 153.24 52.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 111.023 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -100.83 -65.99 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.388 0.613 . . . . 0.0 111.17 -176.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.622 ' HB3' HD22 ' B' ' 16' ' ' ASN . 15.4 t70 -120.54 16.27 12.04 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.628 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.8 -6.54 12.35 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.637 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -111.57 131.78 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 108.893 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.64 137.66 39.58 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.3 pt -118.58 173.74 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -116.82 140.65 49.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.026 1.73 . . . . 0.0 107.221 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.4 126.59 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.25 163.4 38.81 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -64.67 135.41 55.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.72 153.73 36.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 73.8 p -116.44 170.49 8.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.144 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -73.23 152.17 90.25 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.161 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.79 155.85 67.13 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.519 2.813 . . . . 0.0 110.655 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -80.92 -12.52 59.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.471 0.709 . . . . 0.0 112.661 -173.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -95.47 19.93 10.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.023 -0.423 . . . . 0.0 111.606 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.47 156.84 48.24 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.096 0.475 . . . . 0.0 110.99 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -87.91 9.6 21.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 111.714 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.8 84.76 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.807 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.14 162.64 38.45 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.199 1.0 . . . . 0.0 110.873 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -161.87 151.16 15.97 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.853 0.461 . . . . 0.0 109.932 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 117.33 -1.817 . . . . 0.0 111.332 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.562 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.212 0 C5'-C4'-C3' 110.208 -3.528 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.641 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.004 0 C3'-C2'-C1' 104.524 3.36 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 1 C5'-C4'-C3' 108.973 -4.352 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 O4'-C1'-N19 113.696 5.496 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 2 O4'-C1'-N19 112.521 4.321 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 0 O4'-C1'-N19 110.975 2.775 . 0.676 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' B' ' 1' ' ' MET . 6.0 mmt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.035 0.445 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 2' ' ' VAL . 7.2 p -77.28 3.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 CA-C-O 122.612 1.196 . . . . 0.0 109.717 170.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.87 128.0 33.17 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.127 -170.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.17 101.32 9.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.92 126.82 33.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.359 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 46.11 102.94 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 126.405 1.882 . . . . 0.0 113.992 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.542 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 96.8 Cg_exo -49.22 134.78 30.97 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.593 2.195 . . . . 0.0 109.943 171.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.68 50.33 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.85 127.84 37.47 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.51 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.4 mt -113.82 147.83 37.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -102.61 127.44 49.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -117.98 81.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.6 140.74 15.22 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.809 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 5.75 32.77 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 117.272 0.536 . . . . 0.0 111.899 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 19' ' ' THR . 8.0 mt -63.56 160.62 16.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.18 0.49 . . . . 0.0 110.958 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 45.4 t30 -69.23 159.27 33.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -71.69 -4.85 29.74 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.186 -0.321 . . . . 0.0 110.296 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.42 -8.36 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.86 1.264 . . . . 0.0 110.475 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.515 HG21 HD22 ' B' ' 15' ' ' LEU . 35.6 m -79.49 141.38 36.78 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.07 -168.03 2.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.393 0.616 . . . . 0.0 109.803 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.32 -30.57 68.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.97 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -66.77 -29.54 69.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.16 -17.73 28.59 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.68 -28.63 14.23 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.016 0.926 . . . . 0.0 110.495 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.28 -32.28 33.29 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.098 0.475 . . . . 0.0 109.72 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -29.7 43.28 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.208 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' B' ' 28' ' ' PHE . 3.6 p -91.6 -34.83 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 81.5 m-85 -91.42 -9.47 44.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.84 -4.88 86.17 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -78.61 -12.16 60.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.548 1.139 . . . . 0.0 111.193 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -115.63 -13.34 11.5 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.52 171.64 36.84 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 119.88 -1.152 . . . . 0.0 112.127 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -80.89 115.35 20.33 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.397 0.618 . . . . 0.0 109.689 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mt -74.18 139.84 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.745 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -19.06 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.061 175.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -163.15 149.66 12.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.407 0.683 . . . . 0.0 110.025 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.89 144.23 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 109.71 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -119.26 154.42 33.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.573 1.149 . . . . 0.0 108.047 173.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.93 118.97 6.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.6 mmm -92.93 142.41 27.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.665 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.58 151.63 35.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.062 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.42 153.82 18.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.385 1.074 . . . . 0.0 111.66 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -89.28 -14.22 36.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.745 0.418 . . . . 0.0 111.698 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -110.46 -14.05 14.16 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.806 0.443 . . . . 0.0 112.037 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 38.9 p -127.78 -12.94 5.35 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.538 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 59.61 11.71 2.51 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.367 0.417 . . . . 0.0 111.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -82.02 144.14 31.07 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -55.56 136.35 50.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.019 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -66.53 -11.38 52.51 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.218 0.607 . . . . 0.0 109.871 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 1.44 78.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -136.07 157.7 46.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.33 1.065 . . . . 0.0 110.421 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.32 6.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.2 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 48.1 m-85 -141.95 161.09 38.84 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -154.67 140.74 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 46.9 m -111.48 126.94 55.49 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' B' ' 10' ' ' LEU . 4.9 m-85 -99.03 162.35 13.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.451 0.701 . . . . 0.0 110.328 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -72.26 -18.7 61.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -129.28 153.49 80.49 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 123.577 0.751 . . . . 0.0 110.126 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.542 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 22.2 Cg_endo -81.58 3.14 8.05 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 122.714 2.276 . . . . 0.0 110.391 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.46 -15.18 7.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -86.22 -21.44 27.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.74 -28.27 61.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.055 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -69.23 -33.56 73.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.94 -27.33 63.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.97 -46.43 21.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.09 54.63 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.248 0.219 . . . . 0.0 111.369 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -101.69 9.31 41.11 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.298 1.039 . . . . 0.0 112.189 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -50.96 0.88 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.349 1.071 . . . . 0.0 109.127 -175.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.487 ' HA ' ' HG2' ' B' ' 72' ' ' LYS . 50.4 mmm -77.26 -18.56 57.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.27 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -75.95 110.42 10.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.06 -7.94 53.11 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.323 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' B' ' 69' ' ' MET . 8.6 ptpt -90.15 -173.17 3.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.239 1.02 . . . . 0.0 110.446 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' SER . . . . . 0.412 ' N ' ' HG3' ' B' ' 72' ' ' LYS . 47.2 t -122.84 153.52 39.48 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.778 0.799 . . . . 0.0 112.14 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -131.29 126.47 35.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.011 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.0 t70 62.25 -24.04 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 156.62 -10.99 0.29 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.081 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -118.14 137.23 53.11 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.977 0.888 . . . . 0.0 110.591 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.52 138.39 50.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.886 0.475 . . . . 0.0 110.82 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.495 HG21 HD23 ' B' ' 15' ' ' LEU . 23.8 pt -122.53 166.24 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -115.18 146.31 41.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.598 1.559 . . . . 0.0 108.127 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.22 129.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.58 163.53 32.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -61.65 134.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.31 157.49 29.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.948 0.404 . . . . 0.0 112.028 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 63.1 p -116.18 169.44 9.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.392 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.65 153.56 90.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.72 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -62.11 155.36 56.52 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.995 3.13 . . . . 0.0 111.199 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 44.4 m -76.93 -0.03 22.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.693 0.397 . . . . 0.0 111.676 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' PHE . . . . . 0.518 ' CD2' " H2'" ' A' ' 101' ' ' ' A' . 1.2 p90 -97.42 9.79 41.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.92 0.488 . . . . 0.0 111.453 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -130.14 164.71 23.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.909 0.484 . . . . 0.0 110.826 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 21.6 t -143.82 165.61 27.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.898 0.479 . . . . 0.0 110.866 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.84 0.32 82.8 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.615 0.626 . . . . 0.0 112.38 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -136.59 169.41 17.75 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.591 0.696 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -139.94 152.01 46.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.419 -1.767 . . . . 0.0 110.814 179.797 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.563 H5'' ' C8 ' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.18 1 O4'-C1'-N19 112.42 4.22 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.617 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.091 0 C3'-C2'-C1' 104.424 3.249 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.727 -3.849 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 O4'-C1'-N19 113.348 5.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.474 " H3'" " H5'" ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 112.835 4.635 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . 0.518 " H2'" ' CD2' ' B' ' 89' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.129 1 O4'-C1'-N19 114.077 5.877 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.488 ' HA ' ' CE ' ' B' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.314 0.578 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.487 HG22 ' O ' ' B' ' 2' ' ' VAL . 5.9 p -105.21 8.51 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 122.689 1.233 . . . . 0.0 109.125 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -78.77 126.79 31.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.86 105.95 13.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.32 123.31 27.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.094 -171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 46.87 118.55 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.886 2.474 . . . . 0.0 116.041 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 83.6 Cg_exo -51.05 148.98 16.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.053 2.502 . . . . 0.0 111.306 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.74 -20.08 47.26 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -85.61 129.32 34.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.664 0.732 . . . . 0.0 109.209 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.402 HD12 ' CE1' ' B' ' 56' ' ' PHE . 79.1 mt -119.22 153.37 35.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.379 0.671 . . . . 0.0 110.091 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -106.48 131.2 53.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.5 mm -121.85 80.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.19 148.7 19.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.937 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.8 11.02 51.63 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.619 0.709 . . . . 0.0 111.484 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.64 164.39 14.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.449 0.699 . . . . 0.0 111.449 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.585 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.3 t30 -72.59 156.91 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.889 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -76.36 -1.29 26.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.78 0.324 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.09 -5.8 15.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.392 1.077 . . . . 0.0 110.875 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.5 m -80.46 145.65 31.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.349 0.66 . . . . 0.0 110.186 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.59 -168.84 2.13 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.22 -33.19 71.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.48 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.13 -32.9 74.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.27 -22.1 27.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.84 -28.37 22.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.194 1.398 . . . . 0.0 109.453 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.08 -27.91 32.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.391 0.615 . . . . 0.0 110.05 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.6 -21.26 38.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.611 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.574 HG11 HD21 ' B' ' 74' ' ' LEU . 6.2 p -103.51 -34.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.3 m-85 -91.41 -11.63 37.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.949 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.23 -3.44 76.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.72 -12.81 59.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.758 1.223 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.55 -19.52 12.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.608 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.97 166.38 37.06 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.072 0.396 . . . . 0.0 112.369 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -73.9 117.13 15.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.2 mt -75.52 142.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -23.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.049 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.84 150.58 17.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.177 0.591 . . . . 0.0 109.794 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.09 144.63 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 109.75 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -116.74 154.19 31.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.47 117.68 6.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.5 mmm -92.68 138.08 31.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.753 -170.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -145.18 151.7 38.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 111.117 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.52 165.92 11.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.121 0.969 . . . . 0.0 112.006 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -107.44 -2.31 20.62 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.333 0.653 . . . . 0.0 111.824 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.65 -12.07 13.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.359 0.663 . . . . 0.0 111.439 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -132.69 -14.38 2.82 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.688 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 58.86 11.26 1.8 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.84 0.291 . . . . 0.0 111.667 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -85.32 149.54 25.38 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 109.243 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -54.95 139.3 41.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.33 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -67.87 -8.24 34.83 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 109.778 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.06 76.84 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PHE . . . . . 0.56 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 46.1 p90 -140.12 160.71 39.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.536 1.168 . . . . 0.0 110.991 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.14 -176.87 6.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 110.589 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 37.5 m-85 -143.17 162.84 34.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -154.13 144.72 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -116.68 122.63 45.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.327 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.402 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.1 m-85 -92.17 156.27 17.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.536 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.22 -22.53 59.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.085 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.6 t -121.58 140.98 32.61 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 67.7 Cg_endo -74.52 -7.45 19.54 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.809 2.34 . . . . 0.0 110.137 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.69 -15.77 12.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.764 0.256 . . . . 0.0 110.623 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.9 m-20 -71.59 -28.48 63.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.42 56.55 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.91 -37.25 75.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.43 -30.85 67.81 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.27 -46.37 34.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.58 -9.97 52.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.13 -0.356 . . . . 0.0 111.191 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -102.16 8.14 40.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.398 1.079 . . . . 0.0 112.499 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.43 -51.38 0.93 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.323 1.059 . . . . 0.0 109.392 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 47.3 mmm -78.66 -17.26 56.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.846 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -73.31 118.4 16.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -7.91 75.6 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.641 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.5 ptpt -89.89 178.21 6.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.728 1.264 . . . . 0.0 111.261 175.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -105.45 147.18 28.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.705 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.574 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.53 -65.1 1.01 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.325 0.583 . . . . 0.0 110.559 -177.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.585 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.0 t70 -123.15 4.15 9.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.652 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.14 -11.36 2.55 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.214 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -115.51 133.58 55.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.824 0.85 . . . . 0.0 109.834 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.13 136.29 41.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.392 0.432 . . . . 0.0 110.395 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 16.9 pt -112.84 175.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -119.7 142.76 48.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 107.131 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.56 129.94 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.2 163.09 37.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 123.07 20.42 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.58 149.94 47.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 52.2 p -107.27 169.87 8.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.951 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.06 152.78 96.19 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.39 148.29 83.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.141 2.561 . . . . 0.0 110.162 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -82.3 2.19 33.28 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.109 0.563 . . . . 0.0 112.1 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.24 11.99 12.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.918 0.487 . . . . 0.0 110.051 173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 52.11 176.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.281 2.233 . . . . 0.0 114.492 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 22.1 t -149.52 162.35 40.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.896 0.479 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' B' ' 94' ' ' ARG . . . 76.24 1.3 68.99 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.566 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 60.58 -14.2 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.868 1.667 . . . . 0.0 114.036 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' B' ' 92' ' ' GLY . 61.1 ttp180 -151.99 151.88 31.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.791 -0.568 . . . . 0.0 110.123 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.348 -1.807 . . . . 0.0 110.742 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.563 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.481 0 O4'-C1'-N19 112.081 3.881 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.64 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C3'-C2'-C1' 104.583 3.425 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 C5'-C4'-C3' 112.221 -2.186 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 1 O4'-C1'-N19 114.181 5.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.56 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 C4'-C3'-C2' 98.486 -4.214 . 0.362 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.916 0 O4'-C1'-N19 111.664 3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.536 0.208 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 p -94.45 112.16 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.35 139.36 50.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.812 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.81 113.04 25.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.93 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.14 169.8 3.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.737 174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -59.13 153.82 43.89 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -170.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 87.8 Cg_exo -50.53 154.37 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 125.033 3.822 . . . . 0.0 113.747 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -14.27 61.22 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.02 127.73 45.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 117.981 0.891 . . . . 0.0 109.132 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 74.7 mt -114.67 155.94 25.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.286 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.56 129.74 55.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.517 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.1 mm -121.32 75.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.63 146.96 18.41 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.226 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.42 11.0 30.22 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.834 0.817 . . . . 0.0 112.004 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.87 166.55 8.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.28 0.562 . . . . 0.0 112.184 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 58.4 t30 -79.0 -2.65 41.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 1.2 p 66.39 -13.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.929 1.292 . . . . 0.0 112.998 -169.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' B' ' 16' ' ' ASN . 48.1 mm-40 -91.26 -9.05 46.57 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.969 0.908 . . . . 0.0 109.328 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -78.77 144.9 34.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 109.605 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 -172.31 3.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' B' ' 21' ' ' GLU . 36.2 mp0 -65.22 -37.93 88.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.453 0.701 . . . . 0.0 110.342 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -32.41 74.04 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.191 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.48 -21.03 25.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.16 -27.48 24.55 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.903 1.281 . . . . 0.0 109.034 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.64 -27.21 34.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.41 0.624 . . . . 0.0 110.026 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.0 -20.19 35.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.603 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.3 p -104.2 -35.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 88.4 m-85 -92.69 -10.05 38.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.134 175.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.93 -2.93 79.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.5 -11.27 59.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.557 1.143 . . . . 0.0 111.02 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -113.4 -19.34 11.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.786 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.36 161.15 30.12 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -74.07 123.06 23.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.99 143.79 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 -22.78 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.925 178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.95 150.43 15.18 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.32 0.648 . . . . 0.0 109.744 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.66 145.62 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.396 0.617 . . . . 0.0 109.655 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.9 mt -118.52 154.44 32.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.291 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -149.13 117.54 6.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.82 140.15 29.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.913 -169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -149.06 151.22 34.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.424 0.63 . . . . 0.0 112.342 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.23 157.44 16.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.836 1.255 . . . . 0.0 111.333 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -93.36 -22.12 19.13 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 122.813 0.445 . . . . 0.0 111.404 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -102.12 -15.09 16.82 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.773 0.429 . . . . 0.0 112.089 -174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 27.4 p -125.37 -15.39 6.19 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 122.629 0.372 . . . . 0.0 110.819 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.24 7.87 1.84 Allowed 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 123.313 0.383 . . . . 0.0 111.728 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -81.39 147.28 29.88 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 42.3 t -55.86 145.85 23.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 40.1 mmm-85 -67.16 -8.78 33.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.83 0.09 75.64 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' PHE . . . . . 0.484 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 48.1 p90 -139.13 161.88 36.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 117.822 0.811 . . . . 0.0 111.083 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.72 -178.92 7.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.448 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 44.7 m-85 -140.34 162.3 35.63 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -152.98 142.51 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.9 m -114.06 121.7 44.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.29 156.54 17.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.753 0.821 . . . . 0.0 110.731 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -78.72 -23.75 45.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.376 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -114.03 138.09 22.7 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.507 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 69.4 Cg_endo -74.74 -8.13 20.06 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.457 2.105 . . . . 0.0 110.434 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.99 -15.06 13.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.389 0.276 . . . . 0.0 110.891 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.466 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 70.3 m-20 -71.34 -28.17 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.41 51.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.31 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.41 -39.18 81.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.95 -32.62 73.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.58 -43.7 47.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.56 42.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.286 -0.259 . . . . 0.0 110.943 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -106.47 5.03 28.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.294 1.038 . . . . 0.0 112.324 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.81 -53.29 1.33 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.403 ' HE3' HD11 ' B' ' 79' ' ' ILE . 30.2 mmm -82.35 -10.19 59.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.779 1.632 . . . . 0.0 112.102 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.27 126.0 29.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.32 -6.74 81.12 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -80.81 -154.15 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.172 0.989 . . . . 0.0 109.16 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -137.77 159.53 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.798 0.808 . . . . 0.0 112.507 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.43 126.69 31.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.849 176.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 1.9 t70 60.98 -18.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.91 -8.38 0.6 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 119.33 -0.706 . . . . 0.0 113.154 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -121.91 138.51 54.38 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.259 1.03 . . . . 0.0 110.592 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.42 139.38 54.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.808 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.403 HD11 ' HE3' ' B' ' 69' ' ' MET . 25.2 pt -121.43 176.66 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -120.1 141.44 49.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.712 1.605 . . . . 0.0 107.505 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.38 124.56 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.07 163.15 36.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -60.7 133.77 56.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.63 153.71 30.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.8 p -107.56 173.0 6.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.242 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -80.19 153.9 74.57 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.065 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.78 157.75 59.66 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.463 2.775 . . . . 0.0 110.842 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 90.1 p -91.39 -7.23 51.37 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -93.39 15.35 15.96 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 117.943 0.338 . . . . 0.0 111.287 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -139.32 158.01 44.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 122.677 0.391 . . . . 0.0 110.607 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.4 t -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.697 0.799 . . . . 0.0 111.605 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.12 0.28 65.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.074 0.368 . . . . 0.0 112.601 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -147.71 -26.36 0.36 Allowed 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.455 0.702 . . . . 0.0 110.696 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -150.9 165.87 32.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.587 0.755 . . . . 0.0 110.109 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-O 117.212 -1.882 . . . . 0.0 110.523 179.818 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.501 H5'' ' C8 ' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.521 1 C5'-C4'-C3' 109.341 -4.106 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.451 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.115 0 C3'-C2'-C1' 103.911 2.679 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 1 C5'-C4'-C3' 109.18 -4.213 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . 0.419 " H4'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.626 1 O4'-C1'-N19 114.311 6.111 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.484 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 O5'-C5'-C4' 115.437 3.741 . 0.536 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.937 0 O4'-C1'-N19 111.032 2.832 . 0.512 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 30.8 ttp . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.474 HG22 ' O ' ' B' ' 2' ' ' VAL . 8.5 p -91.18 6.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 122.796 1.284 . . . . 0.0 109.686 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.4 139.74 38.75 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.396 -168.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.1 111.71 5.78 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -77.68 55.77 1.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.932 0.893 . . . . 0.0 112.689 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' B' ' 7' ' ' PRO . 75.3 mtp85 60.8 153.31 0.1 Allowed Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.781 2.032 . . . . 0.0 114.303 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 89.3 Cg_exo -54.31 151.38 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.864 3.043 . . . . 0.0 112.887 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.45 -17.93 45.84 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 170.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -98.3 129.93 45.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.054 0.927 . . . . 0.0 108.926 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -114.88 154.04 29.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.87 130.92 55.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.479 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -122.3 80.34 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.2 143.25 16.44 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.538 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 9.65 38.7 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 117.477 0.639 . . . . 0.0 111.882 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.88 165.04 13.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.134 0.573 . . . . 0.0 111.672 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t30 -77.94 157.06 29.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 123.292 0.637 . . . . 0.0 110.924 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -72.63 -8.33 54.73 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.678 0.791 . . . . 0.0 110.283 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.94 -10.46 22.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 110.471 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.1 m -83.49 143.85 29.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -169.02 2.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -68.72 -33.29 73.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -64.6 -33.4 75.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.56 -20.89 27.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.449 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -86.5 -26.74 24.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.125 1.37 . . . . 0.0 109.431 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.9 -28.84 32.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.427 0.632 . . . . 0.0 110.119 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.33 -20.08 41.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.675 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -105.25 -36.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.5 m-85 -88.53 -11.89 44.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.923 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.63 -4.24 75.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -81.5 -12.88 58.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.319 1.048 . . . . 0.0 110.911 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.7 m-85 -109.73 -20.65 12.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.254 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.91 164.66 33.15 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 118.048 0.386 . . . . 0.0 112.959 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -66.41 117.84 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.7 mt -79.16 142.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.966 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -21.7 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.142 0.577 . . . . 0.0 109.91 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.69 150.39 15.64 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.464 0.706 . . . . 0.0 109.826 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.7 145.81 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.138 0.494 . . . . 0.0 110.059 172.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.0 mt -120.3 154.41 35.03 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.362 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.456 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -150.71 119.51 6.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 170.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.422 ' HE3' ' OP2' ' A' ' 101' ' ' ' A' . 12.1 mmm -92.59 141.66 28.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -169.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.456 ' HE2' HD12 ' B' ' 39' ' ' LEU . 11.9 mttt -137.95 158.09 45.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.73 147.57 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.195 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -86.16 -9.58 56.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -122.22 -12.64 8.25 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.9 p -124.19 -14.88 6.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.233 0.47 . . . . 0.0 111.343 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 56.57 20.99 5.32 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.5 -103.05 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.349 1.06 . . . . 0.0 110.009 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 27.0 t -153.06 145.61 24.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.598 1.159 . . . . 0.0 108.343 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.408 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 42.9 mmm-85 -74.11 -10.36 59.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.92 2.73 88.34 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.351 -0.694 . . . . 0.0 111.582 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' PHE . . . . . 0.578 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 51.1 p90 -135.49 161.45 35.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.764 1.282 . . . . 0.0 110.072 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.2 -177.62 6.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.779 0.431 . . . . 0.0 111.164 -174.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 63.2 m-85 -142.73 162.28 35.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.3 142.27 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m -113.35 123.99 51.42 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -95.04 156.35 16.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.931 0.892 . . . . 0.0 110.686 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.47 -21.26 45.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.493 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -116.5 137.93 24.01 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.506 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 53.4 Cg_endo -76.85 -0.13 10.22 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.089 2.526 . . . . 0.0 110.568 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 -15.5 9.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 117.877 0.308 . . . . 0.0 111.198 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.521 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 84.5 m-20 -72.19 -27.96 62.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.62 -27.66 55.81 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.452 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -74.5 -36.59 63.23 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.24 -26.1 64.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.2 -46.38 14.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.03 63.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.3 7.7 46.03 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 -55.58 1.31 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.915 0.864 . . . . 0.0 109.371 -173.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 0.0 OUTLIER -75.48 -15.76 60.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.626 -1.625 . . . . 0.0 111.775 -177.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -73.91 124.06 25.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.32 -7.05 82.14 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -82.91 -153.46 0.12 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 109.361 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -139.69 158.73 43.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.464 0.706 . . . . 0.0 112.395 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -132.43 126.56 33.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.5 -23.34 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.62 -6.51 0.47 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 119.512 -0.604 . . . . 0.0 112.631 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -117.36 134.51 54.74 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.027 0.913 . . . . 0.0 110.134 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.96 139.17 50.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.479 -174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.22 174.55 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -120.89 144.19 48.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.3 1.84 . . . . 0.0 107.776 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -135.97 130.03 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -160.92 163.83 31.61 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -61.43 137.15 58.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.39 158.89 27.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 66.4 p -122.92 172.33 8.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.154 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.43 155.52 91.18 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.356 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.52 151.06 86.81 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.81 2.34 . . . . 0.0 110.635 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 95.0 p -77.13 -9.09 58.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.007 0.523 . . . . 0.0 111.596 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' PHE . . . . . 0.583 ' CD2' " H2'" ' A' ' 101' ' ' ' A' . 6.1 p90 -87.17 4.17 43.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.298 0.239 . . . . 0.0 111.196 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -133.24 167.16 20.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.251 0.62 . . . . 0.0 110.284 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.9 t -144.76 166.06 26.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.963 0.505 . . . . 0.0 110.813 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.53 67.01 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.952 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.01 24.6 0.39 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.979 1.712 . . . . 0.0 114.419 177.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.34 163.19 32.47 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.234 0.614 . . . . 0.0 111.198 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.196 -1.891 . . . . 0.0 111.205 -179.68 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.566 H5'' ' C8 ' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.455 1 C5'-C4'-C3' 108.675 -4.55 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.603 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.991 0 C3'-C2'-C1' 104.879 3.754 OUTLIER-DELTA 0.026 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 C5'-C4'-O4' 112.271 2.193 . 0.02 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 1 O4'-C1'-N19 113.732 5.532 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.578 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.764 0 O5'-C5'-C4' 115.76 3.971 . 0.13 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . 0.583 " H2'" ' CD2' ' B' ' 89' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.052 1 O4'-C1'-N19 114.836 6.636 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 2' ' ' VAL . 4.7 p -141.89 13.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.373 1.869 . . . . 0.0 107.12 172.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.1 139.84 36.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.536 -167.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.47 113.31 13.54 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.588 -1.642 . . . . 0.0 106.664 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -73.66 60.81 0.7 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.65 1.18 . . . . 0.0 113.394 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 60.44 154.46 0.1 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 126.228 1.811 . . . . 0.0 114.412 173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 85.2 Cg_exo -54.31 148.55 41.11 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.681 2.921 . . . . 0.0 112.632 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.5 33.78 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.23 -0.761 . . . . 0.0 111.729 170.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -99.55 128.86 45.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 117.99 0.895 . . . . 0.0 108.872 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -112.56 151.31 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.517 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -104.65 128.41 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.512 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.9 79.05 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 146.48 18.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.937 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.28 10.44 41.87 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 117.68 0.74 . . . . 0.0 111.672 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.63 164.98 13.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.529 0.732 . . . . 0.0 112.129 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' B' ' 75' ' ' ASP . 46.7 t30 -77.1 162.38 27.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 110.657 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -76.71 -1.47 28.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.284 0.233 . . . . 0.0 110.607 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.6 -4.61 16.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.378 1.071 . . . . 0.0 110.815 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 45.2 m -82.7 144.51 30.18 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.945 0.498 . . . . 0.0 110.047 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 -169.23 2.44 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.369 0.604 . . . . 0.0 109.443 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.34 -35.51 73.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.558 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.1 -30.0 70.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.37 -21.02 23.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' B' ' 27' ' ' VAL . 9.9 mt -87.07 -28.82 22.33 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.135 0.974 . . . . 0.0 109.36 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.26 -25.51 39.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.186 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.37 -22.19 35.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.598 HG11 HD21 ' B' ' 74' ' ' LEU . 5.0 p -103.87 -29.3 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.512 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.6 m-85 -99.1 -10.39 22.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.382 174.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.21 -5.83 85.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -77.05 -22.97 52.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.853 1.261 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.7 -19.9 15.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.528 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.44 165.28 34.98 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 118.024 0.374 . . . . 0.0 112.215 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -74.07 116.87 15.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.66 139.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.39 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -23.64 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 122.849 0.46 . . . . 0.0 110.134 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -160.28 149.48 17.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.026 0.53 . . . . 0.0 109.614 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.71 143.58 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 172.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.9 mt -117.39 154.13 31.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.07 119.41 5.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.0 mmm -94.32 136.94 34.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.93 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -145.53 154.02 41.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.363 0.602 . . . . 0.0 111.333 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.81 153.07 17.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.517 1.127 . . . . 0.0 111.318 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -95.58 -0.13 52.29 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.27 -14.08 7.54 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.102 0.561 . . . . 0.0 112.012 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 19.9 p -127.62 -14.12 5.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.203 0.456 . . . . 0.0 111.296 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 62.06 12.21 4.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -80.74 142.24 34.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -53.04 137.9 32.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.955 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -70.23 -10.09 57.83 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.804 0.842 . . . . 0.0 109.965 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.66 1.57 68.17 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.424 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.84 158.87 43.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.62 1.21 . . . . 0.0 110.553 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -178.52 7.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.051 0.541 . . . . 0.0 110.489 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.5 m-85 -142.58 162.39 35.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.846 0.459 . . . . 0.0 110.433 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.21 143.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -115.85 122.37 45.17 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 123.142 0.276 . . . . 0.0 110.306 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.71 156.58 17.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.589 0.755 . . . . 0.0 111.996 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -75.18 -22.89 57.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.599 0.36 . . . . 0.0 111.071 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -120.54 140.69 30.81 Favored Pre-proline 0 CA--C 1.518 -0.262 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 98.3 Cg_endo -73.41 -12.77 25.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.436 2.091 . . . . 0.0 110.189 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.57 -15.59 14.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.165 0.439 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.493 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.8 m-20 -70.95 -29.01 64.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 169.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.57 58.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.008 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -67.59 -38.9 84.68 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.35 -33.56 74.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.05 52.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.73 -8.45 52.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.256 -0.277 . . . . 0.0 110.906 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -104.94 5.35 32.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.191 0.996 . . . . 0.0 112.286 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -52.05 1.28 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.862 0.755 . . . . 0.0 109.442 -175.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.7 mmm -83.36 -10.52 58.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.405 1.482 . . . . 0.0 112.529 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.85 127.26 32.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.83 76.28 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.149 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.84 -157.38 0.22 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -134.46 153.01 52.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.664 0.786 . . . . 0.0 110.891 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.598 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -99.93 -68.32 0.81 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.943 -176.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.601 ' HB3' HD22 ' B' ' 16' ' ' ASN . 11.7 t70 -117.59 7.25 12.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.652 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.25 -7.66 5.37 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -113.41 132.84 55.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 108.932 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 136.62 38.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.27 175.68 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -120.98 140.4 51.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.846 1.658 . . . . 0.0 107.302 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.86 125.12 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.44 162.72 35.72 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -60.71 133.6 56.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.2 158.33 27.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.4 p -116.97 163.21 16.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.143 171.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -62.78 152.59 81.95 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.384 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.08 157.17 58.75 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.488 2.792 . . . . 0.0 110.206 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -80.91 -10.27 59.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -97.11 18.39 15.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.001 0.364 . . . . 0.0 111.202 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -144.33 162.71 35.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 111.062 -175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.3 t -153.64 147.04 24.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.751 0.42 . . . . 0.0 110.119 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.72 -135.03 52.13 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' B' ' 93' ' ' ARG . 37.6 mmt180 56.78 165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.515 1.526 . . . . 0.0 114.29 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -145.41 162.08 38.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.84 -174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.468 -1.74 . . . . 0.0 110.497 179.525 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.58 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.34 1 C5'-C4'-C3' 109.11 -4.26 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.629 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.967 0 C3'-C2'-C1' 104.671 3.523 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 C5'-C4'-C3' 109.745 -3.837 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.937 1 O4'-C1'-N19 113.672 5.472 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 2 C5'-C4'-C3' 109.004 -4.331 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 110.958 2.758 . 0.607 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.1 tmm? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.567 0.698 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.521 HG22 ' O ' ' B' ' 2' ' ' VAL . 6.2 p -128.38 17.17 2.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.915 1.686 . . . . 0.0 107.101 172.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -84.58 138.74 32.56 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.954 -167.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.91 104.08 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.82 -43.15 76.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.997 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -165.64 153.38 9.73 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 118.476 0.58 . . . . 0.0 111.61 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 51.2 Cg_exo -60.27 147.09 94.97 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.699 2.266 . . . . 0.0 110.706 168.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.63 -18.56 56.24 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -85.88 129.98 34.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.3 mt -118.19 152.67 35.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.102 0.561 . . . . 0.0 109.961 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -105.42 128.65 53.64 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.73 81.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.94 146.83 18.41 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.861 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.33 51.09 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 117.707 0.754 . . . . 0.0 111.585 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.23 164.06 11.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.457 0.703 . . . . 0.0 111.295 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' B' ' 75' ' ' ASP . 44.5 t30 -73.1 158.86 34.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.294 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 76.0 p -74.96 -2.75 28.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.99 -7.15 16.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.647 1.179 . . . . 0.0 110.776 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.6 m -80.96 144.34 31.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.532 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -170.24 2.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.58 -34.64 77.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.646 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -65.78 -31.51 72.53 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.974 -0.454 . . . . 0.0 111.022 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -20.1 29.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -89.78 -28.34 19.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.819 1.248 . . . . 0.0 109.848 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -81.77 -28.55 33.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 109.896 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.81 -23.71 39.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.317 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.5 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.9 p -99.77 -37.8 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.5 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.7 m-85 -88.96 -10.58 47.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.772 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.13 -4.61 73.46 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.1 mtpt -79.2 -14.59 58.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.808 1.243 . . . . 0.0 111.377 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.1 m-85 -110.33 -19.8 12.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.723 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.56 163.07 31.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -74.95 125.61 29.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.69 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.342 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.18 -23.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.963 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -161.07 151.08 17.38 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.173 0.589 . . . . 0.0 109.557 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.92 147.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 109.722 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -122.23 156.0 34.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.589 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.24 121.39 5.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.73 138.3 31.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -174.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -150.75 155.21 38.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.164 0.507 . . . . 0.0 112.086 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.13 159.4 11.96 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.706 1.202 . . . . 0.0 111.505 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -99.04 -8.75 24.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.79 0.436 . . . . 0.0 111.793 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.35 -12.6 12.38 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.927 0.491 . . . . 0.0 111.709 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 42.5 p -127.73 -13.99 5.2 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 122.686 0.395 . . . . 0.0 111.304 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 59.21 12.94 2.76 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 123.234 0.334 . . . . 0.0 111.701 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -83.34 143.3 30.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.018 0.527 . . . . 0.0 110.115 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -55.78 140.76 41.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.062 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -77.88 3.42 14.48 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.783 0.433 . . . . 0.0 110.278 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.88 0.7 83.31 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.746 0.689 . . . . 0.0 112.591 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.66 158.34 43.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.439 1.12 . . . . 0.0 110.6 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.42 -179.28 7.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.8 m-85 -140.95 161.51 37.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.03 139.23 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -111.65 121.7 45.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.853 0.359 . . . . 0.0 110.121 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.7 m-85 -92.16 155.26 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.74 0.816 . . . . 0.0 110.444 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.97 -22.88 48.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -114.57 135.72 22.33 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.443 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 46.8 Cg_endo -76.67 0.86 9.13 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.847 2.365 . . . . 0.0 110.499 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.35 -14.76 9.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.525 0.33 . . . . 0.0 111.202 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -72.07 -28.76 63.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.79 58.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.31 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -70.69 -37.82 73.65 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.23 -31.07 70.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -75.38 -44.91 42.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.262 -0.274 . . . . 0.0 111.333 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -99.8 5.72 45.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.047 0.939 . . . . 0.0 112.642 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.49 -51.75 1.27 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.913 0.778 . . . . 0.0 109.197 -174.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.443 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mtp -83.74 -11.16 57.51 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.74 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.89 114.17 10.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.03 -4.81 59.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.54 -154.53 0.11 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.327 1.051 . . . . 0.0 109.309 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -139.77 159.49 42.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 112.474 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.63 127.3 30.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.386 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 60.92 -20.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 150.26 -6.06 0.68 Allowed Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.042 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -118.38 134.73 54.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.869 0.834 . . . . 0.0 110.063 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.81 137.42 47.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.322 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.1 pt -118.5 177.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -122.01 143.35 49.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.562 1.945 . . . . 0.0 107.177 170.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.66 130.42 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -158.96 164.2 35.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -67.53 132.73 48.15 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.34 147.83 34.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 62.9 p -115.58 170.74 8.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.936 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.19 154.38 90.21 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' PRO . . . . . 0.42 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 57.7 Cg_endo -64.87 169.44 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.79 2.994 . . . . 0.0 110.685 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' SER . . . . . 0.527 ' C ' ' H ' ' B' ' 90' ' ' GLU . 49.6 m -108.92 3.68 22.57 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -170.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' PHE . . . . . 0.597 ' CE2' " H2'" ' A' ' 101' ' ' ' A' . 4.9 m-85 -63.89 -0.07 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.796 1.18 . . . . 0.0 110.457 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' B' ' 88' ' ' SER . 5.2 pt-20 -122.07 0.38 9.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.966 1.706 . . . . 0.0 112.186 -172.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 4.3 t -167.45 -3.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.41 5.38 0.14 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.808 0.731 . . . . 0.0 113.845 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.6 147.76 28.52 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.054 0.941 . . . . 0.0 109.048 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 51.39 32.26 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.749 0.819 . . . . 0.0 111.653 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.368 -179.955 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.529 H5'' ' C8 ' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.266 1 C5'-C4'-C3' 109.484 -4.011 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.43 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.963 0 C3'-C2'-C1' 104.076 2.862 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.673 1 C5'-C4'-C3' 109.308 -4.128 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.0 1 O4'-C1'-N19 112.914 4.714 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.428 " H4'" ' OP2' ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.212 1 C4'-C3'-C2' 98.386 -4.314 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . 0.669 " H5'" ' C8 ' ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.967 1 O4'-C1'-N19 114.354 6.154 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p 47.62 42.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 123.031 1.396 . . . . 0.0 108.758 -168.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.54 132.15 46.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.118 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.67 103.23 12.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.47 172.77 5.65 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -52.77 153.1 6.12 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.536 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 98.9 Cg_exo -51.5 154.94 7.95 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.552 3.502 . . . . 0.0 113.21 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.85 -15.37 55.56 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -98.68 128.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.373 1.087 . . . . 0.0 109.044 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.34 153.8 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.048 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -108.08 128.93 55.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.485 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -121.1 80.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.39 144.21 17.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.237 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.71 38.98 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 117.709 0.755 . . . . 0.0 111.466 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.29 162.46 22.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.048 0.539 . . . . 0.0 112.087 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' B' ' 75' ' ' ASP . 39.5 t-20 -76.35 155.15 34.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.014 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -68.93 -10.47 57.41 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 123.548 0.739 . . . . 0.0 110.284 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.78 -11.25 23.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 110.309 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -81.29 144.72 31.33 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.287 0.635 . . . . 0.0 109.345 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.74 -165.98 1.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.392 0.615 . . . . 0.0 109.536 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' B' ' 21' ' ' GLU . 37.1 mp0 -70.61 -38.84 74.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.858 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -68.71 -25.84 64.97 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.5 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.95 -20.19 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' B' ' 27' ' ' VAL . 10.9 mt -90.37 -28.46 18.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.675 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.11 -26.65 48.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 109.79 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.85 -23.87 36.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' B' ' 24' ' ' LEU . 5.3 p -101.82 -36.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.485 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 83.9 m-85 -90.47 -11.61 39.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.21 -0.306 . . . . 0.0 110.951 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.16 -3.13 68.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -81.51 -12.23 58.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.14 . . . . 0.0 111.264 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -111.96 -20.48 11.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.6 0.76 . . . . 0.0 112.412 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.47 161.58 29.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -74.0 124.97 27.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.88 143.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.154 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -20.7 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.477 0.711 . . . . 0.0 110.477 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -160.37 148.82 16.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.304 0.642 . . . . 0.0 109.66 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.06 143.54 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 110.039 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -118.94 156.03 30.28 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.178 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.536 HD12 ' HE2' ' B' ' 41' ' ' LYS . 2.9 tm? -154.98 119.44 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 171.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 13.8 mmm -93.17 142.87 26.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.097 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.536 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.8 mttt -140.78 157.23 45.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.91 141.74 56.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.187 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.411 ' CD ' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -83.7 -4.57 58.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.41 -14.15 9.74 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.5 p -128.84 -14.94 4.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.223 0.465 . . . . 0.0 111.574 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 56.8 21.77 6.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -70.48 -109.31 0.0 OUTLIER 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.911 1.284 . . . . 0.0 109.429 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 t -151.31 146.35 25.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -72.6 -9.98 59.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.17 87.18 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.158 -0.801 . . . . 0.0 111.943 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -136.94 160.34 39.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.922 1.361 . . . . 0.0 110.249 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.9 -178.71 7.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.749 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.9 m-85 -142.93 162.59 35.07 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.61 141.84 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 33.6 m -111.97 122.9 49.03 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.245 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -93.06 156.67 16.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 110.503 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.82 -23.08 42.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.461 -0.305 . . . . 0.0 110.284 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -115.19 137.56 23.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 64.4 Cg_endo -75.04 -7.04 18.78 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.568 2.179 . . . . 0.0 110.474 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.75 -14.71 13.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.844 0.293 . . . . 0.0 110.728 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.484 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.6 m-20 -71.67 -28.13 63.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.14 53.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.556 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.05 -38.94 79.39 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.44 -32.74 72.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.94 -44.78 46.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.43 -8.47 51.16 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.057 -0.402 . . . . 0.0 111.203 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -104.23 4.74 34.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.395 1.078 . . . . 0.0 112.088 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.58 -52.67 1.26 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.759 0.79 . . . . 0.0 109.447 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.2 mmm -82.22 -10.55 59.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.586 1.555 . . . . 0.0 112.401 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.56 126.15 29.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.39 -6.63 83.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -80.64 -153.86 0.09 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.595 1.158 . . . . 0.0 109.691 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -139.88 159.05 43.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.292 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.66 126.18 32.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.024 177.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.9 t70 61.05 -21.38 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.08 -6.35 0.6 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.724 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -117.42 133.16 56.29 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.002 0.901 . . . . 0.0 110.119 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.36 50.78 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.301 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -120.64 178.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -122.57 142.74 50.3 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.399 1.88 . . . . 0.0 107.33 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.97 129.25 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -159.24 162.39 36.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -63.59 134.37 55.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 158.27 29.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 29.5 p -117.55 160.46 21.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.949 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -63.12 154.12 78.79 Favored Pre-proline 0 N--CA 1.45 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' PRO . . . . . 0.407 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 52.9 Cg_endo -62.36 145.66 95.83 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.049 2.499 . . . . 0.0 110.544 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.8 m -93.27 6.56 47.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.72 0.808 . . . . 0.0 111.53 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.19 7.68 8.85 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.46 172.73 13.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.743 0.817 . . . . 0.0 111.303 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 6.4 t -83.13 10.31 8.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.212 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 94' ' ' ARG . . . 78.58 4.63 87.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.808 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 63.12 -18.1 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.911 1.684 . . . . 0.0 113.618 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' B' ' 92' ' ' GLY . 41.3 ptt180 -153.77 164.57 38.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.237 0.472 . . . . 0.0 110.81 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.317 -1.824 . . . . 0.0 110.569 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.543 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.227 1 O4'-C1'-N19 112.512 4.312 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.616 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 C3'-C2'-C1' 104.467 3.296 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 C5'-C4'-C3' 110.329 -3.447 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.946 1 O4'-C1'-N19 114.056 5.856 . 0.109 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.407 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.424 -2.436 1 O4'-C1'-N19 112.621 4.421 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 112.539 4.339 . 0.524 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpp . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.458 0.647 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 120.82 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.12 126.28 26.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.892 0.477 . . . . 0.0 111.213 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.62 106.66 14.79 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.7 -45.5 81.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -170.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -162.09 141.13 7.21 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 118.288 0.494 . . . . 0.0 110.322 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 75.9 Cg_exo -54.83 140.73 78.14 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.883 2.389 . . . . 0.0 110.727 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.79 65.07 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -92.24 125.49 36.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.432 HD12 ' CE1' ' B' ' 56' ' ' PHE . 74.4 mt -110.44 150.84 28.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -105.31 128.85 53.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.486 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.19 78.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.42 142.59 16.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.493 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.56 6.52 46.97 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 122.216 -0.579 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.27 162.32 6.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.331 0.652 . . . . 0.0 111.773 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.52 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.6 t30 -71.25 160.11 33.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 70.9 p -77.85 -1.28 30.87 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.878 0.471 . . . . 0.0 110.669 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.26 -6.1 15.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.409 1.083 . . . . 0.0 111.025 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -83.4 145.74 28.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.285 0.634 . . . . 0.0 110.087 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -169.96 2.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.51 -35.83 79.89 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.54 -174.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -67.89 -27.9 67.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.964 -0.46 . . . . 0.0 111.247 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.02 28.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.71 -26.78 24.07 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.166 1.386 . . . . 0.0 109.352 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -80.19 -32.75 38.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.427 0.632 . . . . 0.0 110.163 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.49 -21.65 45.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.308 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.1 p -103.06 -34.29 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.2 m-85 -91.83 -12.0 34.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.073 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -3.08 72.11 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -81.57 -13.58 57.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.66 1.184 . . . . 0.0 110.89 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -110.94 -19.58 12.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.696 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.13 166.2 36.67 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 118.025 0.375 . . . . 0.0 112.332 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttm105 -72.86 117.81 15.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.2 144.21 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.566 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -18.84 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.167 0.587 . . . . 0.0 110.323 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -160.22 147.35 16.11 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.212 0.605 . . . . 0.0 109.652 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.44 141.75 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.459 0.647 . . . . 0.0 109.583 170.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.2 mt -120.26 155.81 32.49 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.738 175.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.37 120.19 6.14 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.5 mmm -93.59 136.99 33.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.59 -172.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -147.51 153.25 39.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.116 0.484 . . . . 0.0 111.199 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.45 153.47 38.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.109 0.964 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' HD2' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -93.07 -7.05 46.7 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -105.1 -14.76 15.29 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.556 . . . . 0.0 111.75 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 61.8 p -133.35 -14.18 2.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.791 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 62.92 11.74 5.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 117.746 0.248 . . . . 0.0 111.479 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -87.37 145.32 26.36 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.894 0.878 . . . . 0.0 109.926 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 17.2 m -53.13 139.4 28.82 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.372 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 32.1 mmm-85 -71.67 -8.71 55.8 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.538 1.135 . . . . 0.0 109.75 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -1.13 75.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.904 0.764 . . . . 0.0 111.306 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.89 156.64 48.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.724 1.262 . . . . 0.0 110.522 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.54 7.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.872 0.469 . . . . 0.0 110.422 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.0 m-85 -142.42 161.79 37.13 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.534 0.334 . . . . 0.0 110.736 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.56 141.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.0 m -112.08 126.08 54.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.2 m-85 -94.3 155.77 16.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 111.427 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.36 -22.8 61.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.266 -0.397 . . . . 0.0 111.364 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -121.49 141.47 33.51 Favored Pre-proline 0 CA--C 1.518 -0.254 0 CA-C-N 118.295 0.498 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 60.3 Cg_endo -75.14 -3.81 14.45 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.819 2.346 . . . . 0.0 110.289 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.46 -15.84 11.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.581 0.352 . . . . 0.0 110.998 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.494 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -71.77 -29.15 64.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.14 59.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.143 0.577 . . . . 0.0 110.526 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -70.84 -37.84 73.17 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.91 -30.36 68.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.27 -9.41 53.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.176 -0.327 . . . . 0.0 111.228 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -101.82 7.18 41.77 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.546 1.138 . . . . 0.0 112.158 174.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.29 -53.6 1.03 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.862 0.839 . . . . 0.0 109.108 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.531 ' HA ' ' CG ' ' B' ' 72' ' ' LYS . 49.7 mmm -78.44 -10.5 59.72 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.154 1.782 . . . . 0.0 111.916 -176.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -80.65 117.34 21.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.16 62.26 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.609 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' B' ' 69' ' ' MET . 20.7 ptmt -106.93 176.75 5.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.578 1.189 . . . . 0.0 111.954 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -97.76 155.91 16.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -127.23 123.84 37.51 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.359 172.229 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.8 t70 61.66 -23.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 157.56 -11.37 0.25 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.141 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -116.57 135.57 53.7 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.014 0.907 . . . . 0.0 110.513 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.34 140.51 57.26 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 123.199 0.6 . . . . 0.0 110.823 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -125.91 171.9 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -115.35 144.08 44.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.981 1.712 . . . . 0.0 108.015 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.76 130.14 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -160.44 163.86 32.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -63.31 133.31 53.95 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.36 158.55 30.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.038 0.446 . . . . 0.0 111.883 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.8 p -115.82 168.72 9.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.613 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.36 152.36 85.25 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.369 0.668 . . . . 0.0 110.817 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -63.21 154.54 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.619 2.879 . . . . 0.0 111.365 -175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 m -80.68 -3.03 49.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -91.69 4.4 52.82 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.12 0.418 . . . . 0.0 111.066 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.21 158.81 40.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.774 0.43 . . . . 0.0 110.636 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.9 t -152.99 165.12 36.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.474 0.309 . . . . 0.0 110.971 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.05 -2.65 66.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.201 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -143.47 151.55 40.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.714 0.806 . . . . 0.0 109.616 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 54.37 25.62 6.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.083 0.953 . . . . 0.0 111.898 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.307 -1.83 . . . . 0.0 111.125 179.527 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.587 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.435 1 C5'-C4'-C3' 109.13 -4.247 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.553 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 C3'-C2'-C1' 104.099 2.887 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 112.428 -2.048 . 0.102 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 1 O4'-C1'-N19 114.587 6.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 2 O4'-C1'-N19 113.83 5.63 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 O4'-C1'-N19 111.231 3.031 . 0.191 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tmm? . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.195 0.522 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 2' ' ' VAL . 7.2 p -119.67 11.29 6.64 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-O 123.022 1.391 . . . . 0.0 107.987 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -84.11 147.44 27.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.961 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.11 103.26 5.48 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.48 168.51 5.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.271 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -53.87 153.72 8.21 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.501 0.72 . . . . 0.0 112.8 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 99.8 Cg_exo -51.24 154.9 7.28 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.435 3.423 . . . . 0.0 113.114 177.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.06 -13.22 62.08 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.28 127.1 45.24 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 72.7 mt -112.5 154.45 25.87 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.16 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -107.96 127.3 53.63 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -118.85 80.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.29 143.78 16.83 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.624 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.04 36.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.16 163.5 22.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' B' ' 75' ' ' ASP . 40.3 t-20 -73.51 158.85 34.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -73.62 -8.29 55.36 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.301 0.64 . . . . 0.0 110.161 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.38 -11.04 20.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 110.48 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 41.2 m -79.87 144.78 33.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.71 -168.14 2.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.06 -32.27 68.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.578 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -64.4 -32.57 74.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.13 -21.91 27.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.421 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -85.87 -27.88 24.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.226 1.41 . . . . 0.0 109.635 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.93 -29.97 35.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 110.17 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -22.55 41.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.586 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.0 p -102.36 -35.51 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -174.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.508 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.0 m-85 -91.56 -10.06 42.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.873 176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -3.94 71.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.2 mtpt -80.4 -13.08 59.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.619 1.168 . . . . 0.0 111.208 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' B' ' 65' ' ' ALA . 80.3 m-85 -112.29 -18.78 12.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.7 -176.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.34 167.31 38.35 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.161 0.437 . . . . 0.0 112.63 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -74.22 117.28 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.2 142.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.461 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.47 -23.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.148 0.579 . . . . 0.0 110.194 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.51 150.1 15.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.238 0.615 . . . . 0.0 109.683 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.66 147.09 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 109.547 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.5 mt -123.09 156.36 35.08 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.787 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.487 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.44 119.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.7 mmm -93.03 142.58 27.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.902 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE2' HD12 ' B' ' 39' ' ' LEU . 22.8 mttt -140.58 163.86 31.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.5 147.18 53.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.316 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -88.83 -9.36 51.99 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.33 -12.74 8.57 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 19.0 p -122.89 -14.8 7.56 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.332 0.515 . . . . 0.0 111.222 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.18 22.17 7.28 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -77.36 -111.28 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.696 1.198 . . . . 0.0 109.613 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.5 t -148.58 147.21 28.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -73.8 -10.27 59.5 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.67 3.89 87.89 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.351 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.9 161.03 37.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.695 1.248 . . . . 0.0 109.803 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.34 -177.97 6.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.098 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.3 m-85 -142.91 160.93 39.4 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.168 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.3 140.6 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -112.71 121.71 45.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -92.62 155.95 17.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.695 0.798 . . . . 0.0 111.723 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -73.43 -22.57 60.17 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.455 0.302 . . . . 0.0 111.255 174.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -121.16 140.81 31.74 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 118.352 0.524 . . . . 0.0 109.834 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 61.9 Cg_endo -76.3 -1.3 11.32 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 123.122 2.548 . . . . 0.0 110.342 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.36 -16.39 10.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.808 0.443 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 82.5 m-20 -71.28 -27.91 63.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.41 -29.09 56.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -72.97 -38.69 66.6 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.15 -25.39 66.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.71 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -83.59 -43.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 172.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.2 -6.6 48.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.896 -0.502 . . . . 0.0 112.305 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -107.46 7.97 29.21 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.532 0.733 . . . . 0.0 112.311 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.92 -55.07 1.39 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.628 0.728 . . . . 0.0 109.329 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' MET . . . . . 0.408 ' HE3' HD11 ' B' ' 79' ' ' ILE . 25.5 mmm -79.57 -10.03 59.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.538 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -73.46 128.08 34.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.65 79.28 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -81.64 -153.44 0.11 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.628 1.171 . . . . 0.0 109.639 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.1 t -140.03 158.69 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -173.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.74 128.9 31.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.543 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.549 ' HB3' HD22 ' B' ' 16' ' ' ASN . 2.4 t0 52.73 21.52 1.93 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.328 0.585 . . . . 0.0 112.223 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.73 56.29 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.707 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -114.97 130.45 56.93 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.43 1.115 . . . . 0.0 109.875 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.81 139.12 50.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.344 0.258 . . . . 0.0 111.658 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.408 HD11 ' HE3' ' B' ' 69' ' ' MET . 21.9 pt -123.79 177.55 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -121.84 144.54 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.049 1.74 . . . . 0.0 107.567 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.42 126.54 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.79 164.83 28.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -60.36 135.95 57.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.2 159.84 23.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.5 p -113.69 169.59 8.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.649 169.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -70.96 158.69 87.6 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.826 0.451 . . . . 0.0 110.472 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.71 151.73 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.118 2.545 . . . . 0.0 110.928 -176.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 17.0 t -77.84 -11.49 59.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.78 4.61 32.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.954 -0.466 . . . . 0.0 111.278 176.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.03 148.52 46.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.814 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.6 m -155.59 12.55 0.33 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.29 1.036 . . . . 0.0 110.523 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 -158.27 52.68 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 58.56 161.27 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 112.505 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -149.96 151.39 33.29 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.209 0.603 . . . . 0.0 109.851 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.534 -1.704 . . . . 0.0 111.455 179.538 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.543 " H3'" " C5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.238 1 O4'-C1'-N19 112.332 4.132 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.543 " C5'" " H3'" ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.906 0 C5'-C4'-C3' 109.933 -3.712 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 C5'-C4'-C3' 109.761 -3.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.671 1 O4'-C1'-N19 114.368 6.168 . 0.013 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 2 O4'-C1'-N19 113.08 4.88 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.639 0 C5'-C4'-C3' 110.618 -3.254 . 0.165 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.497 HG22 ' O ' ' B' ' 2' ' ' VAL . 3.3 p -127.58 12.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 107.962 173.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.22 145.35 48.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.607 -168.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.01 99.1 3.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.12 128.22 33.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 43.39 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 126.832 2.053 . . . . 0.0 113.915 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.553 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 82.4 Cg_exo -47.78 133.47 22.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 123.069 2.513 . . . . 0.0 110.291 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.78 -10.63 49.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -92.51 127.88 38.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.9 mt -113.3 149.24 34.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -102.72 127.47 49.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.488 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.0 mm -118.61 78.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.73 144.54 17.13 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.729 -0.607 . . . . 0.0 112.157 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 13.45 40.97 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 117.908 0.854 . . . . 0.0 111.827 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -65.81 166.33 11.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.042 0.925 . . . . 0.0 112.928 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.497 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.2 OUTLIER -78.71 145.77 34.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.312 1.445 . . . . 0.0 109.888 176.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 78.7 p -74.32 -8.61 56.83 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.995 0.918 . . . . 0.0 112.301 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.96 -12.39 18.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.265 1.426 . . . . 0.0 109.583 -174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.6 m -77.73 149.02 34.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.55 1.14 . . . . 0.0 110.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 -165.0 1.67 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -66.1 -29.48 69.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.134 0.424 . . . . 0.0 110.952 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.05 -19.7 31.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' B' ' 27' ' ' VAL . 4.9 mt -87.84 -29.18 21.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.64 1.176 . . . . 0.0 109.472 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.52 -27.66 46.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.443 0.64 . . . . 0.0 109.825 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.29 -23.38 37.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.347 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.596 HG11 HD21 ' B' ' 74' ' ' LEU . 5.6 p -102.87 -34.45 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.7 m-85 -90.84 -11.7 38.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.107 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.29 -5.16 76.15 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -79.31 -12.82 59.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.833 1.253 . . . . 0.0 110.729 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.63 -13.5 12.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.48 171.32 37.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.359 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -79.89 115.04 19.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.59 0.71 . . . . 0.0 109.982 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.8 mt -75.0 141.67 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.991 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -21.32 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.206 0.602 . . . . 0.0 110.354 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -161.29 150.38 16.36 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.21 146.11 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.4 0.619 . . . . 0.0 109.849 172.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.4 mt -123.24 155.32 37.39 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.528 1.131 . . . . 0.0 108.234 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.509 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.1 tm? -154.0 119.76 5.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 9.2 mmm -92.81 139.82 30.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.509 ' HE2' HD12 ' B' ' 39' ' ' LEU . 18.1 mttt -137.32 160.61 38.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.51 148.61 50.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.783 173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -93.81 -7.55 43.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.557 0.343 . . . . 0.0 111.844 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -117.57 -12.68 10.32 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.114 0.565 . . . . 0.0 112.337 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 24.5 p -123.88 -14.81 7.08 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 111.071 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.65 18.87 5.01 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -76.65 -108.22 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.36 1.064 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -150.1 148.53 29.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.898 0.879 . . . . 0.0 108.83 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 40.6 mmm-85 -73.08 -10.81 60.18 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 4.07 80.68 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.992 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 157.37 45.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.719 1.26 . . . . 0.0 109.95 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.36 -177.98 6.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.401 0.28 . . . . 0.0 111.076 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 64.7 m-85 -142.68 160.75 39.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.797 0.439 . . . . 0.0 110.463 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -154.1 138.79 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 56.9 m -110.34 126.84 54.66 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.106 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' B' ' 10' ' ' LEU . 3.9 m-85 -98.2 161.81 13.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.403 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -71.52 -18.4 62.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -130.25 153.43 81.21 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 110.104 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.553 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 29.6 Cg_endo -80.68 1.12 9.53 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 171.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.1 -15.59 9.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.76 -21.22 25.26 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 -27.78 61.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -69.58 -32.14 70.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.82 -22.24 61.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.1 -44.16 13.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.25 -15.62 62.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.184 -0.323 . . . . 0.0 111.858 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.36 6.74 46.02 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.19 -55.08 1.36 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.041 0.837 . . . . 0.0 109.461 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 24.4 mmm -78.05 -12.21 59.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.18 1.392 . . . . 0.0 111.965 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -72.83 130.12 39.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -10.05 63.36 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.671 -0.516 . . . . 0.0 112.356 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -83.28 -160.3 0.41 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.166 0.986 . . . . 0.0 109.509 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -132.9 152.61 51.85 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.716 0.806 . . . . 0.0 110.723 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.596 HD21 HG11 ' B' ' 27' ' ' VAL . 0.4 OUTLIER -95.73 -62.81 1.23 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.962 -174.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 15.6 t70 -130.18 0.92 4.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.141 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.75 -14.07 0.78 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.821 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.25 134.5 55.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.05 135.62 38.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.8 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.4 pt -114.26 174.32 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -173.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.55 141.85 47.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.564 1.546 . . . . 0.0 107.554 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.36 125.86 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.29 164.99 34.41 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -63.05 135.71 57.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.46 158.91 29.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 112.309 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 82.5 p -117.54 164.21 15.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.535 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 150.3 89.74 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' PRO . . . . . 0.4 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 65.0 Cg_endo -67.47 160.66 46.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.543 2.828 . . . . 0.0 110.152 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 68.3 p -78.3 -9.73 59.37 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.245 0.618 . . . . 0.0 112.576 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -98.5 20.04 13.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.492 0.317 . . . . 0.0 110.987 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -144.54 158.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 111.234 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.3 t -154.54 156.74 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.668 0.387 . . . . 0.0 110.555 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.5 -133.85 49.37 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -149.59 163.75 37.01 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.718 0.807 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.92 16.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.274 1.83 . . . . 0.0 114.679 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.655 -1.636 . . . . 0.0 111.118 -177.858 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.697 0 O4'-C1'-N19 111.879 3.679 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.658 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 C3'-C2'-C1' 105.079 3.976 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 1 C5'-C4'-C3' 109.007 -4.328 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.763 1 O4'-C1'-N19 113.872 5.672 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.4 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.424 -2.454 2 C5'-C4'-C3' 108.541 -4.639 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 110.855 2.655 . 0.637 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.49 121.2 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -136.96 132.37 34.28 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.206 0.527 . . . . 0.0 111.38 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.03 113.68 7.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.07 135.18 33.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.432 -172.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 45.65 112.34 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 128.149 2.58 . . . . 0.0 115.514 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.457 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 76.2 Cg_exo -53.19 147.54 34.95 Favored 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.472 2.115 . . . . 0.0 110.573 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.71 -20.58 37.89 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -84.52 129.0 34.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 76.6 mt -119.1 155.62 31.21 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.991 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -109.44 130.02 55.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.2 mm -121.68 86.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.87 145.07 16.91 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 121.999 -0.438 . . . . 0.0 112.555 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.12 8.08 45.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.48 HD23 HG21 ' B' ' 79' ' ' ILE . 9.7 mt -64.28 162.65 14.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.085 0.945 . . . . 0.0 112.089 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.476 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.4 OUTLIER -70.14 145.18 51.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.432 1.493 . . . . 0.0 109.568 175.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -70.83 -4.88 26.46 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.927 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.83 -6.49 15.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.984 1.314 . . . . 0.0 109.609 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.3 m -76.52 143.79 40.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.412 1.085 . . . . 0.0 108.751 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.96 -166.7 1.95 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.34 -29.89 68.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.692 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -66.76 -30.61 70.87 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.87 -17.13 28.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -95.28 -28.27 15.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.336 1.054 . . . . 0.0 109.909 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.97 -29.38 29.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.24 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.31 -28.54 38.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.127 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.514 HG13 ' CD2' ' B' ' 28' ' ' PHE . 4.3 p -92.64 -36.45 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.2 m-85 -92.15 -10.48 38.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.276 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.35 -3.48 77.13 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -79.77 -14.73 58.51 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.71 1.204 . . . . 0.0 111.608 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -111.5 -19.0 12.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.803 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.52 164.61 33.28 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 118.208 0.458 . . . . 0.0 112.312 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -72.23 117.45 13.89 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.96 141.23 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.386 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -23.81 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 122.877 0.471 . . . . 0.0 110.067 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.11 150.37 16.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.383 0.673 . . . . 0.0 109.687 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.55 146.06 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.517 0.675 . . . . 0.0 109.951 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.3 mt -118.14 152.13 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.3 119.33 6.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.3 mmm -93.4 139.66 30.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.9 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -143.94 153.7 42.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.129 0.49 . . . . 0.0 112.059 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.58 165.59 14.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.822 1.249 . . . . 0.0 111.721 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -107.31 -8.22 16.44 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.217 0.607 . . . . 0.0 111.55 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -103.64 -14.88 15.97 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.121 0.568 . . . . 0.0 111.113 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -133.42 -15.93 2.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.48 8.7 3.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -83.96 153.56 23.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.492 0.717 . . . . 0.0 109.49 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.2 m -58.07 140.74 51.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.327 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -68.6 -8.64 43.71 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.576 0.75 . . . . 0.0 109.234 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.75 74.07 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -138.94 158.58 43.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.452 1.126 . . . . 0.0 110.671 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -179.04 7.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.385 0.674 . . . . 0.0 110.682 -174.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.2 m-85 -142.84 163.36 33.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.88 140.96 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -113.33 122.89 48.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.693 0.397 . . . . 0.0 110.08 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -93.27 156.63 16.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 111.632 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.72 -22.92 60.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 122.606 0.363 . . . . 0.0 111.441 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -121.54 141.07 32.72 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 118.428 0.558 . . . . 0.0 110.042 174.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 57.3 Cg_endo -76.33 -0.98 10.96 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.833 2.355 . . . . 0.0 110.599 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.6 -16.8 10.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.198 0.454 . . . . 0.0 110.827 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.4 m-20 -70.56 -29.05 65.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.74 -29.98 59.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.438 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -70.9 -39.25 72.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.21 -29.84 69.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.253 -0.276 . . . . 0.0 110.253 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.273 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.53 -12.58 61.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.501 0.32 . . . . 0.0 111.055 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -97.19 6.85 47.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.946 0.899 . . . . 0.0 112.052 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.92 -52.04 1.22 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.002 0.819 . . . . 0.0 109.892 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 54.3 mmm -81.65 -14.75 56.28 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.07 1.748 . . . . 0.0 112.055 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -74.35 116.33 14.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.14 -8.15 60.7 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.372 0.511 . . . . 0.0 112.027 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -82.54 -156.57 0.18 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.361 1.064 . . . . 0.0 109.392 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -144.35 158.8 43.55 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 123.786 0.834 . . . . 0.0 111.779 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.75 125.68 27.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.0 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 3.5 t70 61.07 -24.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 161.05 -12.2 0.14 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.78 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -118.29 137.32 53.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.468 1.134 . . . . 0.0 109.948 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.56 138.32 50.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.037 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.48 HG21 HD23 ' B' ' 15' ' ' LEU . 27.0 pt -120.65 163.74 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -112.56 144.01 42.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.302 1.841 . . . . 0.0 107.963 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 29.2 t -135.07 130.6 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.87 162.26 39.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.12 123.43 21.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.33 146.48 43.97 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 61.8 p -101.09 168.85 9.32 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.36 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.38 150.72 97.6 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.284 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.76 160.92 47.9 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.432 2.754 . . . . 0.0 109.901 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.1 m -118.06 5.5 12.06 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -89.75 9.59 26.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.376 0.534 . . . . 0.0 111.756 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -140.41 148.42 41.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.478 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 39.8 m -148.0 14.89 1.05 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.797 0.839 . . . . 0.0 111.538 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.88 141.62 47.61 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.08 34.88 14.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.365 1.066 . . . . 0.0 111.735 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -150.89 154.07 36.51 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.61 0.364 . . . . 0.0 110.232 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.513 -1.715 . . . . 0.0 111.23 -179.798 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.584 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.32 1 C5'-C4'-C3' 109.257 -4.162 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.657 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.045 0 C3'-C2'-C1' 104.726 3.585 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 C5'-C4'-C3' 109.243 -4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 113.448 5.248 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 2 O4'-C1'-N19 112.96 4.76 . 0.015 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 O4'-C1'-N19 111.163 2.963 . 0.584 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.97 109.18 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.41 135.17 40.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.7 113.19 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -65.77 171.81 4.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.541 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -52.37 149.47 10.24 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.601 0.76 . . . . 0.0 112.617 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 90.1 Cg_exo -51.54 155.24 7.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.623 3.549 . . . . 0.0 113.233 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.83 -13.02 66.83 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -98.24 127.1 44.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' B' ' 56' ' ' PHE . 77.1 mt -113.4 153.26 28.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.971 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -106.4 128.94 54.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.53 81.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.86 143.2 16.46 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.951 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.6 11.63 34.97 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 117.74 0.77 . . . . 0.0 111.752 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -67.33 162.33 23.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 111.706 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.592 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.2 t30 -75.29 156.54 35.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.642 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -71.34 -8.27 52.59 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.244 0.618 . . . . 0.0 110.383 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.26 -10.17 20.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.607 1.163 . . . . 0.0 110.489 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -81.79 146.18 30.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.29 0.636 . . . . 0.0 109.918 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.58 -167.26 2.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.174 -173.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -67.72 -28.54 67.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 118.055 0.388 . . . . 0.0 111.075 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.39 -21.89 30.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.56 -29.02 22.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.107 1.363 . . . . 0.0 109.403 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.23 -28.21 38.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 109.937 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.12 37.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.352 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.589 HG11 HD21 ' B' ' 74' ' ' LEU . 6.0 p -104.35 -35.0 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.524 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -91.95 -10.99 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.909 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.38 -2.9 75.73 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -81.9 -12.17 58.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.708 1.203 . . . . 0.0 111.04 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -112.14 -19.16 12.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.39 166.41 37.39 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 118.264 0.484 . . . . 0.0 112.716 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -73.88 117.1 15.26 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mt -76.29 142.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.67 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -21.97 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.178 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.71 150.17 15.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.019 0.528 . . . . 0.0 109.834 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.98 145.92 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.352 0.596 . . . . 0.0 109.546 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -121.9 154.77 36.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.451 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.501 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.42 119.55 5.44 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.49 141.07 28.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.5 -170.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.501 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.3 mttt -137.91 160.24 39.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.53 149.16 39.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.183 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -93.4 -1.63 55.59 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.76 -13.65 7.86 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.8 p -125.94 -15.79 5.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 118.295 0.498 . . . . 0.0 111.377 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.71 21.9 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.66 -105.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.84 1.256 . . . . 0.0 109.886 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -152.88 146.26 24.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.865 0.866 . . . . 0.0 108.681 172.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.35 -10.31 59.34 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.51 0.31 89.32 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.855 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -133.92 157.11 46.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.637 1.219 . . . . 0.0 110.604 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.137 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 62.5 m-85 -143.05 162.41 35.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.623 0.369 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.79 140.31 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.8 m -112.75 122.56 48.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 123.271 0.357 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' B' ' 10' ' ' LEU . 13.8 m-85 -92.5 156.69 16.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.859 0.864 . . . . 0.0 111.791 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.7 -21.81 59.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.215 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -122.26 139.83 31.38 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 53.2 Cg_endo -75.94 -0.15 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.161 2.574 . . . . 0.0 110.65 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.01 -14.99 9.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.822 0.283 . . . . 0.0 111.141 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.3 m-20 -72.43 -28.5 63.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.27 -29.24 60.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -73.03 -37.25 66.96 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.1 -25.5 65.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.533 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.64 16.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.204 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.4 -8.93 57.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.26 9.03 34.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.341 0.657 . . . . 0.0 112.727 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.09 -53.77 1.3 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.546 0.689 . . . . 0.0 109.461 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 26.8 mmm -81.73 -10.22 59.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.63 1.572 . . . . 0.0 112.055 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -73.43 127.02 31.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.68 79.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.333 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -82.38 -157.42 0.21 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.608 1.163 . . . . 0.0 109.824 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -136.15 153.12 51.37 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.593 0.757 . . . . 0.0 110.858 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.589 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -101.75 -65.88 0.95 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.124 -175.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.592 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.5 t70 -121.54 14.49 11.06 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.391 -175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.44 -6.09 9.25 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.846 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -112.88 131.04 55.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.734 0.814 . . . . 0.0 108.843 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.19 134.98 37.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.116 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 pt -115.12 175.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -118.27 141.72 48.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.058 1.743 . . . . 0.0 107.099 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.71 127.42 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.76 163.79 37.72 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -63.75 134.09 54.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.87 152.7 38.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -106.31 175.75 5.39 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -78.86 155.86 77.65 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 123.036 0.534 . . . . 0.0 109.963 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.35 158.8 47.02 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.444 2.763 . . . . 0.0 111.554 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.9 m -113.04 7.58 18.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -80.12 2.91 22.23 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.962 0.801 . . . . 0.0 112.041 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.34 153.4 35.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.015 0.436 . . . . 0.0 111.939 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 39.7 m -149.0 33.79 0.75 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.267 1.027 . . . . 0.0 110.228 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.36 -6.12 39.04 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.415 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -146.7 135.36 22.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.933 0.866 . . . . 0.0 110.041 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 53.32 -179.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.93 1.292 . . . . 0.0 112.98 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.316 -1.824 . . . . 0.0 110.628 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ' A' . . . . . 0.557 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.43 -1.954 1 C5'-C4'-C3' 109.365 -4.09 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ' U' . . . . . 0.617 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.149 0 C3'-C2'-C1' 104.18 2.977 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 C5'-C4'-C3' 110.422 -3.386 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 1 O4'-C1'-N19 113.787 5.587 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ' A' . . . . . 0.409 ' C8 ' ' CZ ' ' B' ' 53' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.616 2 O4'-C1'-N19 114.279 6.079 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C5'-C4'-C3' 110.696 -3.202 . 0.144 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -98.37 128.25 44.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.146 0.973 . . . . 0.0 108.438 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.7 mt -112.29 155.62 23.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -109.48 128.92 55.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.508 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.7 mm -120.14 79.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 144.81 17.41 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.416 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 9.46 42.0 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.576 0.688 . . . . 0.0 111.534 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.83 164.0 15.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.745 0.783 . . . . 0.0 111.612 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.8 t-20 -74.47 159.37 32.35 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.42 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 42.2 p -74.78 -11.23 60.11 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.084 -0.385 . . . . 0.0 110.279 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.97 -9.36 28.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.107 0.963 . . . . 0.0 110.937 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -76.8 144.83 38.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.84 0.456 . . . . 0.0 109.924 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 -169.1 2.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -69.8 -34.84 74.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.72 -174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -66.83 -29.19 69.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 111.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.85 31.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.39 -28.24 22.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 109.774 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.62 -29.39 36.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.615 0.721 . . . . 0.0 110.111 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.69 -22.76 40.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.307 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.5 p -102.29 -35.16 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.528 ' CD2' HG13 ' B' ' 27' ' ' VAL . 90.3 m-85 -92.09 -10.69 38.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.182 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.57 -2.92 77.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.55 -12.8 58.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.972 1.309 . . . . 0.0 111.116 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.33 -19.04 12.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.686 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.72 165.42 36.15 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.159 0.436 . . . . 0.0 112.37 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -73.54 116.95 14.72 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.9 mt -75.9 141.65 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.636 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -22.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.131 0.573 . . . . 0.0 110.022 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.22 149.16 15.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.933 0.493 . . . . 0.0 109.83 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.36 144.99 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.306 0.574 . . . . 0.0 109.644 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.8 mt -121.12 154.59 35.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.307 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.14 117.93 6.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.4 mmm -88.08 142.06 28.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.75 1.42 85.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.149 0.88 . . . . 0.0 112.287 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.78 161.42 38.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.307 1.053 . . . . 0.0 110.13 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.99 -177.3 6.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.7 m-85 -142.24 160.35 40.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -154.06 140.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -113.11 122.86 48.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.151 0.282 . . . . 0.0 110.357 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -92.39 156.01 17.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.96 0.904 . . . . 0.0 111.93 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -74.22 -21.99 59.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.57 0.348 . . . . 0.0 111.135 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -121.88 141.49 34.13 Favored Pre-proline 0 C--N 1.34 0.164 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.45 -9.72 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.682 2.254 . . . . 0.0 110.3 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.19 -14.48 13.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.285 0.493 . . . . 0.0 110.572 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.5 m-20 -71.95 -28.5 63.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.18 56.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -68.46 -38.35 81.02 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.93 -32.41 72.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.71 -44.03 44.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.78 42.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 122.075 -0.39 . . . . 0.0 111.253 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -105.87 5.32 30.56 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 112.349 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.74 -52.29 1.24 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.498 0.666 . . . . 0.0 109.49 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.4 ' HE3' HD11 ' B' ' 79' ' ' ILE . 31.6 mmm -83.55 -9.46 58.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.397 1.479 . . . . 0.0 111.987 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.8 124.8 27.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.85 -4.92 85.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.23 -152.97 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.569 1.148 . . . . 0.0 109.459 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -140.61 158.86 43.36 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.757 0.789 . . . . 0.0 112.915 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 128.78 31.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.835 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.3 t0 52.57 22.53 2.22 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.145 0.497 . . . . 0.0 112.214 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.92 -3.33 57.16 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 119.32 -0.711 . . . . 0.0 113.853 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -114.99 130.13 56.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.216 1.008 . . . . 0.0 110.304 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 139.47 52.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.749 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.4 HD11 ' HE3' ' B' ' 69' ' ' MET . 18.9 pt -124.89 174.82 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -119.01 144.36 46.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.184 1.794 . . . . 0.0 107.799 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.32 127.26 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -62.27 138.37 58.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.05 35.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 N--CA 1.454 -0.25 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.125 171.694 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.97 126.79 39.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 68.6 mt -113.56 153.27 29.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.062 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -106.7 127.59 53.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -119.62 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.93 142.16 15.93 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.51 35.93 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.691 0.745 . . . . 0.0 111.805 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.39 164.36 16.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.155 0.502 . . . . 0.0 111.858 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.537 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t-20 -77.79 158.31 29.6 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.144 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 57.9 p -73.21 -6.97 49.34 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.401 0.68 . . . . 0.0 110.114 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.52 -10.19 21.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.654 1.181 . . . . 0.0 110.531 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 31.0 m -83.22 144.68 29.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.325 0.65 . . . . 0.0 109.822 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.89 -170.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -66.99 -34.92 78.81 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.093 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -67.6 -29.03 68.27 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 118.016 0.371 . . . . 0.0 111.099 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.27 29.42 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.423 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -87.44 -27.89 22.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 109.555 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.45 -28.23 34.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 109.899 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.65 -21.78 37.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.42 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.522 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.5 p -103.41 -36.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.522 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -90.63 -11.36 40.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.817 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.9 -3.04 73.05 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.62 -11.87 58.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.682 1.193 . . . . 0.0 110.855 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -111.82 -19.5 12.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.83 166.61 37.49 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 118.046 0.384 . . . . 0.0 112.406 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 43.5 ttt-85 -73.74 117.52 15.62 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.09 142.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.56 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -22.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 123.212 0.605 . . . . 0.0 110.137 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -161.73 150.21 15.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.05 0.54 . . . . 0.0 109.878 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.58 146.4 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.056 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -121.3 154.63 36.13 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.378 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.423 HD23 ' CD1' ' B' ' 24' ' ' LEU . 3.0 tm? -152.68 118.36 5.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.6 mmm -91.38 139.85 30.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.851 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.414 ' HE2' HD12 ' B' ' 39' ' ' LEU . 8.9 mttt . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.477 0.656 . . . . 0.0 112.472 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.58 89.45 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.401 -0.666 . . . . 0.0 111.559 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -138.49 157.46 46.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.559 1.18 . . . . 0.0 109.952 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.93 -179.1 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.455 0.302 . . . . 0.0 110.853 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 49.9 m-85 -142.67 162.61 35.01 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.848 0.459 . . . . 0.0 110.215 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.87 141.53 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.6 m -113.3 123.54 50.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.336 0.397 . . . . 0.0 110.135 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.65 156.85 16.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.695 0.798 . . . . 0.0 111.627 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.19 -22.42 59.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.608 0.363 . . . . 0.0 111.275 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -121.23 140.04 30.51 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.395 0.543 . . . . 0.0 110.084 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -76.2 0.72 9.08 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.231 2.62 . . . . 0.0 110.583 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.46 -16.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.063 0.392 . . . . 0.0 111.356 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.9 m-20 -71.75 -28.57 63.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.49 57.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.66 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -74.5 -37.01 63.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.76 -24.61 64.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.488 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.24 14.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.38 45.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -109.06 9.36 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 112.224 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -52.25 1.33 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.54 -175.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mmm -83.12 -9.17 59.35 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.846 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -75.22 127.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.829 -0.544 . . . . 0.0 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.12 83.16 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.51 -154.17 0.11 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.518 1.127 . . . . 0.0 109.436 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.8 t -140.3 159.19 42.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.0 112.311 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -133.37 126.8 32.11 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.046 177.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.537 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.53 -22.24 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.513 1.125 . . . . 0.0 113.821 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.87 -6.28 0.53 Allowed Glycine 0 N--CA 1.439 -1.123 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.19 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -118.46 134.38 55.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.959 0.879 . . . . 0.0 110.341 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.55 138.42 48.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.471 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.08 175.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -119.89 142.46 48.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.13 1.772 . . . . 0.0 107.397 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.56 125.41 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -162.05 164.42 28.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -57.79 134.8 56.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.9 158.8 32.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.271 0.558 . . . . 0.0 112.359 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.491 172.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -101.13 129.9 47.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.018 0.909 . . . . 0.0 108.891 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.406 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.4 mt -113.35 153.61 28.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -107.73 129.23 55.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -121.0 82.37 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.07 144.44 17.28 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.758 -0.589 . . . . 0.0 112.001 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.71 9.21 43.96 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 117.524 0.662 . . . . 0.0 111.597 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.91 162.86 12.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.579 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.6 t-20 -73.51 159.95 32.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.598 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.9 p -74.53 -4.56 37.64 Favored 'General case' 0 N--CA 1.457 -0.075 0 C-N-CA 122.902 0.481 . . . . 0.0 110.366 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.25 -7.68 18.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 110.81 -172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.7 m -80.54 144.19 32.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.922 0.489 . . . . 0.0 109.937 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.63 -169.66 2.45 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -68.85 -35.36 76.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.778 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -65.68 -29.71 70.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.916 -0.49 . . . . 0.0 110.97 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.89 -20.99 28.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -89.34 -27.97 20.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.802 1.241 . . . . 0.0 109.606 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.35 -27.82 31.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 109.907 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -23.26 38.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.309 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.1 p -101.06 -35.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.506 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.8 m-85 -92.1 -10.87 37.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.283 -0.261 . . . . 0.0 111.024 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.67 -2.62 76.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.72 -11.25 59.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.431 1.092 . . . . 0.0 111.159 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.93 -18.85 11.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.39 0.676 . . . . 0.0 112.634 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -174.83 161.19 30.64 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -72.6 124.22 24.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.89 143.49 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.286 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.07 -23.56 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.351 0.66 . . . . 0.0 110.076 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.02 150.47 16.94 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.99 146.58 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 121.28 0.562 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -121.32 153.67 37.43 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.245 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.38 118.83 6.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.7 mmm -92.31 137.59 32.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.932 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 pttt . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.331 0.586 . . . . 0.0 111.293 177.176 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 . . . . . 0 C--O 1.23 0.04 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.46 0.5 79.41 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.698 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -136.92 158.42 44.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.434 1.117 . . . . 0.0 110.376 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.02 -179.5 8.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.868 0.467 . . . . 0.0 110.728 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.8 m-85 -141.85 161.98 36.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.659 0.383 . . . . 0.0 110.231 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.81 141.13 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.3 m -113.52 122.12 46.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.349 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -92.82 156.95 16.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.938 0.895 . . . . 0.0 110.768 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -79.63 -20.97 45.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.451 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -118.16 138.85 25.96 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.46 -6.6 18.55 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.635 2.224 . . . . 0.0 110.431 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.26 -14.77 12.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.201 0.455 . . . . 0.0 111.135 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.464 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.7 m-20 -71.53 -28.46 63.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 -30.52 52.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.394 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.01 -39.14 79.48 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.04 -32.17 72.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.72 45.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.39 -7.55 48.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.209 -0.307 . . . . 0.0 111.163 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -105.26 5.67 32.23 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.521 1.128 . . . . 0.0 112.344 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.16 -51.68 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.768 0.794 . . . . 0.0 109.755 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.404 ' HE3' HD11 ' B' ' 79' ' ' ILE . 28.9 mmm -83.59 -10.13 58.46 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.145 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.7 126.13 29.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.48 -5.74 84.54 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.59 -0.561 . . . . 0.0 111.841 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.54 -153.72 0.11 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.361 1.064 . . . . 0.0 109.473 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -139.84 158.75 43.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.9 126.99 31.58 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.496 177.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.546 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.5 t70 61.19 -21.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.18 -7.03 0.53 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.4 135.16 54.86 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.264 1.032 . . . . 0.0 110.218 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.31 138.89 51.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.597 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.404 HD11 ' HE3' ' B' ' 69' ' ' MET . 19.9 pt -121.22 179.52 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -125.05 145.02 50.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.823 1.649 . . . . 0.0 107.787 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -133.12 129.49 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -158.1 163.31 37.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -65.24 137.06 57.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.22 155.57 38.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.454 -0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.228 173.145 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.244 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -86.13 129.05 34.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' B' ' 56' ' ' PHE . 78.0 mt -116.69 155.53 28.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.362 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.58 129.67 55.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -121.72 80.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.7 144.63 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.267 -0.492 . . . . 0.0 111.977 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.48 7.52 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 117.497 0.649 . . . . 0.0 111.545 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 mt -64.24 164.75 10.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.163 0.585 . . . . 0.0 111.166 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.53 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.0 t-20 -72.1 158.94 35.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.46 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.8 p -75.79 -4.77 42.47 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.218 -0.301 . . . . 0.0 110.375 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.49 -7.38 17.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.127 0.971 . . . . 0.0 111.066 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.2 m -79.18 144.89 34.01 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.09 0.556 . . . . 0.0 109.576 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.93 2.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.171 0.51 . . . . 0.0 110.009 175.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.86 -34.37 76.56 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.756 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.41 -30.36 70.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.046 -0.409 . . . . 0.0 110.923 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.74 -21.41 30.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.84 -28.47 19.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 109.928 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.8 -27.92 33.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.237 0.542 . . . . 0.0 110.119 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.34 -22.95 38.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.241 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -100.96 -36.65 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.6 m-85 -91.03 -10.89 40.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.958 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.75 -3.2 72.58 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -82.12 -11.76 58.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.63 1.172 . . . . 0.0 111.034 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.43 -19.88 11.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.364 0.665 . . . . 0.0 112.538 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.71 165.36 36.06 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 118.051 0.387 . . . . 0.0 112.189 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -73.09 117.97 15.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.3 141.35 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.509 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.74 -24.49 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.871 0.468 . . . . 0.0 110.093 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -160.35 151.36 19.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.66 146.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 109.699 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -118.99 153.95 33.82 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.1 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -153.66 120.23 5.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.41 140.02 30.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.663 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 pttt . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.257 0.551 . . . . 0.0 112.304 176.91 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 . . . . . 0 CA--C 1.527 0.079 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.83 75.79 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.34 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -141.74 157.97 44.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.627 1.213 . . . . 0.0 110.619 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.688 0.395 . . . . 0.0 110.791 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.7 m-85 -141.93 162.44 35.46 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.004 0.522 . . . . 0.0 110.127 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.36 139.86 12.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -112.18 122.17 46.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.7 m-85 -92.16 156.17 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.023 0.929 . . . . 0.0 111.642 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.56 -21.92 59.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 122.612 0.365 . . . . 0.0 111.061 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.7 t -121.23 140.48 31.26 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.45 -7.43 19.57 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.462 2.108 . . . . 0.0 110.472 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.13 -15.87 13.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.369 0.267 . . . . 0.0 110.902 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 75.0 m-20 -70.76 -28.35 64.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.14 54.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.553 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -68.83 -39.04 80.19 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.99 -36.34 81.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.6 64.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.5 47.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.199 -0.313 . . . . 0.0 111.185 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -105.41 7.59 33.26 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.465 1.106 . . . . 0.0 112.274 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.61 -52.27 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.826 0.739 . . . . 0.0 109.568 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.32 -9.88 59.3 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.595 1.558 . . . . 0.0 112.439 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.71 125.38 27.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.74 -5.79 84.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.54 -153.98 0.09 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.474 1.11 . . . . 0.0 109.712 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 26.2 t -139.49 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.865 0.841 . . . . 0.0 112.814 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.46 129.09 30.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.757 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.53 ' HB3' HD22 ' B' ' 16' ' ' ASN . 6.4 t0 52.89 22.24 2.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.058 0.456 . . . . 0.0 112.131 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.86 -2.46 58.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.978 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.92 130.19 56.86 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.251 1.026 . . . . 0.0 110.557 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.46 138.25 50.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.502 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.91 178.39 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -122.8 141.51 51.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.717 2.007 . . . . 0.0 107.317 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.15 130.22 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -159.12 164.15 35.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -69.57 132.44 46.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 148.1 33.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 CA--C 1.517 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.486 175.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.438 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -82.15 129.65 34.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.4 mt -118.89 159.51 23.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.04 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -112.62 129.71 56.28 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.5 mm -122.08 81.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -174.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.38 145.5 17.78 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.197 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.76 33.24 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 117.57 0.685 . . . . 0.0 112.026 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.13 168.03 3.59 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 112.586 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.422 HD22 ' CG ' ' B' ' 75' ' ' ASP . 51.7 t30 -73.27 -6.41 45.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p 68.76 -13.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.652 1.581 . . . . 0.0 113.479 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.72 -7.25 28.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.42 0.688 . . . . 0.0 109.301 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -76.25 147.52 38.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.531 1.132 . . . . 0.0 109.521 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -170.14 2.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.586 0.707 . . . . 0.0 109.566 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.03 -35.79 80.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.542 -173.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.83 -30.14 70.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.82 -20.39 23.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' B' ' 27' ' ' VAL . 8.6 mt -87.08 -28.32 22.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.216 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -80.11 -26.94 39.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 110.058 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.57 38.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.478 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -103.89 -35.59 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.8 m-85 -92.33 -11.24 35.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.944 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.07 -2.84 73.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.77 -12.92 58.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.684 1.193 . . . . 0.0 111.073 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -111.34 -19.18 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 123.756 0.66 . . . . 0.0 112.547 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.33 165.88 35.49 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -73.29 117.09 14.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -76.1 139.08 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.246 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -24.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.944 0.497 . . . . 0.0 109.863 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -160.38 150.87 18.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.078 0.551 . . . . 0.0 109.562 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.4 145.57 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.34 0.591 . . . . 0.0 109.572 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -119.05 153.02 35.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.661 -1.154 . . . . 0.0 107.91 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.02 117.42 5.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.1 mmm -91.88 139.97 30.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.21 1.73 81.24 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.51 157.67 46.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.248 1.024 . . . . 0.0 110.775 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.53 -179.19 7.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.205 0.602 . . . . 0.0 110.62 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 42.6 m-85 -142.53 162.04 36.5 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.91 138.69 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -111.89 122.08 46.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.681 0.392 . . . . 0.0 109.975 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 12.8 m-85 -92.07 156.08 17.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.822 0.849 . . . . 0.0 111.616 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.11 -22.51 60.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.857 0.463 . . . . 0.0 111.063 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.1 t -121.74 139.98 31.05 Favored Pre-proline 0 CA--C 1.52 -0.2 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.59 -3.0 13.19 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.897 2.398 . . . . 0.0 110.48 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.02 -14.84 11.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 123.141 0.276 . . . . 0.0 111.278 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 79.8 m-20 -71.57 -28.93 64.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.42 -30.79 57.56 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.507 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -68.87 -38.83 79.97 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.15 -32.6 72.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.92 -44.48 48.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 -7.38 45.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.315 -0.241 . . . . 0.0 111.41 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -105.59 5.28 31.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.129 0.972 . . . . 0.0 112.08 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.28 -53.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 29.7 mmm -82.2 -10.08 59.28 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.569 1.548 . . . . 0.0 112.205 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.98 126.37 30.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.609 -0.682 . . . . 0.0 109.381 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.11 81.22 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.43 -153.96 0.11 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.449 1.099 . . . . 0.0 109.319 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -137.53 158.68 43.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.529 0.681 . . . . 0.0 112.649 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.422 HD21 HG11 ' B' ' 27' ' ' VAL . 0.1 OUTLIER -132.15 125.27 30.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.422 ' CG ' HD22 ' B' ' 16' ' ' ASN . 11.4 t0 57.16 -2.02 0.05 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 137.62 -11.41 3.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.762 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.35 137.2 54.41 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.315 1.058 . . . . 0.0 111.092 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 140.33 56.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.239 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.51 177.63 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -120.79 142.52 49.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.883 1.673 . . . . 0.0 107.386 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.37 127.19 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -158.88 163.58 36.47 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -65.76 134.61 53.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.14 139.25 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.171 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.437 0 CA-C-O 119.125 -0.82 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.25 127.07 38.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.088 0.944 . . . . 0.0 108.734 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' B' ' 56' ' ' PHE . 76.0 mt -113.39 149.23 34.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.19 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.33 127.88 49.14 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 10.0 mm -118.94 77.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -173.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.59 144.63 17.2 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.14 45.22 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 117.733 0.767 . . . . 0.0 111.752 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.52 163.88 12.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.152 0.581 . . . . 0.0 111.408 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.5 t30 -72.78 155.9 39.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.71 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 62.0 p -74.69 -0.95 19.72 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.367 0.267 . . . . 0.0 111.093 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -110.5 -5.79 15.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 110.668 -171.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -82.93 144.71 29.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.084 0.554 . . . . 0.0 109.571 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -169.74 2.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.19 -35.37 79.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.764 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.32 -29.15 68.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.041 -0.412 . . . . 0.0 111.061 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.51 -21.03 28.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.65 -28.43 20.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.91 1.284 . . . . 0.0 109.532 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.25 -28.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.632 0.73 . . . . 0.0 109.903 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.38 -23.11 40.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.162 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 74' ' ' LEU . 5.4 p -101.92 -34.53 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.4 m-85 -91.48 -10.66 40.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.719 -0.218 . . . . 0.0 111.064 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.3 -2.44 79.17 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -82.21 -11.97 58.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.406 1.082 . . . . 0.0 111.002 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.74 -19.89 11.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.573 0.749 . . . . 0.0 112.739 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.84 166.59 37.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -74.03 116.83 15.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.94 141.13 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -22.71 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -160.85 150.06 16.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.01 0.524 . . . . 0.0 109.846 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.81 144.13 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.1 mt -120.17 158.44 26.93 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.105 175.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -155.91 123.17 5.43 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.99 137.3 33.35 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 pttt . . . . . 0 N--CA 1.451 -0.384 0 O-C-N 123.418 0.449 . . . . 0.0 110.89 173.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.566 0.222 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.15 3.7 78.85 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.436 -0.647 . . . . 0.0 112.127 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.22 157.7 45.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.357 1.079 . . . . 0.0 110.741 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.84 -178.41 7.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.893 0.477 . . . . 0.0 110.501 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.5 m-85 -142.34 163.18 33.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.568 0.347 . . . . 0.0 110.42 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -153.78 146.36 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -117.37 123.44 46.47 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.316 0.385 . . . . 0.0 110.201 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.4 m-85 -93.55 156.15 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.33 0.652 . . . . 0.0 111.925 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.52 -22.67 58.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.2 t -121.33 141.11 32.52 Favored Pre-proline 0 C--O 1.233 0.202 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.29 -8.84 21.3 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.557 2.172 . . . . 0.0 110.08 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.02 -15.24 13.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.588 0.355 . . . . 0.0 110.732 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.498 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.2 m-20 -72.43 -29.02 63.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.07 -29.61 58.05 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.44 -38.13 77.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.24 -32.31 71.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 -46.32 40.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.12 47.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.083 -0.386 . . . . 0.0 111.49 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -102.64 7.38 39.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.468 1.107 . . . . 0.0 112.646 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.28 -51.31 0.94 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.491 1.138 . . . . 0.0 109.373 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 45.4 mmm -79.43 -16.45 56.14 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.669 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -73.96 119.02 17.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.94 74.86 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.359 -0.689 . . . . 0.0 112.652 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 7.9 ptpt -88.26 179.63 6.32 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 118.377 1.088 . . . . 0.0 111.316 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -107.94 146.66 32.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.77 -63.9 1.13 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.4 0.619 . . . . 0.0 110.573 -176.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.579 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.6 t70 -124.45 5.49 8.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.548 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.99 -11.96 2.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.43 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -115.79 133.45 56.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.58 0.752 . . . . 0.0 109.598 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.78 136.95 41.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.793 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 pt -115.29 175.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -120.27 142.67 48.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.58 1.552 . . . . 0.0 107.625 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.21 127.02 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -160.55 162.81 33.04 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -61.12 132.44 53.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.03 27.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 CA--C 1.517 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.768 171.824 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.95 127.12 36.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' B' ' 56' ' ' PHE . 73.8 mt -113.8 153.37 29.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -106.71 127.75 53.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.1 mm -119.05 77.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.63 144.86 17.41 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.67 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.43 10.19 42.12 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 117.589 0.694 . . . . 0.0 111.422 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.78 163.71 13.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.377 0.671 . . . . 0.0 111.96 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.9 t-20 -73.96 160.76 30.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.461 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.3 p -75.74 -3.87 37.28 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.706 0.402 . . . . 0.0 110.382 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.68 -7.42 18.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.358 1.063 . . . . 0.0 110.888 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -81.63 143.7 31.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.737 0.415 . . . . 0.0 110.235 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -170.25 2.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.73 -35.5 78.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.89 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.57 -28.96 68.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.275 -0.265 . . . . 0.0 111.141 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.4 -20.63 27.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.6 -29.17 20.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.969 1.308 . . . . 0.0 109.458 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.52 -29.6 37.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 0.0 109.944 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -23.3 41.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.118 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.49 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.7 p -101.37 -34.26 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 86.4 m-85 -93.55 -10.34 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.335 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -3.66 76.18 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -80.84 -13.26 59.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.697 1.199 . . . . 0.0 111.123 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -111.67 -19.04 12.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.75 163.69 32.21 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 117.897 0.317 . . . . 0.0 112.448 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -67.23 116.08 7.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.87 141.57 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.741 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -21.17 5.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.934 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.77 149.9 15.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.35 144.64 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.309 0.576 . . . . 0.0 109.663 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.4 mt -120.12 155.65 32.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.511 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -152.33 119.15 5.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.8 139.19 30.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.763 -170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 pttt . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.101 0.477 . . . . 0.0 111.644 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 . . . . . 0 N--CA 1.457 -0.111 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 2.01 82.94 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.313 0.959 . . . . 0.0 112.003 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -142.61 162.26 35.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.321 1.06 . . . . 0.0 110.308 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -177.85 6.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.53 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 52.6 m-85 -141.3 162.12 36.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.83 0.348 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -154.05 139.16 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -110.23 124.31 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.755 0.312 . . . . 0.0 110.287 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.1 m-85 -93.53 156.09 16.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.919 0.888 . . . . 0.0 111.062 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.648 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -120.9 140.08 30.21 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.59 -2.54 12.57 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.746 2.297 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.76 -15.25 10.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.03 0.377 . . . . 0.0 111.299 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.486 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.7 m-20 -71.76 -28.43 63.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.4 58.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.172 0.589 . . . . 0.0 110.384 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.16 -37.64 75.27 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.61 -30.74 69.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.3 33.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.99 -7.81 48.87 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.95 -0.469 . . . . 0.0 111.266 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -104.3 4.94 34.2 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 112.462 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.01 -54.2 1.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.706 0.765 . . . . 0.0 109.455 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.4 mmm -81.0 -11.22 59.6 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.444 1.498 . . . . 0.0 112.076 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -73.35 127.54 32.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.93 -7.17 78.7 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.72 -153.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.281 1.032 . . . . 0.0 109.37 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 29.3 t -139.58 159.43 42.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.493 0.663 . . . . 0.0 112.777 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.0 126.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.292 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.547 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 61.33 -21.12 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.51 -7.5 0.52 Allowed Glycine 0 N--CA 1.439 -1.119 0 CA-C-O 119.183 -0.787 . . . . 0.0 112.962 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.04 134.97 54.87 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.188 0.994 . . . . 0.0 110.205 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.99 139.03 50.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.63 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.4 pt -121.28 177.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -121.63 143.49 49.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 107.37 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.88 163.77 36.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -63.55 136.11 57.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.87 38.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.161 0.505 . . . . 0.0 112.239 -172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p . . . . . 0 CA--C 1.519 -0.245 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.265 172.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.307 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.27 129.55 47.25 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.912 0.856 . . . . 0.0 108.78 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.4 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 75.7 mt -113.31 155.11 25.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.338 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -108.39 129.41 55.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.526 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -121.62 80.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -174.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.77 148.8 19.23 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.909 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.43 11.24 45.44 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 117.736 0.768 . . . . 0.0 112.054 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.93 163.02 20.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.435 0.636 . . . . 0.0 111.907 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.622 HD22 ' HB3' ' B' ' 75' ' ' ASP . 32.2 t-20 -71.27 165.52 23.49 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.417 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -85.48 -8.34 58.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.917 -0.489 . . . . 0.0 110.962 -174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -109.41 -1.35 18.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.28 1.432 . . . . 0.0 111.147 -177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 68.6 m -76.61 144.51 39.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.35 -167.58 2.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.06 -32.11 70.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.432 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -65.0 -32.68 74.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -21.88 27.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.16 -27.27 23.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.98 1.312 . . . . 0.0 109.348 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.06 -28.98 32.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 110.121 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.25 -20.37 41.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.505 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 74' ' ' LEU . 6.4 p -104.33 -35.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 90.6 m-85 -91.83 -11.59 36.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.067 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.0 -3.57 75.22 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.53 -13.1 59.37 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.869 1.267 . . . . 0.0 111.002 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.6 -19.32 12.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.58 164.47 34.16 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.1 ttm105 -72.34 117.37 13.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -75.24 141.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.295 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -23.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.203 0.601 . . . . 0.0 109.958 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -161.18 150.51 16.67 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.054 0.541 . . . . 0.0 109.846 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.48 145.58 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.287 0.565 . . . . 0.0 109.812 172.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.3 mt -119.3 156.28 30.29 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.532 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.67 119.11 5.6 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.8 mmm -94.69 144.05 25.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.062 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.428 ' CA ' ' HG2' ' B' ' 49' ' ' ARG . 30.4 mttt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.428 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 48.1 mmm-85 . . . . . 0 CA--C 1.523 -0.066 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.11 2.42 88.12 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.649 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -135.57 160.0 39.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.61 1.205 . . . . 0.0 111.039 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -178.29 7.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.099 0.56 . . . . 0.0 110.716 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 65.7 m-85 -142.42 163.08 33.82 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.893 0.477 . . . . 0.0 109.865 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.66 142.48 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.7 m -114.68 122.92 47.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.437 0.295 . . . . 0.0 110.333 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.06 155.84 17.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.865 0.866 . . . . 0.0 111.974 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.29 -22.7 60.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.883 0.473 . . . . 0.0 111.291 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -121.18 140.88 31.88 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.65 -10.68 23.72 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.588 2.192 . . . . 0.0 110.396 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.63 -14.92 13.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.091 0.405 . . . . 0.0 110.671 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.2 m-20 -72.06 -27.62 62.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.38 -31.99 54.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.207 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -68.0 -39.59 83.21 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.37 -33.99 76.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.21 -44.41 53.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.08 44.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.093 -0.379 . . . . 0.0 111.37 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -105.59 4.51 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.338 1.055 . . . . 0.0 112.181 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.31 -52.91 1.39 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.779 0.799 . . . . 0.0 109.606 -175.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.1 mmm -82.69 -11.26 58.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.216 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.05 126.88 31.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.285 0.493 . . . . 0.0 109.752 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.86 -7.53 76.91 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.797 -0.446 . . . . 0.0 112.114 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.72 -156.94 0.19 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.582 1.153 . . . . 0.0 109.926 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -134.5 153.24 52.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 111.023 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -100.83 -65.99 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.388 0.613 . . . . 0.0 111.17 -176.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.622 ' HB3' HD22 ' B' ' 16' ' ' ASN . 15.4 t70 -120.54 16.27 12.04 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.628 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.8 -6.54 12.35 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.637 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -111.57 131.78 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 108.893 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.64 137.66 39.58 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.3 pt -118.58 173.74 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -116.82 140.65 49.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.026 1.73 . . . . 0.0 107.221 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.4 126.59 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.25 163.4 38.81 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -64.67 135.41 55.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.72 153.73 36.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 N--CA 1.452 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.144 169.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.85 127.84 37.47 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.51 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.4 mt -113.82 147.83 37.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -102.61 127.44 49.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -117.98 81.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.6 140.74 15.22 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.809 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 5.75 32.77 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 117.272 0.536 . . . . 0.0 111.899 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 19' ' ' THR . 8.0 mt -63.56 160.62 16.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.18 0.49 . . . . 0.0 110.958 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 45.4 t30 -69.23 159.27 33.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -71.69 -4.85 29.74 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.186 -0.321 . . . . 0.0 110.296 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.42 -8.36 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.86 1.264 . . . . 0.0 110.475 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.515 HG21 HD22 ' B' ' 15' ' ' LEU . 35.6 m -79.49 141.38 36.78 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.07 -168.03 2.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.393 0.616 . . . . 0.0 109.803 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.32 -30.57 68.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.97 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -66.77 -29.54 69.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.16 -17.73 28.59 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.68 -28.63 14.23 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.016 0.926 . . . . 0.0 110.495 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.28 -32.28 33.29 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.098 0.475 . . . . 0.0 109.72 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -29.7 43.28 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.208 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' B' ' 28' ' ' PHE . 3.6 p -91.6 -34.83 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 81.5 m-85 -91.42 -9.47 44.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.84 -4.88 86.17 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -78.61 -12.16 60.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.548 1.139 . . . . 0.0 111.193 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -115.63 -13.34 11.5 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.52 171.64 36.84 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 119.88 -1.152 . . . . 0.0 112.127 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -80.89 115.35 20.33 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.397 0.618 . . . . 0.0 109.689 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mt -74.18 139.84 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.745 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -19.06 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.061 175.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -163.15 149.66 12.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.407 0.683 . . . . 0.0 110.025 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.89 144.23 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 109.71 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -119.26 154.42 33.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.573 1.149 . . . . 0.0 108.047 173.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.93 118.97 6.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.6 mmm -92.93 142.41 27.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.665 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.062 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 1.44 78.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -136.07 157.7 46.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.33 1.065 . . . . 0.0 110.421 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.32 6.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.2 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 48.1 m-85 -141.95 161.09 38.84 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -154.67 140.74 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 46.9 m -111.48 126.94 55.49 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' B' ' 10' ' ' LEU . 4.9 m-85 -99.03 162.35 13.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.451 0.701 . . . . 0.0 110.328 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -72.26 -18.7 61.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -129.28 153.49 80.49 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 123.577 0.751 . . . . 0.0 110.126 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.58 3.14 8.05 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 122.714 2.276 . . . . 0.0 110.391 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.46 -15.18 7.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -86.22 -21.44 27.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.74 -28.27 61.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.055 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -69.23 -33.56 73.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.94 -27.33 63.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.97 -46.43 21.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.09 54.63 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.248 0.219 . . . . 0.0 111.369 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -101.69 9.31 41.11 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.298 1.039 . . . . 0.0 112.189 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -50.96 0.88 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.349 1.071 . . . . 0.0 109.127 -175.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.487 ' HA ' ' HG2' ' B' ' 72' ' ' LYS . 50.4 mmm -77.26 -18.56 57.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.27 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -75.95 110.42 10.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.06 -7.94 53.11 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.323 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' B' ' 69' ' ' MET . 8.6 ptpt -90.15 -173.17 3.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.239 1.02 . . . . 0.0 110.446 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . 0.412 ' N ' ' HG3' ' B' ' 72' ' ' LYS . 47.2 t -122.84 153.52 39.48 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.778 0.799 . . . . 0.0 112.14 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -131.29 126.47 35.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.011 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.0 t70 62.25 -24.04 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 156.62 -10.99 0.29 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.081 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -118.14 137.23 53.11 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.977 0.888 . . . . 0.0 110.591 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.52 138.39 50.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.886 0.475 . . . . 0.0 110.82 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.495 HG21 HD23 ' B' ' 15' ' ' LEU . 23.8 pt -122.53 166.24 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -115.18 146.31 41.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.598 1.559 . . . . 0.0 108.127 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.22 129.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.58 163.53 32.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -61.65 134.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.31 157.49 29.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.948 0.404 . . . . 0.0 112.028 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 63.1 p . . . . . 0 N--CA 1.454 -0.252 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.392 172.518 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -85.61 129.32 34.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.664 0.732 . . . . 0.0 109.209 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.402 HD12 ' CE1' ' B' ' 56' ' ' PHE . 79.1 mt -119.22 153.37 35.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.379 0.671 . . . . 0.0 110.091 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -106.48 131.2 53.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.5 mm -121.85 80.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.19 148.7 19.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.937 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.8 11.02 51.63 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.619 0.709 . . . . 0.0 111.484 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.64 164.39 14.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.449 0.699 . . . . 0.0 111.449 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.585 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.3 t30 -72.59 156.91 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.889 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -76.36 -1.29 26.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.78 0.324 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.09 -5.8 15.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.392 1.077 . . . . 0.0 110.875 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.5 m -80.46 145.65 31.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.349 0.66 . . . . 0.0 110.186 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.59 -168.84 2.13 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.22 -33.19 71.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.48 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.13 -32.9 74.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.27 -22.1 27.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.84 -28.37 22.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.194 1.398 . . . . 0.0 109.453 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.08 -27.91 32.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.391 0.615 . . . . 0.0 110.05 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.6 -21.26 38.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.611 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.574 HG11 HD21 ' B' ' 74' ' ' LEU . 6.2 p -103.51 -34.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.3 m-85 -91.41 -11.63 37.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.949 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.23 -3.44 76.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.72 -12.81 59.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.758 1.223 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.55 -19.52 12.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.608 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.97 166.38 37.06 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.072 0.396 . . . . 0.0 112.369 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -73.9 117.13 15.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.2 mt -75.52 142.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -23.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.049 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.84 150.58 17.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.177 0.591 . . . . 0.0 109.794 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.09 144.63 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 109.75 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -116.74 154.19 31.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.47 117.68 6.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.5 mmm -92.68 138.08 31.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.753 -170.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttt . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 111.117 176.709 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.06 76.84 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.12 160.71 39.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.536 1.168 . . . . 0.0 110.991 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.14 -176.87 6.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 110.589 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 37.5 m-85 -143.17 162.84 34.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -154.13 144.72 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -116.68 122.63 45.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.327 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.402 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.1 m-85 -92.17 156.27 17.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.536 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.22 -22.53 59.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.085 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.6 t -121.58 140.98 32.61 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.52 -7.45 19.54 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.809 2.34 . . . . 0.0 110.137 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.69 -15.77 12.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.764 0.256 . . . . 0.0 110.623 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.9 m-20 -71.59 -28.48 63.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.42 56.55 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.91 -37.25 75.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.43 -30.85 67.81 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.27 -46.37 34.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.58 -9.97 52.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.13 -0.356 . . . . 0.0 111.191 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -102.16 8.14 40.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.398 1.079 . . . . 0.0 112.499 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.43 -51.38 0.93 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.323 1.059 . . . . 0.0 109.392 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 47.3 mmm -78.66 -17.26 56.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.846 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -73.31 118.4 16.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -7.91 75.6 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.641 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.5 ptpt -89.89 178.21 6.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.728 1.264 . . . . 0.0 111.261 175.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -105.45 147.18 28.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.705 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.574 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.53 -65.1 1.01 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.325 0.583 . . . . 0.0 110.559 -177.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.585 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.0 t70 -123.15 4.15 9.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.652 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.14 -11.36 2.55 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.214 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -115.51 133.58 55.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.824 0.85 . . . . 0.0 109.834 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.13 136.29 41.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.392 0.432 . . . . 0.0 110.395 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 16.9 pt -112.84 175.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -119.7 142.76 48.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 107.131 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.56 129.94 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.2 163.09 37.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 123.07 20.42 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.58 149.94 47.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.951 173.103 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.02 127.73 45.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 117.981 0.891 . . . . 0.0 109.132 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 74.7 mt -114.67 155.94 25.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.286 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.56 129.74 55.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.517 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.1 mm -121.32 75.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.63 146.96 18.41 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.226 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.42 11.0 30.22 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.834 0.817 . . . . 0.0 112.004 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.87 166.55 8.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.28 0.562 . . . . 0.0 112.184 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 58.4 t30 -79.0 -2.65 41.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 1.2 p 66.39 -13.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.929 1.292 . . . . 0.0 112.998 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' B' ' 16' ' ' ASN . 48.1 mm-40 -91.26 -9.05 46.57 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.969 0.908 . . . . 0.0 109.328 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -78.77 144.9 34.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 109.605 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 -172.31 3.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' B' ' 21' ' ' GLU . 36.2 mp0 -65.22 -37.93 88.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.453 0.701 . . . . 0.0 110.342 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -32.41 74.04 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.191 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.48 -21.03 25.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.16 -27.48 24.55 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.903 1.281 . . . . 0.0 109.034 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.64 -27.21 34.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.41 0.624 . . . . 0.0 110.026 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.0 -20.19 35.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.603 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.3 p -104.2 -35.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 88.4 m-85 -92.69 -10.05 38.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.134 175.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.93 -2.93 79.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.5 -11.27 59.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.557 1.143 . . . . 0.0 111.02 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -113.4 -19.34 11.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.786 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.36 161.15 30.12 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -74.07 123.06 23.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.99 143.79 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 -22.78 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.925 178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.95 150.43 15.18 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.32 0.648 . . . . 0.0 109.744 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.66 145.62 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.396 0.617 . . . . 0.0 109.655 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.9 mt -118.52 154.44 32.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.291 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -149.13 117.54 6.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.82 140.15 29.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.913 -169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 pttt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.424 0.63 . . . . 0.0 112.342 178.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 40.1 mmm-85 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.83 0.09 75.64 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' B' ' 49' ' ' ARG . 48.1 p90 -139.13 161.88 36.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 117.822 0.811 . . . . 0.0 111.083 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.72 -178.92 7.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.448 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 44.7 m-85 -140.34 162.3 35.63 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -152.98 142.51 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.9 m -114.06 121.7 44.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.29 156.54 17.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.753 0.821 . . . . 0.0 110.731 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -78.72 -23.75 45.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.376 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -114.03 138.09 22.7 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.74 -8.13 20.06 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.457 2.105 . . . . 0.0 110.434 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.99 -15.06 13.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.389 0.276 . . . . 0.0 110.891 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.466 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 70.3 m-20 -71.34 -28.17 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.41 51.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.31 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.41 -39.18 81.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.95 -32.62 73.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.58 -43.7 47.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.56 42.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.286 -0.259 . . . . 0.0 110.943 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -106.47 5.03 28.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.294 1.038 . . . . 0.0 112.324 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.81 -53.29 1.33 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.403 ' HE3' HD11 ' B' ' 79' ' ' ILE . 30.2 mmm -82.35 -10.19 59.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.779 1.632 . . . . 0.0 112.102 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.27 126.0 29.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.32 -6.74 81.12 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -80.81 -154.15 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.172 0.989 . . . . 0.0 109.16 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -137.77 159.53 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.798 0.808 . . . . 0.0 112.507 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.43 126.69 31.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.849 176.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 1.9 t70 60.98 -18.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.91 -8.38 0.6 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 119.33 -0.706 . . . . 0.0 113.154 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -121.91 138.51 54.38 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.259 1.03 . . . . 0.0 110.592 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.42 139.38 54.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.808 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.403 HD11 ' HE3' ' B' ' 69' ' ' MET . 25.2 pt -121.43 176.66 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -120.1 141.44 49.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.712 1.605 . . . . 0.0 107.505 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.38 124.56 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.07 163.15 36.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -60.7 133.77 56.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.63 153.71 30.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.8 p . . . . . 0 CA--C 1.518 -0.251 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.242 170.009 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -98.3 129.93 45.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.054 0.927 . . . . 0.0 108.926 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -114.88 154.04 29.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.87 130.92 55.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.479 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -122.3 80.34 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.2 143.25 16.44 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.538 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 9.65 38.7 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 117.477 0.639 . . . . 0.0 111.882 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.88 165.04 13.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.134 0.573 . . . . 0.0 111.672 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t30 -77.94 157.06 29.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 123.292 0.637 . . . . 0.0 110.924 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -72.63 -8.33 54.73 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.678 0.791 . . . . 0.0 110.283 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.94 -10.46 22.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 110.471 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.1 m -83.49 143.85 29.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -169.02 2.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -68.72 -33.29 73.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -64.6 -33.4 75.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.56 -20.89 27.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.449 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -86.5 -26.74 24.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.125 1.37 . . . . 0.0 109.431 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.9 -28.84 32.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.427 0.632 . . . . 0.0 110.119 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.33 -20.08 41.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.675 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -105.25 -36.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.5 m-85 -88.53 -11.89 44.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.923 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.63 -4.24 75.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -81.5 -12.88 58.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.319 1.048 . . . . 0.0 110.911 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.7 m-85 -109.73 -20.65 12.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.254 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.91 164.66 33.15 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 118.048 0.386 . . . . 0.0 112.959 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -66.41 117.84 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.7 mt -79.16 142.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.966 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -21.7 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.142 0.577 . . . . 0.0 109.91 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.69 150.39 15.64 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.464 0.706 . . . . 0.0 109.826 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.7 145.81 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.138 0.494 . . . . 0.0 110.059 172.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.0 mt -120.3 154.41 35.03 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.362 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.456 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -150.71 119.51 6.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 170.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 12.1 mmm -92.59 141.66 28.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.456 ' HE2' HD12 ' B' ' 39' ' ' LEU . 11.9 mttt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.408 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 42.9 mmm-85 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.92 2.73 88.34 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.351 -0.694 . . . . 0.0 111.582 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' B' ' 49' ' ' ARG . 51.1 p90 -135.49 161.45 35.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.764 1.282 . . . . 0.0 110.072 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.2 -177.62 6.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.779 0.431 . . . . 0.0 111.164 -174.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 63.2 m-85 -142.73 162.28 35.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.3 142.27 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m -113.35 123.99 51.42 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -95.04 156.35 16.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.931 0.892 . . . . 0.0 110.686 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.47 -21.26 45.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.493 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -116.5 137.93 24.01 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.85 -0.13 10.22 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.089 2.526 . . . . 0.0 110.568 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 -15.5 9.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 117.877 0.308 . . . . 0.0 111.198 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.521 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 84.5 m-20 -72.19 -27.96 62.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.62 -27.66 55.81 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.452 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -74.5 -36.59 63.23 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.24 -26.1 64.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.2 -46.38 14.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.03 63.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.3 7.7 46.03 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 -55.58 1.31 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.915 0.864 . . . . 0.0 109.371 -173.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 0.0 OUTLIER -75.48 -15.76 60.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.626 -1.625 . . . . 0.0 111.775 -177.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -73.91 124.06 25.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.32 -7.05 82.14 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -82.91 -153.46 0.12 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 109.361 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -139.69 158.73 43.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.464 0.706 . . . . 0.0 112.395 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -132.43 126.56 33.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.5 -23.34 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.62 -6.51 0.47 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 119.512 -0.604 . . . . 0.0 112.631 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -117.36 134.51 54.74 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.027 0.913 . . . . 0.0 110.134 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.96 139.17 50.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.479 -174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.22 174.55 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -120.89 144.19 48.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.3 1.84 . . . . 0.0 107.776 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -135.97 130.03 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -160.92 163.83 31.61 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -61.43 137.15 58.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.39 158.89 27.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.154 169.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.335 0 CA-C-O 119.23 -0.761 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -99.55 128.86 45.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 117.99 0.895 . . . . 0.0 108.872 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -112.56 151.31 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.517 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -104.65 128.41 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.512 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.9 79.05 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 146.48 18.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.937 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.28 10.44 41.87 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 117.68 0.74 . . . . 0.0 111.672 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.63 164.98 13.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.529 0.732 . . . . 0.0 112.129 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' B' ' 75' ' ' ASP . 46.7 t30 -77.1 162.38 27.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 110.657 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -76.71 -1.47 28.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.284 0.233 . . . . 0.0 110.607 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.6 -4.61 16.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.378 1.071 . . . . 0.0 110.815 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 45.2 m -82.7 144.51 30.18 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.945 0.498 . . . . 0.0 110.047 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 -169.23 2.44 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.369 0.604 . . . . 0.0 109.443 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.34 -35.51 73.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.558 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.1 -30.0 70.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.37 -21.02 23.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' B' ' 27' ' ' VAL . 9.9 mt -87.07 -28.82 22.33 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.135 0.974 . . . . 0.0 109.36 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.26 -25.51 39.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.186 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.37 -22.19 35.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.598 HG11 HD21 ' B' ' 74' ' ' LEU . 5.0 p -103.87 -29.3 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.512 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.6 m-85 -99.1 -10.39 22.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.382 174.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.21 -5.83 85.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -77.05 -22.97 52.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.853 1.261 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.7 -19.9 15.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.528 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.44 165.28 34.98 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 118.024 0.374 . . . . 0.0 112.215 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -74.07 116.87 15.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.66 139.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.39 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -23.64 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 122.849 0.46 . . . . 0.0 110.134 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -160.28 149.48 17.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.026 0.53 . . . . 0.0 109.614 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.71 143.58 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 172.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.9 mt -117.39 154.13 31.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.07 119.41 5.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.0 mmm -94.32 136.94 34.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.93 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 pttt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.363 0.602 . . . . 0.0 111.333 176.579 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.66 1.57 68.17 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.424 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.84 158.87 43.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.62 1.21 . . . . 0.0 110.553 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -178.52 7.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.051 0.541 . . . . 0.0 110.489 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.5 m-85 -142.58 162.39 35.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.846 0.459 . . . . 0.0 110.433 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.21 143.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -115.85 122.37 45.17 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 123.142 0.276 . . . . 0.0 110.306 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.71 156.58 17.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.589 0.755 . . . . 0.0 111.996 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -75.18 -22.89 57.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.599 0.36 . . . . 0.0 111.071 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -120.54 140.69 30.81 Favored Pre-proline 0 CA--C 1.518 -0.262 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.41 -12.77 25.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.436 2.091 . . . . 0.0 110.189 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.57 -15.59 14.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.165 0.439 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.493 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.8 m-20 -70.95 -29.01 64.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 169.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.57 58.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.008 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -67.59 -38.9 84.68 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.35 -33.56 74.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.05 52.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.73 -8.45 52.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.256 -0.277 . . . . 0.0 110.906 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -104.94 5.35 32.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.191 0.996 . . . . 0.0 112.286 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -52.05 1.28 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.862 0.755 . . . . 0.0 109.442 -175.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.7 mmm -83.36 -10.52 58.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.405 1.482 . . . . 0.0 112.529 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.85 127.26 32.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.83 76.28 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.149 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.84 -157.38 0.22 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -134.46 153.01 52.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.664 0.786 . . . . 0.0 110.891 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.598 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -99.93 -68.32 0.81 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.943 -176.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.601 ' HB3' HD22 ' B' ' 16' ' ' ASN . 11.7 t70 -117.59 7.25 12.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.652 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.25 -7.66 5.37 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -113.41 132.84 55.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 108.932 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 136.62 38.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.27 175.68 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -120.98 140.4 51.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.846 1.658 . . . . 0.0 107.302 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.86 125.12 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.44 162.72 35.72 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -60.71 133.6 56.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.2 158.33 27.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 N--CA 1.454 -0.246 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.143 171.325 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.288 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -85.88 129.98 34.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.3 mt -118.19 152.67 35.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.102 0.561 . . . . 0.0 109.961 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -105.42 128.65 53.64 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.73 81.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.94 146.83 18.41 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.861 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.33 51.09 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 117.707 0.754 . . . . 0.0 111.585 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.23 164.06 11.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.457 0.703 . . . . 0.0 111.295 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' B' ' 75' ' ' ASP . 44.5 t30 -73.1 158.86 34.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.294 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 76.0 p -74.96 -2.75 28.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.99 -7.15 16.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.647 1.179 . . . . 0.0 110.776 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.6 m -80.96 144.34 31.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.532 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -170.24 2.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.58 -34.64 77.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.646 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -65.78 -31.51 72.53 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.974 -0.454 . . . . 0.0 111.022 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -20.1 29.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -89.78 -28.34 19.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.819 1.248 . . . . 0.0 109.848 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -81.77 -28.55 33.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 109.896 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.81 -23.71 39.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.317 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.5 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.9 p -99.77 -37.8 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.5 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.7 m-85 -88.96 -10.58 47.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.772 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.13 -4.61 73.46 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.1 mtpt -79.2 -14.59 58.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.808 1.243 . . . . 0.0 111.377 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.1 m-85 -110.33 -19.8 12.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.723 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.56 163.07 31.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -74.95 125.61 29.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.69 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.342 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.18 -23.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.963 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -161.07 151.08 17.38 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.173 0.589 . . . . 0.0 109.557 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.92 147.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 109.722 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -122.23 156.0 34.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.589 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.24 121.39 5.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.73 138.3 31.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -174.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.164 0.507 . . . . 0.0 112.086 174.378 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.88 0.7 83.31 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.746 0.689 . . . . 0.0 112.591 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.66 158.34 43.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.439 1.12 . . . . 0.0 110.6 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.42 -179.28 7.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.8 m-85 -140.95 161.51 37.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.03 139.23 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -111.65 121.7 45.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.853 0.359 . . . . 0.0 110.121 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.7 m-85 -92.16 155.26 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.74 0.816 . . . . 0.0 110.444 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.97 -22.88 48.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -114.57 135.72 22.33 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.67 0.86 9.13 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.847 2.365 . . . . 0.0 110.499 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.35 -14.76 9.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.525 0.33 . . . . 0.0 111.202 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -72.07 -28.76 63.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.79 58.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.31 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -70.69 -37.82 73.65 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.23 -31.07 70.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -75.38 -44.91 42.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.262 -0.274 . . . . 0.0 111.333 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -99.8 5.72 45.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.047 0.939 . . . . 0.0 112.642 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.49 -51.75 1.27 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.913 0.778 . . . . 0.0 109.197 -174.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.443 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mtp -83.74 -11.16 57.51 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.74 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.89 114.17 10.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.03 -4.81 59.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.54 -154.53 0.11 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.327 1.051 . . . . 0.0 109.309 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -139.77 159.49 42.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 112.474 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.63 127.3 30.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.386 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 60.92 -20.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 150.26 -6.06 0.68 Allowed Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.042 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -118.38 134.73 54.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.869 0.834 . . . . 0.0 110.063 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.81 137.42 47.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.322 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.1 pt -118.5 177.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -122.01 143.35 49.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.562 1.945 . . . . 0.0 107.177 170.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.66 130.42 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -158.96 164.2 35.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -67.53 132.73 48.15 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.34 147.83 34.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.936 173.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -98.68 128.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.373 1.087 . . . . 0.0 109.044 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.34 153.8 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.048 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -108.08 128.93 55.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.485 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -121.1 80.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.39 144.21 17.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.237 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.71 38.98 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 117.709 0.755 . . . . 0.0 111.466 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.29 162.46 22.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.048 0.539 . . . . 0.0 112.087 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' B' ' 75' ' ' ASP . 39.5 t-20 -76.35 155.15 34.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.014 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -68.93 -10.47 57.41 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 123.548 0.739 . . . . 0.0 110.284 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.78 -11.25 23.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 110.309 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -81.29 144.72 31.33 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.287 0.635 . . . . 0.0 109.345 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.74 -165.98 1.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.392 0.615 . . . . 0.0 109.536 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' B' ' 21' ' ' GLU . 37.1 mp0 -70.61 -38.84 74.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.858 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -68.71 -25.84 64.97 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.5 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.95 -20.19 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' B' ' 27' ' ' VAL . 10.9 mt -90.37 -28.46 18.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.675 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.11 -26.65 48.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 109.79 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.85 -23.87 36.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' B' ' 24' ' ' LEU . 5.3 p -101.82 -36.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.485 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 83.9 m-85 -90.47 -11.61 39.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.21 -0.306 . . . . 0.0 110.951 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.16 -3.13 68.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -81.51 -12.23 58.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.14 . . . . 0.0 111.264 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -111.96 -20.48 11.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.6 0.76 . . . . 0.0 112.412 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.47 161.58 29.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -74.0 124.97 27.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.88 143.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.154 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -20.7 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.477 0.711 . . . . 0.0 110.477 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -160.37 148.82 16.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.304 0.642 . . . . 0.0 109.66 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.06 143.54 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 110.039 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -118.94 156.03 30.28 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.178 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.536 HD12 ' HE2' ' B' ' 41' ' ' LYS . 2.9 tm? -154.98 119.44 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 171.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 13.8 mmm -93.17 142.87 26.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.097 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.536 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.8 mttt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.17 87.18 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.158 -0.801 . . . . 0.0 111.943 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -136.94 160.34 39.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.922 1.361 . . . . 0.0 110.249 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.9 -178.71 7.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.749 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.9 m-85 -142.93 162.59 35.07 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.61 141.84 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 33.6 m -111.97 122.9 49.03 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.245 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -93.06 156.67 16.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 110.503 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.82 -23.08 42.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.461 -0.305 . . . . 0.0 110.284 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -115.19 137.56 23.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 -7.04 18.78 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.568 2.179 . . . . 0.0 110.474 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.75 -14.71 13.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.844 0.293 . . . . 0.0 110.728 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.484 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.6 m-20 -71.67 -28.13 63.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.14 53.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.556 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.05 -38.94 79.39 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.44 -32.74 72.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.94 -44.78 46.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.43 -8.47 51.16 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.057 -0.402 . . . . 0.0 111.203 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -104.23 4.74 34.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.395 1.078 . . . . 0.0 112.088 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.58 -52.67 1.26 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.759 0.79 . . . . 0.0 109.447 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.2 mmm -82.22 -10.55 59.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.586 1.555 . . . . 0.0 112.401 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.56 126.15 29.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.39 -6.63 83.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -80.64 -153.86 0.09 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.595 1.158 . . . . 0.0 109.691 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -139.88 159.05 43.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.292 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.66 126.18 32.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.024 177.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.9 t70 61.05 -21.38 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.08 -6.35 0.6 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.724 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -117.42 133.16 56.29 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.002 0.901 . . . . 0.0 110.119 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.36 50.78 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.301 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -120.64 178.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -122.57 142.74 50.3 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.399 1.88 . . . . 0.0 107.33 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.97 129.25 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -159.24 162.39 36.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -63.59 134.37 55.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 158.27 29.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.519 -0.249 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.949 169.63 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -92.24 125.49 36.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.432 HD12 ' CE1' ' B' ' 56' ' ' PHE . 74.4 mt -110.44 150.84 28.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -105.31 128.85 53.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.486 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.19 78.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.42 142.59 16.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.493 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.56 6.52 46.97 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 122.216 -0.579 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.27 162.32 6.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.331 0.652 . . . . 0.0 111.773 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.52 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.6 t30 -71.25 160.11 33.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 70.9 p -77.85 -1.28 30.87 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.878 0.471 . . . . 0.0 110.669 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.26 -6.1 15.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.409 1.083 . . . . 0.0 111.025 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -83.4 145.74 28.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.285 0.634 . . . . 0.0 110.087 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -169.96 2.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.51 -35.83 79.89 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.54 -174.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -67.89 -27.9 67.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.964 -0.46 . . . . 0.0 111.247 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.02 28.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.71 -26.78 24.07 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.166 1.386 . . . . 0.0 109.352 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -80.19 -32.75 38.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.427 0.632 . . . . 0.0 110.163 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.49 -21.65 45.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.308 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.1 p -103.06 -34.29 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.2 m-85 -91.83 -12.0 34.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.073 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -3.08 72.11 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -81.57 -13.58 57.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.66 1.184 . . . . 0.0 110.89 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -110.94 -19.58 12.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.696 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.13 166.2 36.67 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 118.025 0.375 . . . . 0.0 112.332 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttm105 -72.86 117.81 15.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.2 144.21 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.566 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -18.84 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.167 0.587 . . . . 0.0 110.323 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -160.22 147.35 16.11 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.212 0.605 . . . . 0.0 109.652 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.44 141.75 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.459 0.647 . . . . 0.0 109.583 170.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.2 mt -120.26 155.81 32.49 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.738 175.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.37 120.19 6.14 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.5 mmm -93.59 136.99 33.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.59 -172.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 pttp . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.116 0.484 . . . . 0.0 111.199 179.185 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 32.1 mmm-85 . . . . . 0 CA--C 1.525 0.013 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -1.13 75.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.904 0.764 . . . . 0.0 111.306 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.89 156.64 48.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.724 1.262 . . . . 0.0 110.522 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.54 7.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.872 0.469 . . . . 0.0 110.422 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.0 m-85 -142.42 161.79 37.13 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.534 0.334 . . . . 0.0 110.736 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.56 141.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.0 m -112.08 126.08 54.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.2 m-85 -94.3 155.77 16.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 111.427 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.36 -22.8 61.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.266 -0.397 . . . . 0.0 111.364 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -121.49 141.47 33.51 Favored Pre-proline 0 CA--C 1.518 -0.254 0 CA-C-N 118.295 0.498 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.14 -3.81 14.45 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.819 2.346 . . . . 0.0 110.289 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.46 -15.84 11.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.581 0.352 . . . . 0.0 110.998 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.494 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -71.77 -29.15 64.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.14 59.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.143 0.577 . . . . 0.0 110.526 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -70.84 -37.84 73.17 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.91 -30.36 68.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.27 -9.41 53.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.176 -0.327 . . . . 0.0 111.228 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -101.82 7.18 41.77 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.546 1.138 . . . . 0.0 112.158 174.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.29 -53.6 1.03 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.862 0.839 . . . . 0.0 109.108 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.531 ' HA ' ' CG ' ' B' ' 72' ' ' LYS . 49.7 mmm -78.44 -10.5 59.72 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.154 1.782 . . . . 0.0 111.916 -176.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -80.65 117.34 21.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.16 62.26 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.609 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' B' ' 69' ' ' MET . 20.7 ptmt -106.93 176.75 5.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.578 1.189 . . . . 0.0 111.954 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -97.76 155.91 16.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -127.23 123.84 37.51 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.359 172.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.8 t70 61.66 -23.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 157.56 -11.37 0.25 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.141 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -116.57 135.57 53.7 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.014 0.907 . . . . 0.0 110.513 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.34 140.51 57.26 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 123.199 0.6 . . . . 0.0 110.823 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -125.91 171.9 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -115.35 144.08 44.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.981 1.712 . . . . 0.0 108.015 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.76 130.14 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -160.44 163.86 32.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -63.31 133.31 53.95 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.36 158.55 30.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.038 0.446 . . . . 0.0 111.883 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.613 171.649 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.28 127.1 45.24 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 72.7 mt -112.5 154.45 25.87 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.16 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -107.96 127.3 53.63 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -118.85 80.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.29 143.78 16.83 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.624 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.04 36.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.16 163.5 22.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' B' ' 75' ' ' ASP . 40.3 t-20 -73.51 158.85 34.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -73.62 -8.29 55.36 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.301 0.64 . . . . 0.0 110.161 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.38 -11.04 20.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 110.48 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 41.2 m -79.87 144.78 33.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.71 -168.14 2.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.06 -32.27 68.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.578 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -64.4 -32.57 74.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.13 -21.91 27.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.421 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -85.87 -27.88 24.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.226 1.41 . . . . 0.0 109.635 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.93 -29.97 35.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 110.17 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -22.55 41.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.586 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.0 p -102.36 -35.51 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -174.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.508 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.0 m-85 -91.56 -10.06 42.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.873 176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -3.94 71.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.2 mtpt -80.4 -13.08 59.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.619 1.168 . . . . 0.0 111.208 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' B' ' 65' ' ' ALA . 80.3 m-85 -112.29 -18.78 12.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.7 -176.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.34 167.31 38.35 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.161 0.437 . . . . 0.0 112.63 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -74.22 117.28 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.2 142.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.461 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.47 -23.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.148 0.579 . . . . 0.0 110.194 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.51 150.1 15.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.238 0.615 . . . . 0.0 109.683 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.66 147.09 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 109.547 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.5 mt -123.09 156.36 35.08 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.787 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.487 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.44 119.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.7 mmm -93.03 142.58 27.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.902 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE2' HD12 ' B' ' 39' ' ' LEU . 22.8 mttt . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 . . . . . 0 CA--C 1.527 0.061 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.67 3.89 87.89 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.351 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.9 161.03 37.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.695 1.248 . . . . 0.0 109.803 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.34 -177.97 6.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.098 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.3 m-85 -142.91 160.93 39.4 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.168 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.3 140.6 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -112.71 121.71 45.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -92.62 155.95 17.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.695 0.798 . . . . 0.0 111.723 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -73.43 -22.57 60.17 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.455 0.302 . . . . 0.0 111.255 174.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -121.16 140.81 31.74 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 118.352 0.524 . . . . 0.0 109.834 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 -1.3 11.32 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 123.122 2.548 . . . . 0.0 110.342 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.36 -16.39 10.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.808 0.443 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 82.5 m-20 -71.28 -27.91 63.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.41 -29.09 56.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -72.97 -38.69 66.6 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.15 -25.39 66.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.71 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -83.59 -43.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 172.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.2 -6.6 48.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.896 -0.502 . . . . 0.0 112.305 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -107.46 7.97 29.21 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.532 0.733 . . . . 0.0 112.311 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.92 -55.07 1.39 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.628 0.728 . . . . 0.0 109.329 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . 0.408 ' HE3' HD11 ' B' ' 79' ' ' ILE . 25.5 mmm -79.57 -10.03 59.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.538 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -73.46 128.08 34.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.65 79.28 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -81.64 -153.44 0.11 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.628 1.171 . . . . 0.0 109.639 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.1 t -140.03 158.69 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -173.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.74 128.9 31.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.543 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.549 ' HB3' HD22 ' B' ' 16' ' ' ASN . 2.4 t0 52.73 21.52 1.93 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.328 0.585 . . . . 0.0 112.223 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.73 56.29 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.707 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -114.97 130.45 56.93 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.43 1.115 . . . . 0.0 109.875 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.81 139.12 50.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.344 0.258 . . . . 0.0 111.658 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.408 HD11 ' HE3' ' B' ' 69' ' ' MET . 21.9 pt -123.79 177.55 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -121.84 144.54 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.049 1.74 . . . . 0.0 107.567 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.42 126.54 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.79 164.83 28.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -60.36 135.95 57.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.2 159.84 23.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.518 -0.263 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.649 169.541 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -92.51 127.88 38.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.9 mt -113.3 149.24 34.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -102.72 127.47 49.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.488 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.0 mm -118.61 78.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.73 144.54 17.13 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.729 -0.607 . . . . 0.0 112.157 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 13.45 40.97 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 117.908 0.854 . . . . 0.0 111.827 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -65.81 166.33 11.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.042 0.925 . . . . 0.0 112.928 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.497 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.2 OUTLIER -78.71 145.77 34.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.312 1.445 . . . . 0.0 109.888 176.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 78.7 p -74.32 -8.61 56.83 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.995 0.918 . . . . 0.0 112.301 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.96 -12.39 18.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.265 1.426 . . . . 0.0 109.583 -174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.6 m -77.73 149.02 34.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.55 1.14 . . . . 0.0 110.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 -165.0 1.67 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -66.1 -29.48 69.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.134 0.424 . . . . 0.0 110.952 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.05 -19.7 31.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' B' ' 27' ' ' VAL . 4.9 mt -87.84 -29.18 21.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.64 1.176 . . . . 0.0 109.472 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.52 -27.66 46.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.443 0.64 . . . . 0.0 109.825 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.29 -23.38 37.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.347 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.596 HG11 HD21 ' B' ' 74' ' ' LEU . 5.6 p -102.87 -34.45 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.7 m-85 -90.84 -11.7 38.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.107 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.29 -5.16 76.15 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -79.31 -12.82 59.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.833 1.253 . . . . 0.0 110.729 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.63 -13.5 12.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.48 171.32 37.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.359 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -79.89 115.04 19.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.59 0.71 . . . . 0.0 109.982 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.8 mt -75.0 141.67 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.991 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -21.32 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.206 0.602 . . . . 0.0 110.354 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -161.29 150.38 16.36 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.21 146.11 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.4 0.619 . . . . 0.0 109.849 172.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.4 mt -123.24 155.32 37.39 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.528 1.131 . . . . 0.0 108.234 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.509 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.1 tm? -154.0 119.76 5.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 9.2 mmm -92.81 139.82 30.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.509 ' HE2' HD12 ' B' ' 39' ' ' LEU . 18.1 mttt . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 40.6 mmm-85 . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 4.07 80.68 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.992 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 157.37 45.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.719 1.26 . . . . 0.0 109.95 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.36 -177.98 6.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.401 0.28 . . . . 0.0 111.076 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 64.7 m-85 -142.68 160.75 39.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.797 0.439 . . . . 0.0 110.463 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -154.1 138.79 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 56.9 m -110.34 126.84 54.66 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.106 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' B' ' 10' ' ' LEU . 3.9 m-85 -98.2 161.81 13.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.403 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -71.52 -18.4 62.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -130.25 153.43 81.21 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 110.104 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.68 1.12 9.53 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.1 -15.59 9.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.76 -21.22 25.26 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 -27.78 61.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -69.58 -32.14 70.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.82 -22.24 61.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.1 -44.16 13.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.25 -15.62 62.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.184 -0.323 . . . . 0.0 111.858 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.36 6.74 46.02 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.19 -55.08 1.36 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.041 0.837 . . . . 0.0 109.461 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 24.4 mmm -78.05 -12.21 59.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.18 1.392 . . . . 0.0 111.965 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -72.83 130.12 39.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -10.05 63.36 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.671 -0.516 . . . . 0.0 112.356 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -83.28 -160.3 0.41 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.166 0.986 . . . . 0.0 109.509 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -132.9 152.61 51.85 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.716 0.806 . . . . 0.0 110.723 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.596 HD21 HG11 ' B' ' 27' ' ' VAL . 0.4 OUTLIER -95.73 -62.81 1.23 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.962 -174.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 15.6 t70 -130.18 0.92 4.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.141 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.75 -14.07 0.78 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.821 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.25 134.5 55.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.05 135.62 38.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.8 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.4 pt -114.26 174.32 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -173.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.55 141.85 47.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.564 1.546 . . . . 0.0 107.554 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.36 125.86 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.29 164.99 34.41 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -63.05 135.71 57.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.46 158.91 29.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 112.309 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.453 -0.307 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.535 173.221 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -84.52 129.0 34.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 76.6 mt -119.1 155.62 31.21 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.991 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -109.44 130.02 55.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.2 mm -121.68 86.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.87 145.07 16.91 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 121.999 -0.438 . . . . 0.0 112.555 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.12 8.08 45.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.48 HD23 HG21 ' B' ' 79' ' ' ILE . 9.7 mt -64.28 162.65 14.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.085 0.945 . . . . 0.0 112.089 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.476 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.4 OUTLIER -70.14 145.18 51.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.432 1.493 . . . . 0.0 109.568 175.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -70.83 -4.88 26.46 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.927 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.83 -6.49 15.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.984 1.314 . . . . 0.0 109.609 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.3 m -76.52 143.79 40.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.412 1.085 . . . . 0.0 108.751 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.96 -166.7 1.95 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.34 -29.89 68.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.692 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -66.76 -30.61 70.87 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.87 -17.13 28.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -95.28 -28.27 15.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.336 1.054 . . . . 0.0 109.909 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.97 -29.38 29.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.24 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.31 -28.54 38.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.127 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.514 HG13 ' CD2' ' B' ' 28' ' ' PHE . 4.3 p -92.64 -36.45 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.2 m-85 -92.15 -10.48 38.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.276 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.35 -3.48 77.13 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -79.77 -14.73 58.51 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.71 1.204 . . . . 0.0 111.608 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -111.5 -19.0 12.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.803 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.52 164.61 33.28 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 118.208 0.458 . . . . 0.0 112.312 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -72.23 117.45 13.89 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.96 141.23 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.386 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -23.81 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 122.877 0.471 . . . . 0.0 110.067 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.11 150.37 16.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.383 0.673 . . . . 0.0 109.687 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.55 146.06 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.517 0.675 . . . . 0.0 109.951 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.3 mt -118.14 152.13 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.3 119.33 6.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.3 mmm -93.4 139.66 30.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.9 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 pttt . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.129 0.49 . . . . 0.0 112.059 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.75 74.07 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -138.94 158.58 43.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.452 1.126 . . . . 0.0 110.671 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -179.04 7.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.385 0.674 . . . . 0.0 110.682 -174.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.2 m-85 -142.84 163.36 33.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.88 140.96 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -113.33 122.89 48.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.693 0.397 . . . . 0.0 110.08 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -93.27 156.63 16.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 111.632 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.72 -22.92 60.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 122.606 0.363 . . . . 0.0 111.441 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -121.54 141.07 32.72 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 118.428 0.558 . . . . 0.0 110.042 174.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.33 -0.98 10.96 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.833 2.355 . . . . 0.0 110.599 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.6 -16.8 10.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.198 0.454 . . . . 0.0 110.827 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.4 m-20 -70.56 -29.05 65.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.74 -29.98 59.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.438 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -70.9 -39.25 72.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.21 -29.84 69.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.253 -0.276 . . . . 0.0 110.253 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.273 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.53 -12.58 61.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.501 0.32 . . . . 0.0 111.055 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -97.19 6.85 47.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.946 0.899 . . . . 0.0 112.052 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.92 -52.04 1.22 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.002 0.819 . . . . 0.0 109.892 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 54.3 mmm -81.65 -14.75 56.28 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.07 1.748 . . . . 0.0 112.055 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -74.35 116.33 14.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.14 -8.15 60.7 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.372 0.511 . . . . 0.0 112.027 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -82.54 -156.57 0.18 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.361 1.064 . . . . 0.0 109.392 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -144.35 158.8 43.55 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 123.786 0.834 . . . . 0.0 111.779 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.75 125.68 27.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.0 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 3.5 t70 61.07 -24.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 161.05 -12.2 0.14 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.78 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -118.29 137.32 53.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.468 1.134 . . . . 0.0 109.948 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.56 138.32 50.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.037 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.48 HG21 HD23 ' B' ' 15' ' ' LEU . 27.0 pt -120.65 163.74 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -112.56 144.01 42.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.302 1.841 . . . . 0.0 107.963 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 29.2 t -135.07 130.6 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.87 162.26 39.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.12 123.43 21.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.33 146.48 43.97 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 CA--C 1.518 -0.272 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.36 173.304 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -98.24 127.1 44.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' B' ' 56' ' ' PHE . 77.1 mt -113.4 153.26 28.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.971 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -106.4 128.94 54.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.53 81.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.86 143.2 16.46 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.951 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.6 11.63 34.97 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 117.74 0.77 . . . . 0.0 111.752 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -67.33 162.33 23.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 111.706 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.592 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.2 t30 -75.29 156.54 35.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.642 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -71.34 -8.27 52.59 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.244 0.618 . . . . 0.0 110.383 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.26 -10.17 20.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.607 1.163 . . . . 0.0 110.489 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -81.79 146.18 30.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.29 0.636 . . . . 0.0 109.918 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.58 -167.26 2.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.174 -173.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -67.72 -28.54 67.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 118.055 0.388 . . . . 0.0 111.075 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.39 -21.89 30.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.56 -29.02 22.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.107 1.363 . . . . 0.0 109.403 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.23 -28.21 38.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 109.937 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.12 37.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.352 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.589 HG11 HD21 ' B' ' 74' ' ' LEU . 6.0 p -104.35 -35.0 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.524 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -91.95 -10.99 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.909 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.38 -2.9 75.73 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -81.9 -12.17 58.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.708 1.203 . . . . 0.0 111.04 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -112.14 -19.16 12.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.39 166.41 37.39 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 118.264 0.484 . . . . 0.0 112.716 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -73.88 117.1 15.26 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mt -76.29 142.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.67 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -21.97 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.178 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.71 150.17 15.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.019 0.528 . . . . 0.0 109.834 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.98 145.92 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.352 0.596 . . . . 0.0 109.546 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -121.9 154.77 36.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.451 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.501 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.42 119.55 5.44 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.49 141.07 28.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.5 -170.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.501 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.3 mttt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 . . . . . 0 CA--C 1.523 -0.065 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.51 0.31 89.32 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.855 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -133.92 157.11 46.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.637 1.219 . . . . 0.0 110.604 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.137 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 62.5 m-85 -143.05 162.41 35.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.623 0.369 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.79 140.31 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.8 m -112.75 122.56 48.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 123.271 0.357 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' B' ' 10' ' ' LEU . 13.8 m-85 -92.5 156.69 16.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.859 0.864 . . . . 0.0 111.791 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.7 -21.81 59.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.215 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -122.26 139.83 31.38 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.94 -0.15 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.161 2.574 . . . . 0.0 110.65 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.01 -14.99 9.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.822 0.283 . . . . 0.0 111.141 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.3 m-20 -72.43 -28.5 63.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.27 -29.24 60.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -73.03 -37.25 66.96 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.1 -25.5 65.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.533 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.64 16.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.204 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.4 -8.93 57.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.26 9.03 34.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.341 0.657 . . . . 0.0 112.727 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.09 -53.77 1.3 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.546 0.689 . . . . 0.0 109.461 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 26.8 mmm -81.73 -10.22 59.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.63 1.572 . . . . 0.0 112.055 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -73.43 127.02 31.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.68 79.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.333 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -82.38 -157.42 0.21 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.608 1.163 . . . . 0.0 109.824 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -136.15 153.12 51.37 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.593 0.757 . . . . 0.0 110.858 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.589 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -101.75 -65.88 0.95 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.124 -175.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.592 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.5 t70 -121.54 14.49 11.06 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.391 -175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.44 -6.09 9.25 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.846 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -112.88 131.04 55.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.734 0.814 . . . . 0.0 108.843 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.19 134.98 37.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.116 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 pt -115.12 175.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -118.27 141.72 48.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.058 1.743 . . . . 0.0 107.099 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.71 127.42 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.76 163.79 37.72 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -63.75 134.09 54.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.87 152.7 38.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 169.493 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.419 0.152 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -98.89 109.77 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -132.55 136.12 46.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.33 -175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.85 116.24 10.62 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -73.91 74.18 1.64 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 112.297 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' B' ' 7' ' ' PRO . 0.0 OUTLIER 52.17 147.5 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 129.02 2.928 . . . . 0.0 116.206 176.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 73.7 Cg_exo -55.16 145.01 67.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.847 3.031 . . . . 0.0 112.631 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.03 -15.66 51.19 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -98.37 128.25 44.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.146 0.973 . . . . 0.0 108.438 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.7 mt -112.29 155.62 23.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -109.48 128.92 55.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.508 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.7 mm -120.14 79.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.97 144.81 17.41 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.416 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 9.46 42.0 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.576 0.688 . . . . 0.0 111.534 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.83 164.0 15.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.745 0.783 . . . . 0.0 111.612 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.8 t-20 -74.47 159.37 32.35 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.42 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.479 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 42.2 p -74.78 -11.23 60.11 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.084 -0.385 . . . . 0.0 110.279 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.97 -9.36 28.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.107 0.963 . . . . 0.0 110.937 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -76.8 144.83 38.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.84 0.456 . . . . 0.0 109.924 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.74 -169.1 2.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -69.8 -34.84 74.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.72 -174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -66.83 -29.19 69.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.874 0.306 . . . . 0.0 111.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.85 31.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.39 -28.24 22.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.154 1.382 . . . . 0.0 109.774 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.62 -29.39 36.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.615 0.721 . . . . 0.0 110.111 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.69 -22.76 40.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.307 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.5 p -102.29 -35.16 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.528 ' CD2' HG13 ' B' ' 27' ' ' VAL . 90.3 m-85 -92.09 -10.69 38.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.182 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.57 -2.92 77.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.55 -12.8 58.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.972 1.309 . . . . 0.0 111.116 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.33 -19.04 12.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.686 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.72 165.42 36.15 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.159 0.436 . . . . 0.0 112.37 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -73.54 116.95 14.72 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.9 mt -75.9 141.65 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.636 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -22.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.131 0.573 . . . . 0.0 110.022 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.22 149.16 15.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.933 0.493 . . . . 0.0 109.83 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.36 144.99 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.306 0.574 . . . . 0.0 109.644 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.8 mt -121.12 154.59 35.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.307 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.14 117.93 6.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.4 mmm -88.08 142.06 28.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.38 158.59 44.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.77 146.78 24.94 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.101 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -90.0 -2.38 58.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.48 -14.51 10.31 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.03 0.532 . . . . 0.0 112.08 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.8 p -127.98 -15.74 4.74 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.189 0.449 . . . . 0.0 111.609 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 57.01 23.53 8.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -73.66 -90.71 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.28 1.032 . . . . 0.0 111.17 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 23.2 t -165.79 152.47 9.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.649 1.579 . . . . 0.0 108.868 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -89.93 -2.3 58.14 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.75 1.42 85.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.149 0.88 . . . . 0.0 112.287 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.78 161.42 38.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.307 1.053 . . . . 0.0 110.13 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.99 -177.3 6.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.7 m-85 -142.24 160.35 40.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -154.06 140.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -113.11 122.86 48.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.151 0.282 . . . . 0.0 110.357 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -92.39 156.01 17.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.96 0.904 . . . . 0.0 111.93 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -74.22 -21.99 59.56 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.57 0.348 . . . . 0.0 111.135 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -121.88 141.49 34.13 Favored Pre-proline 0 C--N 1.34 0.164 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 98.4 Cg_endo -73.45 -9.72 23.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.682 2.254 . . . . 0.0 110.3 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.19 -14.48 13.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.285 0.493 . . . . 0.0 110.572 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.5 m-20 -71.95 -28.5 63.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.75 -31.18 56.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -68.46 -38.35 81.02 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.93 -32.41 72.0 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.71 -44.03 44.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -6.78 42.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 122.075 -0.39 . . . . 0.0 111.253 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -105.87 5.32 30.56 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 112.349 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.74 -52.29 1.24 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.498 0.666 . . . . 0.0 109.49 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.4 ' HE3' HD11 ' B' ' 79' ' ' ILE . 31.6 mmm -83.55 -9.46 58.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.397 1.479 . . . . 0.0 111.987 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.8 124.8 27.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.85 -4.92 85.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.23 -152.97 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.569 1.148 . . . . 0.0 109.459 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -140.61 158.86 43.36 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.757 0.789 . . . . 0.0 112.915 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 128.78 31.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.835 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.3 t0 52.57 22.53 2.22 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.145 0.497 . . . . 0.0 112.214 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.92 -3.33 57.16 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 119.32 -0.711 . . . . 0.0 113.853 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -114.99 130.13 56.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.216 1.008 . . . . 0.0 110.304 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 139.47 52.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.749 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.4 HD11 ' HE3' ' B' ' 69' ' ' MET . 18.9 pt -124.89 174.82 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -119.01 144.36 46.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.184 1.794 . . . . 0.0 107.799 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.32 127.26 50.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -62.27 138.37 58.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.05 35.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -173.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 75.1 p -112.37 -179.62 3.72 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.125 171.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -85.34 154.04 59.52 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 123.228 0.611 . . . . 0.0 111.138 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.93 162.63 37.06 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.858 3.039 . . . . 0.0 111.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -130.58 10.33 5.17 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -81.71 2.07 31.42 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.699 -0.626 . . . . 0.0 111.986 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -143.54 156.95 44.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.531 0.333 . . . . 0.0 110.46 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 44.5 m -142.81 167.65 21.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.703 0.801 . . . . 0.0 110.795 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 156.16 48.61 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.43 160.38 42.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.439 0.696 . . . . 0.0 111.211 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 46.2 mtm105 56.17 179.39 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.904 1.282 . . . . 0.0 112.468 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.302 0 CA-C-O 117.421 -1.766 . . . . 0.0 111.23 -179.512 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.548 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.301 1 O4'-C1'-N19 112.438 4.238 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.612 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.86 0 O4'-C1'-N19 111.388 3.188 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.021 0 C5'-C4'-C3' 112.411 -2.059 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 1 O4'-C1'-N19 114.683 6.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 2 C5'-C4'-C3' 108.069 -4.954 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C5'-C4'-C3' 111.135 -2.91 . 0.156 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.33 0.586 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.527 ' O ' HG22 ' B' ' 2' ' ' VAL . 3.6 p -133.23 13.54 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.681 1.592 . . . . 0.0 107.351 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -74.56 142.95 44.66 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.502 -167.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.4 105.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -51.99 -70.99 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -148.04 138.98 13.34 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 118.731 0.696 . . . . 0.0 109.999 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 73.9 Cg_exo -54.12 142.45 66.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.92 2.413 . . . . 0.0 110.781 174.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.82 67.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.97 126.79 39.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 68.6 mt -113.56 153.27 29.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.062 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -106.7 127.59 53.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -119.62 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.93 142.16 15.93 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.51 35.93 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 117.691 0.745 . . . . 0.0 111.805 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.39 164.36 16.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.155 0.502 . . . . 0.0 111.858 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.537 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t-20 -77.79 158.31 29.6 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.144 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 57.9 p -73.21 -6.97 49.34 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.401 0.68 . . . . 0.0 110.114 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.52 -10.19 21.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.654 1.181 . . . . 0.0 110.531 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 31.0 m -83.22 144.68 29.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.325 0.65 . . . . 0.0 109.822 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.89 -170.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -66.99 -34.92 78.81 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.093 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -67.6 -29.03 68.27 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 118.016 0.371 . . . . 0.0 111.099 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.27 29.42 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.423 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -87.44 -27.89 22.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 109.555 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -81.45 -28.23 34.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 109.899 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.65 -21.78 37.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.42 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.522 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.5 p -103.41 -36.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.522 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -90.63 -11.36 40.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.817 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.9 -3.04 73.05 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.62 -11.87 58.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.682 1.193 . . . . 0.0 110.855 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -111.82 -19.5 12.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.83 166.61 37.49 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 118.046 0.384 . . . . 0.0 112.406 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 43.5 ttt-85 -73.74 117.52 15.62 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.09 142.37 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.56 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -22.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 123.212 0.605 . . . . 0.0 110.137 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -161.73 150.21 15.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.05 0.54 . . . . 0.0 109.878 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.58 146.4 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.056 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -121.3 154.63 36.13 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.378 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.423 HD23 ' CD1' ' B' ' 24' ' ' LEU . 3.0 tm? -152.68 118.36 5.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.6 mmm -91.38 139.85 30.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.851 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.414 ' HE2' HD12 ' B' ' 39' ' ' LEU . 8.9 mttt -135.84 152.55 51.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.477 0.656 . . . . 0.0 112.472 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.5 143.03 54.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.862 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -82.49 -8.21 59.62 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -117.46 -12.72 10.38 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -129.51 -14.88 4.11 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.217 0.462 . . . . 0.0 111.714 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.8 22.49 7.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.0 -106.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.772 1.229 . . . . 0.0 109.651 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 22.8 t -151.14 143.72 24.33 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -76.59 -6.05 50.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.58 89.45 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.401 -0.666 . . . . 0.0 111.559 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -138.49 157.46 46.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.559 1.18 . . . . 0.0 109.952 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.93 -179.1 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.455 0.302 . . . . 0.0 110.853 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 49.9 m-85 -142.67 162.61 35.01 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.848 0.459 . . . . 0.0 110.215 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.87 141.53 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.6 m -113.3 123.54 50.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.336 0.397 . . . . 0.0 110.135 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.65 156.85 16.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.695 0.798 . . . . 0.0 111.627 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.19 -22.42 59.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.608 0.363 . . . . 0.0 111.275 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -121.23 140.04 30.51 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.395 0.543 . . . . 0.0 110.084 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 56.6 Cg_endo -76.2 0.72 9.08 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.231 2.62 . . . . 0.0 110.583 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.46 -16.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.063 0.392 . . . . 0.0 111.356 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.9 m-20 -71.75 -28.57 63.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.49 57.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.66 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -74.5 -37.01 63.24 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.76 -24.61 64.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.488 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.24 14.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.38 45.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -109.06 9.36 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 112.224 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -52.25 1.33 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.54 -175.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mmm -83.12 -9.17 59.35 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.846 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -75.22 127.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.829 -0.544 . . . . 0.0 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.59 -6.12 83.16 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.51 -154.17 0.11 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.518 1.127 . . . . 0.0 109.436 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.8 t -140.3 159.19 42.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.576 0.703 . . . . 0.0 112.311 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -133.37 126.8 32.11 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.046 177.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.537 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.53 -22.24 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.513 1.125 . . . . 0.0 113.821 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.87 -6.28 0.53 Allowed Glycine 0 N--CA 1.439 -1.123 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.19 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -118.46 134.38 55.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.959 0.879 . . . . 0.0 110.341 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.55 138.42 48.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.471 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.08 175.52 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -119.89 142.46 48.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.13 1.772 . . . . 0.0 107.397 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.56 125.41 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -162.05 164.42 28.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -57.79 134.8 56.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.9 158.8 32.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.271 0.558 . . . . 0.0 112.359 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -119.31 168.04 11.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.491 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -68.17 151.78 96.96 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.526 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.82 164.9 32.9 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.878 3.052 . . . . 0.0 110.369 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -119.44 2.84 11.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -88.23 -1.51 58.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.34 0.518 . . . . 0.0 111.011 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.35 176.97 8.35 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.427 0.691 . . . . 0.0 111.235 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 11.7 t -147.12 165.08 31.05 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.875 0.47 . . . . 0.0 110.398 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.52 128.11 32.38 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -151.6 167.42 28.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.601 0.761 . . . . 0.0 110.479 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 53.04 29.95 8.78 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 0.0 111.992 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.116 -1.936 . . . . 0.0 110.934 -179.063 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.564 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.344 2 C5'-C4'-C3' 109.32 -4.12 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.65 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.985 0 O4'-C1'-N19 111.403 3.203 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 O4'-C1'-N19 110.493 2.293 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 O4'-C1'-N19 114.085 5.885 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 2 C5'-C4'-C3' 109.161 -4.226 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.96 0 O4'-C1'-N19 111.471 3.271 . 0.583 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.287 0.565 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.537 ' O ' HG22 ' B' ' 2' ' ' VAL . 3.5 p -127.6 15.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.316 1.446 . . . . 0.0 107.749 172.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -76.74 139.99 40.65 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.317 -168.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.43 115.86 16.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -73.18 51.63 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 113.068 -173.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' B' ' 7' ' ' PRO . 81.9 mtp180 60.98 147.02 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 127.261 2.224 . . . . 0.0 114.708 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 72.0 Cg_exo -54.17 150.43 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.991 3.127 . . . . 0.0 112.841 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.76 -15.81 58.07 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -101.13 129.9 47.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.018 0.909 . . . . 0.0 108.891 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.406 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 77.4 mt -113.35 153.61 28.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -107.73 129.23 55.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -121.0 82.37 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.07 144.44 17.28 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.758 -0.589 . . . . 0.0 112.001 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.71 9.21 43.96 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 117.524 0.662 . . . . 0.0 111.597 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.91 162.86 12.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.579 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.6 t-20 -73.51 159.95 32.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.598 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.9 p -74.53 -4.56 37.64 Favored 'General case' 0 N--CA 1.457 -0.075 0 C-N-CA 122.902 0.481 . . . . 0.0 110.366 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.25 -7.68 18.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 110.81 -172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.7 m -80.54 144.19 32.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.922 0.489 . . . . 0.0 109.937 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.63 -169.66 2.45 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -68.85 -35.36 76.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.778 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -65.68 -29.71 70.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.916 -0.49 . . . . 0.0 110.97 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.89 -20.99 28.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -89.34 -27.97 20.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.802 1.241 . . . . 0.0 109.606 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.35 -27.82 31.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 109.907 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -23.26 38.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.309 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.1 p -101.06 -35.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.506 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.8 m-85 -92.1 -10.87 37.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.283 -0.261 . . . . 0.0 111.024 176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.67 -2.62 76.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.72 -11.25 59.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.431 1.092 . . . . 0.0 111.159 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.93 -18.85 11.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.39 0.676 . . . . 0.0 112.634 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -174.83 161.19 30.64 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -72.6 124.22 24.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.89 143.49 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.286 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.07 -23.56 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.351 0.66 . . . . 0.0 110.076 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.02 150.47 16.94 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.99 146.58 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 121.28 0.562 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -121.32 153.67 37.43 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.245 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.38 118.83 6.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.7 mmm -92.31 137.59 32.24 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.932 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -148.2 154.04 39.57 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.331 0.586 . . . . 0.0 111.293 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.73 163.94 10.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.047 0.939 . . . . 0.0 110.622 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -111.96 -4.47 14.53 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.86 0.464 . . . . 0.0 111.878 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.24 -14.19 15.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.595 0.758 . . . . 0.0 110.727 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -131.21 -14.95 3.33 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 122.773 0.429 . . . . 0.0 111.722 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 13.1 6.42 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -87.87 144.67 26.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.402 0.681 . . . . 0.0 110.178 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -55.53 138.75 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.474 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -71.09 -9.45 58.07 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.253 1.021 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.46 0.5 79.41 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.698 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -136.92 158.42 44.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.434 1.117 . . . . 0.0 110.376 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.02 -179.5 8.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.868 0.467 . . . . 0.0 110.728 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.8 m-85 -141.85 161.98 36.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.659 0.383 . . . . 0.0 110.231 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.81 141.13 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 34.3 m -113.52 122.12 46.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.349 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -92.82 156.95 16.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.938 0.895 . . . . 0.0 110.768 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -79.63 -20.97 45.49 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.451 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -118.16 138.85 25.96 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 80.2 Cg_endo -74.46 -6.6 18.55 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.635 2.224 . . . . 0.0 110.431 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.26 -14.77 12.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.201 0.455 . . . . 0.0 111.135 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.464 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.7 m-20 -71.53 -28.46 63.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 -30.52 52.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.394 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.01 -39.14 79.48 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.04 -32.17 72.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.72 45.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.39 -7.55 48.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.209 -0.307 . . . . 0.0 111.163 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -105.26 5.67 32.23 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.521 1.128 . . . . 0.0 112.344 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.16 -51.68 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.768 0.794 . . . . 0.0 109.755 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.404 ' HE3' HD11 ' B' ' 79' ' ' ILE . 28.9 mmm -83.59 -10.13 58.46 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.145 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.7 126.13 29.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.48 -5.74 84.54 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.59 -0.561 . . . . 0.0 111.841 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -81.54 -153.72 0.11 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.361 1.064 . . . . 0.0 109.473 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -139.84 158.75 43.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.534 0.683 . . . . 0.0 112.327 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.9 126.99 31.58 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.496 177.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.546 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.5 t70 61.19 -21.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.18 -7.03 0.53 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.4 135.16 54.86 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.264 1.032 . . . . 0.0 110.218 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.31 138.89 51.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.597 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.404 HD11 ' HE3' ' B' ' 69' ' ' MET . 19.9 pt -121.22 179.52 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -125.05 145.02 50.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.823 1.649 . . . . 0.0 107.787 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -133.12 129.49 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -158.1 163.31 37.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -65.24 137.06 57.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.22 155.57 38.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p -120.77 175.29 6.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.228 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.63 152.36 92.84 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.078 0.551 . . . . 0.0 110.426 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.95 154.63 73.2 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.378 2.718 . . . . 0.0 110.331 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 35.2 m -80.7 1.2 31.17 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -97.42 3.37 50.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.06 0.391 . . . . 0.0 111.073 175.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.66 154.02 42.96 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.337 0.589 . . . . 0.0 111.539 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 70.5 m -144.17 20.2 1.75 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.304 1.042 . . . . 0.0 110.623 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.05 -148.56 28.6 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.443 ' HG2' ' H ' ' B' ' 94' ' ' ARG . 25.9 ttp180 49.97 -142.28 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.687 0.795 . . . . 0.0 110.681 -177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' B' ' 93' ' ' ARG . 61.3 ttp180 -148.37 150.56 33.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.861 1.264 . . . . 0.0 109.067 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.475 -1.736 . . . . 0.0 110.928 179.586 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.564 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 O4'-C1'-N19 112.051 3.851 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.621 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.064 0 C3'-C2'-C1' 104.607 3.452 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 C5'-C4'-C3' 112.522 -1.986 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 1 O4'-C1'-N19 114.246 6.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.368 2 O4'-C1'-N19 114.066 5.866 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 0 O4'-C1'-N19 111.244 3.044 . 0.202 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.358 0.599 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.08 127.58 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -130.85 125.12 32.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.058 0.456 . . . . 0.0 111.142 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.33 105.2 13.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.75 -36.18 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -162.75 134.11 3.78 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 118.473 0.579 . . . . 0.0 111.225 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.458 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 71.3 Cg_exo -57.29 149.01 67.29 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.282 2.655 . . . . 0.0 111.637 171.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.96 -19.14 54.76 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -86.13 129.05 34.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' B' ' 56' ' ' PHE . 78.0 mt -116.69 155.53 28.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.362 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.58 129.67 55.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.492 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -121.72 80.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.7 144.63 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.267 -0.492 . . . . 0.0 111.977 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.48 7.52 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 117.497 0.649 . . . . 0.0 111.545 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 mt -64.24 164.75 10.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.163 0.585 . . . . 0.0 111.166 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.53 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.0 t-20 -72.1 158.94 35.01 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.46 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.8 p -75.79 -4.77 42.47 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.218 -0.301 . . . . 0.0 110.375 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.49 -7.38 17.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.127 0.971 . . . . 0.0 111.066 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 52.2 m -79.18 144.89 34.01 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.09 0.556 . . . . 0.0 109.576 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.93 2.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.171 0.51 . . . . 0.0 110.009 175.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.86 -34.37 76.56 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.756 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.41 -30.36 70.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.046 -0.409 . . . . 0.0 110.923 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.74 -21.41 30.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.84 -28.47 19.25 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 109.928 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.8 -27.92 33.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.237 0.542 . . . . 0.0 110.119 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.34 -22.95 38.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.241 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.0 p -100.96 -36.65 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.6 m-85 -91.03 -10.89 40.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.958 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.75 -3.2 72.58 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -82.12 -11.76 58.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.63 1.172 . . . . 0.0 111.034 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.43 -19.88 11.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.364 0.665 . . . . 0.0 112.538 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.71 165.36 36.06 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 118.051 0.387 . . . . 0.0 112.189 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -73.09 117.97 15.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.3 141.35 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.509 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.74 -24.49 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.871 0.468 . . . . 0.0 110.093 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -160.35 151.36 19.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.66 146.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 109.699 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -118.99 153.95 33.82 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.1 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -153.66 120.23 5.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.41 140.02 30.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.663 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -145.98 155.51 42.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.257 0.551 . . . . 0.0 112.304 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.38 161.18 23.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.925 1.29 . . . . 0.0 111.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -103.83 -3.93 24.24 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.045 0.538 . . . . 0.0 112.266 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.17 -14.03 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 111.65 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 33.9 p -128.14 -14.93 4.82 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.546 0.339 . . . . 0.0 111.292 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 63.11 9.56 3.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -83.8 148.86 26.78 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.745 0.818 . . . . 0.0 110.043 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 m -57.73 139.49 53.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.517 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -72.94 -2.7 21.94 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.666 0.786 . . . . 0.0 110.133 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.83 75.79 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.34 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -141.74 157.97 44.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.627 1.213 . . . . 0.0 110.619 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.688 0.395 . . . . 0.0 110.791 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.7 m-85 -141.93 162.44 35.46 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.004 0.522 . . . . 0.0 110.127 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.36 139.86 12.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -112.18 122.17 46.99 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.7 m-85 -92.16 156.17 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.023 0.929 . . . . 0.0 111.642 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.56 -21.92 59.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 122.612 0.365 . . . . 0.0 111.061 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.7 t -121.23 140.48 31.26 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.458 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 68.1 Cg_endo -74.45 -7.43 19.57 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.462 2.108 . . . . 0.0 110.472 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.13 -15.87 13.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.369 0.267 . . . . 0.0 110.902 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 75.0 m-20 -70.76 -28.35 64.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.14 54.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.553 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -68.83 -39.04 80.19 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.99 -36.34 81.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.6 64.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.5 47.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.199 -0.313 . . . . 0.0 111.185 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -105.41 7.59 33.26 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.465 1.106 . . . . 0.0 112.274 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.61 -52.27 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.826 0.739 . . . . 0.0 109.568 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.32 -9.88 59.3 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.595 1.558 . . . . 0.0 112.439 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.71 125.38 27.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.74 -5.79 84.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.54 -153.98 0.09 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.474 1.11 . . . . 0.0 109.712 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 26.2 t -139.49 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.865 0.841 . . . . 0.0 112.814 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.46 129.09 30.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.757 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.53 ' HB3' HD22 ' B' ' 16' ' ' ASN . 6.4 t0 52.89 22.24 2.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.058 0.456 . . . . 0.0 112.131 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.86 -2.46 58.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.978 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.92 130.19 56.86 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.251 1.026 . . . . 0.0 110.557 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.46 138.25 50.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.502 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.91 178.39 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -122.8 141.51 51.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.717 2.007 . . . . 0.0 107.317 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.15 130.22 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -159.12 164.15 35.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -69.57 132.44 46.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 148.1 33.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.9 p -112.25 167.49 10.38 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.486 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -59.14 149.51 67.07 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.107 0.563 . . . . 0.0 111.024 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.02 157.64 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.709 2.939 . . . . 0.0 110.356 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 21.6 t -71.9 -10.74 60.21 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.684 0.794 . . . . 0.0 111.698 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -106.91 6.71 29.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.047 -0.408 . . . . 0.0 111.304 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 49.47 -169.31 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.89 1.676 . . . . 0.0 113.846 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 36.2 t -148.31 148.18 30.13 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.738 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.04 -3.86 88.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -103.77 -30.13 10.59 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.203 0.601 . . . . 0.0 112.078 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -141.4 11.7 2.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.261 -1.855 . . . . 0.0 111.037 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.568 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.367 1 C5'-C4'-C3' 109.104 -4.264 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.634 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.03 0 C3'-C2'-C1' 104.41 3.234 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . 0.433 " H3'" H5'' ' A' ' 99' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.821 1 C5'-C4'-C3' 109.432 -4.045 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . 0.433 H5'' " H3'" ' A' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.773 1 O4'-C1'-N19 114.183 5.983 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 2 O4'-C1'-N19 112.924 4.724 . 0.013 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C5'-C4'-C3' 111.478 -2.682 . 0.578 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.427 0.156 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.54 109.77 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -135.12 141.57 46.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.037 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.64 101.4 3.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 129.17 34.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.707 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 45.96 107.6 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 127.33 2.252 . . . . 0.0 115.066 175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 79.2 Cg_exo -52.56 144.05 43.26 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.925 2.416 . . . . 0.0 110.679 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.86 -17.94 57.65 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -82.15 129.65 34.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.4 mt -118.89 159.51 23.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.04 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -112.62 129.71 56.28 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.5 mm -122.08 81.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -174.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.38 145.5 17.78 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.197 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.76 33.24 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 117.57 0.685 . . . . 0.0 112.026 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.13 168.03 3.59 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 112.586 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.422 HD22 ' CG ' ' B' ' 75' ' ' ASP . 51.7 t30 -73.27 -6.41 45.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 1.7 p 68.76 -13.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.652 1.581 . . . . 0.0 113.479 -170.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.72 -7.25 28.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.42 0.688 . . . . 0.0 109.301 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -76.25 147.52 38.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.531 1.132 . . . . 0.0 109.521 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -170.14 2.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.586 0.707 . . . . 0.0 109.566 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.03 -35.79 80.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.542 -173.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.83 -30.14 70.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.82 -20.39 23.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' B' ' 27' ' ' VAL . 8.6 mt -87.08 -28.32 22.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.216 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -80.11 -26.94 39.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 110.058 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.57 38.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.478 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -103.89 -35.59 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.8 m-85 -92.33 -11.24 35.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.944 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.07 -2.84 73.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -81.77 -12.92 58.36 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.684 1.193 . . . . 0.0 111.073 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -111.34 -19.18 12.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 123.756 0.66 . . . . 0.0 112.547 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.33 165.88 35.49 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -73.29 117.09 14.62 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -76.1 139.08 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.246 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -24.97 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.944 0.497 . . . . 0.0 109.863 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -160.38 150.87 18.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.078 0.551 . . . . 0.0 109.562 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.4 145.57 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.34 0.591 . . . . 0.0 109.572 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -119.05 153.02 35.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 114.661 -1.154 . . . . 0.0 107.91 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.02 117.42 5.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.1 mmm -91.88 139.97 30.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.65 152.29 39.42 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.38 165.45 9.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.978 1.311 . . . . 0.0 111.834 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -109.77 -5.4 15.6 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.375 0.67 . . . . 0.0 111.77 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -111.16 -13.69 13.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.534 0.734 . . . . 0.0 111.63 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 51.6 p -128.38 -15.76 4.53 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.506 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 30.8 m120 59.62 10.35 1.92 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 123.107 0.254 . . . . 0.0 111.609 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -82.23 155.13 25.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 37.3 t -59.66 148.93 32.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.754 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -69.99 -5.12 24.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.21 1.73 81.24 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.51 157.67 46.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.248 1.024 . . . . 0.0 110.775 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.53 -179.19 7.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.205 0.602 . . . . 0.0 110.62 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 42.6 m-85 -142.53 162.04 36.5 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -152.91 138.69 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -111.89 122.08 46.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.681 0.392 . . . . 0.0 109.975 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 12.8 m-85 -92.07 156.08 17.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.822 0.849 . . . . 0.0 111.616 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.11 -22.51 60.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.857 0.463 . . . . 0.0 111.063 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.1 t -121.74 139.98 31.05 Favored Pre-proline 0 CA--C 1.52 -0.2 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 61.6 Cg_endo -74.59 -3.0 13.19 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.897 2.398 . . . . 0.0 110.48 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.02 -14.84 11.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 123.141 0.276 . . . . 0.0 111.278 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 79.8 m-20 -71.57 -28.93 64.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.42 -30.79 57.56 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.507 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -68.87 -38.83 79.97 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.15 -32.6 72.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.92 -44.48 48.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 -7.38 45.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.315 -0.241 . . . . 0.0 111.41 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -105.59 5.28 31.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.129 0.972 . . . . 0.0 112.08 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.28 -53.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 29.7 mmm -82.2 -10.08 59.28 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.569 1.548 . . . . 0.0 112.205 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.98 126.37 30.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.609 -0.682 . . . . 0.0 109.381 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.79 -7.11 81.22 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.43 -153.96 0.11 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.449 1.099 . . . . 0.0 109.319 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -137.53 158.68 43.87 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.529 0.681 . . . . 0.0 112.649 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.422 HD21 HG11 ' B' ' 27' ' ' VAL . 0.1 OUTLIER -132.15 125.27 30.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.422 ' CG ' HD22 ' B' ' 16' ' ' ASN . 11.4 t0 57.16 -2.02 0.05 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 137.62 -11.41 3.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 119.138 -0.812 . . . . 0.0 113.762 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -120.35 137.2 54.41 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.315 1.058 . . . . 0.0 111.092 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 140.33 56.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.239 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.51 177.63 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -120.79 142.52 49.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.883 1.673 . . . . 0.0 107.386 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.37 127.19 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -158.88 163.58 36.47 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -65.76 134.61 53.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.14 139.25 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.2 p -95.8 167.78 11.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.7 154.34 85.37 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.55 159.43 48.02 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.922 2.415 . . . . 0.0 110.15 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -122.8 5.28 9.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.336 0.654 . . . . 0.0 112.638 -170.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -75.37 -2.57 29.1 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.913 -0.492 . . . . 0.0 110.726 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 92' ' ' GLY . 26.5 tt0 -143.36 143.91 31.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.011 0.524 . . . . 0.0 109.826 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -100.9 -0.18 37.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.762 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . -70.66 133.32 23.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -142.64 173.17 11.78 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.679 0.792 . . . . 0.0 110.15 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -127.27 152.28 47.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.715 0.806 . . . . 0.0 110.504 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.02 -1.989 . . . . 0.0 111.128 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.555 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 1 C5'-C4'-C3' 108.581 -4.613 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.609 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.97 0 C3'-C2'-C1' 104.65 3.5 OUTLIER-DELTA 0.013 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.938 0 C5'-C4'-O4' 111.924 1.946 . 0.026 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 1 O4'-C1'-N19 113.153 4.953 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.283 1 O4'-C1'-N19 113.132 4.932 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 O4'-C1'-N19 111.316 3.116 . 0.439 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' B' ' 1' ' ' MET . 8.7 mmt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.465 ' O ' HG22 ' B' ' 2' ' ' VAL . 7.5 p -76.63 6.63 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 122.109 0.957 . . . . 0.0 109.801 170.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' B' ' 1' ' ' MET . 40.6 mm-40 -83.76 129.44 34.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.994 0.918 . . . . 0.0 109.825 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.66 102.54 11.99 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.24 75.32 2.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.402 1.081 . . . . 0.0 112.477 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 60.7 137.75 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 126.425 1.89 . . . . 0.0 114.114 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 88.3 Cg_exo -51.96 147.56 25.78 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.22 2.614 . . . . 0.0 112.169 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.13 -15.61 56.34 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-O 119.125 -0.82 . . . . 0.0 111.137 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -93.25 127.07 38.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.088 0.944 . . . . 0.0 108.734 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' B' ' 56' ' ' PHE . 76.0 mt -113.39 149.23 34.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.19 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.33 127.88 49.14 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 10.0 mm -118.94 77.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -173.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.59 144.63 17.2 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.14 45.22 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 117.733 0.767 . . . . 0.0 111.752 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.52 163.88 12.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.152 0.581 . . . . 0.0 111.408 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.5 t30 -72.78 155.9 39.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.71 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 62.0 p -74.69 -0.95 19.72 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.367 0.267 . . . . 0.0 111.093 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -110.5 -5.79 15.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 110.668 -171.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -82.93 144.71 29.84 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.084 0.554 . . . . 0.0 109.571 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -169.74 2.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.19 -35.37 79.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.764 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.32 -29.15 68.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.041 -0.412 . . . . 0.0 111.061 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.51 -21.03 28.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.65 -28.43 20.62 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.91 1.284 . . . . 0.0 109.532 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.25 -28.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.632 0.73 . . . . 0.0 109.903 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.38 -23.11 40.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.162 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 74' ' ' LEU . 5.4 p -101.92 -34.53 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.4 m-85 -91.48 -10.66 40.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.719 -0.218 . . . . 0.0 111.064 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.3 -2.44 79.17 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -82.21 -11.97 58.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.406 1.082 . . . . 0.0 111.002 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.74 -19.89 11.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.573 0.749 . . . . 0.0 112.739 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.84 166.59 37.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -74.03 116.83 15.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.94 141.13 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -22.71 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -160.85 150.06 16.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.01 0.524 . . . . 0.0 109.846 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.81 144.13 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.1 mt -120.17 158.44 26.93 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.105 175.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -155.91 123.17 5.43 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.99 137.3 33.35 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -143.06 150.86 40.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.418 0.449 . . . . 0.0 110.89 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.84 157.37 35.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.662 0.785 . . . . 0.0 111.579 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -89.13 -11.37 44.11 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.338 0.255 . . . . 0.0 111.2 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -106.05 -15.16 14.96 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 112.106 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 71.2 p -133.33 -13.18 2.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 58.18 14.12 2.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.881 0.309 . . . . 0.0 111.488 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -86.27 147.18 26.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 m -57.0 134.12 55.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -76.31 4.76 8.2 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.566 0.222 . . . . 0.0 110.5 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.15 3.7 78.85 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.436 -0.647 . . . . 0.0 112.127 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -140.22 157.7 45.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.357 1.079 . . . . 0.0 110.741 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.84 -178.41 7.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.893 0.477 . . . . 0.0 110.501 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 51.5 m-85 -142.34 163.18 33.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.568 0.347 . . . . 0.0 110.42 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -153.78 146.36 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -117.37 123.44 46.47 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.316 0.385 . . . . 0.0 110.201 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.4 m-85 -93.55 156.15 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.33 0.652 . . . . 0.0 111.925 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.52 -22.67 58.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.2 t -121.33 141.11 32.52 Favored Pre-proline 0 C--O 1.233 0.202 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.5 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 66.8 Cg_endo -74.29 -8.84 21.3 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.557 2.172 . . . . 0.0 110.08 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.02 -15.24 13.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.588 0.355 . . . . 0.0 110.732 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.498 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.2 m-20 -72.43 -29.02 63.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.07 -29.61 58.05 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.44 -38.13 77.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.24 -32.31 71.46 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 -46.32 40.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.12 47.04 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.083 -0.386 . . . . 0.0 111.49 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -102.64 7.38 39.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.468 1.107 . . . . 0.0 112.646 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.28 -51.31 0.94 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.491 1.138 . . . . 0.0 109.373 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 45.4 mmm -79.43 -16.45 56.14 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.669 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -73.96 119.02 17.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.94 74.86 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.359 -0.689 . . . . 0.0 112.652 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 7.9 ptpt -88.26 179.63 6.32 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 118.377 1.088 . . . . 0.0 111.316 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -107.94 146.66 32.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.77 -63.9 1.13 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.4 0.619 . . . . 0.0 110.573 -176.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.579 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.6 t70 -124.45 5.49 8.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.548 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.99 -11.96 2.85 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.43 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -115.79 133.45 56.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.58 0.752 . . . . 0.0 109.598 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.78 136.95 41.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.793 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 17.5 pt -115.29 175.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -120.27 142.67 48.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.58 1.552 . . . . 0.0 107.625 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.1 t -135.21 127.02 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -160.55 162.81 33.04 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -61.12 132.44 53.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.03 27.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.2 p -116.41 164.44 14.54 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.768 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -62.75 152.1 82.98 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.461 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.84 152.69 80.84 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.429 2.753 . . . . 0.0 110.69 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 70.5 m -79.67 0.22 31.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.824 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -100.9 17.76 21.36 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 118.176 0.444 . . . . 0.0 110.884 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' B' ' 91' ' ' SER . 12.3 tt0 -134.8 166.34 23.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.2 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.422 ' H ' ' HG2' ' B' ' 90' ' ' GLU . 8.1 t -117.56 15.97 14.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.236 0.614 . . . . 0.0 111.51 -175.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.68 15.38 81.38 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.859 -0.526 . . . . 0.0 112.04 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -70.15 -3.05 14.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.271 0.628 . . . . 0.0 112.684 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -138.75 153.38 48.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.352 0.661 . . . . 0.0 109.934 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 CA-C-O 117.631 -1.649 . . . . 0.0 110.827 -178.495 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.594 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.511 1 C5'-C4'-C3' 109.241 -4.173 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.596 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.11 0 C3'-C2'-C1' 104.468 3.298 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 C5'-C4'-C3' 110.166 -3.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.945 1 O4'-C1'-N19 113.848 5.648 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 2 O4'-C1'-N19 112.558 4.358 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 C5'-C4'-C3' 111.411 -2.726 . 0.62 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.521 ' HA ' ' HE2' ' B' ' 1' ' ' MET . 5.3 mmt . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.917 0.389 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.411 ' O ' HG22 ' B' ' 2' ' ' VAL . 7.2 p -78.1 1.64 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-O 122.538 1.161 . . . . 0.0 109.729 171.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.81 146.11 40.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.28 -170.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.39 96.64 3.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.28 123.18 29.35 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 49.83 106.7 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.347 1.859 . . . . 0.0 113.919 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.472 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 91.7 Cg_exo -49.88 136.53 35.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 171.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.0 -11.55 58.87 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.95 127.12 36.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' B' ' 56' ' ' PHE . 73.8 mt -113.8 153.37 29.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -106.71 127.75 53.63 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.1 mm -119.05 77.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -174.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.63 144.86 17.41 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.67 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.43 10.19 42.12 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 117.589 0.694 . . . . 0.0 111.422 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.78 163.71 13.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.377 0.671 . . . . 0.0 111.96 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' B' ' 75' ' ' ASP . 43.9 t-20 -73.96 160.76 30.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.461 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 79.3 p -75.74 -3.87 37.28 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.706 0.402 . . . . 0.0 110.382 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.68 -7.42 18.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.358 1.063 . . . . 0.0 110.888 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -81.63 143.7 31.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.737 0.415 . . . . 0.0 110.235 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -170.25 2.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.73 -35.5 78.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.89 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.57 -28.96 68.94 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.275 -0.265 . . . . 0.0 111.141 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.4 -20.63 27.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.6 -29.17 20.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.969 1.308 . . . . 0.0 109.458 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -80.52 -29.6 37.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.367 0.604 . . . . 0.0 109.944 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -23.3 41.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.118 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.49 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.7 p -101.37 -34.26 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.498 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 86.4 m-85 -93.55 -10.34 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.335 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -3.66 76.18 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -80.84 -13.26 59.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.697 1.199 . . . . 0.0 111.123 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -111.67 -19.04 12.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.75 163.69 32.21 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 117.897 0.317 . . . . 0.0 112.448 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -67.23 116.08 7.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.87 141.57 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.741 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -21.17 5.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.934 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.77 149.9 15.07 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.35 144.64 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.309 0.576 . . . . 0.0 109.663 171.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.4 mt -120.12 155.65 32.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.511 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -152.33 119.15 5.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.9 mmm -92.8 139.19 30.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.763 -170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.68 153.67 37.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.101 0.477 . . . . 0.0 111.644 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -65.49 163.02 16.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.0 111.987 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -102.62 -7.92 21.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.669 0.387 . . . . 0.0 111.867 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.62 -14.33 15.31 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.959 0.504 . . . . 0.0 111.216 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -133.19 -13.28 2.75 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.729 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 32.1 m120 59.0 13.24 2.74 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.155 0.284 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.42 145.96 27.2 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.328 0.651 . . . . 0.0 109.546 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 m -52.9 139.24 27.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.562 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -73.95 -2.19 22.95 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.395 0.678 . . . . 0.0 109.518 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 2.01 82.94 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.313 0.959 . . . . 0.0 112.003 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -142.61 162.26 35.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.321 1.06 . . . . 0.0 110.308 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -177.85 6.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.53 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 52.6 m-85 -141.3 162.12 36.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.83 0.348 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -154.05 139.16 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -110.23 124.31 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.755 0.312 . . . . 0.0 110.287 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.1 m-85 -93.53 156.09 16.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.919 0.888 . . . . 0.0 111.062 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.648 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -120.9 140.08 30.21 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 65.5 Cg_endo -74.59 -2.54 12.57 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.746 2.297 . . . . 0.0 110.376 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.76 -15.25 10.74 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.03 0.377 . . . . 0.0 111.299 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.486 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.7 m-20 -71.76 -28.43 63.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.4 58.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.172 0.589 . . . . 0.0 110.384 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.16 -37.64 75.27 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.61 -30.74 69.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.3 33.19 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.99 -7.81 48.87 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.95 -0.469 . . . . 0.0 111.266 -177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -104.3 4.94 34.2 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 112.462 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.01 -54.2 1.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.706 0.765 . . . . 0.0 109.455 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.4 mmm -81.0 -11.22 59.6 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.444 1.498 . . . . 0.0 112.076 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -73.35 127.54 32.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.93 -7.17 78.7 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.72 -153.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.281 1.032 . . . . 0.0 109.37 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 29.3 t -139.58 159.43 42.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.493 0.663 . . . . 0.0 112.777 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.0 126.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.292 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.547 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 61.33 -21.12 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.51 -7.5 0.52 Allowed Glycine 0 N--CA 1.439 -1.119 0 CA-C-O 119.183 -0.787 . . . . 0.0 112.962 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -119.04 134.97 54.87 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.188 0.994 . . . . 0.0 110.205 -173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.99 139.03 50.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.63 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.4 pt -121.28 177.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -121.63 143.49 49.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.66 1.984 . . . . 0.0 107.37 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.4 127.0 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.88 163.77 36.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -63.55 136.11 57.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.87 38.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.161 0.505 . . . . 0.0 112.239 -172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p -110.16 174.94 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.265 172.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.4 151.4 87.56 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.892 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.67 159.98 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.031 3.154 . . . . 0.0 111.283 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.08 -8.32 57.98 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -96.46 16.05 19.72 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.69 0.677 . . . . 0.0 112.343 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -114.94 148.84 38.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.618 0.723 . . . . 0.0 111.42 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 29.8 m -86.97 15.15 6.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.984 1.314 . . . . 0.0 112.069 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.91 -4.57 34.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.888 -0.396 . . . . 0.0 112.376 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 ptp85 -80.68 -1.94 44.6 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.677 0.739 . . . . 0.0 111.991 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.77 168.4 22.23 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 122.994 0.518 . . . . 0.0 111.237 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.482 -1.732 . . . . 0.0 110.893 177.141 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.566 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.276 1 C5'-C4'-C3' 109.434 -4.044 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.606 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.997 0 C3'-C2'-C1' 104.147 2.941 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 O4'-C1'-N19 110.449 2.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 1 O4'-C1'-N19 114.401 6.201 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 2 C5'-C4'-C3' 108.854 -4.431 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.825 0 C5'-C4'-C3' 110.628 -3.248 . 0.215 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.385 0.612 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.06 126.19 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -132.27 137.2 47.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.726 0.774 . . . . 0.0 111.782 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.26 11.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.44 48.6 0.35 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.407 1.083 . . . . 0.0 112.422 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 61.3 153.02 0.11 Allowed Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 126.977 2.111 . . . . 0.0 114.108 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 88.1 Cg_exo -53.91 151.86 25.26 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.923 3.082 . . . . 0.0 113.063 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.68 -17.45 45.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.27 129.55 47.25 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 117.912 0.856 . . . . 0.0 108.78 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.4 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 75.7 mt -113.31 155.11 25.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.338 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -108.39 129.41 55.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.526 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -121.62 80.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -174.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.77 148.8 19.23 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.28 -0.486 . . . . 0.0 111.909 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.43 11.24 45.44 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 117.736 0.768 . . . . 0.0 112.054 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.93 163.02 20.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.435 0.636 . . . . 0.0 111.907 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.622 HD22 ' HB3' ' B' ' 75' ' ' ASP . 32.2 t-20 -71.27 165.52 23.49 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.417 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -85.48 -8.34 58.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.917 -0.489 . . . . 0.0 110.962 -174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -109.41 -1.35 18.47 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.28 1.432 . . . . 0.0 111.147 -177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 68.6 m -76.61 144.51 39.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.35 -167.58 2.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.06 -32.11 70.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.432 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -65.0 -32.68 74.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -21.88 27.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.16 -27.27 23.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.98 1.312 . . . . 0.0 109.348 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.06 -28.98 32.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 110.121 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.25 -20.37 41.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.505 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 74' ' ' LEU . 6.4 p -104.33 -35.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 90.6 m-85 -91.83 -11.59 36.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.067 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.0 -3.57 75.22 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.53 -13.1 59.37 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.869 1.267 . . . . 0.0 111.002 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -111.6 -19.32 12.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.58 164.47 34.16 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.1 ttm105 -72.34 117.37 13.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 36.5 mt -75.24 141.71 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.295 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -23.97 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.203 0.601 . . . . 0.0 109.958 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -161.18 150.51 16.67 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.054 0.541 . . . . 0.0 109.846 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.48 145.58 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.287 0.565 . . . . 0.0 109.812 172.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.3 mt -119.3 156.28 30.29 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.532 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -152.67 119.11 5.6 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.8 mmm -94.69 144.05 25.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.062 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.428 ' CA ' ' HG2' ' B' ' 49' ' ' ARG . 30.4 mttt -138.34 158.29 44.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.07 141.45 58.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.779 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -89.22 -2.95 58.7 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -115.66 -14.17 11.45 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.243 0.617 . . . . 0.0 111.796 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -128.97 -13.83 4.52 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.116 0.416 . . . . 0.0 111.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 57.56 20.72 6.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -76.01 -116.55 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.489 1.115 . . . . 0.0 108.969 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -141.1 147.78 39.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.075 1.35 . . . . 0.0 107.95 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.428 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 48.1 mmm-85 -69.45 -10.56 58.54 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.11 2.42 88.12 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.649 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -135.57 160.0 39.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.61 1.205 . . . . 0.0 111.039 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -178.29 7.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.099 0.56 . . . . 0.0 110.716 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 65.7 m-85 -142.42 163.08 33.82 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.893 0.477 . . . . 0.0 109.865 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.66 142.48 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 52.7 m -114.68 122.92 47.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.437 0.295 . . . . 0.0 110.333 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.06 155.84 17.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.865 0.866 . . . . 0.0 111.974 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.29 -22.7 60.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.883 0.473 . . . . 0.0 111.291 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -121.18 140.88 31.88 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.507 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 93.5 Cg_endo -73.65 -10.68 23.72 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.588 2.192 . . . . 0.0 110.396 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.63 -14.92 13.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.091 0.405 . . . . 0.0 110.671 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.2 m-20 -72.06 -27.62 62.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.38 -31.99 54.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.207 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -68.0 -39.59 83.21 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.37 -33.99 76.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.21 -44.41 53.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.21 -7.08 44.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.093 -0.379 . . . . 0.0 111.37 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -105.59 4.51 30.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.338 1.055 . . . . 0.0 112.181 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.31 -52.91 1.39 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.779 0.799 . . . . 0.0 109.606 -175.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.1 mmm -82.69 -11.26 58.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.216 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.05 126.88 31.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.285 0.493 . . . . 0.0 109.752 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.86 -7.53 76.91 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.797 -0.446 . . . . 0.0 112.114 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.72 -156.94 0.19 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.582 1.153 . . . . 0.0 109.926 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -134.5 153.24 52.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 111.023 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -100.83 -65.99 0.94 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.388 0.613 . . . . 0.0 111.17 -176.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.622 ' HB3' HD22 ' B' ' 16' ' ' ASN . 15.4 t70 -120.54 16.27 12.04 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.628 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.8 -6.54 12.35 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.637 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -111.57 131.78 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 108.893 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.64 137.66 39.58 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.3 pt -118.58 173.74 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -116.82 140.65 49.19 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.026 1.73 . . . . 0.0 107.221 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.4 126.59 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.25 163.4 38.81 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -64.67 135.41 55.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.72 153.73 36.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 73.8 p -116.44 170.49 8.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.144 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -73.23 152.17 90.25 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.161 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.79 155.85 67.13 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.519 2.813 . . . . 0.0 110.655 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -80.92 -12.52 59.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.471 0.709 . . . . 0.0 112.661 -173.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -95.47 19.93 10.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.023 -0.423 . . . . 0.0 111.606 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.47 156.84 48.24 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.096 0.475 . . . . 0.0 110.99 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -87.91 9.6 21.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 111.714 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.8 84.76 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.807 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.14 162.64 38.45 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.199 1.0 . . . . 0.0 110.873 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -161.87 151.16 15.97 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.853 0.461 . . . . 0.0 109.932 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 117.33 -1.817 . . . . 0.0 111.332 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.562 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.212 0 C5'-C4'-C3' 110.208 -3.528 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.641 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.004 0 C3'-C2'-C1' 104.524 3.36 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 1 C5'-C4'-C3' 108.973 -4.352 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 O4'-C1'-N19 113.696 5.496 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 2 O4'-C1'-N19 112.521 4.321 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 0 O4'-C1'-N19 110.975 2.775 . 0.676 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' B' ' 1' ' ' MET . 6.0 mmt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.035 0.445 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 2' ' ' VAL . 7.2 p -77.28 3.38 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 CA-C-O 122.612 1.196 . . . . 0.0 109.717 170.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.87 128.0 33.17 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.127 -170.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.17 101.32 9.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.92 126.82 33.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.359 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 46.11 102.94 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 126.405 1.882 . . . . 0.0 113.992 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.542 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 96.8 Cg_exo -49.22 134.78 30.97 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.593 2.195 . . . . 0.0 109.943 171.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.68 50.33 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.85 127.84 37.47 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.51 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.4 mt -113.82 147.83 37.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -102.61 127.44 49.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.8 mm -117.98 81.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.6 140.74 15.22 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.809 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 5.75 32.77 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 117.272 0.536 . . . . 0.0 111.899 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 19' ' ' THR . 8.0 mt -63.56 160.62 16.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.18 0.49 . . . . 0.0 110.958 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 45.4 t30 -69.23 159.27 33.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 68.2 p -71.69 -4.85 29.74 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.186 -0.321 . . . . 0.0 110.296 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.42 -8.36 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.86 1.264 . . . . 0.0 110.475 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.515 HG21 HD22 ' B' ' 15' ' ' LEU . 35.6 m -79.49 141.38 36.78 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.07 -168.03 2.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.393 0.616 . . . . 0.0 109.803 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.32 -30.57 68.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.97 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -66.77 -29.54 69.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.16 -17.73 28.59 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.68 -28.63 14.23 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.016 0.926 . . . . 0.0 110.495 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.28 -32.28 33.29 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.098 0.475 . . . . 0.0 109.72 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -29.7 43.28 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.208 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' B' ' 28' ' ' PHE . 3.6 p -91.6 -34.83 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 81.5 m-85 -91.42 -9.47 44.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.84 -4.88 86.17 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -78.61 -12.16 60.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.548 1.139 . . . . 0.0 111.193 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -115.63 -13.34 11.5 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.52 171.64 36.84 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 119.88 -1.152 . . . . 0.0 112.127 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -80.89 115.35 20.33 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.397 0.618 . . . . 0.0 109.689 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mt -74.18 139.84 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.745 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -19.06 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.061 175.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -163.15 149.66 12.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.407 0.683 . . . . 0.0 110.025 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.89 144.23 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 109.71 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 7.4 mt -119.26 154.42 33.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.573 1.149 . . . . 0.0 108.047 173.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.93 118.97 6.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 7.6 mmm -92.93 142.41 27.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.665 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.58 151.63 35.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.062 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.42 153.82 18.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.385 1.074 . . . . 0.0 111.66 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -89.28 -14.22 36.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.745 0.418 . . . . 0.0 111.698 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -110.46 -14.05 14.16 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.806 0.443 . . . . 0.0 112.037 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 38.9 p -127.78 -12.94 5.35 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.538 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 59.61 11.71 2.51 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.367 0.417 . . . . 0.0 111.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -82.02 144.14 31.07 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -55.56 136.35 50.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.019 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -66.53 -11.38 52.51 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.218 0.607 . . . . 0.0 109.871 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 1.44 78.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -136.07 157.7 46.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.33 1.065 . . . . 0.0 110.421 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.32 6.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.2 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 48.1 m-85 -141.95 161.09 38.84 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -154.67 140.74 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 46.9 m -111.48 126.94 55.49 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' B' ' 10' ' ' LEU . 4.9 m-85 -99.03 162.35 13.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.451 0.701 . . . . 0.0 110.328 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -72.26 -18.7 61.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -129.28 153.49 80.49 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 123.577 0.751 . . . . 0.0 110.126 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.542 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 22.2 Cg_endo -81.58 3.14 8.05 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 122.714 2.276 . . . . 0.0 110.391 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.46 -15.18 7.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -86.22 -21.44 27.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.74 -28.27 61.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.055 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -69.23 -33.56 73.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.94 -27.33 63.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.97 -46.43 21.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.09 54.63 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.248 0.219 . . . . 0.0 111.369 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -101.69 9.31 41.11 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.298 1.039 . . . . 0.0 112.189 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -50.96 0.88 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.349 1.071 . . . . 0.0 109.127 -175.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.487 ' HA ' ' HG2' ' B' ' 72' ' ' LYS . 50.4 mmm -77.26 -18.56 57.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.27 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -75.95 110.42 10.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.06 -7.94 53.11 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.594 -0.559 . . . . 0.0 112.323 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' B' ' 69' ' ' MET . 8.6 ptpt -90.15 -173.17 3.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.239 1.02 . . . . 0.0 110.446 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . 0.412 ' N ' ' HG3' ' B' ' 72' ' ' LYS . 47.2 t -122.84 153.52 39.48 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.778 0.799 . . . . 0.0 112.14 -175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -131.29 126.47 35.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.011 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.0 t70 62.25 -24.04 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 156.62 -10.99 0.29 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.081 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -118.14 137.23 53.11 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.977 0.888 . . . . 0.0 110.591 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.52 138.39 50.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.886 0.475 . . . . 0.0 110.82 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.495 HG21 HD23 ' B' ' 15' ' ' LEU . 23.8 pt -122.53 166.24 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -115.18 146.31 41.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.598 1.559 . . . . 0.0 108.127 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.22 129.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.58 163.53 32.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -61.65 134.97 57.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.31 157.49 29.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.948 0.404 . . . . 0.0 112.028 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 63.1 p -116.18 169.44 9.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.392 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.65 153.56 90.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.72 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -62.11 155.36 56.52 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.995 3.13 . . . . 0.0 111.199 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 44.4 m -76.93 -0.03 22.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.693 0.397 . . . . 0.0 111.676 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . 0.518 ' CD2' " H2'" ' A' ' 101' ' ' ' A' . 1.2 p90 -97.42 9.79 41.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.92 0.488 . . . . 0.0 111.453 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -130.14 164.71 23.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.909 0.484 . . . . 0.0 110.826 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 21.6 t -143.82 165.61 27.23 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.898 0.479 . . . . 0.0 110.866 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.84 0.32 82.8 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.615 0.626 . . . . 0.0 112.38 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -136.59 169.41 17.75 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.591 0.696 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -139.94 152.01 46.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.419 -1.767 . . . . 0.0 110.814 179.797 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.563 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.18 1 O4'-C1'-N19 112.42 4.22 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.617 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.091 0 C3'-C2'-C1' 104.424 3.249 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.727 -3.849 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 O4'-C1'-N19 113.348 5.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.474 " H3'" " H5'" ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 112.835 4.635 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . 0.518 " H2'" ' CD2' ' B' ' 89' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.129 1 O4'-C1'-N19 114.077 5.877 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.488 ' CE ' ' HA ' ' B' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.314 0.578 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.487 ' O ' HG22 ' B' ' 2' ' ' VAL . 5.9 p -105.21 8.51 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 122.689 1.233 . . . . 0.0 109.125 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -78.77 126.79 31.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.86 105.95 13.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.32 123.31 27.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.094 -171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 46.87 118.55 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.886 2.474 . . . . 0.0 116.041 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 83.6 Cg_exo -51.05 148.98 16.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.053 2.502 . . . . 0.0 111.306 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.74 -20.08 47.26 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -85.61 129.32 34.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.664 0.732 . . . . 0.0 109.209 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.402 HD12 ' CE1' ' B' ' 56' ' ' PHE . 79.1 mt -119.22 153.37 35.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.379 0.671 . . . . 0.0 110.091 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -106.48 131.2 53.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.5 mm -121.85 80.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -173.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.19 148.7 19.08 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.937 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.8 11.02 51.63 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.619 0.709 . . . . 0.0 111.484 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.64 164.39 14.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.449 0.699 . . . . 0.0 111.449 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.585 HD22 ' HB3' ' B' ' 75' ' ' ASP . 56.3 t30 -72.59 156.91 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.889 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -76.36 -1.29 26.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.78 0.324 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.09 -5.8 15.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.392 1.077 . . . . 0.0 110.875 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.5 m -80.46 145.65 31.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.349 0.66 . . . . 0.0 110.186 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.59 -168.84 2.13 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.22 -33.19 71.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.48 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.13 -32.9 74.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.27 -22.1 27.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.84 -28.37 22.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.194 1.398 . . . . 0.0 109.453 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.08 -27.91 32.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.391 0.615 . . . . 0.0 110.05 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.6 -21.26 38.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.611 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.574 HG11 HD21 ' B' ' 74' ' ' LEU . 6.2 p -103.51 -34.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.514 ' CD2' HG13 ' B' ' 27' ' ' VAL . 87.3 m-85 -91.41 -11.63 37.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.949 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.23 -3.44 76.29 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.72 -12.81 59.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.758 1.223 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.55 -19.52 12.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.608 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.97 166.38 37.06 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.072 0.396 . . . . 0.0 112.369 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -73.9 117.13 15.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.2 mt -75.52 142.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.473 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -23.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.049 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.84 150.58 17.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.177 0.591 . . . . 0.0 109.794 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.09 144.63 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 109.75 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -116.74 154.19 31.07 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.47 117.68 6.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.5 mmm -92.68 138.08 31.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.753 -170.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -145.18 151.7 38.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 111.117 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.52 165.92 11.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.121 0.969 . . . . 0.0 112.006 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -107.44 -2.31 20.62 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.333 0.653 . . . . 0.0 111.824 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.65 -12.07 13.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.359 0.663 . . . . 0.0 111.439 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -132.69 -14.38 2.82 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.688 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 58.86 11.26 1.8 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.84 0.291 . . . . 0.0 111.667 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -85.32 149.54 25.38 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 109.243 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -54.95 139.3 41.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.33 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -67.87 -8.24 34.83 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 109.778 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.06 76.84 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . 0.56 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 46.1 p90 -140.12 160.71 39.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.536 1.168 . . . . 0.0 110.991 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.14 -176.87 6.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 110.589 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 37.5 m-85 -143.17 162.84 34.52 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -154.13 144.72 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -116.68 122.63 45.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.327 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.402 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.1 m-85 -92.17 156.27 17.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.536 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.22 -22.53 59.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.085 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.6 t -121.58 140.98 32.61 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 67.7 Cg_endo -74.52 -7.45 19.54 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.809 2.34 . . . . 0.0 110.137 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.69 -15.77 12.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.764 0.256 . . . . 0.0 110.623 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.9 m-20 -71.59 -28.48 63.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.42 56.55 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.91 -37.25 75.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.43 -30.85 67.81 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.27 -46.37 34.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.58 -9.97 52.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.13 -0.356 . . . . 0.0 111.191 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -102.16 8.14 40.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.398 1.079 . . . . 0.0 112.499 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.43 -51.38 0.93 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.323 1.059 . . . . 0.0 109.392 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 72' ' ' LYS . 47.3 mmm -78.66 -17.26 56.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.846 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -73.31 118.4 16.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -7.91 75.6 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.641 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' B' ' 69' ' ' MET . 8.5 ptpt -89.89 178.21 6.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.728 1.264 . . . . 0.0 111.261 175.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -105.45 147.18 28.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.705 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.574 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -94.53 -65.1 1.01 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.325 0.583 . . . . 0.0 110.559 -177.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.585 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.0 t70 -123.15 4.15 9.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.652 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.14 -11.36 2.55 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.214 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -115.51 133.58 55.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.824 0.85 . . . . 0.0 109.834 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.13 136.29 41.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.392 0.432 . . . . 0.0 110.395 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 16.9 pt -112.84 175.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -119.7 142.76 48.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 107.131 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.56 129.94 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.2 163.09 37.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 123.07 20.42 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.58 149.94 47.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 52.2 p -107.27 169.87 8.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.951 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.06 152.78 96.19 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.39 148.29 83.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.141 2.561 . . . . 0.0 110.162 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -82.3 2.19 33.28 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.109 0.563 . . . . 0.0 112.1 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.24 11.99 12.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.918 0.487 . . . . 0.0 110.051 173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 52.11 176.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.281 2.233 . . . . 0.0 114.492 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 22.1 t -149.52 162.35 40.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.896 0.479 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' B' ' 94' ' ' ARG . . . 76.24 1.3 68.99 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.566 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 60.58 -14.2 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.868 1.667 . . . . 0.0 114.036 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' B' ' 92' ' ' GLY . 61.1 ttp180 -151.99 151.88 31.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.791 -0.568 . . . . 0.0 110.123 -177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.348 -1.807 . . . . 0.0 110.742 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.563 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.481 0 O4'-C1'-N19 112.081 3.881 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.64 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C3'-C2'-C1' 104.583 3.425 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 C5'-C4'-C3' 112.221 -2.186 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 1 O4'-C1'-N19 114.181 5.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.56 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 C4'-C3'-C2' 98.486 -4.214 . 0.362 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.916 0 O4'-C1'-N19 111.664 3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.536 0.208 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 p -94.45 112.16 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.35 139.36 50.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.812 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.81 113.04 25.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.93 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.14 169.8 3.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.737 174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -59.13 153.82 43.89 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -170.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 87.8 Cg_exo -50.53 154.37 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 125.033 3.822 . . . . 0.0 113.747 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -14.27 61.22 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.02 127.73 45.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 117.981 0.891 . . . . 0.0 109.132 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' B' ' 54' ' ' VAL . 74.7 mt -114.67 155.94 25.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.286 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.56 129.74 55.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.517 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.1 mm -121.32 75.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.63 146.96 18.41 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.226 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.42 11.0 30.22 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.834 0.817 . . . . 0.0 112.004 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.87 166.55 8.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.28 0.562 . . . . 0.0 112.184 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' B' ' 75' ' ' ASP . 58.4 t30 -79.0 -2.65 41.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 1.2 p 66.39 -13.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.929 1.292 . . . . 0.0 112.998 -169.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' B' ' 16' ' ' ASN . 48.1 mm-40 -91.26 -9.05 46.57 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.969 0.908 . . . . 0.0 109.328 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -78.77 144.9 34.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 109.605 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 -172.31 3.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' B' ' 21' ' ' GLU . 36.2 mp0 -65.22 -37.93 88.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.453 0.701 . . . . 0.0 110.342 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -32.41 74.04 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 110.191 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.48 -21.03 25.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.16 -27.48 24.55 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.903 1.281 . . . . 0.0 109.034 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.64 -27.21 34.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.41 0.624 . . . . 0.0 110.026 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.0 -20.19 35.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.603 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' B' ' 28' ' ' PHE . 6.3 p -104.2 -35.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 88.4 m-85 -92.69 -10.05 38.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.134 175.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.93 -2.93 79.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -81.5 -11.27 59.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.557 1.143 . . . . 0.0 111.02 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -113.4 -19.34 11.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.786 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -175.36 161.15 30.12 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -74.07 123.06 23.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mt -77.99 143.79 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 -22.78 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.925 178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.95 150.43 15.18 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.32 0.648 . . . . 0.0 109.744 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.66 145.62 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.396 0.617 . . . . 0.0 109.655 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.9 mt -118.52 154.44 32.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.291 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -149.13 117.54 6.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.82 140.15 29.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.913 -169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -149.06 151.22 34.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.424 0.63 . . . . 0.0 112.342 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.23 157.44 16.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.836 1.255 . . . . 0.0 111.333 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -93.36 -22.12 19.13 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 122.813 0.445 . . . . 0.0 111.404 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -102.12 -15.09 16.82 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.773 0.429 . . . . 0.0 112.089 -174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 27.4 p -125.37 -15.39 6.19 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 122.629 0.372 . . . . 0.0 110.819 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 61.24 7.87 1.84 Allowed 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 123.313 0.383 . . . . 0.0 111.728 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -81.39 147.28 29.88 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' B' ' 17' ' ' THR . 42.3 t -55.86 145.85 23.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 40.1 mmm-85 -67.16 -8.78 33.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.83 0.09 75.64 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . 0.484 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 48.1 p90 -139.13 161.88 36.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 117.822 0.811 . . . . 0.0 111.083 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.72 -178.92 7.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.448 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 44.7 m-85 -140.34 162.3 35.63 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -152.98 142.51 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 36.9 m -114.06 121.7 44.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.29 156.54 17.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.753 0.821 . . . . 0.0 110.731 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -78.72 -23.75 45.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.376 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -114.03 138.09 22.7 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.507 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 69.4 Cg_endo -74.74 -8.13 20.06 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.457 2.105 . . . . 0.0 110.434 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.99 -15.06 13.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.389 0.276 . . . . 0.0 110.891 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.466 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 70.3 m-20 -71.34 -28.17 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 169.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.41 51.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.31 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.41 -39.18 81.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.95 -32.62 73.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.58 -43.7 47.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.56 42.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.286 -0.259 . . . . 0.0 110.943 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -106.47 5.03 28.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.294 1.038 . . . . 0.0 112.324 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.81 -53.29 1.33 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.403 ' HE3' HD11 ' B' ' 79' ' ' ILE . 30.2 mmm -82.35 -10.19 59.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.779 1.632 . . . . 0.0 112.102 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -74.27 126.0 29.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.32 -6.74 81.12 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -80.81 -154.15 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.172 0.989 . . . . 0.0 109.16 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -137.77 159.53 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.798 0.808 . . . . 0.0 112.507 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -133.43 126.69 31.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.849 176.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.544 ' HB3' HD22 ' B' ' 16' ' ' ASN . 1.9 t70 60.98 -18.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.91 -8.38 0.6 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 119.33 -0.706 . . . . 0.0 113.154 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -121.91 138.51 54.38 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.259 1.03 . . . . 0.0 110.592 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.42 139.38 54.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.808 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.403 HD11 ' HE3' ' B' ' 69' ' ' MET . 25.2 pt -121.43 176.66 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -120.1 141.44 49.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.712 1.605 . . . . 0.0 107.505 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.38 124.56 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.07 163.15 36.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -60.7 133.77 56.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.63 153.71 30.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 45.8 p -107.56 173.0 6.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.242 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -80.19 153.9 74.57 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.065 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.78 157.75 59.66 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.463 2.775 . . . . 0.0 110.842 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 90.1 p -91.39 -7.23 51.37 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -93.39 15.35 15.96 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 117.943 0.338 . . . . 0.0 111.287 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -139.32 158.01 44.9 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 122.677 0.391 . . . . 0.0 110.607 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.4 t -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.697 0.799 . . . . 0.0 111.605 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.12 0.28 65.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.074 0.368 . . . . 0.0 112.601 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -147.71 -26.36 0.36 Allowed 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.455 0.702 . . . . 0.0 110.696 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -150.9 165.87 32.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.587 0.755 . . . . 0.0 110.109 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-O 117.212 -1.882 . . . . 0.0 110.523 179.818 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.501 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.521 1 C5'-C4'-C3' 109.341 -4.106 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.451 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.115 0 C3'-C2'-C1' 103.911 2.679 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 1 C5'-C4'-C3' 109.18 -4.213 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . 0.419 " H4'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.626 1 O4'-C1'-N19 114.311 6.111 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.484 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 O5'-C5'-C4' 115.437 3.741 . 0.536 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.937 0 O4'-C1'-N19 111.032 2.832 . 0.512 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 30.8 ttp . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.474 HG22 ' O ' ' B' ' 2' ' ' VAL . 8.5 p -91.18 6.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 122.796 1.284 . . . . 0.0 109.686 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -78.4 139.74 38.75 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.396 -168.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.1 111.71 5.78 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -77.68 55.77 1.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.932 0.893 . . . . 0.0 112.689 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' B' ' 7' ' ' PRO . 75.3 mtp85 60.8 153.31 0.1 Allowed Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.781 2.032 . . . . 0.0 114.303 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 89.3 Cg_exo -54.31 151.38 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.864 3.043 . . . . 0.0 112.887 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.45 -17.93 45.84 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 170.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -98.3 129.93 45.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.054 0.927 . . . . 0.0 108.926 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -114.88 154.04 29.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.87 130.92 55.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.479 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 7.0 mm -122.3 80.34 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -173.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.2 143.25 16.44 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.538 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 9.65 38.7 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 117.477 0.639 . . . . 0.0 111.882 172.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.88 165.04 13.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.134 0.573 . . . . 0.0 111.672 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' B' ' 75' ' ' ASP . 42.4 t30 -77.94 157.06 29.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 123.292 0.637 . . . . 0.0 110.924 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -72.63 -8.33 54.73 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.678 0.791 . . . . 0.0 110.283 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -98.94 -10.46 22.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 110.471 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.1 m -83.49 143.85 29.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -169.02 2.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -68.72 -33.29 73.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -64.6 -33.4 75.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.56 -20.89 27.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.449 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -86.5 -26.74 24.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.125 1.37 . . . . 0.0 109.431 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.9 -28.84 32.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.427 0.632 . . . . 0.0 110.119 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.33 -20.08 41.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.675 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.6 p -105.25 -36.39 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.5 m-85 -88.53 -11.89 44.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.923 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.63 -4.24 75.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -81.5 -12.88 58.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.319 1.048 . . . . 0.0 110.911 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.7 m-85 -109.73 -20.65 12.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.254 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.91 164.66 33.15 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 118.048 0.386 . . . . 0.0 112.959 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -66.41 117.84 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.7 mt -79.16 142.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.966 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -21.7 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.142 0.577 . . . . 0.0 109.91 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.69 150.39 15.64 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.464 0.706 . . . . 0.0 109.826 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.7 145.81 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.138 0.494 . . . . 0.0 110.059 172.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.0 mt -120.3 154.41 35.03 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.362 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.456 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -150.71 119.51 6.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 170.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.422 ' HE3' ' OP2' ' A' ' 101' ' ' ' A' . 12.1 mmm -92.59 141.66 28.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -169.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.456 ' HE2' HD12 ' B' ' 39' ' ' LEU . 11.9 mttt -137.95 158.09 45.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.73 147.57 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.195 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -86.16 -9.58 56.36 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -122.22 -12.64 8.25 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.9 p -124.19 -14.88 6.92 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.233 0.47 . . . . 0.0 111.343 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 56.57 20.99 5.32 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.5 -103.05 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.349 1.06 . . . . 0.0 110.009 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 27.0 t -153.06 145.61 24.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.598 1.159 . . . . 0.0 108.343 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.408 ' HB3' ' CE1' ' B' ' 51' ' ' PHE . 42.9 mmm-85 -74.11 -10.36 59.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.92 2.73 88.34 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.351 -0.694 . . . . 0.0 111.582 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . 0.578 ' CZ ' " H5'" ' A' ' 100' ' ' ' A' . 51.1 p90 -135.49 161.45 35.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.764 1.282 . . . . 0.0 110.072 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.2 -177.62 6.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.779 0.431 . . . . 0.0 111.164 -174.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 63.2 m-85 -142.73 162.28 35.89 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.3 142.27 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m -113.35 123.99 51.42 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -95.04 156.35 16.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.931 0.892 . . . . 0.0 110.686 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -79.47 -21.26 45.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.493 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -116.5 137.93 24.01 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.506 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 53.4 Cg_endo -76.85 -0.13 10.22 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.089 2.526 . . . . 0.0 110.568 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.24 -15.5 9.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 117.877 0.308 . . . . 0.0 111.198 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.521 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 84.5 m-20 -72.19 -27.96 62.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.62 -27.66 55.81 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.452 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -74.5 -36.59 63.23 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.24 -26.1 64.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.2 -46.38 14.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.03 63.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.3 7.7 46.03 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 -55.58 1.31 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.915 0.864 . . . . 0.0 109.371 -173.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 0.0 OUTLIER -75.48 -15.76 60.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.626 -1.625 . . . . 0.0 111.775 -177.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -73.91 124.06 25.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.32 -7.05 82.14 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -82.91 -153.46 0.12 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 109.361 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -139.69 158.73 43.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.464 0.706 . . . . 0.0 112.395 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -132.43 126.56 33.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.7 t70 61.5 -23.34 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 152.62 -6.51 0.47 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-O 119.512 -0.604 . . . . 0.0 112.631 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -117.36 134.51 54.74 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.027 0.913 . . . . 0.0 110.134 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.96 139.17 50.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.479 -174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -124.22 174.55 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -120.89 144.19 48.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.3 1.84 . . . . 0.0 107.776 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -135.97 130.03 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -160.92 163.83 31.61 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -61.43 137.15 58.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.39 158.89 27.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 66.4 p -122.92 172.33 8.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.154 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.43 155.52 91.18 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.356 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.52 151.06 86.81 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.81 2.34 . . . . 0.0 110.635 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 95.0 p -77.13 -9.09 58.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.007 0.523 . . . . 0.0 111.596 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . 0.583 ' CD2' " H2'" ' A' ' 101' ' ' ' A' . 6.1 p90 -87.17 4.17 43.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.298 0.239 . . . . 0.0 111.196 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -133.24 167.16 20.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.251 0.62 . . . . 0.0 110.284 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.9 t -144.76 166.06 26.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.963 0.505 . . . . 0.0 110.813 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.53 67.01 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.952 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.01 24.6 0.39 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.979 1.712 . . . . 0.0 114.419 177.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.34 163.19 32.47 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.234 0.614 . . . . 0.0 111.198 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.196 -1.891 . . . . 0.0 111.205 -179.68 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.566 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.455 1 C5'-C4'-C3' 108.675 -4.55 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.603 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.991 0 C3'-C2'-C1' 104.879 3.754 OUTLIER-DELTA 0.026 2o . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 C5'-C4'-O4' 112.271 2.193 . 0.02 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 1 O4'-C1'-N19 113.732 5.532 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.578 " H5'" ' CZ ' ' B' ' 51' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.764 0 O5'-C5'-C4' 115.76 3.971 . 0.13 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . 0.583 " H2'" ' CD2' ' B' ' 89' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.052 1 O4'-C1'-N19 114.836 6.636 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.523 ' O ' HG22 ' B' ' 2' ' ' VAL . 4.7 p -141.89 13.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.373 1.869 . . . . 0.0 107.12 172.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.1 139.84 36.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.536 -167.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.47 113.31 13.54 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 113.588 -1.642 . . . . 0.0 106.664 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -73.66 60.81 0.7 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.65 1.18 . . . . 0.0 113.394 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 60.44 154.46 0.1 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 126.228 1.811 . . . . 0.0 114.412 173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 85.2 Cg_exo -54.31 148.55 41.11 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.681 2.921 . . . . 0.0 112.632 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.5 33.78 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.23 -0.761 . . . . 0.0 111.729 170.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -99.55 128.86 45.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 117.99 0.895 . . . . 0.0 108.872 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 76.6 mt -112.56 151.31 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.517 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -104.65 128.41 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.512 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.9 79.05 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 146.48 18.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.937 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.28 10.44 41.87 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 117.68 0.74 . . . . 0.0 111.672 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.63 164.98 13.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.529 0.732 . . . . 0.0 112.129 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' B' ' 75' ' ' ASP . 46.7 t30 -77.1 162.38 27.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 110.657 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -76.71 -1.47 28.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.284 0.233 . . . . 0.0 110.607 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.6 -4.61 16.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.378 1.071 . . . . 0.0 110.815 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 45.2 m -82.7 144.51 30.18 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.945 0.498 . . . . 0.0 110.047 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 -169.23 2.44 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.369 0.604 . . . . 0.0 109.443 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.34 -35.51 73.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.558 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -65.1 -30.0 70.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.37 -21.02 23.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' B' ' 27' ' ' VAL . 9.9 mt -87.07 -28.82 22.33 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.135 0.974 . . . . 0.0 109.36 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.26 -25.51 39.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.186 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.37 -22.19 35.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.598 HG11 HD21 ' B' ' 74' ' ' LEU . 5.0 p -103.87 -29.3 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.512 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 82.6 m-85 -99.1 -10.39 22.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.382 174.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.21 -5.83 85.66 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -77.05 -22.97 52.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.853 1.261 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.7 -19.9 15.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.528 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.44 165.28 34.98 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 118.024 0.374 . . . . 0.0 112.215 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -74.07 116.87 15.2 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 35.6 mt -75.66 139.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.39 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -23.64 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.058 0 C-N-CA 122.849 0.46 . . . . 0.0 110.134 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -160.28 149.48 17.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.026 0.53 . . . . 0.0 109.614 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.71 143.58 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 172.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.9 mt -117.39 154.13 31.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.07 119.41 5.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.0 mmm -94.32 136.94 34.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.93 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -145.53 154.02 41.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.363 0.602 . . . . 0.0 111.333 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.81 153.07 17.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.517 1.127 . . . . 0.0 111.318 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -95.58 -0.13 52.29 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.27 -14.08 7.54 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.102 0.561 . . . . 0.0 112.012 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 19.9 p -127.62 -14.12 5.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.203 0.456 . . . . 0.0 111.296 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 62.06 12.21 4.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -80.74 142.24 34.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -53.04 137.9 32.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.955 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -70.23 -10.09 57.83 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.804 0.842 . . . . 0.0 109.965 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.66 1.57 68.17 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.424 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.84 158.87 43.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.62 1.21 . . . . 0.0 110.553 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -178.52 7.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.051 0.541 . . . . 0.0 110.489 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.5 m-85 -142.58 162.39 35.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.846 0.459 . . . . 0.0 110.433 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.21 143.5 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -115.85 122.37 45.17 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 123.142 0.276 . . . . 0.0 110.306 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.71 156.58 17.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.589 0.755 . . . . 0.0 111.996 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -75.18 -22.89 57.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 122.599 0.36 . . . . 0.0 111.071 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -120.54 140.69 30.81 Favored Pre-proline 0 CA--C 1.518 -0.262 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 98.3 Cg_endo -73.41 -12.77 25.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.436 2.091 . . . . 0.0 110.189 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.57 -15.59 14.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.165 0.439 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.493 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 76.8 m-20 -70.95 -29.01 64.9 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 169.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.57 58.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.008 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -67.59 -38.9 84.68 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.35 -33.56 74.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.05 52.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.73 -8.45 52.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.256 -0.277 . . . . 0.0 110.906 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -104.94 5.35 32.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.191 0.996 . . . . 0.0 112.286 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -52.05 1.28 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.862 0.755 . . . . 0.0 109.442 -175.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 28.7 mmm -83.36 -10.52 58.41 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.405 1.482 . . . . 0.0 112.529 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -73.85 127.26 32.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.83 76.28 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.149 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -82.84 -157.38 0.22 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -134.46 153.01 52.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.664 0.786 . . . . 0.0 110.891 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.598 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -99.93 -68.32 0.81 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.943 -176.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.601 ' HB3' HD22 ' B' ' 16' ' ' ASN . 11.7 t70 -117.59 7.25 12.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.652 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.25 -7.66 5.37 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -113.41 132.84 55.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 108.932 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 136.62 38.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.27 175.68 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -120.98 140.4 51.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.846 1.658 . . . . 0.0 107.302 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.86 125.12 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -159.44 162.72 35.72 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -60.71 133.6 56.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.2 158.33 27.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.4 p -116.97 163.21 16.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.143 171.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -62.78 152.59 81.95 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.384 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.08 157.17 58.75 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.488 2.792 . . . . 0.0 110.206 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -80.91 -10.27 59.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -97.11 18.39 15.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.001 0.364 . . . . 0.0 111.202 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -144.33 162.71 35.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 111.062 -175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.3 t -153.64 147.04 24.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.751 0.42 . . . . 0.0 110.119 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.72 -135.03 52.13 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' B' ' 93' ' ' ARG . 37.6 mmt180 56.78 165.63 0.03 OUTLIER 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.515 1.526 . . . . 0.0 114.29 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -145.41 162.08 38.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.84 -174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.468 -1.74 . . . . 0.0 110.497 179.525 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.58 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.34 1 C5'-C4'-C3' 109.11 -4.26 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.629 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.967 0 C3'-C2'-C1' 104.671 3.523 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 C5'-C4'-C3' 109.745 -3.837 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.937 1 O4'-C1'-N19 113.672 5.472 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 2 C5'-C4'-C3' 109.004 -4.331 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 110.958 2.758 . 0.607 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.1 tmm? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.567 0.698 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.521 HG22 ' O ' ' B' ' 2' ' ' VAL . 6.2 p -128.38 17.17 2.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.915 1.686 . . . . 0.0 107.101 172.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -84.58 138.74 32.56 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.954 -167.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.91 104.08 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.82 -43.15 76.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.997 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -165.64 153.38 9.73 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 118.476 0.58 . . . . 0.0 111.61 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 51.2 Cg_exo -60.27 147.09 94.97 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.699 2.266 . . . . 0.0 110.706 168.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.63 -18.56 56.24 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -85.88 129.98 34.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 77.3 mt -118.19 152.67 35.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.102 0.561 . . . . 0.0 109.961 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -105.42 128.65 53.64 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.73 81.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.94 146.83 18.41 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.861 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.33 51.09 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 117.707 0.754 . . . . 0.0 111.585 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.23 164.06 11.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.457 0.703 . . . . 0.0 111.295 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' B' ' 75' ' ' ASP . 44.5 t30 -73.1 158.86 34.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.294 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 76.0 p -74.96 -2.75 28.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.704 0.288 . . . . 0.0 110.506 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.99 -7.15 16.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.647 1.179 . . . . 0.0 110.776 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.6 m -80.96 144.34 31.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.532 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -170.24 2.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.58 -34.64 77.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.646 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -65.78 -31.51 72.53 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.974 -0.454 . . . . 0.0 111.022 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.86 -20.1 29.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -89.78 -28.34 19.41 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.819 1.248 . . . . 0.0 109.848 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -81.77 -28.55 33.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 109.896 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.81 -23.71 39.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.317 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.5 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.9 p -99.77 -37.8 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.5 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 87.7 m-85 -88.96 -10.58 47.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.772 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.13 -4.61 73.46 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.1 mtpt -79.2 -14.59 58.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.808 1.243 . . . . 0.0 111.377 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' B' ' 69' ' ' MET . 80.1 m-85 -110.33 -19.8 12.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.723 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.56 163.07 31.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -74.95 125.61 29.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.69 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.342 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.18 -23.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.963 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -161.07 151.08 17.38 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.173 0.589 . . . . 0.0 109.557 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.92 147.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 109.722 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 5.8 mt -122.23 156.0 34.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.589 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.24 121.39 5.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.73 138.3 31.6 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -174.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -150.75 155.21 38.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.164 0.507 . . . . 0.0 112.086 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.13 159.4 11.96 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.706 1.202 . . . . 0.0 111.505 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -99.04 -8.75 24.85 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.79 0.436 . . . . 0.0 111.793 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.35 -12.6 12.38 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.927 0.491 . . . . 0.0 111.709 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 42.5 p -127.73 -13.99 5.2 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 122.686 0.395 . . . . 0.0 111.304 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 59.21 12.94 2.76 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 123.234 0.334 . . . . 0.0 111.701 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -83.34 143.3 30.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.018 0.527 . . . . 0.0 110.115 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -55.78 140.76 41.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.062 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -77.88 3.42 14.48 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.783 0.433 . . . . 0.0 110.278 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.88 0.7 83.31 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.746 0.689 . . . . 0.0 112.591 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.66 158.34 43.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.439 1.12 . . . . 0.0 110.6 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.42 -179.28 7.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.571 -175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.8 m-85 -140.95 161.51 37.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 p -153.03 139.23 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -111.65 121.7 45.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.853 0.359 . . . . 0.0 110.121 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' B' ' 10' ' ' LEU . 15.7 m-85 -92.16 155.26 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.74 0.816 . . . . 0.0 110.444 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.97 -22.88 48.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -114.57 135.72 22.33 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.443 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 46.8 Cg_endo -76.67 0.86 9.13 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.847 2.365 . . . . 0.0 110.499 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.35 -14.76 9.76 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.525 0.33 . . . . 0.0 111.202 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.471 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -72.07 -28.76 63.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.79 58.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.31 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -70.69 -37.82 73.65 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.23 -31.07 70.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -75.38 -44.91 42.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.262 -0.274 . . . . 0.0 111.333 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -99.8 5.72 45.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.047 0.939 . . . . 0.0 112.642 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.49 -51.75 1.27 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.913 0.778 . . . . 0.0 109.197 -174.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.443 ' HG3' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mtp -83.74 -11.16 57.51 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.626 -1.625 . . . . 0.0 112.74 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.89 114.17 10.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.03 -4.81 59.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.54 -154.53 0.11 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.327 1.051 . . . . 0.0 109.309 173.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -139.77 159.49 42.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 112.474 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.63 127.3 30.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.386 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.2 t70 60.92 -20.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 150.26 -6.06 0.68 Allowed Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.489 -0.617 . . . . 0.0 113.042 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -118.38 134.73 54.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.869 0.834 . . . . 0.0 110.063 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.81 137.42 47.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.322 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 22.1 pt -118.5 177.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -122.01 143.35 49.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.562 1.945 . . . . 0.0 107.177 170.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.66 130.42 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -158.96 164.2 35.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -67.53 132.73 48.15 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.34 147.83 34.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 62.9 p -115.58 170.74 8.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.936 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.19 154.38 90.21 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.081 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . 0.42 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 57.7 Cg_endo -64.87 169.44 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.79 2.994 . . . . 0.0 110.685 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . 0.527 ' C ' ' H ' ' B' ' 90' ' ' GLU . 49.6 m -108.92 3.68 22.57 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -170.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . 0.597 ' CE2' " H2'" ' A' ' 101' ' ' ' A' . 4.9 m-85 -63.89 -0.07 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.796 1.18 . . . . 0.0 110.457 174.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' B' ' 88' ' ' SER . 5.2 pt-20 -122.07 0.38 9.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.966 1.706 . . . . 0.0 112.186 -172.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 4.3 t -167.45 -3.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.41 5.38 0.14 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.808 0.731 . . . . 0.0 113.845 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.6 147.76 28.52 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.054 0.941 . . . . 0.0 109.048 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 51.39 32.26 8.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.749 0.819 . . . . 0.0 111.653 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.368 -179.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.529 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.266 1 C5'-C4'-C3' 109.484 -4.011 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.43 ' C6 ' " H5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.963 0 C3'-C2'-C1' 104.076 2.862 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.673 1 C5'-C4'-C3' 109.308 -4.128 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.0 1 O4'-C1'-N19 112.914 4.714 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.428 " H4'" ' OP2' ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.212 1 C4'-C3'-C2' 98.386 -4.314 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . 0.669 " H5'" ' C8 ' ' A' ' 101' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.967 1 O4'-C1'-N19 114.354 6.154 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p 47.62 42.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 123.031 1.396 . . . . 0.0 108.758 -168.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -100.54 132.15 46.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.118 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.67 103.23 12.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.47 172.77 5.65 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -52.77 153.1 6.12 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.536 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 98.9 Cg_exo -51.5 154.94 7.95 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.552 3.502 . . . . 0.0 113.21 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.85 -15.37 55.56 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -98.68 128.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.373 1.087 . . . . 0.0 109.044 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 77.0 mt -113.34 153.8 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.048 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -108.08 128.93 55.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.485 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -121.1 80.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.39 144.21 17.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.237 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.71 38.98 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 117.709 0.755 . . . . 0.0 111.466 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.29 162.46 22.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.048 0.539 . . . . 0.0 112.087 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' B' ' 75' ' ' ASP . 39.5 t-20 -76.35 155.15 34.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.014 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -68.93 -10.47 57.41 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 123.548 0.739 . . . . 0.0 110.284 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.78 -11.25 23.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 110.309 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -81.29 144.72 31.33 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.287 0.635 . . . . 0.0 109.345 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.74 -165.98 1.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.392 0.615 . . . . 0.0 109.536 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' B' ' 21' ' ' GLU . 37.1 mp0 -70.61 -38.84 74.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.858 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -68.71 -25.84 64.97 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.5 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.95 -20.19 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' B' ' 27' ' ' VAL . 10.9 mt -90.37 -28.46 18.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.675 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.11 -26.65 48.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 109.79 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.85 -23.87 36.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' B' ' 24' ' ' LEU . 5.3 p -101.82 -36.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.485 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 83.9 m-85 -90.47 -11.61 39.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.21 -0.306 . . . . 0.0 110.951 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.16 -3.13 68.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -81.51 -12.23 58.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.549 1.14 . . . . 0.0 111.264 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -111.96 -20.48 11.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.6 0.76 . . . . 0.0 112.412 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.47 161.58 29.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -74.0 124.97 27.23 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.88 143.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.154 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -20.7 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.477 0.711 . . . . 0.0 110.477 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -160.37 148.82 16.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.304 0.642 . . . . 0.0 109.66 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.06 143.54 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 110.039 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 8.0 mt -118.94 156.03 30.28 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.178 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.536 HD12 ' HE2' ' B' ' 41' ' ' LYS . 2.9 tm? -154.98 119.44 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 171.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 13.8 mmm -93.17 142.87 26.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.097 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.536 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.8 mttt -140.78 157.23 45.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.91 141.74 56.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.187 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.411 ' CD ' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -83.7 -4.57 58.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.41 -14.15 9.74 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.5 p -128.84 -14.94 4.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.223 0.465 . . . . 0.0 111.574 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 56.8 21.77 6.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -70.48 -109.31 0.0 OUTLIER 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.911 1.284 . . . . 0.0 109.429 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 t -151.31 146.35 25.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -72.6 -9.98 59.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.17 87.18 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.158 -0.801 . . . . 0.0 111.943 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -136.94 160.34 39.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.922 1.361 . . . . 0.0 110.249 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.9 -178.71 7.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.749 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 59.9 m-85 -142.93 162.59 35.07 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.61 141.84 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 33.6 m -111.97 122.9 49.03 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.245 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -93.06 156.67 16.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 110.503 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.82 -23.08 42.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.461 -0.305 . . . . 0.0 110.284 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -115.19 137.56 23.05 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 64.4 Cg_endo -75.04 -7.04 18.78 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.568 2.179 . . . . 0.0 110.474 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.75 -14.71 13.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.844 0.293 . . . . 0.0 110.728 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.484 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 72.6 m-20 -71.67 -28.13 63.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 -31.14 53.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.556 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -69.05 -38.94 79.39 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.44 -32.74 72.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.94 -44.78 46.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.43 -8.47 51.16 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.057 -0.402 . . . . 0.0 111.203 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -104.23 4.74 34.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.395 1.078 . . . . 0.0 112.088 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.58 -52.67 1.26 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.759 0.79 . . . . 0.0 109.447 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 31.2 mmm -82.22 -10.55 59.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.586 1.555 . . . . 0.0 112.401 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.56 126.15 29.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.39 -6.63 83.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -80.64 -153.86 0.09 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.595 1.158 . . . . 0.0 109.691 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -139.88 159.05 43.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.292 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -132.66 126.18 32.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.024 177.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' B' ' 16' ' ' ASN . 4.9 t70 61.05 -21.38 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 151.08 -6.35 0.6 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.724 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -117.42 133.16 56.29 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.002 0.901 . . . . 0.0 110.119 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.36 50.78 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.301 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -120.64 178.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -122.57 142.74 50.3 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.399 1.88 . . . . 0.0 107.33 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.97 129.25 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -159.24 162.39 36.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -63.59 134.37 55.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 158.27 29.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 29.5 p -117.55 160.46 21.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.949 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -63.12 154.12 78.79 Favored Pre-proline 0 N--CA 1.45 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . 0.407 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 52.9 Cg_endo -62.36 145.66 95.83 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.049 2.499 . . . . 0.0 110.544 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.8 m -93.27 6.56 47.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.72 0.808 . . . . 0.0 111.53 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.19 7.68 8.85 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.46 172.73 13.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.743 0.817 . . . . 0.0 111.303 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 6.4 t -83.13 10.31 8.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.212 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 94' ' ' ARG . . . 78.58 4.63 87.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.808 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 63.12 -18.1 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.911 1.684 . . . . 0.0 113.618 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' B' ' 92' ' ' GLY . 41.3 ptt180 -153.77 164.57 38.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.237 0.472 . . . . 0.0 110.81 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.317 -1.824 . . . . 0.0 110.569 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.543 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.227 1 O4'-C1'-N19 112.512 4.312 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.616 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 C3'-C2'-C1' 104.467 3.296 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 C5'-C4'-C3' 110.329 -3.447 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.946 1 O4'-C1'-N19 114.056 5.856 . 0.109 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.407 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.424 -2.436 1 O4'-C1'-N19 112.621 4.421 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 112.539 4.339 . 0.524 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpp . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.458 0.647 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 120.82 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.12 126.28 26.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.892 0.477 . . . . 0.0 111.213 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.62 106.66 14.79 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.7 -45.5 81.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -170.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -162.09 141.13 7.21 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-N 118.288 0.494 . . . . 0.0 110.322 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 75.9 Cg_exo -54.83 140.73 78.14 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.883 2.389 . . . . 0.0 110.727 173.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.79 65.07 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -92.24 125.49 36.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.432 HD12 ' CE1' ' B' ' 56' ' ' PHE . 74.4 mt -110.44 150.84 28.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -105.31 128.85 53.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.486 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 9.0 mm -119.19 78.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.42 142.59 16.11 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.493 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.56 6.52 46.97 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 122.216 -0.579 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.27 162.32 6.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.331 0.652 . . . . 0.0 111.773 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.52 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.6 t30 -71.25 160.11 33.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 70.9 p -77.85 -1.28 30.87 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.878 0.471 . . . . 0.0 110.669 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -109.26 -6.1 15.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.409 1.083 . . . . 0.0 111.025 -171.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -83.4 145.74 28.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.285 0.634 . . . . 0.0 110.087 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -169.96 2.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -67.51 -35.83 79.89 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.54 -174.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -67.89 -27.9 67.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.964 -0.46 . . . . 0.0 111.247 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.02 28.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.71 -26.78 24.07 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.166 1.386 . . . . 0.0 109.352 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -80.19 -32.75 38.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.427 0.632 . . . . 0.0 110.163 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.49 -21.65 45.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.308 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.1 p -103.06 -34.29 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' B' ' 27' ' ' VAL . 84.2 m-85 -91.83 -12.0 34.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.073 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -3.08 72.11 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -81.57 -13.58 57.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.66 1.184 . . . . 0.0 110.89 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -110.94 -19.58 12.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.696 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.13 166.2 36.67 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 118.025 0.375 . . . . 0.0 112.332 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttm105 -72.86 117.81 15.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.2 144.21 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.566 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -18.84 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.167 0.587 . . . . 0.0 110.323 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -160.22 147.35 16.11 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.212 0.605 . . . . 0.0 109.652 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.44 141.75 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.459 0.647 . . . . 0.0 109.583 170.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.2 mt -120.26 155.81 32.49 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.738 175.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.37 120.19 6.14 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 6.5 mmm -93.59 136.99 33.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.59 -172.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -147.51 153.25 39.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.116 0.484 . . . . 0.0 111.199 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -64.45 153.47 38.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.109 0.964 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' H ' ' HD2' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -93.07 -7.05 46.7 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -105.1 -14.76 15.29 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.556 . . . . 0.0 111.75 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 61.8 p -133.35 -14.18 2.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.791 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 62.92 11.74 5.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 117.746 0.248 . . . . 0.0 111.479 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -87.37 145.32 26.36 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.894 0.878 . . . . 0.0 109.926 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 17.2 m -53.13 139.4 28.82 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.372 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 32.1 mmm-85 -71.67 -8.71 55.8 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.538 1.135 . . . . 0.0 109.75 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -1.13 75.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.904 0.764 . . . . 0.0 111.306 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.89 156.64 48.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.724 1.262 . . . . 0.0 110.522 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.54 7.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.872 0.469 . . . . 0.0 110.422 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 56.0 m-85 -142.42 161.79 37.13 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.534 0.334 . . . . 0.0 110.736 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.56 141.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.0 m -112.08 126.08 54.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.2 m-85 -94.3 155.77 16.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 111.427 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.36 -22.8 61.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 119.266 -0.397 . . . . 0.0 111.364 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -121.49 141.47 33.51 Favored Pre-proline 0 CA--C 1.518 -0.254 0 CA-C-N 118.295 0.498 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 60.3 Cg_endo -75.14 -3.81 14.45 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.819 2.346 . . . . 0.0 110.289 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.46 -15.84 11.45 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.581 0.352 . . . . 0.0 110.998 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.494 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 74.8 m-20 -71.77 -29.15 64.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 169.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.14 59.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.143 0.577 . . . . 0.0 110.526 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -70.84 -37.84 73.17 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.91 -30.36 68.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.27 -9.41 53.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.176 -0.327 . . . . 0.0 111.228 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -101.82 7.18 41.77 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.546 1.138 . . . . 0.0 112.158 174.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.29 -53.6 1.03 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.862 0.839 . . . . 0.0 109.108 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.531 ' HA ' ' CG ' ' B' ' 72' ' ' LYS . 49.7 mmm -78.44 -10.5 59.72 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.154 1.782 . . . . 0.0 111.916 -176.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -80.65 117.34 21.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.54 -5.16 62.26 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.609 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' B' ' 69' ' ' MET . 20.7 ptmt -106.93 176.75 5.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.578 1.189 . . . . 0.0 111.954 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.4 t -97.76 155.91 16.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -169.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -127.23 123.84 37.51 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.359 172.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' B' ' 16' ' ' ASN . 3.8 t70 61.66 -23.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 157.56 -11.37 0.25 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.141 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -116.57 135.57 53.7 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.014 0.907 . . . . 0.0 110.513 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.34 140.51 57.26 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 123.199 0.6 . . . . 0.0 110.823 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -125.91 171.9 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -115.35 144.08 44.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.981 1.712 . . . . 0.0 108.015 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 55.9 t -135.76 130.14 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -160.44 163.86 32.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -63.31 133.31 53.95 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.36 158.55 30.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.038 0.446 . . . . 0.0 111.883 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 72.8 p -115.82 168.72 9.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.613 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.36 152.36 85.25 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.369 0.668 . . . . 0.0 110.817 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -63.21 154.54 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.619 2.879 . . . . 0.0 111.365 -175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 28.3 m -80.68 -3.03 49.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -91.69 4.4 52.82 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.12 0.418 . . . . 0.0 111.066 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.21 158.81 40.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.774 0.43 . . . . 0.0 110.636 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.9 t -152.99 165.12 36.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.474 0.309 . . . . 0.0 110.971 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.05 -2.65 66.41 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.201 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -143.47 151.55 40.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.714 0.806 . . . . 0.0 109.616 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 54.37 25.62 6.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.083 0.953 . . . . 0.0 111.898 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.307 -1.83 . . . . 0.0 111.125 179.527 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.587 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.435 1 C5'-C4'-C3' 109.13 -4.247 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.553 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 C3'-C2'-C1' 104.099 2.887 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 112.428 -2.048 . 0.102 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 1 O4'-C1'-N19 114.587 6.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 2 O4'-C1'-N19 113.83 5.63 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 O4'-C1'-N19 111.231 3.031 . 0.191 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tmm? . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.195 0.522 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.486 ' O ' HG22 ' B' ' 2' ' ' VAL . 7.2 p -119.67 11.29 6.64 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-O 123.022 1.391 . . . . 0.0 107.987 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -84.11 147.44 27.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.961 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.11 103.26 5.48 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.48 168.51 5.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.271 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -53.87 153.72 8.21 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.501 0.72 . . . . 0.0 112.8 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 99.8 Cg_exo -51.24 154.9 7.28 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.435 3.423 . . . . 0.0 113.114 177.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.06 -13.22 62.08 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.28 127.1 45.24 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 72.7 mt -112.5 154.45 25.87 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.16 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -107.96 127.3 53.63 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.5 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.6 mm -118.85 80.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.29 143.78 16.83 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.624 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.04 36.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.16 163.5 22.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' B' ' 75' ' ' ASP . 40.3 t-20 -73.51 158.85 34.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 81.2 p -73.62 -8.29 55.36 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.301 0.64 . . . . 0.0 110.161 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.38 -11.04 20.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 110.48 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 41.2 m -79.87 144.78 33.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.71 -168.14 2.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.06 -32.27 68.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.578 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -64.4 -32.57 74.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.13 -21.91 27.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.421 ' CD1' HD23 ' B' ' 39' ' ' LEU . 1.1 mt -85.87 -27.88 24.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.226 1.41 . . . . 0.0 109.635 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.93 -29.97 35.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 110.17 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -22.55 41.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.586 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' B' ' 28' ' ' PHE . 5.0 p -102.36 -35.51 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -174.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.508 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.0 m-85 -91.56 -10.06 42.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.873 176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -3.94 71.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 27' ' ' VAL . 36.2 mtpt -80.4 -13.08 59.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.619 1.168 . . . . 0.0 111.208 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' B' ' 65' ' ' ALA . 80.3 m-85 -112.29 -18.78 12.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.7 -176.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -177.34 167.31 38.35 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.161 0.437 . . . . 0.0 112.63 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -74.22 117.28 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 40.7 mt -76.2 142.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.461 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.47 -23.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.148 0.579 . . . . 0.0 110.194 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -161.51 150.1 15.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.238 0.615 . . . . 0.0 109.683 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.66 147.09 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 109.547 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 9.5 mt -123.09 156.36 35.08 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.787 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.487 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.44 119.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.7 mmm -93.03 142.58 27.13 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.902 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE2' HD12 ' B' ' 39' ' ' LEU . 22.8 mttt -140.58 163.86 31.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.5 147.18 53.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.316 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -88.83 -9.36 51.99 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -121.33 -12.74 8.57 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 19.0 p -122.89 -14.8 7.56 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 118.332 0.515 . . . . 0.0 111.222 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.18 22.17 7.28 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -77.36 -111.28 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.696 1.198 . . . . 0.0 109.613 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.5 t -148.58 147.21 28.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -73.8 -10.27 59.5 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.67 3.89 87.89 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.351 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.9 161.03 37.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.695 1.248 . . . . 0.0 109.803 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.34 -177.97 6.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.098 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 68.3 m-85 -142.91 160.93 39.4 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.168 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -153.3 140.6 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -112.71 121.71 45.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -92.62 155.95 17.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.695 0.798 . . . . 0.0 111.723 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -73.43 -22.57 60.17 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.455 0.302 . . . . 0.0 111.255 174.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -121.16 140.81 31.74 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 118.352 0.524 . . . . 0.0 109.834 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 61.9 Cg_endo -76.3 -1.3 11.32 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 123.122 2.548 . . . . 0.0 110.342 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.36 -16.39 10.28 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.808 0.443 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 82.5 m-20 -71.28 -27.91 63.76 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.41 -29.09 56.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -72.97 -38.69 66.6 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.15 -25.39 66.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.71 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' CG ' ' B' ' 31' ' ' TYR . . . -83.59 -43.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 172.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.2 -6.6 48.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.896 -0.502 . . . . 0.0 112.305 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -107.46 7.97 29.21 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.532 0.733 . . . . 0.0 112.311 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.92 -55.07 1.39 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.628 0.728 . . . . 0.0 109.329 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . 0.408 ' HE3' HD11 ' B' ' 79' ' ' ILE . 25.5 mmm -79.57 -10.03 59.73 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.538 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -73.46 128.08 34.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.65 79.28 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -81.64 -153.44 0.11 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.628 1.171 . . . . 0.0 109.639 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 24.1 t -140.03 158.69 43.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -173.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.74 128.9 31.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.543 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.549 ' HB3' HD22 ' B' ' 16' ' ' ASN . 2.4 t0 52.73 21.52 1.93 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.328 0.585 . . . . 0.0 112.223 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.73 56.29 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.707 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -114.97 130.45 56.93 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.43 1.115 . . . . 0.0 109.875 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.81 139.12 50.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.344 0.258 . . . . 0.0 111.658 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.408 HD11 ' HE3' ' B' ' 69' ' ' MET . 21.9 pt -123.79 177.55 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -121.84 144.54 48.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.049 1.74 . . . . 0.0 107.567 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.42 126.54 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.79 164.83 28.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -60.36 135.95 57.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.2 159.84 23.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 35.5 p -113.69 169.59 8.87 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.649 169.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -70.96 158.69 87.6 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.826 0.451 . . . . 0.0 110.472 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.71 151.73 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.118 2.545 . . . . 0.0 110.928 -176.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 17.0 t -77.84 -11.49 59.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -84.78 4.61 32.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.954 -0.466 . . . . 0.0 111.278 176.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.03 148.52 46.87 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.814 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 20.6 m -155.59 12.55 0.33 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.29 1.036 . . . . 0.0 110.523 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 -158.27 52.68 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 58.56 161.27 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 112.505 -175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -149.96 151.39 33.29 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.209 0.603 . . . . 0.0 109.851 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.534 -1.704 . . . . 0.0 111.455 179.538 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.543 " H3'" " C5'" ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.238 1 O4'-C1'-N19 112.332 4.132 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.543 " C5'" " H3'" ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.906 0 C5'-C4'-C3' 109.933 -3.712 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 C5'-C4'-C3' 109.761 -3.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.671 1 O4'-C1'-N19 114.368 6.168 . 0.013 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 2 O4'-C1'-N19 113.08 4.88 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.639 0 C5'-C4'-C3' 110.618 -3.254 . 0.165 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.497 ' O ' HG22 ' B' ' 2' ' ' VAL . 3.3 p -127.58 12.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 107.962 173.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.22 145.35 48.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.607 -168.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.01 99.1 3.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.12 128.22 33.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 43.39 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 126.832 2.053 . . . . 0.0 113.915 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.553 ' CB ' ' HB3' ' B' ' 59' ' ' PRO . 82.4 Cg_exo -47.78 133.47 22.18 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 123.069 2.513 . . . . 0.0 110.291 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.78 -10.63 49.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -92.51 127.88 38.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' B' ' 56' ' ' PHE . 87.9 mt -113.3 149.24 34.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -102.72 127.47 49.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.488 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 8.0 mm -118.61 78.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.73 144.54 17.13 Favored Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.729 -0.607 . . . . 0.0 112.157 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 13.45 40.97 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 117.908 0.854 . . . . 0.0 111.827 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -65.81 166.33 11.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.042 0.925 . . . . 0.0 112.928 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.497 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.2 OUTLIER -78.71 145.77 34.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.312 1.445 . . . . 0.0 109.888 176.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 78.7 p -74.32 -8.61 56.83 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.995 0.918 . . . . 0.0 112.301 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.96 -12.39 18.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.265 1.426 . . . . 0.0 109.583 -174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.6 m -77.73 149.02 34.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.55 1.14 . . . . 0.0 110.063 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 -165.0 1.67 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -66.1 -29.48 69.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.134 0.424 . . . . 0.0 110.952 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.05 -19.7 31.55 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' B' ' 27' ' ' VAL . 4.9 mt -87.84 -29.18 21.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.64 1.176 . . . . 0.0 109.472 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.52 -27.66 46.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.443 0.64 . . . . 0.0 109.825 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.29 -23.38 37.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.347 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.596 HG11 HD21 ' B' ' 74' ' ' LEU . 5.6 p -102.87 -34.45 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.7 m-85 -90.84 -11.7 38.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.107 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.29 -5.16 76.15 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -79.31 -12.82 59.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.833 1.253 . . . . 0.0 110.729 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -113.63 -13.5 12.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.48 171.32 37.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.359 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -79.89 115.04 19.25 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.59 0.71 . . . . 0.0 109.982 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 34.8 mt -75.0 141.67 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.991 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -21.32 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.206 0.602 . . . . 0.0 110.354 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -161.29 150.38 16.36 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.21 146.11 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.4 0.619 . . . . 0.0 109.849 172.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.4 mt -123.24 155.32 37.39 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.528 1.131 . . . . 0.0 108.234 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.509 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.1 tm? -154.0 119.76 5.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 9.2 mmm -92.81 139.82 30.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.509 ' HE2' HD12 ' B' ' 39' ' ' LEU . 18.1 mttt -137.32 160.61 38.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.51 148.61 50.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.783 173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -93.81 -7.55 43.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.557 0.343 . . . . 0.0 111.844 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -117.57 -12.68 10.32 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.114 0.565 . . . . 0.0 112.337 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 24.5 p -123.88 -14.81 7.08 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 111.071 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.65 18.87 5.01 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -76.65 -108.22 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.36 1.064 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -150.1 148.53 29.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.898 0.879 . . . . 0.0 108.83 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.416 ' HG2' ' CA ' ' B' ' 41' ' ' LYS . 40.6 mmm-85 -73.08 -10.81 60.18 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.47 4.07 80.68 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.992 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 157.37 45.98 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.719 1.26 . . . . 0.0 109.95 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.36 -177.98 6.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.401 0.28 . . . . 0.0 111.076 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 64.7 m-85 -142.68 160.75 39.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.797 0.439 . . . . 0.0 110.463 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -154.1 138.79 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 56.9 m -110.34 126.84 54.66 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.106 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' B' ' 10' ' ' LEU . 3.9 m-85 -98.2 161.81 13.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.403 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -71.52 -18.4 62.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -130.25 153.43 81.21 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 123.295 0.638 . . . . 0.0 110.104 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.553 ' HB3' ' CB ' ' B' ' 7' ' ' PRO . 29.6 Cg_endo -80.68 1.12 9.53 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 171.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.1 -15.59 9.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.76 -21.22 25.26 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 -27.78 61.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -69.58 -32.14 70.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.82 -22.24 61.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.1 -44.16 13.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.25 -15.62 62.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.184 -0.323 . . . . 0.0 111.858 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.36 6.74 46.02 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.19 -55.08 1.36 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.041 0.837 . . . . 0.0 109.461 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 24.4 mmm -78.05 -12.21 59.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.18 1.392 . . . . 0.0 111.965 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -72.83 130.12 39.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -10.05 63.36 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.671 -0.516 . . . . 0.0 112.356 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -83.28 -160.3 0.41 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.166 0.986 . . . . 0.0 109.509 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 33.2 t -132.9 152.61 51.85 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.716 0.806 . . . . 0.0 110.723 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.596 HD21 HG11 ' B' ' 27' ' ' VAL . 0.4 OUTLIER -95.73 -62.81 1.23 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.962 -174.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 15.6 t70 -130.18 0.92 4.67 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.141 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.75 -14.07 0.78 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.821 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -115.25 134.5 55.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.05 135.62 38.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.8 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 26.4 pt -114.26 174.32 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -173.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.55 141.85 47.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.564 1.546 . . . . 0.0 107.554 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.36 125.86 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.29 164.99 34.41 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -63.05 135.71 57.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.46 158.91 29.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 112.309 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 82.5 p -117.54 164.21 15.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.535 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 150.3 89.74 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . 0.4 ' HB3' ' C8 ' ' A' ' 100' ' ' ' A' . 65.0 Cg_endo -67.47 160.66 46.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.543 2.828 . . . . 0.0 110.152 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 68.3 p -78.3 -9.73 59.37 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.245 0.618 . . . . 0.0 112.576 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -98.5 20.04 13.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.492 0.317 . . . . 0.0 110.987 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -144.54 158.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 111.234 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.3 t -154.54 156.74 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.668 0.387 . . . . 0.0 110.555 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.5 -133.85 49.37 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -149.59 163.75 37.01 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.718 0.807 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.92 16.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.274 1.83 . . . . 0.0 114.679 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.655 -1.636 . . . . 0.0 111.118 -177.858 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.697 0 O4'-C1'-N19 111.879 3.679 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.658 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 C3'-C2'-C1' 105.079 3.976 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 1 C5'-C4'-C3' 109.007 -4.328 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.763 1 O4'-C1'-N19 113.872 5.672 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.4 ' C8 ' ' HB3' ' B' ' 87' ' ' PRO . . . . . . . . 0 O4'--C4' 1.424 -2.454 2 C5'-C4'-C3' 108.541 -4.639 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 110.855 2.655 . 0.637 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.49 121.2 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -136.96 132.37 34.28 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.206 0.527 . . . . 0.0 111.38 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.03 113.68 7.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.07 135.18 33.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.432 -172.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 45.65 112.34 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 128.149 2.58 . . . . 0.0 115.514 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.457 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 76.2 Cg_exo -53.19 147.54 34.95 Favored 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.472 2.115 . . . . 0.0 110.573 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.71 -20.58 37.89 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -84.52 129.0 34.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' B' ' 54' ' ' VAL . 76.6 mt -119.1 155.62 31.21 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.991 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -109.44 130.02 55.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.2 mm -121.68 86.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.87 145.07 16.91 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 121.999 -0.438 . . . . 0.0 112.555 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.12 8.08 45.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.48 HD23 HG21 ' B' ' 79' ' ' ILE . 9.7 mt -64.28 162.65 14.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.085 0.945 . . . . 0.0 112.089 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.476 ' CG ' ' HB3' ' B' ' 75' ' ' ASP . 0.4 OUTLIER -70.14 145.18 51.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.432 1.493 . . . . 0.0 109.568 175.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -70.83 -4.88 26.46 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.927 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.83 -6.49 15.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.984 1.314 . . . . 0.0 109.609 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 97.3 m -76.52 143.79 40.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.412 1.085 . . . . 0.0 108.751 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.96 -166.7 1.95 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.34 -29.89 68.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.692 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -66.76 -30.61 70.87 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.87 -17.13 28.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -95.28 -28.27 15.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.336 1.054 . . . . 0.0 109.909 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.97 -29.38 29.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.24 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.31 -28.54 38.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.127 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.514 HG13 ' CD2' ' B' ' 28' ' ' PHE . 4.3 p -92.64 -36.45 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' B' ' 12' ' ' ILE . 84.2 m-85 -92.15 -10.48 38.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.276 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.35 -3.48 77.13 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -79.77 -14.73 58.51 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.71 1.204 . . . . 0.0 111.608 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -111.5 -19.0 12.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.803 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -178.52 164.61 33.28 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 118.208 0.458 . . . . 0.0 112.312 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -72.23 117.45 13.89 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.96 141.23 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.386 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -23.81 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 122.877 0.471 . . . . 0.0 110.067 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -161.11 150.37 16.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.383 0.673 . . . . 0.0 109.687 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.55 146.06 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.517 0.675 . . . . 0.0 109.951 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.3 mt -118.14 152.13 36.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.3 119.33 6.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 10.3 mmm -93.4 139.66 30.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.9 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -143.94 153.7 42.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.129 0.49 . . . . 0.0 112.059 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.58 165.59 14.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.822 1.249 . . . . 0.0 111.721 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -107.31 -8.22 16.44 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.217 0.607 . . . . 0.0 111.55 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -103.64 -14.88 15.97 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.121 0.568 . . . . 0.0 111.113 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -133.42 -15.93 2.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.48 8.7 3.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -83.96 153.56 23.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.492 0.717 . . . . 0.0 109.49 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.2 m -58.07 140.74 51.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.327 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -68.6 -8.64 43.71 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.576 0.75 . . . . 0.0 109.234 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.75 74.07 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -138.94 158.58 43.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.452 1.126 . . . . 0.0 110.671 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -179.04 7.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.385 0.674 . . . . 0.0 110.682 -174.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 46.2 m-85 -142.84 163.36 33.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.8 p -153.88 140.96 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -113.33 122.89 48.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.693 0.397 . . . . 0.0 110.08 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -93.27 156.63 16.7 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 111.632 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.72 -22.92 60.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 122.606 0.363 . . . . 0.0 111.441 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -121.54 141.07 32.72 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 118.428 0.558 . . . . 0.0 110.042 174.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 57.3 Cg_endo -76.33 -0.98 10.96 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.833 2.355 . . . . 0.0 110.599 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.6 -16.8 10.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.198 0.454 . . . . 0.0 110.827 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 80.4 m-20 -70.56 -29.05 65.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.74 -29.98 59.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.438 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -70.9 -39.25 72.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.21 -29.84 69.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.253 -0.276 . . . . 0.0 110.253 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.273 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.53 -12.58 61.45 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.501 0.32 . . . . 0.0 111.055 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -97.19 6.85 47.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.946 0.899 . . . . 0.0 112.052 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.92 -52.04 1.22 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.002 0.819 . . . . 0.0 109.892 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 54.3 mmm -81.65 -14.75 56.28 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.07 1.748 . . . . 0.0 112.055 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -74.35 116.33 14.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.14 -8.15 60.7 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.372 0.511 . . . . 0.0 112.027 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -82.54 -156.57 0.18 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.361 1.064 . . . . 0.0 109.392 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -144.35 158.8 43.55 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 123.786 0.834 . . . . 0.0 111.779 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 76' ' ' GLY . 0.0 OUTLIER -134.75 125.68 27.46 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.0 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' B' ' 16' ' ' ASN . 3.5 t70 61.07 -24.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' B' ' 74' ' ' LEU . . . 161.05 -12.2 0.14 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 118.983 -0.898 . . . . 0.0 113.78 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -118.29 137.32 53.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.468 1.134 . . . . 0.0 109.948 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.56 138.32 50.83 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.037 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.48 HG21 HD23 ' B' ' 15' ' ' LEU . 27.0 pt -120.65 163.74 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -112.56 144.01 42.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.302 1.841 . . . . 0.0 107.963 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 29.2 t -135.07 130.6 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.87 162.26 39.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.12 123.43 21.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.33 146.48 43.97 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 61.8 p -101.09 168.85 9.32 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.36 173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.38 150.72 97.6 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.284 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.76 160.92 47.9 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.432 2.754 . . . . 0.0 109.901 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 67.1 m -118.06 5.5 12.06 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -89.75 9.59 26.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.376 0.534 . . . . 0.0 111.756 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -140.41 148.42 41.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.478 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 39.8 m -148.0 14.89 1.05 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.797 0.839 . . . . 0.0 111.538 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.88 141.62 47.61 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.08 34.88 14.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.365 1.066 . . . . 0.0 111.735 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -150.89 154.07 36.51 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.61 0.364 . . . . 0.0 110.232 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.513 -1.715 . . . . 0.0 111.23 -179.798 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.584 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.32 1 C5'-C4'-C3' 109.257 -4.162 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.657 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.045 0 C3'-C2'-C1' 104.726 3.585 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 C5'-C4'-C3' 109.243 -4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 113.448 5.248 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 2 O4'-C1'-N19 112.96 4.76 . 0.015 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 O4'-C1'-N19 111.163 2.963 . 0.584 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.97 109.18 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -135.41 135.17 40.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.7 113.19 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -65.77 171.81 4.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.541 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -52.37 149.47 10.24 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.601 0.76 . . . . 0.0 112.617 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' B' ' 59' ' ' PRO . 90.1 Cg_exo -51.54 155.24 7.66 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.623 3.549 . . . . 0.0 113.233 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.83 -13.02 66.83 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -98.24 127.1 44.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' B' ' 56' ' ' PHE . 77.1 mt -113.4 153.26 28.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.971 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -106.4 128.94 54.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.498 HD12 ' CZ ' ' B' ' 28' ' ' PHE . 6.7 mm -120.53 81.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.86 143.2 16.46 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.951 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.6 11.63 34.97 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 117.74 0.77 . . . . 0.0 111.752 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -67.33 162.33 23.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 111.706 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.592 HD22 ' HB3' ' B' ' 75' ' ' ASP . 47.2 t30 -75.29 156.54 35.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.642 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -71.34 -8.27 52.59 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.244 0.618 . . . . 0.0 110.383 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.26 -10.17 20.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.607 1.163 . . . . 0.0 110.489 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -81.79 146.18 30.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.29 0.636 . . . . 0.0 109.918 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.58 -167.26 2.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.174 -173.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -67.72 -28.54 67.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 118.055 0.388 . . . . 0.0 111.075 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.39 -21.89 30.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.56 -29.02 22.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.107 1.363 . . . . 0.0 109.403 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.23 -28.21 38.58 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 109.937 173.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.94 -21.12 37.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.352 -175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.589 HG11 HD21 ' B' ' 74' ' ' LEU . 6.0 p -104.35 -35.0 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.524 ' CD2' HG13 ' B' ' 27' ' ' VAL . 89.9 m-85 -91.95 -10.99 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.909 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.38 -2.9 75.73 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -81.9 -12.17 58.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.708 1.203 . . . . 0.0 111.04 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -112.14 -19.16 12.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' B' ' 61' ' ' ASP . . . -176.39 166.41 37.39 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 118.264 0.484 . . . . 0.0 112.716 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -73.88 117.1 15.26 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mt -76.29 142.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.67 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -21.97 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.178 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -161.71 150.17 15.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.019 0.528 . . . . 0.0 109.834 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.98 145.92 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.352 0.596 . . . . 0.0 109.546 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' B' ' 53' ' ' PHE . 6.8 mt -121.9 154.77 36.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.451 175.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.501 HD12 ' HE2' ' B' ' 41' ' ' LYS . 3.0 tm? -153.42 119.55 5.44 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . . . . . . . . . 11.1 mmm -92.49 141.07 28.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.5 -170.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.501 ' HE2' HD12 ' B' ' 39' ' ' LEU . 13.3 mttt -137.91 160.24 39.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.53 149.16 39.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.183 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -93.4 -1.63 55.59 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.76 -13.65 7.86 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.8 p -125.94 -15.79 5.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 118.295 0.498 . . . . 0.0 111.377 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.71 21.9 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.66 -105.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.84 1.256 . . . . 0.0 109.886 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -152.88 146.26 24.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.865 0.866 . . . . 0.0 108.681 172.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -75.35 -10.31 59.34 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.51 0.31 89.32 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.855 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -133.92 157.11 46.85 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.637 1.219 . . . . 0.0 110.604 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.137 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' B' ' 38' ' ' LEU . 62.5 m-85 -143.05 162.41 35.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.623 0.369 . . . . 0.0 110.281 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.79 140.31 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 35.8 m -112.75 122.56 48.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 123.271 0.357 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' B' ' 10' ' ' LEU . 13.8 m-85 -92.5 156.69 16.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.859 0.864 . . . . 0.0 111.791 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.7 -21.81 59.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.215 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -122.26 139.83 31.38 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' B' ' 7' ' ' PRO . 53.2 Cg_endo -75.94 -0.15 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.161 2.574 . . . . 0.0 110.65 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.01 -14.99 9.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.822 0.283 . . . . 0.0 111.141 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' HA3' ' B' ' 32' ' ' GLY . 78.3 m-20 -72.43 -28.5 63.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.27 -29.24 60.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -73.03 -37.25 66.96 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.1 -25.5 65.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.533 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.64 16.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.204 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.4 -8.93 57.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.26 9.03 34.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.341 0.657 . . . . 0.0 112.727 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.09 -53.77 1.3 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.546 0.689 . . . . 0.0 109.461 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 26.8 mmm -81.73 -10.22 59.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.63 1.572 . . . . 0.0 112.055 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -73.43 127.02 31.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.68 79.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.333 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -82.38 -157.42 0.21 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.608 1.163 . . . . 0.0 109.824 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 31.9 t -136.15 153.12 51.37 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.593 0.757 . . . . 0.0 110.858 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.589 HD21 HG11 ' B' ' 27' ' ' VAL . 0.3 OUTLIER -101.75 -65.88 0.95 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.124 -175.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.592 ' HB3' HD22 ' B' ' 16' ' ' ASN . 14.5 t70 -121.54 14.49 11.06 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.391 -175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.44 -6.09 9.25 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.846 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -112.88 131.04 55.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.734 0.814 . . . . 0.0 108.843 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.19 134.98 37.53 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.116 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 pt -115.12 175.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -118.27 141.72 48.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.058 1.743 . . . . 0.0 107.099 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.71 127.42 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.76 163.79 37.72 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -63.75 134.09 54.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.87 152.7 38.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -106.31 175.75 5.39 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -78.86 155.86 77.65 Favored Pre-proline 0 N--CA 1.452 -0.351 0 C-N-CA 123.036 0.534 . . . . 0.0 109.963 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.35 158.8 47.02 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.444 2.763 . . . . 0.0 111.554 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.9 m -113.04 7.58 18.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -80.12 2.91 22.23 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.962 0.801 . . . . 0.0 112.041 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.34 153.4 35.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.015 0.436 . . . . 0.0 111.939 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 39.7 m -149.0 33.79 0.75 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.267 1.027 . . . . 0.0 110.228 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.36 -6.12 39.04 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.415 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -146.7 135.36 22.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.933 0.866 . . . . 0.0 110.041 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 53.32 -179.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.93 1.292 . . . . 0.0 112.98 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.316 -1.824 . . . . 0.0 110.628 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ' A' . . . . . 0.557 ' C8 ' H5'' ' A' ' 96' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.43 -1.954 1 C5'-C4'-C3' 109.365 -4.09 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ' U' . . . . . 0.617 " H5'" ' C6 ' ' A' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.149 0 C3'-C2'-C1' 104.18 2.977 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 C5'-C4'-C3' 110.422 -3.386 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 1 O4'-C1'-N19 113.787 5.587 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ' A' . . . . . 0.409 ' C8 ' ' CZ ' ' B' ' 53' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.616 2 O4'-C1'-N19 114.279 6.079 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C5'-C4'-C3' 110.696 -3.202 . 0.144 2[ . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_